Dataset_id,Public_dataset_id,Data_path,Data_type,Notes_download,Pubmed_id,Disease,Status,Control,Species,Brain_region,Treatment,Sex,Stage,Age,N_cells,Protocol,Methodology,Model,Protocol details,JUST KEEP FOR SEARCH (NO NEED),Notes,
AD001001,syn18485175; syn21125841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001001.h5ad,ssREAD,,"31042697,31932797",AD,Healthy,,Human,Prefrontal cortex,,Male,1 - 3; 2 - 4,75-90+ years; 77-90+ years,29342,,,NA,,,,
AD001002,syn18485175,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001002.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Male,"""5-6""",75-90+ years,5103,,,NA,,,,
AD001003,syn18485175,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001003.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Female,"""5-6""",75-90+ years,5679,,,NA,,,,
AD001004,syn18485175,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001004.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Male,"""5-6""",75-90+ years,8283,,,NA,,,,
AD001005,syn18485175,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001005.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Female,"""5-6""",75-90+ years,11542,,,NA,,,,
AD001006,syn18485175; syn21125841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001006.h5ad,ssREAD,,"31042697,31932797",AD,Healthy,,Human,Prefrontal cortex,,Female,"1 - 4; 1, 3, 4",75-90+ years; 77-90+ years,56329,,,NA,,,,
AD001007,syn21125841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001007.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Male,"3, 5",77-90+ years,16954,,,NA,,,,
AD001008,syn21125841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001008.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Male,"""5-6""",77-90+ years,11403,,,NA,,,,
AD001009,syn21125841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001009.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Female,"3, 5",77-90+ years,9891,,,NA,,,,
AD001010,syn21125841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD001010.h5ad,ssREAD,,"31042697,31932797",AD,Disease,,Human,Prefrontal cortex,,Female,"1, 4 - 5",77-90+ years,15300,,,NA,,,,
AD002001,GSE138852; GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD002001.h5ad,ssREAD,,"31768052,33432193",AD,Healthy,,Human,Entorhinal Cortex,,Male,0,"mean age 77.6, range 67.3-91 years; 50-91 years",29993,,,NA,,,,
AD002002,GSE138852,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD002002.h5ad,ssREAD,,"31768052,33432193",AD,Healthy,,Human,Entorhinal Cortex,,Female,NA,"mean age 77.6, range 67.3-91 years",1122,,,NA,,,,
AD002003,GSE138852,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD002003.h5ad,ssREAD,,"31768052,33432193",AD,Disease,,Human,Entorhinal Cortex,,Male,"""5-6""","mean age 77.6, range 67.3-91 years",3770,,,NA,,,,
AD002004,GSE138852,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD002004.h5ad,ssREAD,,"31768052,33432193",AD,Disease,,Human,Entorhinal Cortex,,Female,4,"mean age 77.6, range 67.3-91 years",2303,,,NA,,,,
AD002005,GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD002005.h5ad,ssREAD,,"31768052,33432193",AD,Disease,,Human,Entorhinal Cortex,,Male,2,50-91 years,19282,,,NA,,,,
AD002006,GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD002006.h5ad,ssREAD,,"31768052,33432193",AD,Disease,,Human,Entorhinal Cortex,,Male,6,50-91 years,25537,,,NA,,,,
AD003001,GSE98969; GSE140510,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003001.h5ad,ssREAD,,"28602351,31932797",AD,Healthy,,Mouse,Cortex,,Male,NA,6 month; 7 months,25775,,,C57BL/6J; B6,,,,
AD003002,GSE140399,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003002.h5ad,ssREAD,,"28602351,31932797",AD,Healthy,,Mouse,Cortex,,Male,NA,15 months,10548,,,B6,,,,
AD003003,GSE98969,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003003.h5ad,ssREAD,,"28602351,31932797",AD,Disease,,Mouse,Cortex,,Male,NA,6 months,2261,,,5XFAD,,,,
AD003004,GSE140510,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003004.h5ad,ssREAD,,"28602351,31932797",AD,Disease,,Mouse,Cortex,,Male,NA,7 months,21444,,,Trem2_KO mice,,,,
AD003005,GSE140510,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003005.h5ad,ssREAD,,"28602351,31932797",AD,Disease,,Mouse,Cortex,,Male,NA,7 months,16810,,,WT_5XFAD mice,,,,
AD003006,GSE140510,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003006.h5ad,ssREAD,,"28602351,31932797",AD,Disease,,Mouse,Cortex,,Male,NA,7 months,19188,,,Trem2_KO_5XFAD mice,,,,
AD003007,GSE140399,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003007.h5ad,ssREAD,,"28602351,31932797",AD,Disease,,Mouse,Cortex,,Male,NA,15 months,6675,,,Trem2_KO mice,,,,
AD003008,GSE140399,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003008.h5ad,ssREAD,,"28602351,31932797",AD,Disease,,Mouse,Cortex,,Male,NA,15 months,4742,,,s,,,,
AD003009,GSE140399,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD003009.h5ad,ssREAD,,"28602351,31932797",AD,Disease,,Mouse,Cortex,,Male,NA,15 months,4708,,,Trem2_KO_5XFAD,,,,
AD004001,GSE147495,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD004001.h5ad,ssREAD,,32320664,AD,Healthy,,Mouse,Other/combined,,Female,NA,10-12 months,8153,,,B6C3,,,,
AD004002,GSE147495,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD004002.h5ad,ssREAD,,32320664,AD,Disease,,Mouse,Other/combined,,Female,NA,10-12 months,6243,,,APP/PS1 transgenic mice,,,,
AD004003,GSE147495,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD004003.h5ad,ssREAD,,32320664,AD,Disease,,Mouse,Other/combined,,Female,NA,10-12 months,7942,,,APP/PS1 IL33 mice,,,,
AD004004,GSE147495,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD004004.h5ad,ssREAD,,32320664,AD,Disease,,Mouse,Other/combined,,Male,NA,10-12 months,3314,,,Veh_IL33 mice,,,,
AD004005,GSE147495,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD004005.h5ad,ssREAD,,32320664,AD,Disease,,Mouse,Other/combined,,Male,NA,10-12 months,1697,,,DB2313_IL33 mice,,,,
AD005001,GSE98969,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD005001.h5ad,ssREAD,,28602351,AD,Healthy,,Mouse,Whole brain,,Male,NA,6 months,740,,,C57BL/6,,,,
AD005002,GSE98969,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD005002.h5ad,ssREAD,,28602351,AD,Disease,,Mouse,Whole brain,,Male,NA,6 months,2304,,,5XFAD,,,,
AD006001,GSE143758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD006001.h5ad,ssREAD,,32341542,AD,Healthy,,Mouse,Hippocampus,,Male,NA,7 months,1572,,,C57BL/6,,,,
AD006002,GSE143758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD006002.h5ad,ssREAD,,32341542,AD,Healthy,,Mouse,Hippocampus,,Male,NA,10 months,1148,,,C57BL/6,,,,
AD006003,GSE143758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD006003.h5ad,ssREAD,,32341542,AD,Disease,,Mouse,Hippocampus,,Male,NA,7 months,1146,,,5XFAD,,,,
AD006004,GSE143758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD006004.h5ad,ssREAD,,32341542,AD,Disease,,Mouse,Hippocampus,,Male,NA,10 months,2079,,,5XFAD,,,,
AD007002,GSE141044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007002.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Healthy,,Mouse,Hippocampus,,Male,NA,6 months,432,,,C57BL/6J,,,,
AD007003,GSE130626; GSE140399,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007003.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Healthy,,Mouse,Hippocampus,,Male,NA,12-14 months; 15 months,3764,,,C57BL/6J; B6,,,,
AD007004,GSE141044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007004.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Healthy,,Mouse,Hippocampus,,Female,NA,6 months,519,,,C57BL/6J,,,,
AD007005,GSE141044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007005.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Healthy,,Mouse,Hippocampus,,Female,NA,24 months,655,,,C57BL/6J,,,,
AD007008,GSE103334,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007008.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,"3 months, 3.25 months, 3.5months, 4.5 months",1049,,,CK,,,,
AD007009,GSE103334,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007009.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,"3 months, 3.25 months, 3.5months, 4.5 months",1150,,,CK-p25,,,,
AD007010,GSE141044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007010.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,6 months,278,,,APP23 transgenic mice (B6. Cg-Tg (Thy1-APP)3Somm/J),,,,
AD007011,GSE130626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007011.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,12-14 months,755,,,Trem2 +/+ mice,,,,
AD007012,GSE130626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007012.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,12-14 months,794,,,Trem2 +/- mice,,,,
AD007013,GSE130626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007013.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,12-14 months,875,,,Trem2 -/- mice,,,,
AD007014,GSE130626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007014.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,15 months,2538,,,Trem2_KO mice,,,,
AD007015,GSE130626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007015.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,15 months,2974,,,WT_5XFAD mice,,,,
AD007016,GSE130626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007016.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,15 months,2696,,,Trem2_KO_5XFAD mice,,,,
AD007017,GSE141044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007017.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Male,NA,24 months,456,,,APP23 transgenic mice (B6. Cg-Tg (Thy1-APP)3Somm/J),,,,
AD007018,GSE141044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007018.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Female,NA,6 months,563,,,APP23 transgenic mice (B6. Cg-Tg (Thy1-APP)3Somm/J),,,,
AD007019,GSE141044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD007019.h5ad,ssREAD,,"29020624,31902528,31928331,31932797",AD,Disease,,Mouse,Hippocampus,,Female,NA,24 months,377,,,APP23 transgenic mice (B6. Cg-Tg (Thy1-APP)3Somm/J),,,,
AD008001,GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD008001.h5ad,ssREAD,,33432193,AD,Healthy,,Human,Prefrontal cortex,,Male,0,50-91 years,33711,,,NA,,,,
AD008002,GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD008002.h5ad,ssREAD,,33432193,AD,Disease,,Human,Prefrontal cortex,,Male,2,50-91 years,27946,,,NA,,,,
AD008003,GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD008003.h5ad,ssREAD,,33432193,AD,Disease,,Human,Prefrontal cortex,,Male,6,50-91 years,32901,,,NA,,,,
AD009001,GSE150358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD009001.h5ad,ssREAD,,32579671,AD,Healthy,,Mouse,Cortex and hippocampus,,Female,NA,5.5 months,2793,,,5XFAD-CV,,,,
AD009002,GSE150358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD009002.h5ad,ssREAD,,32579671,AD,Healthy,,Mouse,Cortex and hippocampus,,Female,NA,5.5 months,18144,,,5XFAD-R47H,,,,
AD009003,GSE150358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD009003.h5ad,ssREAD,,32579671,AD,Disease,,Mouse,Cortex and hippocampus,,Female,NA,5.5 months,5937,,,5XFAD-CV,,,,
AD009004,GSE150358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD009004.h5ad,ssREAD,,32579671,AD,Disease,,Mouse,Cortex and hippocampus,,Female,NA,5.5 months,16886,,,5XFAD-R47H,,,,
AD010001,GSE142853,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD010001.h5ad,ssREAD,,32503894,AD,Healthy,,Mouse,Subventricular zone and hippocampus,,Female,NA,8 months,1676,,,B6129SF2/J,,,,
AD010002,GSE142853,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD010002.h5ad,ssREAD,,32503894,AD,Healthy,,Mouse,Subventricular zone and hippocampus,,Female,NA,7 months,1689,,,isotype treated 3XTg-AD,,,,
AD010003,GSE142853,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD010003.h5ad,ssREAD,,32503894,AD,Disease,,Mouse,Subventricular zone and hippocampus,,Female,NA,8 months,1695,,,Triple-transgenic Alzheimer disease (AD) mouse model,,,,
AD010004,GSE142853,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD010004.h5ad,ssREAD,,32503894,AD,Disease,,Mouse,Subventricular zone and hippocampus,,Female,NA,7 months,1164,,,anti-Nk1.1 treated 3XTg-AD,,,,
AD011001,GSE129308,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD011001.h5ad,ssREAD,,35882228,AD,Healthy,,Human,Prefrontal cortex,,Male,6,57-93 years,13502,,,NA,,,,
AD011002,GSE129308,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD011002.h5ad,ssREAD,,35882228,AD,Healthy,,Human,Prefrontal cortex,,Female,6,57-93 years,25014,,,NA,,,,
AD011003,GSE129308,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD011003.h5ad,ssREAD,,35882228,AD,Disease,,Human,Prefrontal cortex,,Male,6,57-93 years,9120,,,NA,,,,
AD011004,GSE129308,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD011004.h5ad,ssREAD,,35882228,AD,Disease,,Human,Prefrontal cortex,,Female,6,57-93 years,11873,,,NA,,,,
AD012001,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD012001.h5ad,ssREAD,,33192286,AD,Healthy,,Human,Superior parietal lobe,,Male,NA,72-103 years,779,,,NA,,,,
AD012002,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD012002.h5ad,ssREAD,,33192286,AD,Healthy,,Human,Superior parietal lobe,,Female,NA,72-103 years,939,,,NA,,,,
AD012003,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD012003.h5ad,ssREAD,,33192286,AD,Disease,,Human,Superior parietal lobe,,Male,NA,72-103 years,3127,,,NA,,,,
AD012004,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD012004.h5ad,ssREAD,,33192286,AD,Disease,,Human,Superior parietal lobe,,Female,NA,72-103 years,963,,,NA,,,,
AD012005,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD012005.h5ad,ssREAD,,33192286,AD,Disease,,Human,Superior parietal lobe,,Male,NA,72-103 years,1731,,,NA,,,,
AD012006,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD012006.h5ad,ssREAD,,33192286,AD,Disease,,Human,Superior parietal lobe,,Female,NA,72-103 years,8632,,,NA,,,,
AD013001,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD013001.h5ad,ssREAD,,32989152,AD,Healthy,,Human,Prefrontal cortex,,Male,"1,2",85.4 years,23304,,,NA,,,,
AD013002,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD013002.h5ad,ssREAD,,32989152,AD,Healthy,,Human,Prefrontal cortex,,Female,"1,2",85.4 years,7663,,,NA,,,,
AD013003,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD013003.h5ad,ssREAD,,32989152,AD,Disease,,Human,Prefrontal cortex,,Male,"""4-6""",74.6 years,28183,,,NA,,,,
AD013004,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD013004.h5ad,ssREAD,,32989152,AD,Disease,,Human,Prefrontal cortex,,Female,"""4-6""",74.6 years,5480,,,NA,,,,
AD014001,syn21438358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD014001.h5ad,ssREAD,,33257666,AD,Healthy,,Human,Prefrontal cortex,,Male,3,93-96 years,10283,,,NA,,,,
AD014002,syn21438358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD014002.h5ad,ssREAD,,33257666,AD,Healthy,,Human,Prefrontal cortex,,Female,3,93-96 years,4492,,,NA,,,,
AD014003,syn21438358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD014003.h5ad,ssREAD,,33257666,AD,Disease,,Human,Prefrontal cortex,,Male,"""1-3""",79-98 years,24786,,,NA,,,,
AD014004,syn21438358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD014004.h5ad,ssREAD,,33257666,AD,Disease,,Human,Prefrontal cortex,,Female,"""1-3""",79-98 years,27291,,,NA,,,,
AD015001,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015001.h5ad,ssREAD,,33446504,AD,Healthy,,Mouse,Cortex,,Male,NA,8 months,12583,,,TREM2CV-5XFAD (IgG),,,,
AD015002,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015002.h5ad,ssREAD,,33446504,AD,Healthy,,Mouse,Cortex,,Female,NA,8 months,6194,,,TREM2CV-5XFAD (IgG),,,,
AD015003,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015003.h5ad,ssREAD,,33446504,AD,Healthy,,Mouse,Cortex,,Female,NA,8 months,13954,,,Trem2-/--5XFAD (IgG),,,,
AD015004,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015004.h5ad,ssREAD,,33446504,AD,Healthy,,Mouse,Cortex,,Male,NA,8 months,9876,,,TREM2R47H-5XFAD (IgG),,,,
AD015005,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015005.h5ad,ssREAD,,33446504,AD,Healthy,,Mouse,Cortex,,Female,NA,8 months,17232,,,TREM2R47H-5XFAD (IgG),,,,
AD015006,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015006.h5ad,ssREAD,,33446504,AD,Disease,,Mouse,Cortex,,Male,NA,8 months,31334,,,TREM2CV-5XFAD (hT2AB),,,,
AD015007,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015007.h5ad,ssREAD,,33446504,AD,Disease,,Mouse,Cortex,,Female,NA,8 months,12121,,,TREM2CV-5XFAD (hT2AB),,,,
AD015008,GSE156183,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD015008.h5ad,ssREAD,,33446504,AD,Disease,,Mouse,Cortex,,Female,NA,8 months,1967,,,Trem2-/--5XFAD (hT2AB),,,,
AD016001,GSE160512; GSE181786; GSE153895,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD016001.h5ad,ssREAD,,34965428,AD,Healthy,,Mouse,Hippocampus,,Female,NA,8 months,15278,,,Triple-transgenic Alzheimer disease (AD) mouse model,,,,
AD016002,GSE160512; GSE181786; GSE153895,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD016002.h5ad,ssREAD,,34965428,AD,Healthy,,Mouse,Hippocampus,,Female,NA,8 months,30363,,,anti-Nk1.1 treated 3XTg-AD,,,,
AD016003,GSE160512; GSE181786; GSE153895,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD016003.h5ad,ssREAD,,34965428,AD,Disease,,Mouse,Hippocampus,,Female,NA,7 months,7686,,,Triple-transgenic Alzheimer disease (AD) mouse model,,,,
AD016004,GSE160512; GSE181786; GSE153895,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD016004.h5ad,ssREAD,,34965428,AD,Disease,,Mouse,Hippocampus,,Female,NA,15 months,3606,,,anti-Nk1.1 treated 3XTg-AD,,,,
AD017001,GSE166548,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD017001.h5ad,ssREAD,,33606969,AD,Healthy,,Mouse,Other/combined,,Male,6,50-91 years,3564,,,NA,,,,
AD017002,GSE166304,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD017002.h5ad,ssREAD,,33606969,AD,Healthy,,Mouse,Other/combined,,Female,6,77+ years,6148,,,NA,,,,
AD017003,GSE166548,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD017003.h5ad,ssREAD,,33606969,AD,Disease,,Mouse,Other/combined,,Male,6,77+ years,5918,,,NA,,,,
AD017004,GSE166304,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD017004.h5ad,ssREAD,,33606969,AD,Disease,,Mouse,Other/combined,,Female,6,77+ years,5498,,,NA,,,,
AD018001,GSE143758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD018001.h5ad,ssREAD,,32341542,AD,Healthy,,Mouse,Hippocampus,,Male,NA,15 months,7006,,,C57BL/6,,,,
AD018002,GSE143758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD018002.h5ad,ssREAD,,32341542,AD,Disease,,Mouse,Hippocampus,,Male,NA,15 months,21515,,,5XFAD,,,,
AD019001,GSE163577,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD019001.h5ad,ssREAD,,35165441,AD,Healthy,,Human,Other/combined,,Male,1 - 3; 2 - 4,57-93 years,2442,,,NA,,,,
AD019002,GSE163577,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD019002.h5ad,ssREAD,,35165441,AD,Disease,,Human,Other/combined,,Male,"""5-6""",57-93 years,7817,,,NA,,,,
AD019003,GSE163577,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD019003.h5ad,ssREAD,,35165441,AD,Disease,,Human,Other/combined,,Female,"""5-6""",57-93 years,11473,,,NA,,,,
AD019004,GSE163577,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD019004.h5ad,ssREAD,,35165441,AD,Disease,,Human,Other/combined,,Male,"""5-6""",57-93 years,10898,,,NA,,,,
AD019005,GSE163577,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD019005.h5ad,ssREAD,,35165441,AD,Disease,,Human,Other/combined,,Female,"""5-6""",10 months,32671,,,NA,,,,
AD019006,GSE163577,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD019006.h5ad,ssREAD,,35165441,AD,Healthy,,Human,Other/combined,,Female,"1 - 4; 1, 3, 4",75-90+ years,37554,,,NA,,,,
AD020001,GSE160936,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD020001.h5ad,ssREAD,,34767070,AD,Healthy,,Human,Other/combined,,Male,NA,75-90+ years; 77-90+ years,10715,,,NA,,,,
AD020002,GSE160936,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD020002.h5ad,ssREAD,,34767070,AD,Healthy,,Human,Other/combined,,Female,NA,75-90+ years,14908,,,NA,,,,
AD020003,GSE160936,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD020003.h5ad,ssREAD,,34767070,AD,Disease,,Human,Other/combined,,Male,NA,75-90+ years,33224,,,NA,,,,
AD021001,GSE176032,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD021001.h5ad,ssREAD,,34103079,AD,Healthy,,Mouse,Whole brain,,Female,NA,8 months,4417,,,B6129SF2/J,,,,
AD021002,GSE176032,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD021002.h5ad,ssREAD,,34103079,AD,Healthy,,Mouse,Whole brain,,Female,NA,8 months,3344,,,isotype treated 3XTg-AD,,,,
AD021003,GSE176032,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD021003.h5ad,ssREAD,,34103079,AD,Disease,,Mouse,Whole brain,,Female,NA,7 months,9826,,,Triple-transgenic Alzheimer disease (AD) mouse model,,,,
AD022001,GSE165306,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD022001.h5ad,ssREAD,,34021136,AD,Disease,,Mouse,Other/combined,,Male,"""5-6""",24 weeks,17423,,,NA,,,,
AD022002,GSE165306,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD022002.h5ad,ssREAD,,34021136,AD,Disease,,Mouse,Other/combined,,Male,"""5-6""",8 months,8726,,,NA,,,,
AD022003,GSE165306,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD022003.h5ad,ssREAD,,34021136,AD,Disease,,Mouse,Other/combined,,Male,"""5-6""",8 months,39457,,,NA,,,,
AD023001,GSE167497,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD023001.h5ad,ssREAD,,33958804,AD,Healthy,,Mouse,Hippocampus,,Male,0,72-103 years,9055,,,NA,,,,
AD023002,GSE167497,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD023002.h5ad,ssREAD,,33958804,AD,Healthy,,Mouse,Hippocampus,,Female,NA,50-91 years,5208,,,NA,,,,
AD023003,GSE167497,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD023003.h5ad,ssREAD,,33958804,AD,Disease,,Mouse,Hippocampus,,Male,"""5-6""",50-91 years,16411,,,NA,,,,
AD023004,GSE167497,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD023004.h5ad,ssREAD,,33958804,AD,Disease,,Mouse,Hippocampus,,Female,4,50-91 years,25238,,,NA,,,,
AD024001,GSE148822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD024001.h5ad,ssREAD,,33609158,AD,Healthy,,Human,Occipital lobe,,Male,NA,50-91 years,7364,,,TREM2CV-5XFAD (IgG),,,,
AD024002,GSE148822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD024002.h5ad,ssREAD,,33609158,AD,Healthy,,Human,Occipital lobe,,Female,NA,,4560,,,TREM2CV-5XFAD (IgG),,,,
AD024003,GSE148822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD024003.h5ad,ssREAD,,33609158,AD,Healthy,,Human,Occipital lobe,,Female,NA,,50578,,,Trem2-/--5XFAD (IgG),,,,
AD024004,GSE148822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD024004.h5ad,ssREAD,,33609158,AD,Healthy,,Human,Occipital lobe,,Male,NA,,37508,,,TREM2R47H-5XFAD (IgG),,,,
AD024005,GSE148822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD024005.h5ad,ssREAD,,33609158,AD,Disease,,Human,Occipital lobe,,Female,4,"mean age 77.6, range 67.3-91 years; 50-91 years",27831,,,TREM2R47H-5XFAD (IgG),,,,
AD024006,GSE148822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD024006.h5ad,ssREAD,,33609158,AD,Disease,,Human,Occipital lobe,,Male,5,"mean age 77.6, range 67.3-91 years",53127,,,TREM2CV-5XFAD (hT2AB),,,,
AD025001,syn23763409,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD025001.h5ad,ssREAD,,33567283,AD,Healthy,,Mouse,Whole brain,,Female,4,24 weeks,9032,,,B6C3,,,,
AD025002,syn23763409,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD025002.h5ad,ssREAD,,33567283,AD,Disease,,Mouse,Whole brain,,Female,5,8 months,20901,,,APP/PS1 transgenic mice,,,,
AD025003,syn23763409,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD025003.h5ad,ssREAD,,33567283,AD,Disease,,Mouse,Whole brain,,Female,NA,7 months,2373,,,APP/PS1 IL33 mice,,,,
AD026001,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD026001.h5ad,ssREAD,,33192286,AD,Healthy,,Mouse,Other/combined,,Male,NA,7 months,10200,,,B6,,,,
AD026002,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD026002.h5ad,ssREAD,,33192286,AD,Disease,,Mouse,Other/combined,,Male,NA,7 months,19859,,,5XFAD,,,,
AD026003,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD026003.h5ad,ssREAD,,33192286,AD,Disease,,Mouse,Other/combined,,Male,NA,8 months,25255,,,Trem2_KO mice,,,,
AD026004,GSE146639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD026004.h5ad,ssREAD,,33192286,AD,Disease,,Mouse,Other/combined,,Male,NA,7 months,22860,,,Trem2_KO mice,,,,
AD027001,GSE158234,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD027001.h5ad,ssREAD,,33097708,AD,Healthy,,Human,Cortex,,Male,NA,7 months,1084,,,B6,,,,
AD027002,GSE158234,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD027002.h5ad,ssREAD,,33097708,AD,Disease,,Human,Cortex,,Male,NA,7 months,4867,,,5XFAD,,,,
AD028001,GSE153807,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD028001.h5ad,ssREAD,,32997994,AD,Healthy,,Human,Temporal lobe,,Male,6,75-90+ years,5115,,,NA,,,,
AD028002,GSE153807,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD028002.h5ad,ssREAD,,32997994,AD,Healthy,,Human,Temporal lobe,,Female,6,50-91 years,16076,,,NA,,,,
AD028003,GSE153807,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD028003.h5ad,ssREAD,,32997994,AD,Disease,,Human,Temporal lobe,,Male,6,50-91 years,9574,,,NA,,,,
AD028004,GSE153807,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD028004.h5ad,ssREAD,,32997994,AD,Disease,,Human,Temporal lobe,,Female,6,75-90+ years,9097,,,NA,,,,
AD029001,GSE152867,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD029001.h5ad,ssREAD,,32726626,AD,Healthy,,Mouse,Other/combined,,Female,NA,NA,32961,,,E5487,,,,
AD029002,GSE152867,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD029002.h5ad,ssREAD,,32726626,AD,Disease,,Mouse,Other/combined,,Female,NA,NA,23879,,,E5487,,,,
AD029003,GSE152867,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD029003.h5ad,ssREAD,,32726626,AD,Healthy,,Mouse,Other/combined,,Female,NA,NA,11252,,,E4KI,,,,
AD029004,GSE152867,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD029004.h5ad,ssREAD,,32726626,AD,Disease,,Mouse,Other/combined,,Female,NA,NA,14303,,,E4KI,,,,
AD030001,GSE140511,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD030001.h5ad,ssREAD,,31932797,AD,Healthy,,Mouse,Prefrontal cortex,,Male,NA,NA,18945,,,C57BL/6J; B6,,,,
AD030002,GSE140511,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD030002.h5ad,ssREAD,,31932797,AD,Healthy,,Mouse,Prefrontal cortex,,Male,NA,NA,16375,,,B6,,,,
AD030003,GSE140511,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD030003.h5ad,ssREAD,,31932797,AD,Disease,,Mouse,Prefrontal cortex,,Male,NA,15 months,12353,,,5XFAD,,,,
AD030004,GSE140511,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD030004.h5ad,ssREAD,,31932797,AD,Disease,,Mouse,Prefrontal cortex,,Male,NA,7 months,34943,,,Trem2_KO mice,,,,
AD030005,GSE140511,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD030005.h5ad,ssREAD,,31932797,AD,Disease,,Mouse,Prefrontal cortex,,Male,NA,7 months,24253,,,WT_5XFAD mice,,,,
AD030006,GSE140511,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD030006.h5ad,ssREAD,,31932797,AD,Disease,,Mouse,Prefrontal cortex,,Male,NA,7 months,33778,,,Trem2_KO_5XFAD mice,,,,
AD031001,GSE142267; GSE110741,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD031001.h5ad,ssREAD,,31951107,AD,Healthy,,Mouse,Hippocampus,,Male,"1,2",50-91 years,22315,,,NA,,,,
AD031002,GSE142267; GSE110741,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD031002.h5ad,ssREAD,,31951107,AD,Healthy,,Mouse,Hippocampus,,Female,NA,NA,624,,,NA,,,,
AD031003,GSE142267; GSE110741,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD031003.h5ad,ssREAD,,31951107,AD,Disease,,Mouse,Hippocampus,,Male,NA,NA,15619,,,NA,,,,
AD031004,GSE142267; GSE110741,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD031004.h5ad,ssREAD,,31951107,AD,Disease,,Mouse,Hippocampus,,Female,NA,50-91 years,39058,,,NA,,,,
AD032001,GSE174367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD032001.h5ad,ssREAD,,34239132,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,NA,8226,,,TREM2CV-5XFAD (IgG),,,,
AD032002,GSE174367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD032002.h5ad,ssREAD,,34239132,AD,Healthy,,Human,Prefrontal cortex,,Female,NA,77+ years,6658,,,TREM2CV-5XFAD (IgG),,,,
AD032003,GSE174367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD032003.h5ad,ssREAD,,34239132,AD,Healthy,,Human,Prefrontal cortex,,Female,NA,NA,32061,,,Trem2-/--5XFAD (IgG),,,,
AD032004,GSE174367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD032004.h5ad,ssREAD,,34239132,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,NA,3296,,,TREM2R47H-5XFAD (IgG),,,,
AD032005,GSE174367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD032005.h5ad,ssREAD,,34239132,AD,Disease,,Human,Prefrontal cortex,,Female,NA,NA,57044,,,TREM2R47H-5XFAD (IgG),,,,
AD032006,GSE174367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD032006.h5ad,ssREAD,,34239132,AD,Disease,,Human,Prefrontal cortex,,Male,NA,NA,7195,,,TREM2CV-5XFAD (hT2AB),,,,
AD033001,GSE157985,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD033001.h5ad,ssREAD,,34156424,AD,Healthy,,Mouse,Hippocampus,,Female,NA,8 months,1930,,,E5487,,,,
AD033002,GSE157985,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD033002.h5ad,ssREAD,,34156424,AD,Disease,,Mouse,Hippocampus,,Female,NA,8 months,4546,,,E5487,,,,
AD033003,GSE157985,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD033003.h5ad,ssREAD,,34156424,AD,Disease,,Mouse,Hippocampus,,Female,NA,8 months,65826,,,E4KI,,,,
AD034001,GSE160523,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD034001.h5ad,ssREAD,,33859405,AD,Healthy,,Mouse,Cortex,,Female,NA,8 months,8616,,,5XFAD-R47H,,,,
AD034002,GSE160523,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD034002.h5ad,ssREAD,,33859405,AD,Disease,,Mouse,Cortex,,Female,NA,8 months,27317,,,5XFAD-CV,,,,
AD035001,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035001.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Female,3,75-90+ years,4482,,,NA,,,,
AD035002,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035002.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Female,4,75-90+ years,12297,,,NA,,,,
AD035003,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035003.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Female,5,75-90+ years,27153,,,NA,,,,
AD035004,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035004.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Female,6,75-90+ years,4263,,,NA,,,,
AD035005,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035005.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Male,0,75-90+ years,20628,,,NA,,,,
AD035006,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035006.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Male,2,NA,23100,,,NA,,,,
AD035007,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035007.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Male,3,NA,7178,,,NA,,,,
AD035008,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035008.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Male,4,NA,6896,,,NA,,,,
AD035009,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035009.h5ad,ssREAD,,39402379,AD,Healthy,,Human,Middle temporal gyrus,,Male,5,NA,41870,,,NA,,,,
AD035010,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035010.h5ad,ssREAD,,39402379,AD,Disease,,Human,Middle temporal gyrus,,Female,2,NA,28067,,,NA,,,,
AD035011,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035011.h5ad,ssREAD,,39402379,AD,Disease,,Human,Middle temporal gyrus,,Female,4,80+ years,28525,,,NA,,,,
AD035012,syn26223298,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD035012.h5ad,ssREAD,,39402379,AD,Disease,,Human,Middle temporal gyrus,,Female,5,80+ years,56092,,,NA,,,,
AD035013,This data will be filled in later,,,,,,,,,dorsolateral prefrontal cortex,,,,,,,,,,,,
AD036001,GSE173731,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD036001.h5ad,ssREAD,,35158371,AD,Healthy,,Human,Temporal Lobe,,Male,NA,80+ years,15513,,,NA,,,,
AD036002,GSE173731,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD036002.h5ad,ssREAD,,35158371,AD,Disease,,Human,Temporal Lobe,,Female,NA,80+ years,13327,,,NA,,,,
AD036003,GSE173731,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD036003.h5ad,ssREAD,,35158371,AD,Healthy,,Human,Temporal Lobe,,Male,NA,80+ years,29816,,,NA,,,,
AD036004,GSE173731,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD036004.h5ad,ssREAD,,35158371,AD,Disease,,Human,Temporal Lobe,,Female,NA,80+ years,15930,,,NA,,,,
AD037003,GSE202297,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD037003.h5ad,ssREAD,,35760863,AD,Healthy,,Mouse,Whole Brain,,Female,NA,NA,10960,,,E4KI,,,,
AD037004,GSE202297,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD037004.h5ad,ssREAD,,35760863,AD,Disease,,Mouse,Whole Brain,,Female,NA,NA,10620,,,E4KI,,,,
AD037005,GSE202297,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD037005.h5ad,ssREAD,,35760863,AD,Healthy,,Mouse,Whole Brain,,Male,NA,NA,32166,,,C57BL/6J; B6,,,,
AD038001,GSE208683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD038001.h5ad,ssREAD,,37258678,AD,Healthy,,Mouse,Cortex,,Female,NA,NA,35422,,,E5487,,,,
AD038002,GSE208683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD038002.h5ad,ssREAD,,37258678,AD,Disease,,Mouse,Cortex,,Female,NA,NA,33130,,,E5487,,,,
AD038003,GSE208683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD038003.h5ad,ssREAD,,37258678,AD,Healthy,,Mouse,Cortex,,Female,NA,NA,869,,,E4KI,,,,
AD038004,GSE208683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD038004.h5ad,ssREAD,,37258678,AD,Disease,,Mouse,Cortex,,Female,NA,NA,9737,,,E4KI,,,,
AD038007,GSE208683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD038007.h5ad,ssREAD,,37258678,AD,Disease,,Mouse,Cortex,,Male,NA,NA,84790,,,5XFAD,,,,
AD039001,GSE178295,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD039001.h5ad,ssREAD,,37258678,AD,Healthy,,Mouse,Cortex,,Female,NA,NA,23355,,,E5487,,,,
AD039002,GSE178295,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD039002.h5ad,ssREAD,,37258678,AD,Disease,,Mouse,Cortex,,Female,NA,NA,6210,,,E5487,,,,
AD039003,GSE178295,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD039003.h5ad,ssREAD,,37258678,AD,Healthy,,Mouse,Cortex,,Female,NA,NA,20400,,,E4KI,,,,
AD039004,GSE178295,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD039004.h5ad,ssREAD,,37258678,AD,Disease,,Mouse,Cortex,,Female,NA,NA,28229,,,E4KI,,,,
AD040001,NG00108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD040001.h5ad,ssREAD,,37085492,AD,Healthy,,Human,Parietal Lobe,,Male,NA,70+ years,26657,,,NA,,,,
AD040002,NG00108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD040002.h5ad,ssREAD,,37085492,AD,Disease,,Human,Parietal Lobe,,Female,NA,70+ years,4727,,,NA,,,,
AD040003,NG00108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD040003.h5ad,ssREAD,,37085492,AD,Healthy,,Human,Parietal Lobe,,Male,NA,70+ years,3743,,,NA,,,,
AD040004,NG00108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD040004.h5ad,ssREAD,,37085492,AD,Disease,,Human,Parietal Lobe,,Female,NA,70+ years,2609,,,NA,,,,
AD041001,syn22079621,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD041001.h5ad,ssREAD,,37085492,AD,Healthy,,Human,Parietal Lobe,,Male,NA,70+ years,7729,,,NA,,,,
AD041002,syn22079621,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD041002.h5ad,ssREAD,,37085492,AD,Disease,,Human,Parietal Lobe,,Female,NA,70+ years,825,,,NA,,,,
AD041003,syn22079621,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD041003.h5ad,ssREAD,,37085492,AD,Healthy,,Human,Parietal Lobe,,Male,NA,70+ years,20979,,,NA,,,,
AD041004,syn22079621,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD041004.h5ad,ssREAD,,37085492,AD,Disease,,Human,Parietal Lobe,,Female,NA,70+ years,6971,,,NA,,,,
AD042001,GSE181279,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD042001.h5ad,ssREAD,,34447367,AD,Healthy,,Human,Other/Combined,,Male,NA,70+ years,7025,,,NA,,,,
AD042002,GSE181279,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD042002.h5ad,ssREAD,,34447367,AD,Disease,,Human,Other/Combined,,Female,NA,70+ years,2335,,,NA,,,,
AD042003,GSE181279,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD042003.h5ad,ssREAD,,34447367,AD,Healthy,,Human,Other/Combined,,Male,NA,70+ years,28658,,,NA,,,,
AD042004,GSE181279,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD042004.h5ad,ssREAD,,34447367,AD,Disease,,Human,Other/Combined,,Female,NA,70+ years,47174,,,NA,,,,
AD043001,EGAS00001006019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD043001.h5ad,ssREAD,,35203328,AD,Healthy,,Human,Other/Combined,,Male,NA,70+ years,11658,,,NA,,,,
AD043002,EGAS00001006019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD043002.h5ad,ssREAD,,35203328,AD,Disease,,Human,Other/Combined,,Female,NA,70+ years,13772,,,NA,,,,
AD043003,EGAS00001006019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD043003.h5ad,ssREAD,,35203328,AD,Healthy,,Human,Other/Combined,,Male,NA,70+ years,22947,,,NA,,,,
AD043004,EGAS00001006019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD043004.h5ad,ssREAD,,35203328,AD,Disease,,Human,Other/Combined,,Female,NA,70+ years,3121,,,NA,,,,
AD044001,GSE185553,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD044001.h5ad,ssREAD,,36332572,AD,Healthy,,Human,Hippocampus,,Male,NA,70+ years,32932,,,NA,,,,
AD044002,GSE185553,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD044002.h5ad,ssREAD,,36332572,AD,Disease,,Human,Hippocampus,,Female,NA,70+ years,39303,,,NA,,,,
AD044003,GSE185553,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD044003.h5ad,ssREAD,,36332572,AD,Healthy,,Human,Hippocampus,,Male,NA,70+ years,29050,,,NA,,,,
AD044004,GSE185553,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD044004.h5ad,ssREAD,,36332572,AD,Disease,,Human,Hippocampus,,Female,"1,2",75-90+ years,28174,,,NA,,,,
AD045001,GSE198323,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD045001.h5ad,ssREAD,,36332572,AD,Healthy,,Human,Hippocampus,,Male,NA,75-90+ years,24604,,,NA,,,,
AD045002,GSE198323,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD045002.h5ad,ssREAD,,36332572,AD,Disease,,Human,Hippocampus,,Female,NA,75-90+ years,13054,,,NA,,,,
AD045003,GSE198323,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD045003.h5ad,ssREAD,,36332572,AD,Healthy,,Human,Hippocampus,,Male,NA,75-90+ years,45800,,,NA,,,,
AD045004,GSE198323,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD045004.h5ad,ssREAD,,36332572,AD,Disease,,Human,Hippocampus,,Female,NA,75-90+ years,19293,,,NA,,,,
AD046001,GSE199243,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD046001.h5ad,ssREAD,,36332572,AD,Healthy,,Human,Hippocampus,,Male,NA,75-90+ years,7512,,,NA,,,,
AD046002,GSE199243,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD046002.h5ad,ssREAD,,36332572,AD,Disease,,Human,Hippocampus,,Female,NA,75-90+ years,2642,,,NA,,,,
AD046003,GSE199243,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD046003.h5ad,ssREAD,,36332572,AD,Healthy,,Human,Hippocampus,,Male,NA,75-90+ years,3311,,,NA,,,,
AD046004,GSE199243,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD046004.h5ad,ssREAD,,36332572,AD,Disease,,Human,Hippocampus,,Female,NA,75-90+ years,4756,,,NA,,,,
AD047001,syn16780177,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD047001.h5ad,ssREAD,,37336975,AD,Healthy,,Human,Prefrontal cortex,,Male,"1,2",75-90+ years,48158,,,NA,,,,
AD047002,syn16780177,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD047002.h5ad,ssREAD,,37336975,AD,Disease,,Human,Prefrontal cortex,,Female,"1,2",75-90+ years,18192,,,NA,,,,
AD047003,syn16780177,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD047003.h5ad,ssREAD,,37336975,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,75-90+ years,1685,,,NA,,,,
AD047004,syn16780177,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD047004.h5ad,ssREAD,,37336975,AD,Disease,,Human,Prefrontal cortex,,Female,NA,75-90+ years,20024,,,NA,,,,
AD048001,syn52293417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD048001.h5ad,ssREAD,,37774677,AD,Healthy,,Human,Prefrontal cortex,,Male,"1,2",50-91 years,30390,,,NA,,,,
AD048002,syn52293417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD048002.h5ad,ssREAD,,37774677,AD,Disease,,Human,Prefrontal cortex,,Female,"1,2",50-91 years,38299,,,NA,,,,
AD048003,syn52293417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD048003.h5ad,ssREAD,,37774677,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,50-91 years,26241,,,NA,,,,
AD049001,GSE227222,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD049001.h5ad,ssREAD,,37774678,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,50-91 years,48005,,,NA,,,,
AD049002,GSE227222,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD049002.h5ad,ssREAD,,37774678,AD,Disease,,Human,Prefrontal cortex,,Female,NA,50-91 years,10779,,,NA,,,,
AD049003,GSE227222,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD049003.h5ad,ssREAD,,37774678,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,50-91 years,31291,,,NA,,,,
AD049004,GSE227222,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD049004.h5ad,ssREAD,,37774678,AD,Disease,,Human,Prefrontal cortex,,Female,NA,50-91 years,5428,,,NA,,,,
AD050001,GSE227445,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD050001.h5ad,ssREAD,,37774679,AD,Healthy,,Mouse,Prefrontal cortex,,Male,NA,50-91 years,12290,,,NA,,,,
AD050002,GSE227445,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD050002.h5ad,ssREAD,,37774679,AD,Disease,,Mouse,Prefrontal cortex,,Female,NA,50-91 years,6833,,,NA,,,,
AD050003,GSE227445,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD050003.h5ad,ssREAD,,37774679,AD,Healthy,,Mouse,Prefrontal cortex,,Male,NA,50-91 years,30073,,,NA,,,,
AD050004,GSE227445,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD050004.h5ad,ssREAD,,37774679,AD,Disease,,Mouse,Prefrontal cortex,,Female,NA,50-91 years,42693,,,NA,,,,
AD051001,syn52293417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD051001.h5ad,ssREAD,,37774680,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,50-91 years,13216,,,NA,,,,
AD051002,syn52293417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD051002.h5ad,ssREAD,,37774680,AD,Disease,,Human,Prefrontal cortex,,Female,NA,50-91 years,1174,,,NA,,,,
AD051003,syn52293417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD051003.h5ad,ssREAD,,37774680,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,50-91 years,17018,,,NA,,,,
AD051004,syn52293417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD051004.h5ad,ssREAD,,37774680,AD,Disease,,Human,Prefrontal cortex,,Female,NA,50-91 years,52375,,,NA,,,,
AD052001,https://braincelldata.org/resource,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD052001.h5ad,ssREAD,,37774681,AD,Healthy,,Human,Cortex,,Male,NA,50-91 years,2418,,,NA,,,,
AD052002,https://braincelldata.org/resource,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD052002.h5ad,ssREAD,,37774681,AD,Disease,,Human,Cortex,,Male,NA,50-91 years,7453,,,NA,,,,
AD053001,E-MTAB-11918,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD053001.h5ad,ssREAD,,36747024,AD,Healthy,,Mouse,Cortex,,Female,NA,3 months,9106,,,TREM2CV-5XFAD (IgG),,,,
AD053002,E-MTAB-11918,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD053002.h5ad,ssREAD,,36747024,AD,Disease,,Mouse,Cortex,,Female,NA,3 months,35439,,,TREM2CV-5XFAD (IgG),,,,
AD054001,GSE245201,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD054001.h5ad,ssREAD,,37919286,AD,Healthy,,Mouse,Hippocampus,,Male,NA,3 months,10634,,,Trem2-/--5XFAD (IgG),,,,
AD054002,GSE245201,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD054002.h5ad,ssREAD,,37919286,AD,Disease,,Mouse,Hippocampus,,Male,NA,3 months,12372,,,TREM2R47H-5XFAD (IgG),,,,
AD055001,GSE230240,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD055001.h5ad,ssREAD,,37667395,AD,Healthy,,Mouse,Hippocampus,,Female,NA,3 months,43689,,,TREM2R47H-5XFAD (IgG),,,,
AD055002,GSE230240,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD055002.h5ad,ssREAD,,37667395,AD,Disease,,Mouse,Hippocampus,,Female,NA,3 months,42338,,,TREM2CV-5XFAD (hT2AB),,,,
AD056001,GSE233400,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD056001.h5ad,ssREAD,,37587511,AD,Healthy,,Mouse,Hippocampus,,Male,NA,3 months,19530,,,TREM2CV-5XFAD (hT2AB),,,,
AD056002,GSE233400,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD056002.h5ad,ssREAD,,37587511,AD,Disease,,Mouse,Hippocampus,,Male,NA,3 months,13087,,,Trem2-/--5XFAD (hT2AB),,,,
AD057001,GSE167494,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD057001.h5ad,ssREAD,,35381189,AD,Disease,,Human,Prefrontal cortex,,Female,NA,50-91 years,2699,,,Triple-transgenic Alzheimer disease (AD) mouse model,,,,
AD057002,GSE167494,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD057002.h5ad,ssREAD,,35381189,AD,Disease,,Human,Prefrontal cortex,,Female,NA,50-91 years,13655,,,anti-Nk1.1 treated 3XTg-AD,,,,
AD057003,GSE167494,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD057003.h5ad,ssREAD,,35381189,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,50-91 years,15930,,,Triple-transgenic Alzheimer disease (AD) mouse model,,,,
AD057004,GSE167494,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD057004.h5ad,ssREAD,,35381189,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,"mean age 77.6, range 67.3-91 years; 50-91 years",5119,,,anti-Nk1.1 treated 3XTg-AD,,,,
AD058001,GSE212317,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD058001.h5ad,ssREAD,,36871219,AD,Healthy,,Mouse,Whole brain,,Male,NA,5 months,45838,,,E3_5xFAD,,,,
AD058002,GSE212317,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD058002.h5ad,ssREAD,,36871219,AD,Disease,,Mouse,Whole brain,,Male,NA,5 months,30690,,,E3_5xFAD,,,,
AD059001,GSE215444,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD059001.h5ad,ssREAD,,36871219,AD,Healthy,,Mouse,Whole brain,,Female,NA,6 weeks,59102,,,APOE44,,,,
AD059002,GSE215444,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD059002.h5ad,ssREAD,,36871219,AD,Disease,,Mouse,Whole brain,,Female,NA,6 weeks,9544,,,APOE44,,,,
AD059003,GSE215444,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD059003.h5ad,ssREAD,,36871219,AD,Disease,,Mouse,Whole brain,,Female,NA,6 weeks,21047,,,APOE44,,,,
AD060001,PRJNA766517,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD060001.h5ad,ssREAD,,36271414,AD,Healthy,,Mouse,Other/combined,,Male,NA,NA,10406,,,5xFAD,,,,
AD060002,PRJNA766517,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD060002.h5ad,ssREAD,,36271414,AD,Disease,,Mouse,Other/combined,,Male,NA,NA,4347,,,5xFAD,,,,
AD061001,GSE174265,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD061001.h5ad,ssREAD,,36170369,AD,Healthy,,Mouse,Cortex,,Female,Baseline,NA,4019,,,CKp25,,,,
AD061002,GSE174265,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD061002.h5ad,ssREAD,,36170369,AD,Disease,,Mouse,Cortex,,Female,Stage1,NA,7647,,,CKp25,,,,
AD061003,GSE174265,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD061003.h5ad,ssREAD,,36170369,AD,Disease,,Mouse,Cortex,,Female,Stage2,NA,36455,,,CKp25,,,,
AD062001,GSE189626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD062001.h5ad,ssREAD,,37429840,AD,Healthy,,Mouse,Hippocampus,,Male,NA,12 weeks,29931,,,NGFR Lv16,,,,
AD062002,GSE189626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD062002.h5ad,ssREAD,,37429840,AD,Disease,,Mouse,Hippocampus,,Male,NA,12 weeks,39594,,,NGFR Lv16,,,,
AD063001,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD063001.h5ad,ssREAD,,32989152,AD,Healthy,,Human,Prefrontal cortex,,Female,NA,77+ years,22894,,,NA,,,,
AD063002,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD063002.h5ad,ssREAD,,32989152,AD,Disease,,Human,Prefrontal cortex,,Female,NA,77+ years,41757,,,NA,,,,
AD063003,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD063003.h5ad,ssREAD,,32989152,AD,Healthy,,Human,Prefrontal cortex,,Male,NA,77+ years,44071,,,NA,,,,
AD063004,GSE157827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD063004.h5ad,ssREAD,,32989152,AD,Disease,,Human,Prefrontal cortex,,Male,NA,77+ years,8891,,,NA,,,,
AD064001,GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD064001.h5ad,ssREAD,,33432193,AD,Healthy,,Human,Other/combined,,Male,NA,4 weeks,30324,,,NA,,,,
AD064002,GSE147528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD064002.h5ad,ssREAD,,33432193,AD,Disease,,Human,Other/combined,,Male,NA,4 weeks,14259,,,NA,,,,
AD065001,GSE148612,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD065001.h5ad,ssREAD,,34413515,AD,Healthy,,Mouse,Cortex,,Female,NA,90 weeks,5939,,,NA,,,,
AD065002,GSE148612,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD065002.h5ad,ssREAD,,34413515,AD,Healthy,,Mouse,Cortex,,Female,NA,90 weeks,3289,,,NA,,,,
AD066001,GSE218352,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD066001.h5ad,ssREAD,,37436901,AD,Healthy,,Mouse,Cortex,,Male,NA,90 weeks,40083,,,NA,,,,
AD066002,GSE218352,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD066002.h5ad,ssREAD,,37436901,AD,Disease,,Mouse,Cortex,,Male,NA,90 weeks,21538,,,NA,,,,
AD067001,GSE207848,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD067001.h5ad,ssREAD,,36580914,AD,Healthy,,Mouse,Other/combined,,Female,NA,24 weeks,23842,,,Trem2 +/+ mice,,,,
AD067002,GSE207848,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD067002.h5ad,ssREAD,,36580914,AD,Healthy,,Mouse,Other/Combined,,Male,NA,24 weeks,28336,,,Trem2 +/+ mice,,,,
AD067003,GSE207848,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD067003.h5ad,ssREAD,,36580914,AD,Disease,,Mouse,Other/Combined,,Female,NA,24 weeks,32643,,,Trem2 +/- mice,,,,
AD067004,GSE207848,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/ssREAD_data/h5ad/AD067004.h5ad,ssREAD,,36580914,AD,Healthy,,Mouse,Other/Combined,,Female,NA,24 weeks,58416,,,Trem2 -/- mice,,,,
AD068001,GSM4888887,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888887_CTRL1_,10x_matrix,,36993867,AD,Healthy,,Human,Putamen,no data available,F,no data available,78.5,4606,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068002,GSM4888888,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888888_CTRL2_,10x_matrix,,36993867,AD,Healthy,,Human,Putamen,no data available,F,no data available,85.4,2193,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068003,GSM4888889,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888889_CTRL3_,10x_matrix,,36993867,AD,Healthy,,Human,Putamen,no data available,M,no data available,78,2324,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068004,GSM4888890,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888890_CTRL4_,10x_matrix,,36993867,AD,Healthy,,Human,Putamen,no data available,M,no data available,73.3,1607,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068005,GSM4888891,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888891_AD1_,10x_matrix,,36993867,AD,Disease,,Human,Putamen,no data available,M,no data available,71,2506,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068006,GSM4888892,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888892_AD2_,10x_matrix,,36993867,AD,Disease,,Human,Putamen,no data available,F,no data available,72.5,4167,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068007,GSM4888893,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888893_AD3_,10x_matrix,,36993867,AD,Disease,,Human,Putamen,no data available,M,no data available,75.1,3892,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068008,GSM4888894,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888894_AD4_,10x_matrix,,36993867,AD,Disease,,Human,Putamen,no data available,F,no data available,81.7,3605,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068009,GSM4888895,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888895_PD1_,10x_matrix,,36993867,PD,Disease,,Human,Putamen,no data available,F,no data available,69,no data available,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068010,GSM4888896,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888896_PD2_,10x_matrix,,36993867,PD,Disease,,Human,Putamen,no data available,M,no data available,77,no data available,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068011,GSM4888897,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888897_PD3_,10x_matrix,,36993867,PD,Disease,,Human,Putamen,no data available,M,no data available,76,no data available,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD068012,GSM4888898,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36993867/GSM4888898_PD4_,10x_matrix,,36993867,PD,Disease,,Human,Putamen,no data available,F,no data available,70,no data available,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD069001,"GSM6924928,GSM6924929",C114_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,56,Autosomal dominant Alzheimer's Disease,
AD069002,"GSM6924930,GSM6924931",C135_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,55,Autosomal dominant Alzheimer's Disease,
AD069003,GSM6924932,C140_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,55,Autosomal dominant Alzheimer's Disease,
AD069004,GSM6924933,C142_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,53,Autosomal dominant Alzheimer's Disease,
AD069005,GSM6924934,C361_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,57,Autosomal dominant Alzheimer's Disease,
AD069006,GSM6924935,C363_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,55,Autosomal dominant Alzheimer's Disease,
AD069007,"GSM6924936,GSM6924937        ",C379_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,70,Autosomal dominant Alzheimer's Disease,
AD069008,GSM6924938,C377_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,PSEN1-E280A,,74,Autosomal dominant Alzheimer's Disease,
AD069009,GSM6924939,C226_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Female,Non-disease,84,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,,
AD069010,GSM6924940,C240_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Female,Non-disease,67,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,,
AD069011,GSM6924941,C262_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Male,Non-disease,69,,10X Genomics,Single-nucleus RNA sequencing,#N/A,,,,
AD069012,GSM6924942,C291_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Male,Non-disease,49,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,,
AD069013,GSM6924943	,C327_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Male,Non-disease,46,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,,
AD069014,GSM6924944,C342_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Female,Non-disease,44,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,,
AD069015,GSM6924945,C350_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Male,Non-disease,38,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,,
AD069016,GSM6924946,C364_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Healthy,health control,Human,frontal cortex,no,Male,Non-disease,73,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,,
AD069017,GSM6924947,C381_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,Sporadic AD,69,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,,,Sporadic Alzheimer's Disease,
AD069018,GSM6924948,C323_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,Sporadic AD,68,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,Sporadic Alzheimer's Disease,
AD069019,GSM6924949,C255_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,Sporadic AD,67,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,Sporadic Alzheimer's Disease,
AD069020,GSM6924950,C210_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,Sporadic AD,80,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,Sporadic Alzheimer's Disease,
AD069021,GSM6924951,C269_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Male,Sporadic AD,87,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,,,Sporadic Alzheimer's Disease,
AD069022,GSM6924952,C99_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,Sporadic AD,91,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,Sporadic Alzheimer's Disease,
AD069023,GSM6924953,C181_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,Sporadic AD,88,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,,,Sporadic Alzheimer's Disease,
AD069024,GSM6924954,C277_C01,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38417436/GSE222494_BrainFRONTAL_counts.csv.gz,whole,38417436,AD,Disease,,Human,frontal cortex,no,Female,Sporadic AD,82,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,,,Sporadic Alzheimer's Disease,
AD070001,GSE254205,1527,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,84,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070002,GSE254205,1420,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Female,IV,93,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070003,GSE254205,1828,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,82,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070004,GSE254205,1820,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Male,IV,87,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070005,GSE254205,1354,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,85,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070006,GSE254205,1875,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Female,IV,81,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070007,GSE254205,0406,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,V,84,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070008,GSE254205,1402,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Female,IV,86,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070009,GSE254205,1372,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,73,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070010,GSE254205,1114,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,101,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070011,GSE254205,9915,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,VI,83,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070012,GSE254205,1244,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Female,III,80,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070013,GSE254205,1629,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Male,IV,96,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070014,GSE254205,1414,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,IV,78,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070015,GSE254205,444,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,VI,81,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070016,GSE254205,1868,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Male,IV,96,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070017,GSE254205,1227,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,89,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070018,GSE254205,0527,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,V,67,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070019,GSE254205,1630,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Healthy,Control,Human,frontal cortex,no data available,Male,IV,101,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070020,GSE254205,1237,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,VI,82,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070021,GSE254205,1046,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,VI,86,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD070022,GSE254205,354,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,V,76,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070023,GSE254205,1369,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,64,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070024,GSE254205,1159,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,V,83,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070025,GSE254205,1342,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Male,VI,80,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 4/4,,,,
AD070026,GSE254205,552,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38480892/GSE254205_ad_raw.h5ad,whole,38480892,AD,Disease,,Human,frontal cortex,no data available,Female,VI,70,,10X Genomics,Single-nucleus RNA sequencing,genotype: APOE 3/3,,,,
AD071001,GSM7080013,1028,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,66,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071002,GSM7080014,1241,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,78,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071003,GSM7080015,906,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,47,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071004,GSM7080016,1034,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,60,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071005,GSM7080017,1055,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,87,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071006,GSM7080018,1092,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,85,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071007,GSM7080019,1120,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,59,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071008,GSM7080020,1160,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,78,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071009,GSM7080021,254,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,72,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071010,GSM7080022,1052,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,74,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071011,GSM7080023,516,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,66,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071012,GSM7080024,696,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,81,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071013,GSM7080025,1273,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,79,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071014,GSM7080026,738,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,74,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071015,GSM7080027,911,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071016,GSM7080028,1180,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,63,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071017,GSM7080029,773,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,64,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071018,GSM7080030,863,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,66,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071019,GSM7080031,1279,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,68,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071020,GSM7080032,598,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,83,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071021,GSM7080033,917,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,84,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071022,GSM7080034,932,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,59,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071023,GSM7080035,780,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,73,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071024,GSM7080036,802,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,79,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071025,GSM7080037,1020,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,63,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071026,GSM7080038,942,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,61,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071027,GSM7080039,968,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,78,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071028,GSM7080040,1147,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,75,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071029,GSM7080041,781,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,72,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071030,GSM7080042,1111,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,57,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071031,GSM7080043,656,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,72,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071032,GSM7080044,912,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,75,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071033,GSM7080045,978,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,72,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071034,GSM7080046,1282,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,69,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071035,GSM7080047,953,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,83,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071036,GSM7080048,820,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,87,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071037,GSM7080049,1162,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,83,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071038,GSM7080050,989,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,67,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071039,GSM7080051,1010,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Female,no data available,74,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071040,GSM7080052,965,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,68,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071041,GSM7080053,921,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,85,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071042,GSM7080054,230,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,89,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071043,GSM7080055,836,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,73,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071044,GSM7080056,1236,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071045,GSM7080057,1237,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,73,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071046,GSM7080058,1200,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,63,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071047,GSM7080059,947,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Male,no data available,62,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071048,GSM7080060,70,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Disease,,Human,Peripheral blood mononuclear cells,no data,Female,no data available,68,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071049,GSM7080061,970,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,70,,10X Genomics,Single-cell RNA sequencing,,,,,
AD071050,GSM7080062,905,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38340719/GSE226602_rna_raw_counts.h5ad,whole,38340719,AD,Healthy,health control,Human,Peripheral blood mononuclear cells,no data,Male,no data available,87,,10X Genomics,Single-cell RNA sequencing,,,,,
AD072001,GSM8224478,IGF113055,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,M,0,73,3048,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072002,GSM8224479,IGF113075,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,F,2,91,3193,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072003,GSM8224480,IGF113088,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,F,1,80,2767,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072004,GSM8224481,IGF113060,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,M,4,87,3290,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072005,GSM8224482,IGF113073,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,M,6,79,9454,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072006,GSM8224483,IGF113080,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,M,1,81,2368,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072007,GSM8224484,IGF113067,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,F,5,85,1512,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072008,GSM8224485,IGF113079,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,M,0,77,4127,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072009,GSM8224486,IGF113094,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,F,5,85,1767,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072010,GSM8224487,IGF113058,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,M,0,73,1841,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072011,GSM8224488,IGF113072,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,M,6,79,12418,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072012,GSM8224489,IGF113083,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,M,0,73,4217,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072013,GSM8224490,IGF113063,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,M,5,83,2739,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072014,GSM8224491,IGF113059,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,F,3,68,5585,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072015,GSM8224492,IGF113061,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,M,5,83,4930,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072016,GSM8224493,IGF113092,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,F,2,76,5201,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072017,GSM8224494,IGF113062,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,M,4,87,1160,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072018,GSM8224495,IGF113078,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,F,1,80,4556,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072019,GSM8224496,IGF113090,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,mTemp,no data,F,5,85,3701,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072020,GSM8224497,IGF113066,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,M,0,77,4568,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072021,GSM8224498,IGF113086,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,mTemp,no data,M,6,79,2079,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072022,GSM8224499,IGF113069,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,M,1,81,1094,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072023,GSM8224500,IGF113081,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,mTemp,no data,M,4,87,3804,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072024,GSM8224501,IGF113082,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,mTemp,no data,M,5,83,5041,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072025,GSM8224502,IGF113085,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,mTemp,no data,F,3,68,5729,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072026,GSM8224503,IGF113087,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,F,2,91,6826,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072027,GSM8224504,IGF113089,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,mTemp,no data,M,3,83,5421,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072028,GSM8224505,IGF113093,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,M,0,92,7101,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072029,GSM8224506,IGF113091,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,F,3,92,6132,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072030,GSM8224507,IGF113065,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,F,5,85,5070,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072031,GSM8224508,IGF113076,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,F,2,91,5305,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072032,GSM8224509,IGF113056,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,M,0,77,2377,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072033,GSM8224510,IGF113068,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,M,3,83,2378,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072034,GSM8224511,IGF113077,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,F,1,80,3318,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072035,GSM8224512,IGF113064,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,M,3,83,4983,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072036,GSM8224513,IGF113070,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,M,1,81,2563,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072037,GSM8224514,IGF113057,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,F,3,68,2128,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072038,GSM8224515,IGF113096,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,F,2,76,7340,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072039,GSM8224516,IGF113099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,F,2,92,2415,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072040,GSM8224517,IGF113098,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,mTemp,no data,F,6,90,2683,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072041,GSM8224518,IGF113097,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,mTemp,no data,M,0,92,6873,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072042,GSM8224519,IGF113100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,F,3,92,4653,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072043,GSM8224520,IGF113104,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,EC,no data,F,6,90,1761,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072044,GSM8224521,IGF113103,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,F,5,85,4778,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072045,GSM8224522,IGF113101,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,F,2,76,5802,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072046,GSM8224523,IGF113105,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,EC,no data,F,2,92,1009,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072047,GSM8224524,IGF113102,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,M,0,92,6532,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072048,GSM8224525,IGF113106,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Healthy,,Human,SSC,no data,F,2,92,4175,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD072049,GSM8224526,IGF113107,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38695952/GSE264648.clean_output.h5ad,whole,38695952,AD,Disease,,Human,SSC,no data,F,6,90,2158,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD073001,GSM8184339,GSM8184339_pool1_NMA22-205-B1,,,40050704,AD,Disease,,Human,FCX,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073002,GSM8184339,GSM8184339_pool1_NMA22-205-B3,,,40050704,AD,Disease,,Human,TCX,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073003,GSM8184339,GSM8184339_pool1_NMA22-205-B4,,,40050704,AD,Disease,,Human,PCX,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073004,GSM8184339,GSM8184339_pool1_NMA22-205-B9,,,40050704,AD,Disease,,Human,HIP,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073005,GSM8184339,GSM8184339_pool1_NMA22-300-A1,,,40050704,AD,Disease,Yes,Human,FCX,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073006,GSM8184339,GSM8184339_pool1_NMA22-300-A3,,,40050704,AD,Disease,Yes,Human,TCX,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073007,GSM8184339,GSM8184339_pool1_NMA22-300-A4,,,40050704,AD,Disease,Yes,Human,PCX,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073008,GSM8184339,GSM8184339_pool1_NMA22-300-A9,,,40050704,AD,Disease,Yes,Human,HIP,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073009,GSM8184340,GSM8184340_pool2_NMA22-205-B1,,,40050704,AD,Disease,,Human,FCX,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073010,GSM8184340,GSM8184340_pool2_NMA22-205-B3,,,40050704,AD,Disease,,Human,TCX,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073011,GSM8184340,GSM8184340_pool2_NMA22-205-B4,,,40050704,AD,Disease,,Human,PCX,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073012,GSM8184340,GSM8184340_pool2_NMA22-205-B9,,,40050704,AD,Disease,,Human,HIP,LCMB,F,no data,65,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073013,GSM8184340,GSM8184340_pool2_NMA22-300-A1,,,40050704,AD,Disease,Yes,Human,FCX,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073014,GSM8184340,GSM8184340_pool2_NMA22-300-A3,,,40050704,AD,Disease,Yes,Human,TCX,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073015,GSM8184340,GSM8184340_pool2_NMA22-300-A4,,,40050704,AD,Disease,Yes,Human,PCX,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073016,GSM8184340,GSM8184340_pool2_NMA22-300-A9,,,40050704,AD,Disease,Yes,Human,HIP,no treatment,M,no data,82,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073017,GSM8651169,GSM8651169_A11-170-A1,,,40050704,AD,Disease,Yes,Human,FCX,no treatment,F,no data,66,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073018,GSM8651169,GSM8651169_A11-170-A3,,,40050704,AD,Disease,Yes,Human,TCX,no treatment,F,no data,66,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073019,GSM8651169,GSM8651169_A11-170-A4,,,40050704,AD,Disease,Yes,Human,PCX,no treatment,F,no data,66,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073020,GSM8651169,GSM8651169_A11-170-A9,,,40050704,AD,Disease,Yes,Human,HIP,no treatment,F,no data,66,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073021,GSM8651169,GSM8651169_A11-193-A1,,,40050704,AD,Disease,Yes,Human,FCX,no treatment,F,no data,64,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073022,GSM8651169,GSM8651169_A11-193-A3,,,40050704,AD,Disease,Yes,Human,TCX,no treatment,F,no data,64,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073023,GSM8651169,GSM8651169_A11-193-A4,,,40050704,AD,Disease,Yes,Human,PCX,no treatment,F,no data,64,,10X Genomics,Single-cell RNA sequencing,,,,,
AD073024,GSM8651169,GSM8651169_A11-193-A9,,,40050704,AD,Disease,Yes,Human,HIP,no treatment,F,no data,64,,10X Genomics,Single-cell RNA sequencing,,,,,
AD074001,GSM7712860,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39147742/GSM7712860_ArcPMX1_,10x_matrix,read split.,39147742,AD,Disease/Healthy,,Mouse,hippocampus,H2O_PMX,no data available,no data available,10 month,,Split-seq,,WT_Arctic48,"Wildtype and Arctic mice were treated or not for 12 weeks with PMX205, a cyclic hexipetide antagonist of the C5a receptor, C5aR1 (20ug/ml) in drinking water. Animals were separately housed during treatment until perfusion in HBSS with Actimomycin D and Triptolide at 10 mo of age.Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei). Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei).Half hippocampi from 2-3 mice of the same sex, genotype and treatment were pooled for microglia isolation and processing (HBSS with Actinomycin D (5 g/ml), Triptolide (10 M) and Anisomycin (27.1 g/ml)) (3 samples per sex/genotype/treatment) . Following dissociation with gentle MACS Octo Dissociator and Adult Brain Dissociation Kit, cells were filtered (70 m), debris removed, and myelin was cleared with Myelin removal beads II. Microglia were isolated using Anti-CD11b MicroBeads. Cells were counted and resuspended in 0.05% BSA in DPBS, to reach a minimum of 1,000 cells/L up to around 7,000 cells/L. For sn-RNA-Seq, perfused half hippocampi (3 per sex/genotype/treatment) were placed into Nuclei Extraction Buffer (Miltenyi) with 0.2 U/L RNase inhibitor), processed in gentleMACSTM Octo Dissociator, filtered (70 m), centrifuged and resuspended in PBS with 0.1% BSA and 0.2 U/L RNase inhibitor, passed through a 30 m filter, and counted). 4 million nuclei were collected from the stock of each cell preparation, and processed per Parse Biosciences. RNA was reverse transcribed in situ and barcoded cDNA was extracted following Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq). Illumina Split-seq: Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq).Library preparation was performed following manufacturers instructions for the Single Cell Whole Transcriptome Kit, where the cells are mixed for the next 2 sets of barcoding reactions followed by sublibrary generation.",,,
AD074002,GSM7712861,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39147742/GSM7712861_ArcPMX2_,10x_matrix,read split.,39147742,AD,Disease/Healthy,,Mouse,hippocampus,H2O_PMX,no data available,no data available,10 month,,Split-seq,Single-cell RNA sequencing/Single-nucleus RNA sequencing,WT_Arctic49,"Wildtype and Arctic mice were treated or not for 12 weeks with PMX205, a cyclic hexipetide antagonist of the C5a receptor, C5aR1 (20ug/ml) in drinking water. Animals were separately housed during treatment until perfusion in HBSS with Actimomycin D and Triptolide at 10 mo of age.Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei). Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei).Half hippocampi from 2-3 mice of the same sex, genotype and treatment were pooled for microglia isolation and processing (HBSS with Actinomycin D (5 g/ml), Triptolide (10 M) and Anisomycin (27.1 g/ml)) (3 samples per sex/genotype/treatment) . Following dissociation with gentle MACS Octo Dissociator and Adult Brain Dissociation Kit, cells were filtered (70 m), debris removed, and myelin was cleared with Myelin removal beads II. Microglia were isolated using Anti-CD11b MicroBeads. Cells were counted and resuspended in 0.05% BSA in DPBS, to reach a minimum of 1,000 cells/L up to around 7,000 cells/L. For sn-RNA-Seq, perfused half hippocampi (3 per sex/genotype/treatment) were placed into Nuclei Extraction Buffer (Miltenyi) with 0.2 U/L RNase inhibitor), processed in gentleMACSTM Octo Dissociator, filtered (70 m), centrifuged and resuspended in PBS with 0.1% BSA and 0.2 U/L RNase inhibitor, passed through a 30 m filter, and counted). 4 million nuclei were collected from the stock of each cell preparation, and processed per Parse Biosciences. RNA was reverse transcribed in situ and barcoded cDNA was extracted following Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq). Illumina Split-seq: Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq).Library preparation was performed following manufacturers instructions for the Single Cell Whole Transcriptome Kit, where the cells are mixed for the next 2 sets of barcoding reactions followed by sublibrary generation.",,,
AD074003,GSM7712862,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39147742/GSM7712862_ArcPMX3_,10x_matrix,read split.,39147742,AD,Disease/Healthy,,Mouse,hippocampus,H2O_PMX,no data available,no data available,10 month,,Split-seq,Single-cell RNA sequencing/Single-nucleus RNA sequencing,WT_Arctic50,"Wildtype and Arctic mice were treated or not for 12 weeks with PMX205, a cyclic hexipetide antagonist of the C5a receptor, C5aR1 (20ug/ml) in drinking water. Animals were separately housed during treatment until perfusion in HBSS with Actimomycin D and Triptolide at 10 mo of age.Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei). Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei).Half hippocampi from 2-3 mice of the same sex, genotype and treatment were pooled for microglia isolation and processing (HBSS with Actinomycin D (5 g/ml), Triptolide (10 M) and Anisomycin (27.1 g/ml)) (3 samples per sex/genotype/treatment) . Following dissociation with gentle MACS Octo Dissociator and Adult Brain Dissociation Kit, cells were filtered (70 m), debris removed, and myelin was cleared with Myelin removal beads II. Microglia were isolated using Anti-CD11b MicroBeads. Cells were counted and resuspended in 0.05% BSA in DPBS, to reach a minimum of 1,000 cells/L up to around 7,000 cells/L. For sn-RNA-Seq, perfused half hippocampi (3 per sex/genotype/treatment) were placed into Nuclei Extraction Buffer (Miltenyi) with 0.2 U/L RNase inhibitor), processed in gentleMACSTM Octo Dissociator, filtered (70 m), centrifuged and resuspended in PBS with 0.1% BSA and 0.2 U/L RNase inhibitor, passed through a 30 m filter, and counted). 4 million nuclei were collected from the stock of each cell preparation, and processed per Parse Biosciences. RNA was reverse transcribed in situ and barcoded cDNA was extracted following Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq). Illumina Split-seq: Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq).Library preparation was performed following manufacturers instructions for the Single Cell Whole Transcriptome Kit, where the cells are mixed for the next 2 sets of barcoding reactions followed by sublibrary generation.",,,
AD074004,GSM7712863,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39147742/GSM7712863_ArcPMX4_,10x_matrix,read split.,39147742,AD,Disease/Healthy,,Mouse,hippocampus,H2O_PMX,no data available,no data available,10 month,,Split-seq,Single-cell RNA sequencing/Single-nucleus RNA sequencing,WT_Arctic51,"Wildtype and Arctic mice were treated or not for 12 weeks with PMX205, a cyclic hexipetide antagonist of the C5a receptor, C5aR1 (20ug/ml) in drinking water. Animals were separately housed during treatment until perfusion in HBSS with Actimomycin D and Triptolide at 10 mo of age.Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei). Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei).Half hippocampi from 2-3 mice of the same sex, genotype and treatment were pooled for microglia isolation and processing (HBSS with Actinomycin D (5 g/ml), Triptolide (10 M) and Anisomycin (27.1 g/ml)) (3 samples per sex/genotype/treatment) . Following dissociation with gentle MACS Octo Dissociator and Adult Brain Dissociation Kit, cells were filtered (70 m), debris removed, and myelin was cleared with Myelin removal beads II. Microglia were isolated using Anti-CD11b MicroBeads. Cells were counted and resuspended in 0.05% BSA in DPBS, to reach a minimum of 1,000 cells/L up to around 7,000 cells/L. For sn-RNA-Seq, perfused half hippocampi (3 per sex/genotype/treatment) were placed into Nuclei Extraction Buffer (Miltenyi) with 0.2 U/L RNase inhibitor), processed in gentleMACSTM Octo Dissociator, filtered (70 m), centrifuged and resuspended in PBS with 0.1% BSA and 0.2 U/L RNase inhibitor, passed through a 30 m filter, and counted). 4 million nuclei were collected from the stock of each cell preparation, and processed per Parse Biosciences. RNA was reverse transcribed in situ and barcoded cDNA was extracted following Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq). Illumina Split-seq: Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq).Library preparation was performed following manufacturers instructions for the Single Cell Whole Transcriptome Kit, where the cells are mixed for the next 2 sets of barcoding reactions followed by sublibrary generation.",,,
AD074005,GSM7712864,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39147742/GSM7712864_ArcPMX5_,10x_matrix,read split.,39147742,AD,Disease/Healthy,,Mouse,hippocampus,H2O_PMX,no data available,no data available,10 month,,Split-seq,Single-cell RNA sequencing/Single-nucleus RNA sequencing,WT_Arctic52,"Wildtype and Arctic mice were treated or not for 12 weeks with PMX205, a cyclic hexipetide antagonist of the C5a receptor, C5aR1 (20ug/ml) in drinking water. Animals were separately housed during treatment until perfusion in HBSS with Actimomycin D and Triptolide at 10 mo of age.Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei). Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei).Half hippocampi from 2-3 mice of the same sex, genotype and treatment were pooled for microglia isolation and processing (HBSS with Actinomycin D (5 g/ml), Triptolide (10 M) and Anisomycin (27.1 g/ml)) (3 samples per sex/genotype/treatment) . Following dissociation with gentle MACS Octo Dissociator and Adult Brain Dissociation Kit, cells were filtered (70 m), debris removed, and myelin was cleared with Myelin removal beads II. Microglia were isolated using Anti-CD11b MicroBeads. Cells were counted and resuspended in 0.05% BSA in DPBS, to reach a minimum of 1,000 cells/L up to around 7,000 cells/L. For sn-RNA-Seq, perfused half hippocampi (3 per sex/genotype/treatment) were placed into Nuclei Extraction Buffer (Miltenyi) with 0.2 U/L RNase inhibitor), processed in gentleMACSTM Octo Dissociator, filtered (70 m), centrifuged and resuspended in PBS with 0.1% BSA and 0.2 U/L RNase inhibitor, passed through a 30 m filter, and counted). 4 million nuclei were collected from the stock of each cell preparation, and processed per Parse Biosciences. RNA was reverse transcribed in situ and barcoded cDNA was extracted following Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq). Illumina Split-seq: Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq).Library preparation was performed following manufacturers instructions for the Single Cell Whole Transcriptome Kit, where the cells are mixed for the next 2 sets of barcoding reactions followed by sublibrary generation.",,,
AD074006,GSM7712865,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39147742/GSM7712865_ArcPMX6_,10x_matrix,read split.,39147742,AD,Disease/Healthy,,Mouse,hippocampus,H2O_PMX,no data available,no data available,10 month,,Split-seq,Single-cell RNA sequencing/Single-nucleus RNA sequencing,WT_Arctic53,"Wildtype and Arctic mice were treated or not for 12 weeks with PMX205, a cyclic hexipetide antagonist of the C5a receptor, C5aR1 (20ug/ml) in drinking water. Animals were separately housed during treatment until perfusion in HBSS with Actimomycin D and Triptolide at 10 mo of age.Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei). Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei).Half hippocampi from 2-3 mice of the same sex, genotype and treatment were pooled for microglia isolation and processing (HBSS with Actinomycin D (5 g/ml), Triptolide (10 M) and Anisomycin (27.1 g/ml)) (3 samples per sex/genotype/treatment) . Following dissociation with gentle MACS Octo Dissociator and Adult Brain Dissociation Kit, cells were filtered (70 m), debris removed, and myelin was cleared with Myelin removal beads II. Microglia were isolated using Anti-CD11b MicroBeads. Cells were counted and resuspended in 0.05% BSA in DPBS, to reach a minimum of 1,000 cells/L up to around 7,000 cells/L. For sn-RNA-Seq, perfused half hippocampi (3 per sex/genotype/treatment) were placed into Nuclei Extraction Buffer (Miltenyi) with 0.2 U/L RNase inhibitor), processed in gentleMACSTM Octo Dissociator, filtered (70 m), centrifuged and resuspended in PBS with 0.1% BSA and 0.2 U/L RNase inhibitor, passed through a 30 m filter, and counted). 4 million nuclei were collected from the stock of each cell preparation, and processed per Parse Biosciences. RNA was reverse transcribed in situ and barcoded cDNA was extracted following Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq). Illumina Split-seq: Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq).Library preparation was performed following manufacturers instructions for the Single Cell Whole Transcriptome Kit, where the cells are mixed for the next 2 sets of barcoding reactions followed by sublibrary generation.",,,
AD074007,GSM7712866,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39147742/GSM7712866_ArcPMX7_,10x_matrix,read split.,39147742,AD,Disease/Healthy,,Mouse,hippocampus,H2O_PMX,no data available,no data available,10 month,,Split-seq,Single-cell RNA sequencing/Single-nucleus RNA sequencing,WT_Arctic54,"Wildtype and Arctic mice were treated or not for 12 weeks with PMX205, a cyclic hexipetide antagonist of the C5a receptor, C5aR1 (20ug/ml) in drinking water. Animals were separately housed during treatment until perfusion in HBSS with Actimomycin D and Triptolide at 10 mo of age.Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei). Mouse microglial single-cell in hippocampi and hippocampi nuclei were collected for Split-seq and dispersed into 48 wells of a 96 well plate containing unique barcodes per well (24 wells of microglial cells, 24 wells of hippocampi nuclei).Half hippocampi from 2-3 mice of the same sex, genotype and treatment were pooled for microglia isolation and processing (HBSS with Actinomycin D (5 g/ml), Triptolide (10 M) and Anisomycin (27.1 g/ml)) (3 samples per sex/genotype/treatment) . Following dissociation with gentle MACS Octo Dissociator and Adult Brain Dissociation Kit, cells were filtered (70 m), debris removed, and myelin was cleared with Myelin removal beads II. Microglia were isolated using Anti-CD11b MicroBeads. Cells were counted and resuspended in 0.05% BSA in DPBS, to reach a minimum of 1,000 cells/L up to around 7,000 cells/L. For sn-RNA-Seq, perfused half hippocampi (3 per sex/genotype/treatment) were placed into Nuclei Extraction Buffer (Miltenyi) with 0.2 U/L RNase inhibitor), processed in gentleMACSTM Octo Dissociator, filtered (70 m), centrifuged and resuspended in PBS with 0.1% BSA and 0.2 U/L RNase inhibitor, passed through a 30 m filter, and counted). 4 million nuclei were collected from the stock of each cell preparation, and processed per Parse Biosciences. RNA was reverse transcribed in situ and barcoded cDNA was extracted following Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq). Illumina Split-seq: Parse Biosciences Single Cell Whole Transcriptome Kit (also called Split-seq).Library preparation was performed following manufacturers instructions for the Single Cell Whole Transcriptome Kit, where the cells are mixed for the next 2 sets of barcoding reactions followed by sublibrary generation.",,,
AD075001,GSM7904792,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39500314/E3_Ctrl_filtered_feature_bc_matrix/,10x_matrix,,39500314,AD,Healthy,,Mouse,hippocampus,no data available,male,no data available,3-5 months,,10X Genomics,Single-cell RNA sequencing,Human APOE3 neurons + mouse APOE3 knock-in (control),"Human induced pluripotent stem cell (hiPSC)-derived neurons (at culture days 35-42) were collected and single cells were then centrifuged and resuspended to concentration of 500 cells/nL in 1X HBSS (GIBCO) supplemented with 10 ng/mL BDNF (Peprotech), 10 ng/mL GDNF (Peprotech) and 100 ng/mL DNaseI (Roche) and kept at 4C until transplantation. Mice were anesthetized with an intraperitoneal injection of ketamine (60 mg/kg) and xylazine (30 mg/kg) and maintained on 0.8%-1.0% isofluorane (Henry Schein). Mice were secured in a stereotaxic alignment system model 940 using earbars and a tooth bar (Kopf Instruments). The scalp was prepared by removing hair with scissors and sterilizing with 70% ethanol. The scalp was then cut open using a scalpel and sterilized with 70% ethanol. Cell suspensions (500 cells/nL) were loaded into 60 m tip diameter, 30 beveled glass micropipette needles (Nanoject, Drummond Scientific Company). Approximately 30,000 cells per site were injected at 4 sites (2 per hemibrain) at a rate of 25 nL/sec and allowed to diffuse for 1 min. Each mouse received four total cell transplants, two per hemibrain hippocampus. Following surgery, mice were sutured with nylon monofilament non-absorbable 6-0 sutures (Henry Schein), and administered analgesics buprenorphine (0.0375 mg/kg intraperitoneally), ketofen (5 mg/kg subcutaneously), and saline (500L intraperitoneally). Immunosuppressants were administered immediately after transplantation (day 0) via intraperitoneal injection followed by injections on day 2, 4, and 6 post transplantation. APOE3 and APOE4 knock-in (E3KI and E4KI) mice on a C57BL/6 background were originally obtained from Taconic. All animals were bred in-house using trio breeding producing 810 pups per litter on average, which were weaned at 28 days. Male littermates at 3-5 months of age were randomly assigned to experimental groups. Animals were housed in a pathogen-free barrier facility on a 12 hr light cycle (lights on at 7 am and off at 7 pm) at 1923C and 30%70% humidity. Mice were genotyped by polymerase chain reaction (PCR) of a tail clipping at weaning. All mouse experiments were conducted in accordance with the guidelines and regulations of the National Institutes of Health, the University of California, and the Gladstone Institutes under IACUC protocol AN117112.The hippocampus of each mouses left hemi-brain was dissected on ice, rinsed with cold Dissection Buffer, and placed into a pre-chilled 12-well plate with 2 mL/well of Hibernate A Buffer. Hippocampi from 4-6 mice per condition were pooled into one well for further processing. Tissue from each pooled sample was moved to a 100mm dish, minced with a razor blade, then placed in a 5mL Eppendorf tube with 1mL pre-warmed Enzyme Buffer. Samples in Eppendorf tubes were then incubated in a 35C water bath for 30 minutes, with gentle trituration at the 15-, 25-, and 30-minute timepoints. The homogenate was then filtered (70um MACS SmartStrainers) into a 50mL conical tube and centrifuged and washed at 4C for a few times. The cells were resuspended in Blocking Buffer (BD Biosciences). After a 5-minute incubation at 4C, cells were incubated in Antibody Solution (1X DPBS, 0.2% BSA, 1.89ug/mL CD45 PE-Cyanine7 (Thermofisher), 3.53ug/mL CD11b Brilliant Violet 421 (BioLegend)) for 40 minutes at 4C. After being washed with 1X DPBS with 0.2% BSA and filtered through a 40um Flowmi Cell Strainer (Millipore Sigma) into a pre-chilled 5mL FACS tubes (Stem Cell Technologies), live single cells were identified and gated per standard sorting protocols, then further sorted to isolate a CD11b+/CD45int microglia population (Supp Fig 6) with a BD FACS Aria Fusion I or BD Aria II at 4C with a 100um nozzle (20 psi). The sorted microglia were centrifuged at 500g at 4C for 5 minutes, then loaded onto 10x Genomics Next GEM chip G at cell counts of approximately 25,000 cells.The scRNA-seq libraries were prepared using the Chromium Next GEM Single Cell 3 Library and Gel Bead kit v.3.1 (10x Genomics) according to the manufacturers instructions. Libraries were sequenced on an Illumina NovaSeq 6000 sequencer at the UCSF CAT Core.",,,
AD075002,GSM7904793,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39500314/E4_Ctrl_filtered_feature_bc_matrix/,10x_matrix,,39500314,AD,Disease,,Mouse,hippocampus,no data available,male,no data available,3-5 months,,10X Genomics,Single-cell RNA sequencing,Human APOE4 neurons + mouse APOE4 knock-in (AD-susceptible model),"Human induced pluripotent stem cell (hiPSC)-derived neurons (at culture days 35-42) were collected and single cells were then centrifuged and resuspended to concentration of 500 cells/nL in 1X HBSS (GIBCO) supplemented with 10 ng/mL BDNF (Peprotech), 10 ng/mL GDNF (Peprotech) and 100 ng/mL DNaseI (Roche) and kept at 4C until transplantation. Mice were anesthetized with an intraperitoneal injection of ketamine (60 mg/kg) and xylazine (30 mg/kg) and maintained on 0.8%-1.0% isofluorane (Henry Schein). Mice were secured in a stereotaxic alignment system model 940 using earbars and a tooth bar (Kopf Instruments). The scalp was prepared by removing hair with scissors and sterilizing with 70% ethanol. The scalp was then cut open using a scalpel and sterilized with 70% ethanol. Cell suspensions (500 cells/nL) were loaded into 60 m tip diameter, 30 beveled glass micropipette needles (Nanoject, Drummond Scientific Company). Approximately 30,000 cells per site were injected at 4 sites (2 per hemibrain) at a rate of 25 nL/sec and allowed to diffuse for 1 min. Each mouse received four total cell transplants, two per hemibrain hippocampus. Following surgery, mice were sutured with nylon monofilament non-absorbable 6-0 sutures (Henry Schein), and administered analgesics buprenorphine (0.0375 mg/kg intraperitoneally), ketofen (5 mg/kg subcutaneously), and saline (500L intraperitoneally). Immunosuppressants were administered immediately after transplantation (day 0) via intraperitoneal injection followed by injections on day 2, 4, and 6 post transplantation. APOE3 and APOE4 knock-in (E3KI and E4KI) mice on a C57BL/6 background were originally obtained from Taconic. All animals were bred in-house using trio breeding producing 810 pups per litter on average, which were weaned at 28 days. Male littermates at 3-5 months of age were randomly assigned to experimental groups. Animals were housed in a pathogen-free barrier facility on a 12 hr light cycle (lights on at 7 am and off at 7 pm) at 1923C and 30%70% humidity. Mice were genotyped by polymerase chain reaction (PCR) of a tail clipping at weaning. All mouse experiments were conducted in accordance with the guidelines and regulations of the National Institutes of Health, the University of California, and the Gladstone Institutes under IACUC protocol AN117112. The hippocampus of each mouses left hemi-brain was dissected on ice, rinsed with cold Dissection Buffer, and placed into a pre-chilled 12-well plate with 2 mL/well of Hibernate A Buffer. Hippocampi from 4-6 mice per condition were pooled into one well for further processing. Tissue from each pooled sample was moved to a 100mm dish, minced with a razor blade, then placed in a 5mL Eppendorf tube with 1mL pre-warmed Enzyme Buffer. Samples in Eppendorf tubes were then incubated in a 35C water bath for 30 minutes, with gentle trituration at the 15-, 25-, and 30-minute timepoints. The homogenate was then filtered (70um MACS SmartStrainers) into a 50mL conical tube and centrifuged and washed at 4C for a few times. The cells were resuspended in Blocking Buffer (BD Biosciences). After a 5-minute incubation at 4C, cells were incubated in Antibody Solution (1X DPBS, 0.2% BSA, 1.89ug/mL CD45 PE-Cyanine7 (Thermofisher), 3.53ug/mL CD11b Brilliant Violet 421 (BioLegend)) for 40 minutes at 4C. After being washed with 1X DPBS with 0.2% BSA and filtered through a 40um Flowmi Cell Strainer (Millipore Sigma) into a pre-chilled 5mL FACS tubes (Stem Cell Technologies), live single cells were identified and gated per standard sorting protocols, then further sorted to isolate a CD11b+/CD45int microglia population (Supp Fig 6) with a BD FACS Aria Fusion I or BD Aria II at 4C with a 100um nozzle (20 psi). The sorted microglia were centrifuged at 500g at 4C for 5 minutes, then loaded onto 10x Genomics Next GEM chip G at cell counts of approximately 25,000 cells.The scRNA-seq libraries were prepared using the Chromium Next GEM Single Cell 3 Library and Gel Bead kit v.3.1 (10x Genomics) according to the manufacturers instructions. Libraries were sequenced on an Illumina NovaSeq 6000 sequencer at the UCSF CAT Core.",,,
AD075003,GSM7904794,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39500314/E3KI_filtered_feature_bc_matrix/,10x_matrix,,39500314,AD,Healthy,,Mouse,hippocampus,no data available,male,no data available,3-5 months,,10X Genomics,Single-cell RNA sequencing,"No transplanted human neurons, only mouse APOE3 knock-in","Human induced pluripotent stem cell (hiPSC)-derived neurons (at culture days 35-42) were collected and single cells were then centrifuged and resuspended to concentration of 500 cells/nL in 1X HBSS (GIBCO) supplemented with 10 ng/mL BDNF (Peprotech), 10 ng/mL GDNF (Peprotech) and 100 ng/mL DNaseI (Roche) and kept at 4C until transplantation. Mice were anesthetized with an intraperitoneal injection of ketamine (60 mg/kg) and xylazine (30 mg/kg) and maintained on 0.8%-1.0% isofluorane (Henry Schein). Mice were secured in a stereotaxic alignment system model 940 using earbars and a tooth bar (Kopf Instruments). The scalp was prepared by removing hair with scissors and sterilizing with 70% ethanol. The scalp was then cut open using a scalpel and sterilized with 70% ethanol. Cell suspensions (500 cells/nL) were loaded into 60 m tip diameter, 30 beveled glass micropipette needles (Nanoject, Drummond Scientific Company). Approximately 30,000 cells per site were injected at 4 sites (2 per hemibrain) at a rate of 25 nL/sec and allowed to diffuse for 1 min. Each mouse received four total cell transplants, two per hemibrain hippocampus. Following surgery, mice were sutured with nylon monofilament non-absorbable 6-0 sutures (Henry Schein), and administered analgesics buprenorphine (0.0375 mg/kg intraperitoneally), ketofen (5 mg/kg subcutaneously), and saline (500L intraperitoneally). Immunosuppressants were administered immediately after transplantation (day 0) via intraperitoneal injection followed by injections on day 2, 4, and 6 post transplantation.APOE3 and APOE4 knock-in (E3KI and E4KI) mice on a C57BL/6 background were originally obtained from Taconic. All animals were bred in-house using trio breeding producing 810 pups per litter on average, which were weaned at 28 days. Male littermates at 3-5 months of age were randomly assigned to experimental groups. Animals were housed in a pathogen-free barrier facility on a 12 hr light cycle (lights on at 7 am and off at 7 pm) at 1923C and 30%70% humidity. Mice were genotyped by polymerase chain reaction (PCR) of a tail clipping at weaning. All mouse experiments were conducted in accordance with the guidelines and regulations of the National Institutes of Health, the University of California, and the Gladstone Institutes under IACUC protocol AN117112. The hippocampus of each mouses left hemi-brain was dissected on ice, rinsed with cold Dissection Buffer, and placed into a pre-chilled 12-well plate with 2 mL/well of Hibernate A Buffer. Hippocampi from 4-6 mice per condition were pooled into one well for further processing. Tissue from each pooled sample was moved to a 100mm dish, minced with a razor blade, then placed in a 5mL Eppendorf tube with 1mL pre-warmed Enzyme Buffer. Samples in Eppendorf tubes were then incubated in a 35C water bath for 30 minutes, with gentle trituration at the 15-, 25-, and 30-minute timepoints. The homogenate was then filtered (70um MACS SmartStrainers) into a 50mL conical tube and centrifuged and washed at 4C for a few times. The cells were resuspended in Blocking Buffer (BD Biosciences). After a 5-minute incubation at 4C, cells were incubated in Antibody Solution (1X DPBS, 0.2% BSA, 1.89ug/mL CD45 PE-Cyanine7 (Thermofisher), 3.53ug/mL CD11b Brilliant Violet 421 (BioLegend)) for 40 minutes at 4C. After being washed with 1X DPBS with 0.2% BSA and filtered through a 40um Flowmi Cell Strainer (Millipore Sigma) into a pre-chilled 5mL FACS tubes (Stem Cell Technologies), live single cells were identified and gated per standard sorting protocols, then further sorted to isolate a CD11b+/CD45int microglia population (Supp Fig 6) with a BD FACS Aria Fusion I or BD Aria II at 4C with a 100um nozzle (20 psi). The sorted microglia were centrifuged at 500g at 4C for 5 minutes, then loaded onto 10x Genomics Next GEM chip G at cell counts of approximately 25,000 cells.The scRNA-seq libraries were prepared using the Chromium Next GEM Single Cell 3 Library and Gel Bead kit v.3.1 (10x Genomics) according to the manufacturers instructions. Libraries were sequenced on an Illumina NovaSeq 6000 sequencer at the UCSF CAT Core.",,,
AD075004,GSM7904795,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39500314/E4KI_filtered_feature_bc_matrix/,10x_matrix,,39500314,AD,no data available,,Mouse,hippocampus,no data available,male,no data available,3-5 months,,10X Genomics,Single-cell RNA sequencing,"No transplanted human neurons, only mouse APOE4 knock-in","Human induced pluripotent stem cell (hiPSC)-derived neurons (at culture days 35-42) were collected and single cells were then centrifuged and resuspended to concentration of 500 cells/nL in 1X HBSS (GIBCO) supplemented with 10 ng/mL BDNF (Peprotech), 10 ng/mL GDNF (Peprotech) and 100 ng/mL DNaseI (Roche) and kept at 4C until transplantation. Mice were anesthetized with an intraperitoneal injection of ketamine (60 mg/kg) and xylazine (30 mg/kg) and maintained on 0.8%-1.0% isofluorane (Henry Schein). Mice were secured in a stereotaxic alignment system model 940 using earbars and a tooth bar (Kopf Instruments). The scalp was prepared by removing hair with scissors and sterilizing with 70% ethanol. The scalp was then cut open using a scalpel and sterilized with 70% ethanol. Cell suspensions (500 cells/nL) were loaded into 60 m tip diameter, 30 beveled glass micropipette needles (Nanoject, Drummond Scientific Company). Approximately 30,000 cells per site were injected at 4 sites (2 per hemibrain) at a rate of 25 nL/sec and allowed to diffuse for 1 min. Each mouse received four total cell transplants, two per hemibrain hippocampus. Following surgery, mice were sutured with nylon monofilament non-absorbable 6-0 sutures (Henry Schein), and administered analgesics buprenorphine (0.0375 mg/kg intraperitoneally), ketofen (5 mg/kg subcutaneously), and saline (500L intraperitoneally). Immunosuppressants were administered immediately after transplantation (day 0) via intraperitoneal injection followed by injections on day 2, 4, and 6 post transplantation. 	APOE3 and APOE4 knock-in (E3KI and E4KI) mice on a C57BL/6 background were originally obtained from Taconic. All animals were bred in-house using trio breeding producing 810 pups per litter on average, which were weaned at 28 days. Male littermates at 3-5 months of age were randomly assigned to experimental groups. Animals were housed in a pathogen-free barrier facility on a 12 hr light cycle (lights on at 7 am and off at 7 pm) at 1923C and 30%70% humidity. Mice were genotyped by polymerase chain reaction (PCR) of a tail clipping at weaning. All mouse experiments were conducted in accordance with the guidelines and regulations of the National Institutes of Health, the University of California, and the Gladstone Institutes under IACUC protocol AN117112.The hippocampus of each mouses left hemi-brain was dissected on ice, rinsed with cold Dissection Buffer, and placed into a pre-chilled 12-well plate with 2 mL/well of Hibernate A Buffer. Hippocampi from 4-6 mice per condition were pooled into one well for further processing. Tissue from each pooled sample was moved to a 100mm dish, minced with a razor blade, then placed in a 5mL Eppendorf tube with 1mL pre-warmed Enzyme Buffer. Samples in Eppendorf tubes were then incubated in a 35C water bath for 30 minutes, with gentle trituration at the 15-, 25-, and 30-minute timepoints. The homogenate was then filtered (70um MACS SmartStrainers) into a 50mL conical tube and centrifuged and washed at 4C for a few times. The cells were resuspended in Blocking Buffer (BD Biosciences). After a 5-minute incubation at 4C, cells were incubated in Antibody Solution (1X DPBS, 0.2% BSA, 1.89ug/mL CD45 PE-Cyanine7 (Thermofisher), 3.53ug/mL CD11b Brilliant Violet 421 (BioLegend)) for 40 minutes at 4C. After being washed with 1X DPBS with 0.2% BSA and filtered through a 40um Flowmi Cell Strainer (Millipore Sigma) into a pre-chilled 5mL FACS tubes (Stem Cell Technologies), live single cells were identified and gated per standard sorting protocols, then further sorted to isolate a CD11b+/CD45int microglia population (Supp Fig 6) with a BD FACS Aria Fusion I or BD Aria II at 4C with a 100um nozzle (20 psi). The sorted microglia were centrifuged at 500g at 4C for 5 minutes, then loaded onto 10x Genomics Next GEM chip G at cell counts of approximately 25,000 cells.The scRNA-seq libraries were prepared using the Chromium Next GEM Single Cell 3 Library and Gel Bead kit v.3.1 (10x Genomics) according to the manufacturers instructions. Libraries were sequenced on an Illumina NovaSeq 6000 sequencer at the UCSF CAT Core.",,,
AD075005,GSM7904796,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39500314/EKO_Ctrl_filtered_feature_bc_matrix/,10x_matrix,,39500314,AD,no data available,,Mouse,hippocampus,no data available,male,no data available,3-5 months,,10X Genomics,Single-cell RNA sequencing,human APOE-KO + mouse APOE4 knock-in,"Human induced pluripotent stem cell (hiPSC)-derived neurons (at culture days 35-42) were collected and single cells were then centrifuged and resuspended to concentration of 500 cells/nL in 1X HBSS (GIBCO) supplemented with 10 ng/mL BDNF (Peprotech), 10 ng/mL GDNF (Peprotech) and 100 ng/mL DNaseI (Roche) and kept at 4C until transplantation. Mice were anesthetized with an intraperitoneal injection of ketamine (60 mg/kg) and xylazine (30 mg/kg) and maintained on 0.8%-1.0% isofluorane (Henry Schein). Mice were secured in a stereotaxic alignment system model 940 using earbars and a tooth bar (Kopf Instruments). The scalp was prepared by removing hair with scissors and sterilizing with 70% ethanol. The scalp was then cut open using a scalpel and sterilized with 70% ethanol. Cell suspensions (500 cells/nL) were loaded into 60 m tip diameter, 30 beveled glass micropipette needles (Nanoject, Drummond Scientific Company). Approximately 30,000 cells per site were injected at 4 sites (2 per hemibrain) at a rate of 25 nL/sec and allowed to diffuse for 1 min. Each mouse received four total cell transplants, two per hemibrain hippocampus. Following surgery, mice were sutured with nylon monofilament non-absorbable 6-0 sutures (Henry Schein), and administered analgesics buprenorphine (0.0375 mg/kg intraperitoneally), ketofen (5 mg/kg subcutaneously), and saline (500L intraperitoneally). Immunosuppressants were administered immediately after transplantation (day 0) via intraperitoneal injection followed by injections on day 2, 4, and 6 post transplantation. 	APOE3 and APOE4 knock-in (E3KI and E4KI) mice on a C57BL/6 background were originally obtained from Taconic. All animals were bred in-house using trio breeding producing 810 pups per litter on average, which were weaned at 28 days. Male littermates at 3-5 months of age were randomly assigned to experimental groups. Animals were housed in a pathogen-free barrier facility on a 12 hr light cycle (lights on at 7 am and off at 7 pm) at 1923C and 30%70% humidity. Mice were genotyped by polymerase chain reaction (PCR) of a tail clipping at weaning. All mouse experiments were conducted in accordance with the guidelines and regulations of the National Institutes of Health, the University of California, and the Gladstone Institutes under IACUC protocol AN117112.The hippocampus of each mouses left hemi-brain was dissected on ice, rinsed with cold Dissection Buffer, and placed into a pre-chilled 12-well plate with 2 mL/well of Hibernate A Buffer. Hippocampi from 4-6 mice per condition were pooled into one well for further processing. Tissue from each pooled sample was moved to a 100mm dish, minced with a razor blade, then placed in a 5mL Eppendorf tube with 1mL pre-warmed Enzyme Buffer. Samples in Eppendorf tubes were then incubated in a 35C water bath for 30 minutes, with gentle trituration at the 15-, 25-, and 30-minute timepoints. The homogenate was then filtered (70um MACS SmartStrainers) into a 50mL conical tube and centrifuged and washed at 4C for a few times. The cells were resuspended in Blocking Buffer (BD Biosciences). After a 5-minute incubation at 4C, cells were incubated in Antibody Solution (1X DPBS, 0.2% BSA, 1.89ug/mL CD45 PE-Cyanine7 (Thermofisher), 3.53ug/mL CD11b Brilliant Violet 421 (BioLegend)) for 40 minutes at 4C. After being washed with 1X DPBS with 0.2% BSA and filtered through a 40um Flowmi Cell Strainer (Millipore Sigma) into a pre-chilled 5mL FACS tubes (Stem Cell Technologies), live single cells were identified and gated per standard sorting protocols, then further sorted to isolate a CD11b+/CD45int microglia population (Supp Fig 6) with a BD FACS Aria Fusion I or BD Aria II at 4C with a 100um nozzle (20 psi). The sorted microglia were centrifuged at 500g at 4C for 5 minutes, then loaded onto 10x Genomics Next GEM chip G at cell counts of approximately 25,000 cells.The scRNA-seq libraries were prepared using the Chromium Next GEM Single Cell 3 Library and Gel Bead kit v.3.1 (10x Genomics) according to the manufacturers instructions. Libraries were sequenced on an Illumina NovaSeq 6000 sequencer at the UCSF CAT Core.",,,
AD077001,GSM7092584,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38385967/WT/,10x_matrix,,38385967,AD,Healthy,,Mouse,whole brain,Young Wild-Type with daily saline injections,no data available,no data available,7 months,,10X Genomics,Single-cell RNA sequencing,Young Wild-Type,"Whole brain tissue was collected at 7 months of age after 5 months of daily i.p. injection. Brain tissue disassociated following the 10x Genomics Mouse Neural Tissue protocol. Library constructed follwing manufacturer protocol for the 10x Genomics Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit",,,
AD077002,GSM7092585,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38385967/WT-APC/,10x_matrix,,38385967,AD,Healthy,,Mouse,whole brain,Young Wild-Type with daily APC injections,no data available,no data available,7 months,,10X Genomics,Single-cell RNA sequencing,Young Wild-Type,"Whole brain tissue was collected at 7 months of age after 5 months of daily i.p. injection. Brain tissue disassociated following the 10x Genomics Mouse Neural Tissue protocol. Library constructed follwing manufacturer protocol for the 10x Genomics Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit",,,
AD077003,GSM7092586,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38385967/FAD/,10x_matrix,,38385967,AD,Disease,,Mouse,whole brain,5xFAD with daily saline injections,no data available,no data available,7 months,,10X Genomics,Single-cell RNA sequencing,5xFAD,"Whole brain tissue was collected at 7 months of age after 5 months of daily i.p. injection. Brain tissue disassociated following the 10x Genomics Mouse Neural Tissue protocol. Library constructed follwing manufacturer protocol for the 10x Genomics Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit",,,
AD077004,GSM7092587,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38385967/FAD-APC/,10x_matrix,,38385967,AD,Disease,,Mouse,whole brain,5xFAD with daily APC injections,no data available,no data available,7 months,,10X Genomics,Single-cell RNA sequencing,5xFAD,"Whole brain tissue was collected at 7 months of age after 5 months of daily i.p. injection. Brain tissue disassociated following the 10x Genomics Mouse Neural Tissue protocol. Library constructed follwing manufacturer protocol for the 10x Genomics Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit",,,
AD078001,GSM7835054,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835054_01WTM_scRNA_MM48_NPG_S1_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078002,GSM7835055,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835055_02TGM_scRNA_MM48_NPG_S2_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078003,GSM7835056,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835056_03WTF_scRNA_MM48_NPG_S3_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078004,GSM7835057,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835057_04TGF_scRNA_MM48_NPG_S4_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078005,GSM7835058,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835058_05WTM_scRNA_MM48_NPG_S9_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078006,GSM7835059,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835059_06WTM_scRNA_MM48_NPG_S10_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078007,GSM7835060,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835060_07WTM_scRNA_MM48_NPG_S11_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078008,GSM7835061,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835061_08TGM_scRNA_MM48_NPG_S12_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078009,GSM7835062,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835062_09TGM_scRNA_MM48_NPG_S1_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078010,GSM7835063,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835063_10TGM_scRNA_MM48_NPG_S2_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078011,GSM7835064,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835064_11WTF_scRNA_MM48_NPG_S3_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078012,GSM7835065,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835065_12WTF_scRNA_MM48_NPG_S4_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078013,GSM7835066,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835066_13WTF_scRNA_MM48_NPG_S5_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078014,GSM7835067,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835067_14TGF_scRNA_MM48_NPG_S6_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078015,GSM7835068,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835068_15TGF_scRNA_MM48_NPG_S7_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078016,GSM7835069,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835069_16TGF_scRNA_MM48_NPG_S8_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078017,GSM7835070,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835070_17WTM_scRNA_MM48_NPG_S5_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078018,GSM7835071,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835071_18TGM_scRNA_MM48_NPG_S6_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,male,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078019,GSM7835072,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835072_19WTF_scRNA_MM48_NPG_S7_DGE.txt,txt,,38453894,AD,Healthy,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,WT,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD078020,GSM7835073,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38453894/GSM7835073_20TGF_scRNA_MM48_NPG_S8_DGE.txt,txt,,38453894,AD,Disease,,Mouse,Cortex,no data available,Female,early stage,28 weeks,,drop-seq,Single-cell RNA sequencing,TG,"THY1-Tau22 breeders were obtained from Luc Bue (University of Lille, France) under a Material Transfer Agreement. The line was rederived and bred by crossing heterozygous male breeders with commercially obtained C57Bl6/J females. The mice were kept in specialized facilities maintained under specific pathogen-free conditions. They were provided with unrestricted access to standard mouse food (Ssniff, # V 1534-300) and water at all times. Offspring was let age until 28 weeks.RNA was extracted from the cortex using RNeasy Universal Kit (Qiagen). RNA samples were deemed of acceptable quality when their RNA integrity value exceeded 8.5, and their absorbance ratios at 260/230 and 260/280 were equal to or greater than 1.8 and 2, respectively. These high-quality RNA samples were subsequently preserved at -80C until they were utilized. For single cell gene expression profiling, freshly dissected mouse cortex was disrupted with the Adult - Brain Dissociation (Miltenyi Biotec).The 3 end enriched cDNA libraries were prepared by tagmentation reaction of 600 pg cDNA library using the standard Nextera XT tagmentation kit (Illumina). Reactions were performed according to the manufacturers instructions. The PCR amplification cycling programme used was 95 C 30 s, and 12 cycles of 95 C (10 s), 55 C (30 s), and 72 C (30 s), followed by a final extension step of 72 C (5 min). Libraries were purified twice to reduce primers and short DNA fragments with 0.6and 1Agencourt AMPure XP beads (Beckman Coulter), respectively, in accordance with the manufacturers protocol. Finally, purified libraries were eluted in 10 l Molecular Grade Water. Quality and quantity of the tagmented cDNA library were evaluated using Bioanalyzer High Sensitivity DNA Chip. The average size of the tagmented libraries prior to sequencing was between 400 and 700 bps.Purified Drop-seq cDNA libraries were sequenced using an Illumina NextSeq 500 machine with the recommended sequencing protocol, except for 6 pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG CAGAGTAC) applied for priming of read 1. Paired-end sequencing was performed for the read 1 of 20 bases (covering the random cell barcode 112 bases and the rest 1320 bases of random unique molecular identifier (UMI) and for read 2 of 60 bases of the genes. Raw reads were further demultiplexed and processed using a dedicated Drop-seq computational pipeline",,,
AD079001,GSM6186021,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186021_DeJager_MO_LOAD11_G_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079002,GSM6186022,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186022_MA001_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079003,GSM6186023,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186023_MA002_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA4,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079004,GSM6186024,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186024_MA003_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,FN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079005,GSM6186025,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186025_MA004_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079006,GSM6186026,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186026_PM004_filtered_feature_bc_matrix.h5,h5,,39406950,DLBD-PD,Disease,,Human,BA9,no data available,Male,no data available,88,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079007,GSM6186027,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186027_PM005_filtered_feature_bc_matrix.h5,h5,,39406950,DLBD-PD,Disease,,Human,SN,no data available,Male,no data available,88,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079008,GSM6186028,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186028_PM006_filtered_feature_bc_matrix.h5,h5,,39406950,DLBD-PD,Disease,,Human,SN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079009,GSM6186029,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186029_PM007_filtered_feature_bc_matrix.h5,h5,,39406950,DLBD-PD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079010,GSM6186030,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186030_PM013_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079011,GSM6186031,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186031_PM014_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079012,GSM6186032,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186032_PM016_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079013,GSM6186033,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186033_PM017_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,SN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079014,GSM6186034,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186034_PM018_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079015,GSM6186035,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186035_PM020_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079016,GSM6186036,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186036_PM021_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,SN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079017,GSM6186037,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186037_PM022_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079018,GSM6186038,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186038_PM023_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079019,GSM6186039,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186039_PM024_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079020,GSM6186040,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186040_PM025_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,SN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079021,GSM6186041,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186041_PM026_filtered_feature_bc_matrix.h5,h5,,39406950,PSP,Disease,,Human,SN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079022,GSM6186042,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186042_PM027_filtered_feature_bc_matrix.h5,h5,,39406950,PSP,Disease,,Human,H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079023,GSM6186043,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186043_PM029_filtered_feature_bc_matrix.h5,h5,,39406950,PSP,Disease,,Human,BA9,no data available,Male,no data available,77,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079024,GSM6186044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186044_PM030_filtered_feature_bc_matrix.h5,h5,,39406950,FTD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079025,GSM6186045,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186045_PM031_filtered_feature_bc_matrix.h5,h5,,39406950,FTD,Disease,,Human,H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079026,GSM6186046,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186046_PM036_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA4,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079027,GSM6186047,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186047_PM037_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079028,GSM6186048,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186048_PM038_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,FN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079029,GSM6186049,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186049_PM039_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079030,GSM6186050,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186050_PM040_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,FN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079031,GSM6186051,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186051_PM041_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079032,GSM6186052,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186052_PM042_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079033,GSM6186053,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186053_PM043_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA4,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079034,GSM6186054,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186054_PM045_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079035,GSM6186055,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186055_PM046_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,FN,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079036,GSM6186056,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186056_PM047_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA4,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079037,GSM6186057,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186057_PM048_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079038,GSM6186058,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186058_PM051_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA4,no data available,no data,no data available,5 months,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079039,GSM6186059,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186059_PM052_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079040,GSM6186060,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186060_PM053_filtered_feature_bc_matrix.h5,h5,,39406950,DLBD-PD,Disease,,Human,BA9,no data available,Male,no data available,82,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079041,GSM6186061,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186061_PM054_filtered_feature_bc_matrix.h5,h5,,39406950,DLBD-PD,Disease,,Human,SN,no data available,Male,no data available,82,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079042,GSM6186062,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186062_PM055_filtered_feature_bc_matrix.h5,h5,,39406950,MS,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079043,GSM6186063,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186063_PM056_filtered_feature_bc_matrix.h5,h5,,39406950,MS,Disease,,Human,TH,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079044,GSM6186064,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186064_PM057_filtered_feature_bc_matrix.h5,h5,,39406950,MS,Disease,,Human,AWS,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079045,GSM6186065,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186065_PM058_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9+BA4+SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079046,GSM6186066,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186066_PM059_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079047,GSM6186067,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186067_PM060_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079048,GSM6186068,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186068_PM061_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079049,GSM6186069,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186069_PM062_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9+BA4+SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079050,GSM6186070,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186070_PM063_filtered_feature_bc_matrix.h5,h5,,39406950,"ALS, FTD",Disease,,Human,BA9+BA4+SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079051,GSM6186071,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186071_PM064_filtered_feature_bc_matrix.h5,h5,,39406950,MS,Disease,,Human,BA9+TH+Lesion+AWS,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079052,GSM6186072,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186072_PM065_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079053,GSM6186073,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186073_PM066_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,Male,no data available,47,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079054,GSM6186074,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186074_PM067_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079055,GSM6186075,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186075_PM068_filtered_feature_bc_matrix.h5,h5,,39406950,DLBD-PD,Disease,,Human,BA9+SN,no data available,Male,no data available,82,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079056,GSM6186076,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186076_PM069_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9+BA4+SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079057,GSM6186078,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186078_PM075_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079058,GSM6186079,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186079_PM076_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+H,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079059,GSM6186080,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186080_PM077_filtered_feature_bc_matrix.h5,h5,,39406950,"ALS, FTD",Disease,,Human,BA9+BA4+SC+SN,no data available,Female,no data available,80,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079060,GSM6186081,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186081_PM078_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,Male,no data available,70,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079061,GSM6186082,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186082_PM080_filtered_feature_bc_matrix.h5,h5,,39406950,ALS,Disease,,Human,BA9+BA4+SC,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079062,GSM6186083,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186083_PM082_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,Female,no data available,89,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079063,GSM6186084,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186084_PM083_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,Male,no data available,60,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079064,GSM6186085,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186085_PM084_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,Male,no data available,67,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079065,GSM6186086,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186086_PM085_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+AWS,no data available,no data,no data available,60-95,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079066,GSM6186087,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186087_PM086_filtered_feature_bc_matrix.h5,h5,,39406950,AD,Disease,,Human,BA9+BA20+H,no data available,Female,no data available,78,,10X Genomics,Single-cell RNA sequencing,,"CD45+ cells were isolated from autopsy tissue or surgical resections using a cold mechanical dissociation protocol, as described in our publication. (Tuddenham, Taga, Haage, et al. 2022)10x Genomics Chromium 3' v2 and v3 chemistry",,,
AD079067,GSM6186077,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39406950/GSM6186077_PM073_filtered_feature_bc_matrix.h5,,,39406950,AD,Healthy,,Human,,,,,,,,,,,,,
AD080001,GSM6948202,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948202_Sample4_,10x_matrix,,40205047,AD,Disease,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,TIM-3 knock out; 5xFAD,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080002,GSM6948203,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948203_Sample5_,10x_matrix,,40205047,AD,Disease,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,5xFAD,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080003,GSM6948204,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948204_Sample6_,10x_matrix,,40205047,AD,Healthy,Yes,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,WT,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080004,GSM6948205,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948205_Sample7_,10x_matrix,,40205047,AD,Disease,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,TIM-3 knock out; 5xFAD,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080005,GSM6948206,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948206_Sample8_,10x_matrix,,40205047,AD,Healthy,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,TIM-3 knock out,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080006,GSM6948207,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948207_Sample9_,10x_matrix,,40205047,AD,Healthy,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,TIM-3 knock out,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080007,GSM6948208,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948208_Sample10_,10x_matrix,,40205047,AD,Disease,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,5xFAD,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080008,GSM6948209,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948209_Sample11_,10x_matrix,,40205047,AD,Healthy,Yes,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,WT,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080009,GSM6948210,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948210_Sample12_,10x_matrix,,40205047,AD,Disease,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,5xFAD,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080010,GSM6948211,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM6948211_Sample13_,10x_matrix,,40205047,AD,Disease,,Mouse,Brain cortex,no data available,Female,no data available,5 months,,10X Genomics,Single-nucleus RNA sequencing,TIM-3 knock out; 5xFAD,"Nuclei from frozen mouse brain were isolated according to the protocol described in a previous report. In brief, frozen mouse frontal cortex was thawed and mechanically dissociated in ST buffer (10mM Tris-HCL pH7.5, 146mM NaCl, 1mM CaCl2, 21mM MgCl2) with 0.49% CHAPS (Millipore). Single-nuclei suspensions were filtered using a 40 m strainer, centrifuged at 500g for 5min, and resuspended in ST buffer supplemented with 0.01% BSA (Sigma).Nuclear suspensions were counted using a hemocytometer. 10x Chromium Single Cell 3 Reagent Kit v3 (10x Genomics) was used according to manufacturer's protocol. In brief, 11,000 nuclei were loaded on the Chromium Chip (10x Genomics) and processed in the Chromium Controller. Single-nuclei were partitioned into Gel Beads-in-emulsion (GEMs), followed by RNA reverse transcription with barcoding. Libraries were created by breaking GEMs and pooling barcoded fractions, cDNA amplification, fragmentation and attachment of sample index and adapter.",,,
AD080011,GSM8275372,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM8275372_con1_cortex_,10x_matrix,,40205047,AD,Disease,Yes,Mouse,Brain cortex,no data available,Female,no data available,4-6 week,,10X Genomics,Single-cell RNA sequencing,5FAD,"Cell suspensions are handed off to the Broad Clinical Labs Single Cell processing team. Appropriate volume adjustments are made to ensure thetarget cell recoveryis met prior to the addition of reverse transcription mastermix. The cells in mastermix are then added to the 10x chip G along with 10x gel beads and partitioning oil. The chip is run on the 10x Chromium Controller to create an emulsion of single cells, RT mastermix and a barcoded gel bead. After emulsions are created, samples are immediately put on reverse transcription thermalcycler protocol set at 53OC for 45 minutes, 85OC for 5 minutes before holding at 4OC. The emulsion is then broken, and debris is removed via a Silane bead cleanup. The purified cDNA is then amplified with the following PCR conditions: Initial denaturation at 98C for 3 minutes, followed by12 cyclesof denaturation at 98C for 15 seconds, annealing at 63C for 20 seconds, and extension at 72C for 1 minute. A 0.6X SPRI cleanup is performed before being quanted on a Qubit.cDNA library construction is run on an entirely automated workflow. The cDNA is fragmented and repaired with the addition of an A-tail at 32OC for 5 minutes then 65OC for 30 minutes. A 0.8X double sided SPRI cleanup then removes undesired fragments. Adapters are ligated onto the DNA at 20OC for 15 minutes followed by a 0.8X SPRI. 10x dual indexed barcodes are added before a PCR reaction with the following conditions: An initial denaturation at 98C for 45 seconds, followed by 12 cycles of denaturation at 98C for 20 seconds, annealing at 54C for 30 seconds, and extension at 72C for 20 seconds. These libraries undergo a final 0.8X double sided SPRI cleanup for size selection. Following PCR Cleanup, quality is confirmed using Quant-iT PicoGreen and an Agilent TapeStation to confirm library size. Samples are pooled together to accommodate the desired reads per cell.",,,
AD080012,GSM8275373,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40205047/GSM8275373_con2_cortex_,10x_matrix,,40205047,AD,Disease,Yes,Mouse,Brain cortex,no data available,Female,no data available,4-6 week,,10X Genomics,Single-cell RNA sequencing,5FAD,,,,
AD083001,GSM8702680,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702680_WT1_,10x_matrix,,39928878,AD,Healthy,,Mouse,Hippocampi,aCSF,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,wt,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083002,GSM8702681,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702681_WT2_,10x_matrix,,39928878,AD,Healthy,,Mouse,Hippocampi,aCSF,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,wt,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083003,GSM8702682,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702682_WT3_,10x_matrix,,39928878,AD,Healthy,,Mouse,Hippocampi,aCSF,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,wt,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083004,GSM8702683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702683_AD1_,10x_matrix,,39928878,AD,Disease,,Mouse,Hippocampi,aCSF,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,app/ps1,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083005,GSM8702684,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702684_AD2_,10x_matrix,,39928878,AD,Disease,,Mouse,Hippocampi,aCSF,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,app/ps1,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083006,GSM8702685,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702685_AD3_,10x_matrix,,39928878,AD,Disease,,Mouse,Hippocampi,aCSF,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,app/ps1,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083007,GSM8702686,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702686_ADKYL1_,10x_matrix,,39928878,AD,Disease,,Mouse,Hippocampi,KYL,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,app/ps1,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083008,GSM8702687,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702687_ADKYL2_,10x_matrix,,39928878,AD,Disease,,Mouse,Hippocampi,KYL,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,app/ps1,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD083009,GSM8702688,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39928878/GSM8702688_ADKYL3_,10x_matrix,,39928878,AD,Disease,,Mouse,Hippocampi,KYL,no data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,app/ps1,"Mice were anesthetized with isoflurane, and their brains were dissected. Hippocampi were dissected from brain, immediately frozen in liquid nitogen and stored at 80CThe frozen hippocampal tissues were homogenized with prechilled Dounce homogenizer with ice-cold homogenization buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM tricine-KOH [pH 7.8], 1 mM dithiothreitol, 0.15 mM spermine, 0.5 mM spermidine, protease inhibitors, 5 g/mL actinomycin, 0.32% Nonidet P-40, and 0.04% bovine serum albumin). After 25 strokes with a loose pestle, the homogenate was mixed 1:1 with OptiPrep, and the solution was centrifuged at 10,000  g for 20 min at 4C. The pellet of separated nuclei was washed to remove the OptiPrep and resuspended in DMEM/F12 supplemented with 10% fetal bovine serum. The nuclei were counted with a hemocytometer and then diluted to 400 nuclei per microliter. All buffers and gradient solutions for nuclear extraction contained 60 U/mL RNasin (Promega). the snRNA-seq libraries were generated using a Chromium Single Cell 3 Library Kit v3 (10x Genomics, 1000078) according to the manufacturers instructions. The concentrations of the final libraries were measured by Qubit (Thermo Fisher Scientific), and fragment lengths were determined using Fragment Analyzer (Advanced Analytical Technologies). The libraries were subjected to paired-end sequencing.",,,
AD085001,GSM8295013,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295013_6289-MW-0199_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,71 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085002,GSM8295014,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295014_6289-MW-0197_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085003,GSM8295015,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295015_6289-MW-0195_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085004,GSM8295016,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295016_6289-MW-0193_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085005,GSM8295017,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295017_6289-MW-0191_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085006,GSM8295018,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295018_6289-MW-0189_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085007,GSM8295019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295019_6289-MW-0187_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085008,GSM8295020,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295020_6289-MW-0185_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085009,GSM8295021,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295021_6289-MW-0183_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085010,GSM8295022,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295022_6289-MW-0181_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085011,GSM8295023,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295023_6289-MW-0019_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085012,GSM8295024,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295024_6289-MW-0179_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085013,GSM8295025,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295025_6289-MW-0177_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085014,GSM8295026,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295026_6289-MW-0175_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085015,GSM8295027,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295027_6289-MW-0173_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085016,GSM8295028,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295028_6289-MW-0171_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085017,GSM8295029,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295029_6289-MW-0169_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085018,GSM8295030,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295030_6289-MW-0167_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085019,GSM8295031,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295031_6289-MW-0165_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085020,GSM8295032,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295032_6289-MW-0163_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085021,GSM8295033,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295033_6289-MW-0161_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085022,GSM8295034,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295034_6289-MW-0017_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085023,GSM8295035,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295035_6289-MW-0159_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085024,GSM8295036,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295036_6289-MW-0157_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,87 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085025,GSM8295037,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295037_6289-MW-0155_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,87 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085026,GSM8295038,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295038_6289-MW-0153_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,87 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085027,GSM8295039,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295039_6289-MW-0151_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,87 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085028,GSM8295040,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295040_6289-MW-0149_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,87 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085029,GSM8295041,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295041_6289-MW-0147_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085030,GSM8295042,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295042_6289-MW-0145_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085031,GSM8295043,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295043_6289-MW-0143_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085032,GSM8295044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295044_6289-MW-0141_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085033,GSM8295045,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295045_6289-MW-0015_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085034,GSM8295046,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295046_6289-MW-0139_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085035,GSM8295047,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295047_6289-MW-0137_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,78 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085036,GSM8295048,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295048_6289-MW-0135_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,78 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085037,GSM8295049,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295049_6289-MW-0133_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,78 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085038,GSM8295050,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295050_6289-MW-0131_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,78 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085039,GSM8295051,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295051_6289-MW-0129_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085040,GSM8295052,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295052_6289-MW-0127_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085041,GSM8295053,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295053_6289-MW-0125_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085042,GSM8295054,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295054_6289-MW-0123_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085043,GSM8295055,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295055_6289-MW-0121_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085044,GSM8295056,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295056_6289-MW-0013_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085045,GSM8295057,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295057_6289-MW-0119_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085046,GSM8295058,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295058_6289-MW-0117_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085047,GSM8295059,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295059_6289-MW-0115_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085048,GSM8295060,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295060_6289-MW-0113_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085049,GSM8295061,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295061_6289-MW-0111_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085050,GSM8295062,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295062_6289-MW-0109_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,72 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085051,GSM8295063,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295063_6289-MW-0063_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,92 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085052,GSM8295064,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295064_6289-MW-0061_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,92 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085053,GSM8295065,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295065_6289-MW-0007_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,75 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085054,GSM8295066,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295066_6289-MW-0059_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085055,GSM8295067,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295067_6289-MW-0057_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085056,GSM8295068,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295068_6289-MW-0055_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085057,GSM8295069,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295069_6289-MW-0053_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085058,GSM8295070,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295070_6289-MW-0051_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085059,GSM8295071,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295071_6289-MW-0049_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085060,GSM8295072,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295072_6289-MW-0047_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085061,GSM8295073,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295073_6289-MW-0045_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085062,GSM8295074,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295074_6289-MW-0043_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085063,GSM8295075,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295075_6289-MW-0041_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085064,GSM8295076,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295076_6289-MW-0005_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,75 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085065,GSM8295077,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295077_6289-MW-0039_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085066,GSM8295078,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295078_6289-MW-0037_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085067,GSM8295079,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295079_6289-MW-0035_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,86 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085068,GSM8295080,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295080_6289-MW-0033_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,79 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085069,GSM8295081,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295081_6289-MW-0031_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,79 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085070,GSM8295082,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295082_6289-MW-0292_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,65 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085071,GSM8295083,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295083_6289-MW-0291_,10x_matrix,,39528672,AD,Healthy,,Human,BA20,no data available,Female,no data available,58 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085072,GSM8295084,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295084_6289-MW-0289_,10x_matrix,,39528672,AD,Healthy,,Human,V1,no data available,Female,no data available,58 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085073,GSM8295085,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295085_6289-MW-0286_,10x_matrix,,39528672,AD,Healthy,,Human,V2,no data available,Female,no data available,58 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085074,GSM8295086,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295086_6289-MW-0284_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,78 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085075,GSM8295087,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295087_6289-MW-0107_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,72 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085076,GSM8295088,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295088_6289-MW-0105_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,72 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085077,GSM8295089,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295089_6289-MW-0103_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,72 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085078,GSM8295090,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295090_6289-MW-0101_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,72 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085079,GSM8295091,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295091_6289-MW-0011_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085080,GSM8295092,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295092_6289-MW-0099_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085081,GSM8295093,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295093_6289-MW-0097_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085082,GSM8295094,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295094_6289-MW-0095_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085083,GSM8295095,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295095_6289-MW-0093_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085084,GSM8295096,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295096_6289-MW-0091_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085085,GSM8295097,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295097_6289-MW-0089_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085086,GSM8295098,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295098_6289-MW-0087_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085087,GSM8295099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295099_6289-MW-0085_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085088,GSM8295100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295100_6289-MW-0083_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085089,GSM8295101,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295101_6289-MW-0081_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085090,GSM8295102,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295102_6289-MW-0009_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085091,GSM8295103,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295103_6289-MW-0079_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085092,GSM8295104,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295104_6289-MW-0077_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085093,GSM8295105,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295105_6289-MW-0075_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085094,GSM8295106,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295106_6289-MW-0073_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085095,GSM8295107,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295107_6289-MW-0071_,10x_matrix,,39528672,AD,Healthy,,Human,V1,no data available,Female,no data available,73 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085096,GSM8295108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295108_6289-MW-0069_,10x_matrix,,39528672,AD,Healthy,,Human,BA20,no data available,Female,no data available,73 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085097,GSM8295109,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295109_6289-MW-0067_,10x_matrix,,39528672,AD,Healthy,,Human,V2,no data available,Female,no data available,73 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085098,GSM8295110,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295110_6289-MW-0065_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,92 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085099,GSM8295111,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295111_6289-MW-0282_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,65 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085100,GSM8295112,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295112_6289-MW-0029_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,79 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085101,GSM8295113,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295113_6289-MW-0280_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,65 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085102,GSM8295114,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295114_6289-MW-0276_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,65 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085103,GSM8295115,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295115_6289-MW-0270_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085104,GSM8295116,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295116_6289-MW-0268_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085105,GSM8295117,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295117_6289-MW-0266_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085106,GSM8295118,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295118_6289-MW-0264_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085107,GSM8295119,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295119_6289-MW-0262_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,84 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085108,GSM8295120,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295120_6289-MW-0260_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085109,GSM8295121,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295121_6289-MW-0258_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085110,GSM8295122,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295122_6289-MW-0256_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085111,GSM8295123,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295123_6289-MW-0027_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,79 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085112,GSM8295124,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295124_6289-MW-0254_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085113,GSM8295125,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295125_6289-MW-0252_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,82 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085114,GSM8295126,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295126_6289-MW-0250_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,91 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085115,GSM8295127,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295127_6289-MW-0248_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,60 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085116,GSM8295128,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295128_6289-MW-0246_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,60 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085117,GSM8295129,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295129_6289-MW-0244_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,60 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085118,GSM8295130,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295130_6289-MW-0242_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,60 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085119,GSM8295131,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295131_6289-MW-0240_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,60 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085120,GSM8295132,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295132_6289-MW-0239_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,91 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085121,GSM8295133,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295133_6289-MW-0238_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,91 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085122,GSM8295134,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295134_6289-MW-0025_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,79 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085123,GSM8295135,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295135_6289-MW-0237_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,91 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085124,GSM8295136,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295136_6289-MW-0236_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,91 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085125,GSM8295137,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295137_6289-MW-0235_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,68 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085126,GSM8295138,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295138_6289-MW-0233_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,68 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085127,GSM8295139,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295139_6289-MW-0231_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,68 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085128,GSM8295140,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295140_6289-MW-0229_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085129,GSM8295141,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295141_6289-MW-0227_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085130,GSM8295142,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295142_6289-MW-0225_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085131,GSM8295143,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295143_6289-MW-0223_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085132,GSM8295144,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295144_6289-MW-0221_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085133,GSM8295145,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295145_6289-MW-0023_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085134,GSM8295146,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295146_6289-MW-0219_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085135,GSM8295147,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295147_6289-MW-0217_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085136,GSM8295148,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295148_6289-MW-0215_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085137,GSM8295149,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295149_6289-MW-0213_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085138,GSM8295150,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295150_6289-MW-0211_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085139,GSM8295151,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295151_6289-MW-0209_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,90+ years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085140,GSM8295152,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295152_6289-MW-0207_,10x_matrix,,39528672,AD,Disease,,Human,BA20,no data available,male,no data available,71 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085141,GSM8295153,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295153_6289-MW-0205_,10x_matrix,,39528672,AD,Disease,,Human,EC,no data available,male,no data available,71 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085142,GSM8295154,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295154_6289-MW-0203_,10x_matrix,,39528672,AD,Disease,,Human,V2,no data available,male,no data available,71 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085143,GSM8295155,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295155_6289-MW-0201_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,71 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085144,GSM8295156,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295156_6289-MW-0021_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,male,no data available,85 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085145,GSM8295157,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295157_6289-MW-0003_,10x_matrix,,39528672,AD,Disease,,Human,BA46,no data available,Female,no data available,75 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD085146,GSM8295158,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39528672/GSM8295158_6289-MW-0001_,10x_matrix,,39528672,AD,Disease,,Human,V1,no data available,Female,no data available,75 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated and sorted following published procedures18. Briefly, 30-40 forty-m-thick cryostat sections were lysed in a sucrose lysis buffer (10 mM Tris-HCl pH 8.0, 320 mM sucrose, 5 mM CaCl2, 3 M Mg(Ac)2, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton X-100). The resulting lysates were filtered through a 70 m-pore cell strainer and nuclei were purified from filtrates by ultracentrifugation (107,000xg for 1.5 h at 4oC) through a sucrose cushion (10 mM Tris-HCl pH 8.0, 1.8 M sucrose, 3 M Mg(Ac)2, 0.1 mM EDTA, and 1 mM DTT). Supernatants were removed and pellets were resuspended in 2% BSA/PBS containing RNase inhibitor (0.2 U/L, Roche). To enrich astrocyte nuclei, we followed a strategy of depletion of neurons and oligodendrocytes. Nuclei were labeled with AlexaFluor647- conjugated mouse monoclonal anti-NeuN antibody (clone 1B7, Novus Biologicals, NBP1-92693AF647) and PE-conjugated mouse monoclonal anti-OLIG2 antibody (clone 211F1.1, EMD Millipore, MABN50A4). After washes, nuclei were stained with Sytox blue (Thermo Fisher) and sorted on a BD FACSAria Fusion. For each sample, we collected SytoxposNeuNposOLIG2neg and SytoxposNeuNnegOLIG2neg.Single-nucleus cDNA libraries were constructed using the Chromium Single Cell 3 Reagents Kit V3 following the manufacturers instructions (10x Genomics). Samples were pooled and sequenced targeting at least 30K reads per cell on a Illumina NovaSeq 6000. Separation of NeuNposOLIG2neg and NeuNnegOLIG2neg into unique libraries allowed for increased number of reads and detected genes in non-neuronal cells as compared to published studies containing non-enriched nuclei snRNA-seq",,,
AD086001,GSM7054709,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38902234/GSM7054709_CP001_filtered_bc_matrix,10x,,38902234,AD,Healthy,Control,Zebrafish (Danio rerio),Telencephalon,no data available,No data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,WT-AB,"Amyloid toxicity was induced as described84,85 in the adult telencephalon of double reporter transgenic zebrafish line  Tg(her4:DsRed)86 and Tg(fli1a:eGFP)26. At 3 days after cerebroventricular injection, the brains were dissected, and single cell suspensions were generated as previously described143,144. After fluorescence-activated cell sorting (FACS) of GFP+ and DsRed+ cells in a separate tube via FACSAria II sorter (Gating strategy is depicted in Supplementary Fig. 24), Chromium Single Cell 3 Gel Bead and Library Kit v3.1 (10X Genomics, 120237) was used to generate single cell cDNA libraries. Generated libraries were sequenced via Illumina NovaSeq 6000 as described",,,
AD086002,GSM7054710,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38902234/GSM7054710_CP003_filtered_bc_matrix,10x,,38902234,AD,Healthy,Tg(her4.1:dRED); Tg(kdrl:GFP),Zebrafish (Danio rerio),GLIA;vascular,PBS,No data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,Tg(her4.1:dRED); Tg(kdrl:GFP),"Amyloid toxicity was induced as described84,85 in the adult telencephalon of double reporter transgenic zebrafish line  Tg(her4:DsRed)86 and Tg(fli1a:eGFP)26. At 3 days after cerebroventricular injection, the brains were dissected, and single cell suspensions were generated as previously described143,144. After fluorescence-activated cell sorting (FACS) of GFP+ and DsRed+ cells in a separate tube via FACSAria II sorter (Gating strategy is depicted in Supplementary Fig. 24), Chromium Single Cell 3 Gel Bead and Library Kit v3.1 (10X Genomics, 120237) was used to generate single cell cDNA libraries. Generated libraries were sequenced via Illumina NovaSeq 6000 as described",,,
AD086003,GSM7054711,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38902234/GSM7054711_CP004_filtered_bc_matrix,10x,,38902234,AD,Disease,Tg(her4.1:dRED); Tg(kdrl:GFP),Zebrafish (Danio rerio),GLIA;vascular,AB42,No data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,Tg(her4.1:dRED); Tg(kdrl:GFP),"Amyloid toxicity was induced as described84,85 in the adult telencephalon of double reporter transgenic zebrafish line  Tg(her4:DsRed)86 and Tg(fli1a:eGFP)26. At 3 days after cerebroventricular injection, the brains were dissected, and single cell suspensions were generated as previously described143,144. After fluorescence-activated cell sorting (FACS) of GFP+ and DsRed+ cells in a separate tube via FACSAria II sorter (Gating strategy is depicted in Supplementary Fig. 24), Chromium Single Cell 3 Gel Bead and Library Kit v3.1 (10X Genomics, 120237) was used to generate single cell cDNA libraries. Generated libraries were sequenced via Illumina NovaSeq 6000 as described",,,
AD086004,GSM7054712,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38902234/GSM7054712_CP013_filtered_bc_matrix,10x,,38902234,AD,Healthy,Tg(fli1a:GFP),Zebrafish (Danio rerio),GLIA,PBS,No data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,Tg(fli1a:GFP),"Amyloid toxicity was induced as described84,85 in the adult telencephalon of double reporter transgenic zebrafish line  Tg(her4:DsRed)86 and Tg(fli1a:eGFP)26. At 3 days after cerebroventricular injection, the brains were dissected, and single cell suspensions were generated as previously described143,144. After fluorescence-activated cell sorting (FACS) of GFP+ and DsRed+ cells in a separate tube via FACSAria II sorter (Gating strategy is depicted in Supplementary Fig. 24), Chromium Single Cell 3 Gel Bead and Library Kit v3.1 (10X Genomics, 120237) was used to generate single cell cDNA libraries. Generated libraries were sequenced via Illumina NovaSeq 6000 as described",,,
AD086005,GSM7054713,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38902234/GSM7054713_CP014_filtered_bc_matrix,10x,,38902234,AD,Healthy,Tg(her4.1:dRED),Zebrafish (Danio rerio),vascular,PBS,No data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,Tg(her4.1:dRED),"Amyloid toxicity was induced as described84,85 in the adult telencephalon of double reporter transgenic zebrafish line  Tg(her4:DsRed)86 and Tg(fli1a:eGFP)26. At 3 days after cerebroventricular injection, the brains were dissected, and single cell suspensions were generated as previously described143,144. After fluorescence-activated cell sorting (FACS) of GFP+ and DsRed+ cells in a separate tube via FACSAria II sorter (Gating strategy is depicted in Supplementary Fig. 24), Chromium Single Cell 3 Gel Bead and Library Kit v3.1 (10X Genomics, 120237) was used to generate single cell cDNA libraries. Generated libraries were sequenced via Illumina NovaSeq 6000 as described",,,
AD086006,GSM7054714,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38902234/GSM7054714_CP015_filtered_bc_matrix,10x,,38902234,AD,Disease,Tg(fli1a:GFP),Zebrafish (Danio rerio),GLIA,AB42,No data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,Tg(fli1a:GFP),"Amyloid toxicity was induced as described84,85 in the adult telencephalon of double reporter transgenic zebrafish line  Tg(her4:DsRed)86 and Tg(fli1a:eGFP)26. At 3 days after cerebroventricular injection, the brains were dissected, and single cell suspensions were generated as previously described143,144. After fluorescence-activated cell sorting (FACS) of GFP+ and DsRed+ cells in a separate tube via FACSAria II sorter (Gating strategy is depicted in Supplementary Fig. 24), Chromium Single Cell 3 Gel Bead and Library Kit v3.1 (10X Genomics, 120237) was used to generate single cell cDNA libraries. Generated libraries were sequenced via Illumina NovaSeq 6000 as described",,,
AD086007,GSM7054715,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38902234/GSM7054715_CP016_filtered_bc_matrix,10x,,38902234,AD,Disease,Tg(her4.1:dRED),Zebrafish (Danio rerio),vascular,AB42,No data,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,Tg(her4.1:dRED),"Amyloid toxicity was induced as described84,85 in the adult telencephalon of double reporter transgenic zebrafish line  Tg(her4:DsRed)86 and Tg(fli1a:eGFP)26. At 3 days after cerebroventricular injection, the brains were dissected, and single cell suspensions were generated as previously described143,144. After fluorescence-activated cell sorting (FACS) of GFP+ and DsRed+ cells in a separate tube via FACSAria II sorter (Gating strategy is depicted in Supplementary Fig. 24), Chromium Single Cell 3 Gel Bead and Library Kit v3.1 (10X Genomics, 120237) was used to generate single cell cDNA libraries. Generated libraries were sequenced via Illumina NovaSeq 6000 as described",,,
AD087001,A277/12_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,M,6,79,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087002,A319/11_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,M,1,74,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087003,A277/12_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,M,6,79,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087004,A115/17_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,M,0,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087005,A115/17_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,M,0,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087006,A019/12_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,F,3,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087007,A051/14_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,F,2,76,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087008,A282/14_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,F,3,68,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087009,PDC016_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,F,2,91,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087010,A051/14_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,F,2,76,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087011,A169/10_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,F,5,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087012,A402/14_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,M,3,83,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087013,A163/17_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,M,5,83,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087014,A170/13_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,F,5,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087015,A019/12_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,F,3,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087016,A053/11_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,M,0,77,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087017,PDC026_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,F,1,80,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087018,A354/16_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,F,2,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087019,A319/11_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,M,1,74,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087020,PDC026_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,F,1,80,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087021,A096/14_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,M,4,87,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087022,PDC016_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,F,2,91,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087023,A127/11_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,M,0,73,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087024,A163/17_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,M,5,83,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087025,A297/16_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,M,1,81,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087026,A402/14_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,M,3,83,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087027,A053/11_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,M,0,77,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087028,A272/15_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,F,6,90,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087029,A282/14_SSC,,rds,individual_brain_region,38472200,AD,Disease,,Human,SSC,no data available,F,3,68,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087030,A127/11_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,M,0,73,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087031,A170/13_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,F,5,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087032,A272/15_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,F,6,90,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087033,A169/10_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,F,5,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087034,A096/14_EC,,rds,individual_brain_region,38472200,AD,Disease,,Human,EC,no data available,M,4,87,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087035,A297/16_SSC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,SSC,no data available,M,1,81,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD087036,A354/16_EC,,rds,individual_brain_region,38472200,AD,Healthy,,Human,EC,no data available,F,2,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD088001,GSM7510285,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40093585/GSM7510285_Normal1_,10x_matrix,,40093585,AD,Healthy,Control,Tupaia belangeri,Hippocampus,no data available,No data,no data available,56 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei isolated from tissues are re-suspended, filtered and used for 10x channel loading, Using Chromium Next GEM Single Cell 3  Reagent Kits v3.1 in Chromium Controller (10 x Genomics) was prepared on mononuclear RNA - seq library.",,,
AD088002,GSM7510286,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40093585/GSM7510286_Normal2_,10x_matrix,,40093585,AD,Healthy,Control,Tupaia belangeri,Hippocampus,no data available,No data,no data available,56 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei isolated from tissues are re-suspended, filtered and used for 10x channel loading, Using Chromium Next GEM Single Cell 3  Reagent Kits v3.1 in Chromium Controller (10 x Genomics) was prepared on mononuclear RNA - seq library.",,,
AD088003,GSM7510287,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40093585/GSM7510287_Normal3_,10x_matrix,,40093585,AD,Healthy,Control,Tupaia belangeri,Hippocampus,no data available,No data,no data available,56 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei isolated from tissues are re-suspended, filtered and used for 10x channel loading, Using Chromium Next GEM Single Cell 3  Reagent Kits v3.1 in Chromium Controller (10 x Genomics) was prepared on mononuclear RNA - seq library.",,,
AD088004,GSM7510288,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40093585/GSM7510288_AD1_,10x_matrix,,40093585,AD,Disease,Alzheimer'slike pathology,Tupaia belangeri,Hippocampus,no data available,No data,no data available,56 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei isolated from tissues are re-suspended, filtered and used for 10x channel loading, Using Chromium Next GEM Single Cell 3  Reagent Kits v3.1 in Chromium Controller (10 x Genomics) was prepared on mononuclear RNA - seq library.",,,
AD088005,GSM7510289,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40093585/GSM7510289_AD2_,10x_matrix,,40093585,AD,Disease,Alzheimer'slike pathology,Tupaia belangeri,Hippocampus,no data available,No data,no data available,56 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei isolated from tissues are re-suspended, filtered and used for 10x channel loading, Using Chromium Next GEM Single Cell 3  Reagent Kits v3.1 in Chromium Controller (10 x Genomics) was prepared on mononuclear RNA - seq library.",,,
AD088006,GSM7510290,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40093585/GSM7510290_AD3_,10x_matrix,,40093585,AD,Disease,Alzheimer'slike pathology,Tupaia belangeri,Hippocampus,no data available,No data,no data available,56 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei isolated from tissues are re-suspended, filtered and used for 10x channel loading, Using Chromium Next GEM Single Cell 3  Reagent Kits v3.1 in Chromium Controller (10 x Genomics) was prepared on mononuclear RNA - seq library.",,,
AD089001,GSM8077099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38918830/GSM8077099_CTL_,10x_matrix,,38918830,AD,Healthy,Control,Mouse,Blood,no data available,Female,no data available,7 month old,,10X Genomics,Single-nucleus RNA sequencing,wt,Single-cell suspensions were prepared according to the protocol of Chromium Single Cell 3 Solution (V3 chemistry). Reverse transcription and library preparation were performed using the 10 Genomics Single-Cell v3.0 kit following the 10 Genomics protocol. Single-cell libraries were submitted to 150 bp paired-end sequencing on the Illumina NavoSeq platform. Preprocessing of the data was done using the 10 Genomics Cell Ranger software version 5.0.0 in default mode. The 10 Genomics supplied reference data for the mm10 assembly and corresponding gene annotation was used for alignment and quantification.,,,
AD089002,GSM8077100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38918830/GSM8077099_CTL_,10x_matrix,,38918830,AD,Disease,AD,Mouse,Blood,no data available,Female,no data available,7 month old,,10X Genomics,Single-nucleus RNA sequencing,app/ps1,Single-cell suspensions were prepared according to the protocol of Chromium Single Cell 3 Solution (V3 chemistry). Reverse transcription and library preparation were performed using the 10 Genomics Single-Cell v3.0 kit following the 10 Genomics protocol. Single-cell libraries were submitted to 150 bp paired-end sequencing on the Illumina NavoSeq platform. Preprocessing of the data was done using the 10 Genomics Cell Ranger software version 5.0.0 in default mode. The 10 Genomics supplied reference data for the mm10 assembly and corresponding gene annotation was used for alignment and quantification.,,,
AD090001,GSM7431053,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431053_control_male_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Healthy,,Mouse,brain,no data available,Male,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,wt,10X Genomics,,,
AD090002,GSM7431054,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431054_control_female_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Healthy,,Mouse,brain,no data available,Female,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,wt,10X Genomics,,,
AD090003,GSM7431055,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431055_control_female_2_raw_feature_bc_matrix.h5,h5,,38347225,AD,Healthy,,Mouse,brain,no data available,Female,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,wt,10X Genomics,,,
AD090004,GSM7431056,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431056_bri2ko_male_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Male,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,BRI2 knock out,10X Genomics,,,
AD090005,GSM7431057,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431057_bri2ko_male_2_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Male,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,BRI2 knock out,10X Genomics,,,
AD090006,GSM7431058,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431058_bri2ko_female_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Female,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,BRI2 knock out,10X Genomics,,,
AD090007,GSM7431059,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431059_bri2ko_female_2_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Female,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,BRI2 knock out,10X Genomics,,,
AD090008,GSM7431060,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431060_trem2ko_male_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Male,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,TREM2 knock out,10X Genomics,,,
AD090009,GSM7431061,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431061_trem2ko_female_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Female,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,TREM2 knock out,10X Genomics,,,
AD090010,GSM7431062,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431062_bri2-trem2dko_male_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Male,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,BRI2 knock out;TREM2 knock out,10X Genomics,,,
AD090011,GSM7431063,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38347225/GSM7431063_bri2-trem2dko_female_1_raw_feature_bc_matrix.h5,h5,,38347225,AD,Disease,,Mouse,brain,no data available,Female,no data available,15 month,,10X Genomics,Single-cell RNA sequencing,BRI2 knock out;TREM2 knock out,10X Genomics,,,
AD091002,GSM7812883,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39308178/GSM7812883_s18685_,10x_matrix,,39308178,AD,Disease,,Mouse,"Mouse frontal lobe, brain",no data available,no data,no data available,16m,,10X Genomics,Single-cell RNA sequencing,SwDI/TKO,10X Genomics,,,
AD091003,GSM7812884,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39308178/GSM7812884_s18687_,10x_matrix,,39308178,AD,Disease,,Mouse,"Mouse frontal lobe, brain",no data available,no data,no data available,16m,,10X Genomics,Single-cell RNA sequencing,SwDI/TWT,10X Genomics,,,
AD091004,GSM7812885,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39308178/GSM7812885_s18775_,10x_matrix,,39308178,AD,Disease,,Mouse,"Mouse frontal lobe, brain",no data available,no data,no data available,16m,,10X Genomics,Single-cell RNA sequencing,SwDI/TWT,10X Genomics,,,
AD091005,GSM7812886,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39308178/GSM7812886_s18986_,10x_matrix,,39308178,AD,Disease,,Mouse,"Mouse frontal lobe, brain",no data available,no data,no data available,16m,,10X Genomics,Single-cell RNA sequencing,SwDI/TKO,10X Genomics,,,
AD091006,GSM7812887,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39308178/GSM7812887_s18988_,10x_matrix,,39308178,AD,Disease,,Mouse,"Mouse frontal lobe, brain",no data available,no data,no data available,16m,,10X Genomics,Single-cell RNA sequencing,SwDI/TKO,10X Genomics,,,
AD091007,GSM7812882,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39308178/GSM7812882_s18682_,,,39308178,AD,Disease,,Mouse,,,,,,,,,SwDI/TKO,,,,
AD093001,GSM7646113,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646113_GEX_1R/GEX_1R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093002,GSM7646114,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646114_GEX_2R/GEX_2R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093003,GSM7646115,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646115_GEX_3R/GEX_3R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093004,GSM7646116,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646116_GEX_4R/GEX_4R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093005,GSM7646117,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646117_GEX_5R/GEX_5R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093006,GSM7646118,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646118_GEX_6R/GEX_6R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093007,GSM7646119,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646119_GEX_7R/GEX_7R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093008,GSM7646120,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646120_GEX_8R/GEX_8R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093009,GSM7646121,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646121_GEX_9R/GEX_9R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E4/E4,10X Genomics,,,
AD093010,GSM7646122,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646122_GEX_10R/GEX_10R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093011,GSM7646123,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646123_GEX_11R/GEX_11R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093012,GSM7646124,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646124_GEX_12R/GEX_12R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093013,GSM7646125,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646125_GEX_13R/GEX_13R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093014,GSM7646126,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646126_GEX_14R/GEX_14R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093015,GSM7646127,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646127_GEX_15R/GEX_15R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093016,GSM7646128,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646128_GEX_17R/GEX_17R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093017,GSM7646129,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646129_GEX_18R/GEX_18R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E4/E4,10X Genomics,,,
AD093018,GSM7646130,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646130_GEX_19R/GEX_19R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093019,GSM7646131,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646131_GEX_20R/GEX_20R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093020,GSM7646132,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646132_GEX_21R/GEX_21R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093021,GSM7646133,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646133_GEX_22R/GEX_22R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093022,GSM7646134,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646134_GEX_23R/GEX_23R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093023,GSM7646135,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646135_GEX_24R/GEX_24R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093024,GSM7646136,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646136_GEX_26R/GEX_26R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093025,GSM7646137,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646137_GEX_27R/GEX_27R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093026,GSM7646138,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646138_GEX_28R/GEX_28R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093027,GSM7646139,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646139_GEX_29R/GEX_29R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093028,GSM7646140,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646140_GEX_30R/GEX_30R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E4/E4,10X Genomics,,,
AD093029,GSM7646141,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646141_GEX_31R/GEX_31R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093030,GSM7646142,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646142_GEX_32R/GEX_32R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093031,GSM7646143,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646143_GEX_33R/GEX_33R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E4/E4,10X Genomics,,,
AD093032,GSM7646144,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646144_GEX_34R/GEX_34R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093033,GSM7646145,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646145_GEX_35R/GEX_35R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093034,GSM7646146,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646146_GEX_36R/GEX_36R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093035,GSM7646147,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646147_GEX_37R/GEX_37R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093036,GSM7646148,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646148_GEX_38R/GEX_38R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093037,GSM7646149,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646149_GEX_39R/GEX_39R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093038,GSM7646150,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646150_GEX_40R/GEX_40R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093039,GSM7646151,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646151_GEX_41R/GEX_41R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093040,GSM7646152,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646152_GEX_42R/GEX_42R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E4/E4,10X Genomics,,,
AD093041,GSM7646153,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646153_GEX_43R/GEX_43R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093042,GSM7646154,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646154_GEX_44R/GEX_44R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093043,GSM7646155,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646155_GEX_45R/GEX_45R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E4/E4,10X Genomics,,,
AD093044,GSM7646156,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646156_GEX_46R/GEX_46R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093045,GSM7646157,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646157_GEX_47R/GEX_47R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093046,GSM7646158,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646158_GEX_48R/GEX_48R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093047,GSM7646159,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646159_GEX_49R/GEX_49R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093048,GSM7646160,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646160_GEX_50R/GEX_50R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093049,GSM7646161,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646161_GEX_51R/GEX_51R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093050,GSM7646162,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646162_GEX_52R/GEX_52R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093051,GSM7646163,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646163_GEX_55R/GEX_55R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093052,GSM7646164,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646164_GEX_56R/GEX_56R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093053,GSM7646165,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646165_GEX_57R/GEX_57R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD093054,GSM7646166,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646166_GEX_58R/GEX_58R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E3,10X Genomics,,,
AD093055,GSM7646167,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646167_GEX_59R/GEX_59R,10x,,40112813,AD,Healthy,control,Human,temporal cortex,no data,Female,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E3/E4,10X Genomics,,,
AD093056,GSM7646168,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40112813/GSM7646168_GEX_60R/GEX_60R,10x,,40112813,AD,Disease,,Human,temporal cortex,no data,Male,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,E2/E3,10X Genomics,,,
AD094001,GSM8148077,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/3_D10CEFH/,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,head,no data,Female,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094002,GSM8148078,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/11_D20CEFH/,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,head,no data,Female,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094003,GSM8148079,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/23_D30CEFH/,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,head,no data,Female,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094004,GSM8148080,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/4_D10CEFB,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,body,no data,Female,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094005,GSM8148081,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/12_D20CEFB,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,body,no data,Female,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094006,GSM8148082,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/24_D30CEFB,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,body,no data,Female,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094007,GSM8148083,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/1_D10CEMH,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,head,no data,Male,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094008,GSM8148084,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/9_D20CEMH,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,head,no data,Male,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094009,GSM8148085,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/21_D30CEMH,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,head,no data,Male,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094010,GSM8148086,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/2_D10CEMB,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,body,no data,Male,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094011,GSM8148087,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/10_D20CEMB,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,body,no data,Male,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094012,GSM8148088,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/22_D30CEMB,10x,,40381615,AD,Healthy,control,Drosophila melanogaster,body,no data,Male,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,,10X Genomics,,,
AD094013,GSM8148089,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/7_D10ABFH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Female,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094014,GSM8148090,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/15_D20ABFH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Female,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094015,GSM8148091,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/8_D10ABFB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Female,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094016,GSM8148092,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/16_D20ABFB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Female,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094017,GSM8148093,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/5_D10ABMH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Male,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094018,GSM8148094,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/13_D20ABMH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Male,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094019,GSM8148095,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/6_D10ABMB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Male,no data available,10,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094020,GSM8148096,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/14_D20ABMB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Male,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,AB42,10X Genomics,,,
AD094021,GSM8148097,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/19_D20TWFH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Female,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD094022,GSM8148098,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/27_D30TWFH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Female,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD094023,GSM8148099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/20_D20TWFB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Female,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD094024,GSM8148100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/28_D30TWFB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Female,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD094025,GSM8148101,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/17_D20TWMH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Male,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD094026,GSM8148102,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/25_D30TWMH,10x,,40381615,AD,Disease,,Drosophila melanogaster,head,no data,Male,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD094027,GSM8148103,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/18_D20TWMB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Male,no data available,20,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD094028,GSM8148104,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40381615/26_D30TWMB,10x,,40381615,AD,Disease,,Drosophila melanogaster,body,no data,Male,no data available,30,,10X Genomics,Single-nucleus RNA sequencing,hTau,10X Genomics,,,
AD096001,GSM8147266,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147266_Ta1_,10x_matrix,,40026671,AD,Disease,,Mouse,left hippocampus,no data,Female,no data available,6m,,10X Genomics,Single-nucleus RNA sequencing,3xTg-AD,10X Genomics,,,
AD096002,GSM8147267,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147267_Ta2_,10x_matrix,,40026671,AD,Disease,,Mouse,left hippocampus,no data,Female,no data available,12m,,10X Genomics,Single-nucleus RNA sequencing,3xTg-AD,10X Genomics,,,
AD096003,GSM8147268,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147268_Ta3_,10x_matrix,,40026671,AD,Healthy,,Mouse,left hippocampus,no data,Female,no data available,6m,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD096004,GSM8147269,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147269_Ta4_,10x_matrix,,40026671,AD,Healthy,,Mouse,left hippocampus,no data,Female,no data available,12m,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD096005,GSM8147270,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147270_Ta5_,10x_matrix,,40026671,AD,Disease,,Mouse,left hippocampus,no data,Female,no data available,6m,,10X Genomics,Single-nucleus RNA sequencing,3xTg-AD,10X Genomics,,,
AD096006,GSM8147271,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147271_Ta6_,10x_matrix,,40026671,AD,Disease,,Mouse,left hippocampus,no data,Female,no data available,12m,,10X Genomics,Single-nucleus RNA sequencing,3xTg-AD,10X Genomics,,,
AD096007,GSM8147272,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147272_Ta7_,10x_matrix,,40026671,AD,Healthy,,Mouse,left hippocampus,no data,Female,no data available,6m,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD096008,GSM8147273,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147273_Ta8_,10x_matrix,,40026671,AD,Healthy,,Mouse,left hippocampus,no data,Female,no data available,12m,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD096009,GSM8147274,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147274_Ta9_,10x_matrix,,40026671,AD,Disease,,Mouse,left hippocampus,no data,Female,no data available,6m,,10X Genomics,Single-nucleus RNA sequencing,3xTg-AD,10X Genomics,,,
AD096010,GSM8147275,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147275_Ta10_,10x_matrix,,40026671,AD,Disease,,Mouse,left hippocampus,no data,Female,no data available,12m,,10X Genomics,Single-nucleus RNA sequencing,3xTg-AD,10X Genomics,,,
AD096011,GSM8147277,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147277_Ta11_,10x_matrix,,40026671,AD,Healthy,,Mouse,left hippocampus,no data,Female,no data available,6m,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD096012,GSM8147278,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40026671/GSM8147278_Ta12_,10x_matrix,,40026671,AD,Healthy,,Mouse,left hippocampus,no data,Female,no data available,12m,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD099001,GSM7951587; JP62,,,,38352874,AD,Healthy,,Mouse,whole brain,no data,no data,no data,3m,,10X Genomics,Single-cell RNA sequencing,wt,10X Genomics,,,
AD099002,GSM7951588; JP60,,,,38352874,AD,Disease,,Mouse,whole brain,no data,no data,no data,3m,,10X Genomics,Single-cell RNA sequencing,NLRP3.KO,10X Genomics,,,
AD099003,GSM7951589; JP61,,,,38352874,AD,Disease,,Mouse,whole brain,no data,no data,no data,3m,,10X Genomics,Single-cell RNA sequencing,APP/PS1,10X Genomics,,,
AD099004,GSM7951590; JP59,,,,38352874,AD,Disease,,Mouse,whole brain,no data,no data,no data,3m,,10X Genomics,Single-cell RNA sequencing,APP/PS1,10X Genomics,,,
AD099005,GSM7951591; K71,,,,38352874,AD,Healthy,,Mouse,whole brain,no data,no data,no data,6m,,10X Genomics,Single-cell RNA sequencing,wt,10X Genomics,,,
AD099006,GSM7951592; K69,,,,38352874,AD,Disease,,Mouse,whole brain,no data,no data,no data,6m,,10X Genomics,Single-cell RNA sequencing,NLRP3.KO,10X Genomics,,,
AD099007,GSM7951593; ISC4,,,,38352874,AD,Healthy,,Mouse,whole brain,no data,no data,no data,9m,,10X Genomics,Single-cell RNA sequencing,wt,10X Genomics,,,
AD099008,GSM7951594; ISC2,,,,38352874,AD,Disease,,Mouse,whole brain,no data,no data,no data,9m,,10X Genomics,Single-cell RNA sequencing,NLRP3.KO,10X Genomics,,,
AD099009,GSM7951595; ISC3,,,,38352874,AD,Disease,,Mouse,whole brain,no data,no data,no data,9m,,10X Genomics,Single-cell RNA sequencing,APP/PS1,10X Genomics,,,
AD099010,GSM7951596; ISC1,,,,38352874,AD,Disease,,Mouse,whole brain,no data,no data,no data,9m,,10X Genomics,Single-cell RNA sequencing,APP/PS1,10X Genomics,,,
AD100017,GSM8439438,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40570367/GSM8439438_NT-APD_,10x_matrix,,40570367,AD,Healthy,no cytokines,Human,THP-1 macrophages,non-treated,Male,no data available,1 year,,10X Genomics,Single-cell RNA sequencing,THP-1;no cytokines,10X Genomics,,,
AD100018,GSM8439439,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40570367/GSM8439439_NT-CRM_,10x_matrix,,40570367,AD,Healthy,no cytokines,Human,THP-1 macrophages,non-treated,Male,no data available,1 year,,10X Genomics,Single-cell RNA sequencing,THP-1;no cytokines,10X Genomics,,,
AD100019,GSM8439440,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40570367/GSM8439440_MIX-APD_,10x_matrix,,40570367,AD,Disease,MIX treatment,Human,THP-1 macrophages,MIX,Male,no data available,1 year,,10X Genomics,Single-cell RNA sequencing,THP-1;MIXIL34 + MCSF + TGF + IL4,10X Genomics,,,
AD100020,GSM8439441,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40570367/GSM8439441_MIX-CRM_,10x_matrix,,40570367,AD,Disease,MIX treatment,Human,THP-1 macrophages,MIX,Male,no data available,1 year,,10X Genomics,Single-cell RNA sequencing,THP-1;MIXIL34 + MCSF + TGF + IL4,10X Genomics,,,
AD101001,GSM8399625,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399625_WT_1_matrix.h5,h5,,40264187,AD,Healthy,,Mouse,hippocampus,Vehicle (10%PEG-400 in H2O),no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD101002,GSM8399626,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399626_WT_2_matrix.h5,h5,,40264187,AD,Healthy,,Mouse,hippocampus,Vehicle (10%PEG-400 in H2O),no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD101003,GSM8399627,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399627_WT_TPPU_1_matrix.h5,h5,,40264187,AD,Healthy,,Mouse,hippocampus,TPPU 3mg/kg for 12 weeks,no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD101004,GSM8399628,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399628_WT_TPPU_2_matrix.h5,h5,,40264187,AD,Healthy,,Mouse,hippocampus,TPPU 3mg/kg for 12 weeks,no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,wt,10X Genomics,,,
AD101005,GSM8399629,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399629_PS19_1_matrix.h5,h5,,40264187,AD,Disease,,Mouse,hippocampus,Vehicle (10%PEG-400 in H2O),no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,PS19,10X Genomics,,,
AD101006,GSM8399630,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399630_PS19_2_matrix.h5,h5,,40264187,AD,Disease,,Mouse,hippocampus,Vehicle (10%PEG-400 in H2O),no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,PS19,10X Genomics,,,
AD101007,GSM8399631,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399631_PS19_TPPU_1_matrix.h5,h5,,40264187,AD,Disease,,Mouse,hippocampus,TPPU 3mg/kg for 12 weeks,no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,PS19,10X Genomics,,,
AD101008,GSM8399632,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40264187/GSM8399632_PS19_TPPU_2_matrix.h5,h5,,40264187,AD,Disease,,Mouse,hippocampus,TPPU 3mg/kg for 12 weeks,no data,no data available,9.5 months old,,10X Genomics,Single-nucleus RNA sequencing,PS19,10X Genomics,,,
AD104001,GSM8395395,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40275379/GSM8395395_scrambledAB_MinusMicroglia_,10x_matrix,,40275379,AD,Healthy,,Human,MinusMicroglia,scrambled A1-42 for 3 weeks,no data,no data available,no data,,10X Genomics,Single-nucleus RNA sequencing,hiPSC (KOLF2.1J),10X Genomics,,,
AD104002,GSM8395396,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40275379/GSM8395396_scrambledAB_PlusMicroglia_,10x_matrix,,40275379,AD,Healthy,,Human,PlusMicroglia,scrambled A1-42 for 3 weeks,no data,no data available,no data,,10X Genomics,Single-nucleus RNA sequencing,hiPSC (KOLF2.1J),10X Genomics,,,
AD104003,GSM8395397,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40275379/GSM8395397_3week_AB_MinusMicroglia_,10x_matrix,,40275379,AD,Disease,,Human,MinusMicroglia,A1-42 synthetic A for 3 weeks,no data,no data available,3 weeks,,10X Genomics,Single-nucleus RNA sequencing,hiPSC (KOLF2.1J),10X Genomics,,,
AD104004,GSM8395398,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40275379/GSM8395398_3week_AB_PlusMicroglia_,10x_matrix,,40275379,AD,Disease,,Human,PlusMicroglia,A1-42 synthetic A for 3 weeks,no data,no data available,3 weeks,,10X Genomics,Single-nucleus RNA sequencing,hiPSC (KOLF2.1J),10X Genomics,,,
AD104005,GSM8395399,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40275379/GSM8395399_5week_AB_MinusMicroglia_,10x_matrix,,40275379,AD,Disease,,Human,MinusMicroglia,A1-42 synthetic A for 5 weeks,no data,no data available,5 weeks,,10X Genomics,Single-nucleus RNA sequencing,hiPSC (KOLF2.1J),10X Genomics,,,
AD104006,GSM8395400,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40275379/GSM8395400_5week_AB_PlusMicroglia_,10x_matrix,,40275379,AD,Disease,,Human,PlusMicroglia,A1-42 synthetic A for 5 weeks,no data,no data available,5 weeks,,10X Genomics,Single-nucleus RNA sequencing,hiPSC (KOLF2.1J),10X Genomics,,,
AD105001,syn52368912,,,h5ad,39048816,AD,no data available,no data available,	Human,Astrocytes,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105002,syn52368925,,,h5ad,39048816,AD,no data available,no data available,	Human,Excitatory neurons,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105003,syn52368950,,,h5ad,39048816,AD,no data available,no data available,	Human,Excitatory neurons,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105004,syn52368932,,,h5ad,39048816,AD,no data available,no data available,	Human,Excitatory neurons,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105005,syn52368905,,,h5ad,39048816,AD,no data available,no data available,	Human,Immune cells,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105006,syn52368921,,,h5ad,39048816,AD,no data available,no data available,	Human,Inhibitory neurons,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105007,syn52368910,,,h5ad,39048816,AD,no data available,no data available,	Human,OPCs,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105008,syn52368918,,,h5ad,39048816,AD,no data available,no data available,	Human,Oligodendrocytes,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105009,syn52368904,,,h5ad,39048816,AD,no data available,no data available,	Human,Vasculature cells,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105010,syn52408594,,,h5ad,39048816,AD,no data available,no data available,	Human,Angular gyrus,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105011,syn52408588,,,h5ad,39048816,AD,no data available,no data available,	Human,Entorhinal cortex,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105012,syn52408592,,,h5ad,39048816,AD,no data available,no data available,	Human,Hippocampus,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105013,syn52408595,,,h5ad,39048816,AD,no data available,no data available,	Human,Midtemporal cortex,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105014,syn52408599,,,h5ad,39048816,AD,no data available,no data available,	Human,Prefrontal cortex,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD105015,syn52408586,,,h5ad,39048816,AD,no data available,no data available,	Human,Thalamus,no data available,no data available,no data available,no data available,no data available,10X Genomics,Single-nucleus RNA sequencing,,"The protocol for the isolation of nuclei from frozen post-mortem brain tissue was adapted from a previous study (Mathys et al., 2019). All procedures were carried out on ice or at 4 C. In brief, post-mortem brain tissue was homogenized in 700 l homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 0.1% IGEPAL CA-630, 1 mM -mercaptoethanol, and 0.4 U l1 recombinant RNase inhibitor (Clontech)) using a Wheaton Dounce tissue grinder (15 strokes with the loose pestle). Then the homogenized tissue was filtered through a 40-m cell strainer, mixed with an equal volume of working solution (50% OptiPrep density gradient medium (Sigma-Aldrich), 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, and 1 mM -mercaptoethanol) and loaded on top of an OptiPrep density gradient (750 l 30% OptiPrep solution (30% OptiPrep density gradient medium,134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.04% IGEPAL CA-630, and 0.17 U l1 recombinant RNase inhibitor) on top of 300 l 40% OptiPrep solution (40% OptiPrep density gradient medium, 96 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl pH 7.8, 0.1 mM EDTA pH 8.0, 1 mM -mercaptoethanol, 0.03% IGEPAL CA-630, and 0.12 U l1 recombinant RNase inhibitor). The nuclei were separated by centrifugation (5 min, 10,000 g, 4 C). A total of 100 l of nuclei was collected from the 30%/40% interphase and washed with 1 ml of PBS containing 0.04% BSA. The nuclei were centrifuged at 300g for 3 min (4 C) and washed with 1 ml of PBS containing 0.04% BSA. Then the nuclei were centrifuged at 300g for 3 min (4 C) and re-suspended in 100 l PBS containing 0.04% BSA. The nuclei were counted and diluted to a concentration of 1,000 nuclei per microliter in PBS containing 0.04% BSA.For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3 Reagent Kits v3 according to the manufacturers protocol (10x Genomics). The generated snRNA-seq libraries were sequenced using NextSeq 500/550 High Output v2 kits (150 cycles) or NovaSeq 6000 S2 Reagent Kits.",,,
AD107001,191122-B6-R1969233-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R1969233-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107002,200715-B35-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200715-B35-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107003,200316-B24-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200316-B24-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107004,200707-B30-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200707-B30-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107005,200729-B40-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200729-B40-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107006,200312-B21-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200312-B21-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107007,200309-B17-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200309-B17-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107008,191213-B7-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191213-B7-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107009,191213-B7-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191213-B7-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107010,200810-B45-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200810-B45-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107011,200316-B24-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200316-B24-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107012,200805-B43-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200805-B43-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107013,201002-B56-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201002-B56-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107014,200728-B39-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200728-B39-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107015,201024-B59-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201024-B59-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107016,191217-B8-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191217-B8-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107017,200910-B52-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200910-B52-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107018,200909-B51-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200909-B51-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107019,191122-B6-R9101940-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R9101940-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107020,200915-B53-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200915-B53-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107021,200908-B50-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200908-B50-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107022,200730-B41-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200730-B41-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107023,200730-B41-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200730-B41-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107024,200729-B40-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200729-B40-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107025,200806-B44-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200806-B44-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107026,200310-B18-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200310-B18-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107027,200709-B32-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200709-B32-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107028,201207-B63-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201207-B63-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107029,200825-B48-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200825-B48-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107030,201021-B60-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201021-B60-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107031,200826-B49-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200826-B49-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107032,200310-B18-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200310-B18-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107033,201028-B62-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201028-B62-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107034,191122-B6-R1710143-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R1710143-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107035,200309-B17-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200309-B17-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107036,190409-B5-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/190409-B5-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107037,200225-B10-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200225-B10-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107038,200805-B43-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200805-B43-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107039,200810-B46-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200810-B46-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107040,200305-B15-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200305-B15-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107041,200810-B47-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200810-B47-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107042,200302-B13-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200302-B13-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107043,191122-B6-R6622577-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R6622577-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107044,200225-B10-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200225-B10-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107045,200302-B13-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200302-B13-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107046,200226-B11-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200226-B11-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107047,200810-B46-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200810-B46-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107048,200317-B26-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200317-B26-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107049,200702-B29-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200702-B29-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107050,200317-B27-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200317-B27-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107051,201007-B58-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201007-B58-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107052,201007-B57-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201007-B57-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107053,200313-B22-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200313-B22-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107054,200714-B34-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200714-B34-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107055,200915-B53-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200915-B53-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107056,200713-B33-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200713-B33-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107057,200312-B20-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200312-B20-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107058,200316-B25-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200316-B25-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107059,200311-B19-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200311-B19-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107060,200708-B31-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200708-B31-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107061,200720-B36-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200720-B36-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107062,191219-B9-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191219-B9-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107063,200721-B37-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200721-B37-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107064,190403-B4-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/190403-B4-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107065,200722-B38-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200722-B38-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107066,201022-B61-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201022-B61-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107067,191122-B6-R7641350-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R7641350-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107068,191122-B6-R7090624-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R7090624-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107069,201028-B62-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201028-B62-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107070,201207-B63-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201207-B63-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107071,200317-B27-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200317-B27-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107072,200909-B51-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200909-B51-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107073,200721-B37-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200721-B37-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107074,200728-B39-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200728-B39-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107075,200303-B14-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200303-B14-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107076,190409-B5-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/190409-B5-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107077,200720-B36-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200720-B36-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107078,200722-B38-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200722-B38-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107079,200806-B44-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200806-B44-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107080,200227-B12-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200227-B12-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107081,200930-B55-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200930-B55-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107082,200701-B28-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200701-B28-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107083,201022-B61-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201022-B61-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107084,191122-B6-R4078277-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R4078277-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107085,200810-B47-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200810-B47-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107086,200312-B20-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200312-B20-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107087,200305-B15-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200305-B15-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107088,200316-B25-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200316-B25-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107089,200227-B12-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200227-B12-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107090,200303-B14-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200303-B14-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107091,200825-B48-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200825-B48-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107092,201007-B57-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201007-B57-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107093,200702-B29-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200702-B29-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107094,201021-B60-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201021-B60-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107095,200714-B34-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200714-B34-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107096,200311-B19-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200311-B19-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107097,200908-B50-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200908-B50-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107098,191122-B6-R4388056-alone,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191122-B6-R4388056-alone.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107099,200306-B16-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200306-B16-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107100,200916-B54-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200916-B54-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107101,200313-B23-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200313-B23-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107102,201014-B59-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201014-B59-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107103,200312-B21-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200312-B21-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107104,201002-B56-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201002-B56-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107105,200317-B26-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200317-B26-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107106,191217-B8-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191217-B8-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107107,200810-B45-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200810-B45-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107108,200313-B23-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200313-B23-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107109,191121-B6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191121-B6.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107110,200306-B16-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200306-B16-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107111,200930-B55-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200930-B55-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107112,200708-B31-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200708-B31-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107113,191219-B9-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/191219-B9-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107114,200826-B49-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200826-B49-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107115,200713-B33-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200713-B33-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107116,190403-B4-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/190403-B4-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107117,200226-B11-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200226-B11-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107118,200804-B42-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200804-B42-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107119,200313-B22-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200313-B22-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107120,200916-B54-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200916-B54-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107121,201007-B58-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/201007-B58-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107122,200701-B28-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200701-B28-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107123,200707-B30-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200707-B30-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107124,200910-B52-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200910-B52-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107125,200715-B35-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200715-B35-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107126,200804-B42-A,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200804-B42-A.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD107127,200709-B32-B,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39641382/200709-B32-B.,10x_matrix,,39641382,AD,no data available,,	Human,Dorsolateral prefrontal cortex,no data available,no data available,no data available,no data available,,unkown,Single-nucleus RNA sequencing,,,,,
AD108001,GSM7412790,,,rds,39578645,AD,Need to open data,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108002,GSM7412791,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108003,GSM7412792,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108004,GSM7412793,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108005,GSM7412794,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108006,GSM7412795,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108007,GSM7412796,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108008,GSM7412797,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108009,GSM7412798,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108010,GSM7412799,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108011,GSM7412800,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108012,GSM7412801,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108013,GSM7412802,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108014,GSM7412803,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108015,GSM7412804,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108016,GSM7412805,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108017,GSM7412806,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108018,GSM7412807,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108019,GSM7412808,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108020,GSM7412809,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108021,GSM7412810,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108022,GSM7412811,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108023,GSM7412812,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108024,GSM7412813,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108025,GSM7412814,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108026,GSM7412815,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108027,GSM7412816,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108028,GSM7412817,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108029,GSM7412818,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108030,GSM7412819,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108031,GSM7412820,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108032,GSM7412821,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108033,GSM7412822,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108034,GSM7412823,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108035,GSM7412824,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108036,GSM7412825,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108037,GSM7412826,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108038,GSM7412827,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108039,GSM7412828,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108040,GSM7412829,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD108041,GSM7412830,,,rds,39578645,AD,,,Human,Prefrontal Cortex,,,,,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109001,GSM8117703,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117703_APOE3_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,5,77,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109002,GSM8117704,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117704_APOE4_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,5,75,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109003,GSM8117705,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117705_APOE5_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,5,90,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109004,GSM8117706,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117706_APOE6_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,5,67,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109005,GSM8117707,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117707_APOE7_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,1,86,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109006,GSM8117708,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117708_APOE8_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,2,82,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109007,GSM8117709,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117709_APOE9_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,1,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109008,GSM8117710,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117710_APOE10_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,0,79,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109009,GSM8117711,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117711_APOE13_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,5,78,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109010,GSM8117712,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117712_APOE14_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,6,76,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109011,GSM8117713,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117713_APOE15_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,5,84,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109012,GSM8117714,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117714_APOE16_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,5,95,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109013,GSM8117715,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117715_APOE17_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,2,69,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109014,GSM8117716,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117716_APOE18_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,2,73,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109015,GSM8117717,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117717_APOE19_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,2,84,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109016,GSM8117718,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117718_APOE20_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,1,88,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109017,GSM8117719,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117719_APOE23_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,6,72,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109018,GSM8117720,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117720_APOE24_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,5,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109019,GSM8117721,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117721_APOE25_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,5,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109020,GSM8117722,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117722_APOE26_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,5,67,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109021,GSM8117723,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117723_APOE27_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,2,78,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109022,GSM8117724,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117724_APOE28_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,2,72,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109023,GSM8117725,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117725_APOE29_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,1,68,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109024,GSM8117726,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117726_APOE30_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,1,89,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109025,GSM8117727,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117727_APOE34_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,5,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109026,GSM8117728,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117728_APOE35_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,5,84,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109027,GSM8117729,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117729_APOE36_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,6,70,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109028,GSM8117730,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117730_APOE37_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,3,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109029,GSM8117731,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117731_APOE38_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,3,88,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109030,GSM8117732,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117732_APOE39_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,1,93,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109031,GSM8117733,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117733_APOE40_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,1,96,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109032,GSM8117734,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117734_APOE44_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,5,79,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109033,GSM8117735,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117735_APOE45_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Female,5,84,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109034,GSM8117736,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117736_APOE46_,10x_matrix,,38961225,AD,Disease,,Human,superior parietal gyrus,no data available,Male,6,73,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109035,GSM8117737,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117737_APOE47_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,2,60,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109036,GSM8117738,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117738_APOE49_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,2,72,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109037,GSM8117739,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117739_APOE50_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,1,91,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109038,GSM8117740,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117740_APOE57_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Female,1,89,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD109039,GSM8117741,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38961225/GSM8117741_APOE60_,10x_matrix,,38961225,AD,Healthy,,Human,superior parietal gyrus,no data available,Male,2,90,,10X Genomics,Single-nucleus RNA sequencing,,,,,
AD110001,GSM6927920,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38734693/GSM6927920_A3772-WT_raw,10x_matrix,,38734693,AD,Disease,Control,Mouse,right hemisphere minus olfactory bulb and cerebellum,no data available,Female,no data available,4 months,,10X Genomics,Single-cell RNA sequencing,5XFAD,,,,
AD110002,GSM6927921,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38734693/GSM6927921_A3773-TG_raw,10x_matrix,,38734693,AD,Disease,Transgenic,Mouse,right hemisphere minus olfactory bulb and cerebellum,no data available,Female,no data available,4 months,,10X Genomics,Single-cell RNA sequencing,PU.1 Transgenic,,,,
AD110003,GSM6927922,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38734693/GSM6927922_A3774-WT_raw,10x_matrix,,38734693,AD,Disease,Control,Mouse,right hemisphere minus olfactory bulb and cerebellum,no data available,Female,no data available,4 months,,10X Genomics,Single-cell RNA sequencing,5XFAD,,,,
AD110004,GSM6927923,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38734693/GSM6927923_A3778-TG_raw,10x_matrix,,38734693,AD,Disease,Transgenic,Mouse,right hemisphere minus olfactory bulb and cerebellum,no data available,Female,no data available,4 months,,10X Genomics,Single-cell RNA sequencing,PU.1 Transgenic,,,,
AD112001,GSM7049627,,,,38159571,AD,Disease,,Mouse,Hippocampal and cortical regions of brain,no data available,no data available,no data available,10 weeks,,10x Genomics,single-cell RNA sequencing,5XFADhet APOE-knockin,,,,
AD112002,GSM7049629,,,,38159572,AD,Disease,,Mouse,Hippocampal and cortical regions of brain,no data available,no data available,no data available,20 weeks,,10x Genomics,single-cell RNA sequencing,5XFADhet APOE-knockin,,,,
AD112003,GSM7049631,,,,38159573,AD,Disease,,Mouse,Hippocampal and cortical regions of brain,no data available,no data available,no data available,60 weeks,,10x Genomics,single-cell RNA sequencing,5XFADhet APOE-knockin,,,,
AD112004,GSM7049633,,,,38159574,AD,Disease,,Mouse,Hippocampal and cortical regions of brain,no data available,no data available,no data available,96 weeks,,10x Genomics,single-cell RNA sequencing,5XFADhet APOE-knockin,,,,
AD112005,GSM7049634,,,,38159575,AD,Disease,,Mouse,Hippocampal and cortical regions of brain,no data available,no data available,no data available,96 weeks,,10x Genomics,single-cell RNA sequencing,5XFADhet APOE-knockin,,,,
AD113001,6289-MW-0274,,,,40448997,AD,Healthy,Yes,Human,BA46,no treatment,F,0,58,,10x Genomics,Single-nucleus RNA sequencing,,,donorid: 22,,
AD113002,6289-MW-0064,,,,40448997,AD,Healthy,Yes,Human,BA20,no treatment,M,II,92,,10x Genomics,Single-nucleus RNA sequencing,,,26,,
AD113003,6289-MW-0056,,,,40448997,AD,Disease,,Human,BA46,no treatment,M,VI,86,,10x Genomics,Single-nucleus RNA sequencing,,,29,,
AD113004,6289-MW-0072,,,,40448997,AD,Healthy,Yes,Human,V1,no treatment,F,0,73,,10x Genomics,Single-nucleus RNA sequencing,,,27,,
AD113005,6289-MW-0112,,,,40448997,AD,Healthy,Yes,Human,BA46,no treatment,F,II,90+,,10x Genomics,Single-nucleus RNA sequencing,,,18,,
AD113006,6289-MW-0066,,,,40448997,AD,Healthy,Yes,Human,V2,no treatment,M,II,92,,10x Genomics,Single-nucleus RNA sequencing,,,26,,
AD113007,6289-MW-0116,,,,40448997,AD,Healthy,Yes,Human,V1,no treatment,F,II,90+,,10x Genomics,Single-nucleus RNA sequencing,,,18,,
AD113008,6289-MW-0036,,,,40448997,AD,Healthy,Yes,Human,V2,no treatment,M,I,86,,10x Genomics,Single-nucleus RNA sequencing,,,28,,
AD113009,6289-MW-0068,,,,40448997,AD,Healthy,Yes,Human,V2,no treatment,F,0,73,,10x Genomics,Single-nucleus RNA sequencing,,,27,,
AD113010,6289-MW-0198,,,,40448997,AD,Disease,,Human,BA46,no treatment,M,V,85,,10x Genomics,Single-nucleus RNA sequencing,,,15,,
AD113011,6289-MW-0058,,,,40448997,AD,Disease,,Human,V1,no treatment,M,VI,86,,10x Genomics,Single-nucleus RNA sequencing,,,29,,
AD113012,6289-MW-0060,,,,40448997,AD,Disease,,Human,V2,no treatment,M,VI,86,,10x Genomics,Single-nucleus RNA sequencing,,,29,,
AD113013,6289-MW-0114,,,,40448997,AD,Healthy,Yes,Human,BA20,no treatment,F,II,90+,,10x Genomics,Single-nucleus RNA sequencing,,,18,,
AD113014,6289-MW-0038,,,,40448997,AD,Healthy,Yes,Human,BA20,no treatment,M,I,86,,10x Genomics,Single-nucleus RNA sequencing,,,28,,
AD113015,6289-MW-0070,,,,40448997,AD,Healthy,Yes,Human,BA20,no treatment,F,0,73,,10x Genomics,Single-nucleus RNA sequencing,,,27,,
AD113016,6289-MW-0188,,,,40448997,AD,Disease,,Human,BA46,no treatment,F,V,84,,10x Genomics,Single-nucleus RNA sequencing,,,17,,
AD113017,6289-MW-0290,,,,40448997,AD,Disease,,Human,V1,no treatment,F,III,90+,,10x Genomics,Single-nucleus RNA sequencing,,,21,,
AD113018,6289-MW-0040,,,,40448997,AD,Healthy,Yes,Human,V1,no treatment,M,I,86,,10x Genomics,Single-nucleus RNA sequencing,,,28,,
AD113019,6289-MW-0184,,,,40448997,AD,Disease,,Human,BA20,no treatment,F,V,84,,10x Genomics,Single-nucleus RNA sequencing,,,17,,
AD113020,6289-MW-0180,,,,40448997,AD,Disease,,Human,EC,no treatment,F,V,84,,10x Genomics,Single-nucleus RNA sequencing,,,17,,
AD113021,6289-MW-0052,,,,40448997,AD,Disease,,Human,BA20,no treatment,M,VI,86,,10x Genomics,Single-nucleus RNA sequencing,,,29,,
AD113022,6289-MW-0288,,,,40448997,AD,Disease,,Human,BA20,no treatment,F,III,90+,,10x Genomics,Single-nucleus RNA sequencing,,,21,,
AD113023,6289-MW-0196,,,,40448997,AD,Disease,,Human,V1,no treatment,M,V,85,,10x Genomics,Single-nucleus RNA sequencing,,,15,,
AD113024,6289-MW-0192,,,,40448997,AD,Disease,,Human,BA20,no treatment,M,V,85,,10x Genomics,Single-nucleus RNA sequencing,,,15,,
AD113025,6289-MW-0287,,,,40448997,AD,Disease,,Human,V2,no treatment,F,III,90+,,10x Genomics,Single-nucleus RNA sequencing,,,21,,
AD113026,6289-MW-0194,,,,40448997,AD,Disease,,Human,EC,no treatment,M,V,85,,10x Genomics,Single-nucleus RNA sequencing,,,15,,
AD114001,GSM8181019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181019_Ctrl_forebrain_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,Forebrain,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114002,GSM8181020,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181020_Ctrl_forebrain_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,Forebrain,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114003,GSM8181021,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181021_Ctrl_forebrain_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,Forebrain,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114004,GSM8181022,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181022_Inulin_forebrain_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,Forebrain,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114005,GSM8181023,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181023_Inulin_forebrain_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,Forebrain,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114006,GSM8181024,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181024_Inulin_forebrain_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,Forebrain,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114007,GSM8181025,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181025_Ctrl_interbrain_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,thalamus+hypothalamus,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114008,GSM8181026,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181026_Ctrl_interbrain_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,thalamus+hypothalamus,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114009,GSM8181027,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181027_Ctrl_interbrain_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,thalamus+hypothalamus,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114010,GSM8181028,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181028_Inulin_interbrain_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,thalamus+hypothalamus,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114011,GSM8181029,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181029_Inulin_interbrain_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,thalamus+hypothalamus,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114012,GSM8181030,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181030_Inulin_interbrain_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,thalamus+hypothalamus,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114013,GSM8181031,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181031_Ctrl_brainstem_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,midbrain+hindbrain,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114014,GSM8181032,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181032_Ctrl_brainstem_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,midbrain+hindbrain,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114015,GSM8181033,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181033_Ctrl_brainstem_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,midbrain+hindbrain,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114016,GSM8181034,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181034_Inulin_brainstem_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,midbrain+hindbrain,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114017,GSM8181035,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181035_Inulin_brainstem_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,midbrain+hindbrain,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114018,GSM8181036,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181036_Inulin_brainstem_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,midbrain+hindbrain,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114019,GSM8181037,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181037_Ctrl_cerebellum_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,cerebellum,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114020,GSM8181038,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181038_Ctrl_cerebellum_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,cerebellum,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114021,GSM8181039,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181039_Ctrl_cerebellum_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,Yes,Mouse,cerebellum,Ain-93G/M (standard rodent diets),male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114022,GSM8181040,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181040_Inulin_cerebellum_1_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,cerebellum,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114023,GSM8181041,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181041_Inulin_cerebellum_2_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,cerebellum,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD114024,GSM8181042,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40346662/GSM8181042_Inulin_cerebellum_3_CellBender_feature_bc_matrix_filtered.h5,h5,,40346662,AD,Disease,,Mouse,cerebellum,Inulin,male,no data available,no data available,,10x Genomics,Single-nucleus RNA sequencing,5xFAD,,,,
AD115001,GSM5550450,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550450_Gan_1.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,5,91 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E2E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115002,GSM5550451,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550451_Gan_2.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E2E4; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115003,GSM5550452,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550452_Gan_3.,10x_matrix,,34851693,AD/DLBD,Disease,no data available,Human,frontal cortical,no data available,Female,5,81 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115004,GSM5550453,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550453_Gan_4.,10x_matrix,,34851693,AD/DLBD,Disease,no data available,Human,frontal cortical,no data available,Female,5,85 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115005,GSM5550454,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550454_Gan_5.,10x_matrix,,34851693,AD/CAA,Disease,no data available,Human,frontal cortical,no data available,male,5,65 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115006,GSM5550455,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550455_Gan_6.,10x_matrix,,34851693,AD/CAA,Disease,no data available,Human,frontal cortical,no data available,male,6,65 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115007,GSM5550456,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550456_Gan_7.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,6,62 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115008,GSM5550457,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550457_Gan_8.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,5,67 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115009,GSM5550458,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550458_Gan_9.,10x_matrix,,34851693,AD/DLBD,Disease,no data available,Human,frontal cortical,no data available,male,5.5,71 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115010,GSM5550459,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550459_Gan_10.,10x_matrix,,34851693,AD/DLBD,Disease,no data available,Human,frontal cortical,no data available,male,5.5,72 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E3; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115011,GSM5550460,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550460_Gan_11.,10x_matrix,,34851693,AD/ALB,Disease,no data available,Human,frontal cortical,no data available,Female,5.5,85 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115012,GSM5550461,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550461_Gan_13.,10x_matrix,,34851693,AD/VaD,Disease,no data available,Human,frontal cortical,no data available,Female,5,87 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115013,GSM5550462,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550462_Gan_14.,10x_matrix,,34851693,AD/VaD,Disease,no data available,Human,frontal cortical,no data available,Female,5,86 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115014,GSM5550463,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550463_Gan_15.,10x_matrix,,34851693,AD/VaD,Disease,no data available,Human,frontal cortical,no data available,Female,6,85 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115015,GSM5550464,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550464_Gan_16.,10x_matrix,,34851693,AD/VaD,Disease,no data available,Human,frontal cortical,no data available,Female,4,85 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115016,GSM5550465,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550465_Gan_18.,10x_matrix,,34851693,AD/VaD,Disease,no data available,Human,frontal cortical,no data available,Female,6,81 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115017,GSM5550466,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550466_Gan_19.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,5,81 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115018,GSM5550467,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550467_Gan_20.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,80 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115019,GSM5550468,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550468_Gan_21.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,5,66 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115020,GSM5550469,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550469_Gan_22.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,6,67 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115021,GSM5550470,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550470_Gan_23.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,6,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115022,GSM5550471,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550471_Gan_24.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,6,81 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; wt,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115023,GSM5550472,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550472_Gan_25.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,4.5,88 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115024,GSM5550473,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550473_Gan_26.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,5,89 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115025,GSM5550474,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550474_Gan_27.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,5,74 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115026,GSM5550475,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550475_Gan_29.,10x_matrix,,34851693,AD/TLBD,Disease,no data available,Human,frontal cortical,no data available,male,6,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115027,GSM5550476,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550476_Gan_30.,10x_matrix,,34851693,AD/TLBD,Disease,no data available,Human,frontal cortical,no data available,male,6,79 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115028,GSM5550477,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550477_Gan_31.,10x_matrix,,34851693,AD/TLBD,Disease,no data available,Human,frontal cortical,no data available,Female,6,77 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115029,GSM5550478,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550478_Gan_33.,10x_matrix,,34851693,AD/DLBD,Disease,no data available,Human,frontal cortical,no data available,Female,6,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115030,GSM5550479,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550479_Gan_35.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,5,71 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115031,GSM5550480,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550480_Gan_37.,10x_matrix,,34851693,AD/CAA,Disease,no data available,Human,frontal cortical,no data available,male,6,79 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115032,GSM5550481,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550481_Gan_38.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,5.5,80 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115033,GSM5550482,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550482_Gan_39.,10x_matrix,,34851693,AD/CAA/BLBD,Disease,no data available,Human,frontal cortical,no data available,Female,6,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115034,GSM5550483,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550483_Gan_40.,10x_matrix,,34851693,AD/CAA/BLBD,Disease,no data available,Human,frontal cortical,no data available,Female,6,74 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115035,GSM5550484,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550484_Gan_43.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,6,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115036,GSM5550485,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550485_Gan_44.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,6,87 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115037,GSM5550486,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550486_Gan_45.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,5,72 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4/E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115038,GSM5550487,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550487_Gan_46.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115039,GSM5550488,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550488_Gan_47.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,64 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115040,GSM5550489,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550489_Gan_48.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,71 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115041,GSM5550490,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550490_Gan_49.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E4/E4; WT,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115042,GSM5550491,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550491_Gan_50.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E2/E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115043,GSM5550492,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550492_Gan_51.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,Female,5,71 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115044,GSM5550493,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550493_Gan_52.,10x_matrix,,34851693,AD/ALS,Disease,no data available,Human,frontal cortical,no data available,Female,5,87 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115045,GSM5550494,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550494_Gan_54.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115046,GSM5550495,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550495_Gan_55.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,6,77 years,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4; R47H,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115047,GSM5550496,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550496_Gan_56.,10x_matrix,,34851693,AD,Disease,no data available,Human,frontal cortical,no data available,male,no data available,60 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115048,GSM5550497,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550497_Gan_59.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,Female,no data available,72 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115049,GSM5550498,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550498_Gan_60.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115050,GSM5550499,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550499_Gan_61.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,Female,no data available,75 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115051,GSM5550500,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550500_Gan_62.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,male,no data available,68 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115052,GSM5550501,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550501_Gan_63.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,male,no data available,72 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115053,GSM5550502,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550502_Gan_64.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,male,no data available,61 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115054,GSM5550503,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550503_Gan_65.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,male,no data available,75 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115055,GSM5550504,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5550504_Gan_66.,10x_matrix,,34851693,AD,Healthy,no data available,Human,frontal cortical,no data available,male,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Nuclei isolation adapted from Grubman et al. 2019Chromium Single Cell 3' Reagent Kits v3 (10x Genomics),,,
AD115056,GSM5509164,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509164_LG72_119.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,none,no data available,no data available,no data available,,,,r47h genotype: mTrem2,,,,
AD115057,GSM5509165,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509165_LG72_120.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: mTrem2,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115058,GSM5509166,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509166_LG72_127.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: mTrem2,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115059,GSM5509167,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509167_LG72_135.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: mTrem2,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115060,GSM5509168,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509168_LG72_71.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115061,GSM5509169,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509169_LG72_102.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115062,GSM5509170,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509170_LG72_132.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115063,GSM5509171,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509171_LG72_78.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115064,GSM5509172,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509172_LG72_95.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115065,GSM5509173,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509173_LG72_146.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115066,GSM5509174,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509174_LG72_149.,10x_matrix,,34851693,AD,Healthy,Yes,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115067,GSM5509175,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509175_LG72_70.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115068,GSM5509176,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509176_LG72_79.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115069,GSM5509177,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509177_LG72_105.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115070,GSM5509178,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509178_LG72_136.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,none,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115071,GSM5509179,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509179_LG72_111.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115072,GSM5509180,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509180_LG72_112.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115073,GSM5509181,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509181_LG72_130.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
AD115074,GSM5509182,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34851693/GSM5509182_LG72_142.,10x_matrix,,34851693,AD,Disease,no data available,Mouse,hippocampus,MK-2206,no data available,no data available,no data available,,10X Genomics,Single-nucleus RNA sequencing,r47h genotype: hTREM2-R47H; P301S mutation,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001019,GSM4972290,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM4972290_P4B_,10x_matrix,,35879464,FTD,Healthy,,	Human,	Occipital Cortex,no data available,Female,bvFTD,77 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001020,GSM4972291,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM4972291_P4D_,10x_matrix,,35879464,FTD,Healthy,,	Human,	Temporal Cortex,no data available,Female,bvFTD,77 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001021,GSM4972293,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM4972293_P5B_,10x_matrix,,35879464,FTD,Healthy,,	Human,	Occipital Cortex,no data available,Female,bvFTD,52 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001022,GSM4972294,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM4972294_P5D_,10x_matrix,,35879464,FTD,Healthy,,	Human,Temporal Cortex,no data available,Female,bvFTD,52 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001023,GSM5437044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437044_C4A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,Female,bvFTD,69 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001024,GSM5437045,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437045_C4B_,10x_matrix,,35879464,FTD,Healthy,,	Human,Occipital Cortex,no data available,Female,no data avaliable,69 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001025,GSM5437046,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437046_C4C_,10x_matrix,,35879464,FTD,Healthy,,	Human,Temporal Cortex,no data available,Female,no data avaliable,69 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001026,GSM5437047,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437047_P11A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,male,no data avaliable,60 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001027,GSM5437048,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437048_P11D_,10x_matrix,,35879464,FTD,Healthy,,	Human,Temporal Cortex,no data available,male,mixed PPA,60 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001028,GSM5437049,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437049_P12A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,Female,mixed PPA,51 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001029,GSM5437050,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437050_P12B_,10x_matrix,,35879464,FTD,Healthy,,	Human,Occipital Cortex,no data available,Female,bvFTD,51 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001030,GSM5437051,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437051_P12D_,10x_matrix,,35879464,FTD,Healthy,,	Human, Temporal Cortex,no data available,Female,bvFTD,51 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001031,GSM5437052,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437052_P16A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,male,bvFTD,63 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001032,GSM5437053,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437053_P18A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,male,bvFTD,66 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001033,GSM5437054,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437054_P19A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,male,bvFTD,67 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001034,GSM5437055,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437055_P20A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,male,FTD NOS,65 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001035,GSM5437056,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437056_P21A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,Female,bvFTD,68 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001036,GSM5437057,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437057_P8A_,10x_matrix,,35879464,FTD,Healthy,,	Human,Frontal Cortex,no data available,Female,bvFTD,67 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001037,GSM5437058,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437058_P8B_,10x_matrix,,35879464,FTD,Healthy,,	Human,Occipital Cortex,no data available,Female,bvFTD,67 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD001038,GSM5437059,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35879464/GSM5437059_P8D_,10x_matrix,,35879464,FTD,Healthy,,	Human,Temporal Cortex,no data available,Female,bvFTD,67 years,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from fresh frozen human brain tissue using a sucrose gradient ultracentrifugation protocol. Nuclei were separated into 3 populations using FANS: 1) NEUNpos neurons used for bulk RNAseq, 2) OLIG2pos oligodendrocytes and OPCs used for bulk RNAseq, 3) NEUNnegOLIG2neg nuclei used for single-nucleus RNAseq. For bulk RNAseq RNA was isolated with the Arcturus PicoPure RNA Isolation Kit from Thermo Fisher ScientificBulk: Lexogen QuantSeq 3 mRNA-Seq Library Prep Kit (FWD with UMI) from Illumina. snRNAseq: Chromium Single Cell 3 Reagents Kit v3 from 10X Genomics",,,
FTD002001,GSM7225754,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225754_HO001.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002002,GSM7225755,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225755_GO004.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002003,GSM7225756,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225756_GO006.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002004,GSM7225757,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225757_HO008.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002005,GSM7225758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225758_HO010.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002006,GSM7225759,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225759_HO012.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002007,GSM7225760,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225760_HO002.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002008,GSM7225761,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225761_GO003.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002009,GSM7225762,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225762_GO005.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002010,GSM7225763,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225763_HO007.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002011,GSM7225764,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225764_HO009.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002012,GSM7225765,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225765_HO011.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002013,GSM7225766,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225766_HO013.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human,whole brain,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002014,GSM7225767,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225767_GF010.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002015,GSM7225768,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225768_GF012.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002016,GSM7225769,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225769_GF014.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002017,GSM7225770,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225770_GF016.txt,"txt, manually",whole,38626772,FTD,Healthy,Yes,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002018,GSM7225771,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225771_GF011.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC; MAPT-N279K,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002019,GSM7225772,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225772_GF013.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC; MAPT-N279K,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002020,GSM7225773,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225773_GF015.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC; MAPT-N279K,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD002021,GSM7225774,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38626772/GSM7225774_GF017.txt,"txt, manually",whole,38626772,FTD,Disease,,	Human, neural graft,no data available,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,iPSC; MAPT-N279K,"Neural progenitor cells (NPCs) were generated and cultured as previously described (Hargus et al., 2014; Reinhardt et al., 2013). Briefly, iPSC colonies were detached from MEFs 34 days after splitting using 2 mg/ml collagenase IV. Pieces of colonies were collected by sedimentation and resuspended in human ESC media (without FGF2) supplemented with 10 M SB-431542 (Ascent Scientific), 1 M dorsomorphin (Tocris), 3 M CHIR 99021 (Axon Medchem), and 0.5 M purmorphamine (PMA; Alexis) and subsequently cultured as embryoid bodies (EBs) in Petri dishes. On day 2, media was changed to N2B27 media containing the same small-molecule supplements. N2B27 medium consisted of Dulbeccos modified Eagles media (DMEM)-F12 (Invitrogen)/Neurobasal (Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100 B27 supplement lacking vitamin A (Invitrogen) with1%penicillin/streptomycin/glutamine (PAA). On day 4, SB-431542 and dorsomorphin were withdrawn and 150 mM ascorbic acid (AA; Sigma) was added to the media. On day 6, EBs were triturated into smaller pieces and plated on Matrigel- coated (Matrigel, growth factor reduced, high concentration; BD Biosciences) 12-well plates (Nunc) in NPC expansion media (N2B27 with CHIR, PMA, and AA). Media was changed every other day and cells were typically split 1:101:15 every 56 days. For splitting, cells were digested to single cells for approximately 10 min at 37C using prewarmed Accutase (PAA). Cells were diluted in DMEM (PAA) and spun down at 1,000 rpm for 5 min. The cell pellet was resuspended in fresh NPC expansion media and plated on Matrigel-coated cell culture dishes.        (Post-mortem samples) Nuclei were isolated from frozen surgical resection specimen as described previously (Al- Dalahmah et al., 2020). Briefly, frozen tissue samples were homogenized using a dounce homogenizer in ice-cold 30% sucrose 0.1% Triton-X 100 based homogenization buffer. 10-15 strokes of the loose dounce pestle were followed by 10-15 strokes of the tight dounce pestle on ice. Mixing using a P1000 pipette followed before filtration through a BD Falcon 40um filters. Filtration was repeated after a 10-minute spin at 1000g at 4c. A cleanup step followed using a density gradient step as described (Krishnaswami et al., 2016)For neuronal differentiation of NPCs, expansion media was changed 2 days after splitting to neuronal induction media consisting of N2B27 medium supplemented with 1 M PMA, 200 M AA and 3 M CHIR 99021. After 6 days of differentiation the neuronal induction media was replaced by neuronal maturation media consisting of N2B27 with 20 ng/ml BDNF, 10 ng/ml GDNF, 1 ng/ml TGF-3 (Peprotech), 200 M AA, and 500 M dbcAMP (Sigma Aldrich). Media was changed every other day and cultures were analyzed after three weeks in maturation conditions.(Post-mortem samples) The nuclear pellet was suspended in 1% BSA in PBS resuspension buffer containing RNAse inhibitors. A final filteration step using 20um Flowmi TM filters followed before dilution to 700-1200 nuclei per ul in resuspension buffer. The nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2, catalog number: 120237; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics).Grafts composed of human iPSC-derived neural cells were microdissected and submitted to nuclei isolation, followed by a standard single nucleus RNA-seq library preparation and sequencing.snRNA (single-nuclei RNA sequencing)",,,
FTD003001,GSM5456188,,,csv,34675437,FTD,Healthy,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,WTSli042-B,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003002,GSM5456189,,,csv,34675437,FTD,Healthy,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,WTSli042-B,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003003,GSM5456190,,,csv,34675437,FTD,Healthy,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,A18945,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003004,GSM5456191,,,csv,34675437,FTD,Healthy,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,A18946,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003005,GSM5456192,,,csv,34675437,ALS/FTD,Disease,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,CS30iALS-C9nxx,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003006,GSM5456193,,,csv,34675437,ALS/FTD,Disease,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,CS30iALS-C9nxx,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003007,GSM5456194,,,csv,34675437,ALS/FTD,Disease,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,CS29iALS-C9n1.ISOxx,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003008,GSM5456195,,,csv,34675437,ALS/FTD,Disease,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,CS29iALS-C9n1.ISOxx,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003009,GSM5456196,,,csv,34675437,ALS/FTD,no data available,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,CS29iALS-C9nxx,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD003010,GSM5456197,,,csv,34675437,ALS/FTD,no data available,,	Human,cerebral organoid,no data available,no data avaliable,no data avaliable,150 days,,10X Genomics,Single-cell RNA sequencing,CS29iALS-C9nxx,"Induced pluripotent stem cell-derived cerebral organoids were generated and grown as slice cultures as described in Szebenyi et al., 2021.Organoids were supplemented with serum-free slice culture medium (SFSCM): Neurobasal (Invitrogen, cat. #21103049), 1:50 (v/v) B27+A (Invitrogen, cat. #17504044), 0.5% (w/v) glucose, 1X (v/v) Glutamax supplemented with Antibiotic-Antimycotic (ThermoFisher, cat. #15240062). The cultures were maintained in SFSCM at 37 C and 5% CO2 with daily media changes.Dissociation of the slices was achieved by Accumax (Sigma, A7089) using the gentleMACS Octo Dissociator. The cell suspension was run through a 70m strainer prior to processing through the 10X Genomics platform. scRNA-seq libraries were prepared for sequencing using the 10X Genomics Chromium Single Cell 3 Library & Gel Bead Kit (10X Genomics, 120237) workflow.The cell suspension was loaded onto a 10X Genomics Chromium Single Cell 3 Chip with the appropriate amount of Mastermix. RNA extraction was performed following the same 10X Genomics Chromium workflow (Next GEM sequencing v3.0 for batch 1 and 3.1 for batch 2).The reverse transcriptase reaction and subsequent amplification was carried out in a C1000 Touch Thermal Cycler (Biorad), with the cDNA being amplified for 12 cycles. Before sequencing, libraries were quality tested using the 2100 Bioanalyzer Instrument (Agilent) and their concentration was measured by qPCR.",,,
FTD004001,GSM6346105,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346105_1mFB_406RR2_0202_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,1 month,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004002,GSM6346106,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346106_1mFB_406RW2_0202_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004003,GSM6346107,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346107_2mFB_406RR2_0303_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004004,GSM6346108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346108_2mFB_406RR2_0306_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004005,GSM6346109,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346109_2mFB_406RW2_0303_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004006,GSM6346110,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346110_2mFB_406RW2_0306_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004007,GSM6346111,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346111_2mFB_406WW1_0303_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 406W/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004008,GSM6346112,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346112_3mFB_406RR2_0404_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004009,GSM6346113,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346113_3mFB_406RR2_0406_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing, wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004010,GSM6346114,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346114_3mFB_406RW2_0404_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004011,GSM6346115,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346115_3mFB_406RW2_0406_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004012,GSM6346116,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346116_3mFB_406WW1_0404_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 406W/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004013,GSM6346117,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346117_4mFB_337VV1_0506_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004014,GSM6346118,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346118_4mFB_337VM1_0506_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004015,GSM6346119,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346119_4mFB_337VV2_0606_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004016,GSM6346120,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346120_4mFB_337VM2_0606_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004017,GSM6346121,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346121_6mFB_406RR1_0605_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004018,GSM6346122,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346122_6mFB_406RR1_0612_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004019,GSM6346123,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346123_6mFB_406RW1_0605_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004020,GSM6346124,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346124_6mFB_406RW1_0612_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004021,GSM6346125,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346125_6mFB_337VV2_0808_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004022,GSM6346126,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346126_6mFB_337VV2_0813_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing, wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004023,GSM6346127,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346127_6mFB_337VM2_0808_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004024,GSM6346128,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346128_6mFB_337VM2_0813_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004025,GSM6346129,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346129_2mFB_406RR1_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004026,GSM6346130,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346130_2mFB_406RR1_0909_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004027,GSM6346131,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346131_2mFB_406RW1_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004028,GSM6346132,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346132_2mFB_406RW1_0909_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004029,GSM6346133,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346133_2mFB_337VV2_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004030,GSM6346134,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346134_2mFB_337VM2_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004031,GSM6346135,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346135_2moFB_337VV3B12_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004032,GSM6346136,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346136_2mFB_337VV3F02_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004033,GSM6346137,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346137_2mFB_337VM3_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004034,GSM6346138,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346138_2mFB_406WW1_0908_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 406W/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004035,GSM6346139,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346139_4mFB_337VV1_0707_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004036,GSM6346140,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346140_4mFB_337VM1_0707_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004037,GSM6346141,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346141_6mFB_337VV1_0707_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004038,GSM6346142,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346142_6mFB_337VV1_0713_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004039,GSM6346143,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346143_6mFB_337VM1_0707_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004040,GSM6346144,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346144_6mFB_337VM1_0713_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing, MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004041,GSM6346145,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346145_3mFB_406RR1_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004042,GSM6346146,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346146_3mFB_406RW1_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004043,GSM6346147,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346147_3mFB_337VV2_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004044,GSM6346148,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346148_3mFB_337VM2_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004045,GSM6346149,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346149_3mFB_337VV3B12_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004046,GSM6346150,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346150_3mFB_337VV3F02_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing, wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004047,GSM6346151,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346151_3mFB_337VM3_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004048,GSM6346152,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346152_3mFB_406WW1_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 406W/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004049,GSM6346153,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346153_8mFB_406RR1_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,8 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004050,GSM6346154,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346154_8mFB_406RR1_1013_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,8 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004051,GSM6346155,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346155_8mFB_406RW1_1010_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,8 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004052,GSM6346156,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346156_8mFB_406RW1_1013_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,8 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004053,GSM6346157,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346157_4mFB_406RR1_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004054,GSM6346158,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346158_4mFB_406RW1_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004055,GSM6346159,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346159_4mFB_337VV2_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004056,GSM6346160,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346160_4mFB_337VM2_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004057,GSM6346161,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346161_4mFB_337VV3B12_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004058,GSM6346162,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346162_4mFB_337VV3F02_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing, wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004059,GSM6346163,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346163_4mFB_337VM3_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004060,GSM6346164,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346164_4mFB_406WW1_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 406W/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004061,GSM6346165,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346165_3mFB_337VV1_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004062,GSM6346166,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346166_3mFB_337VM1_1211_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,3 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004063,GSM6346167,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346167_6mFB_406RR1_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004064,GSM6346168,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346168_6mFB_406RW1_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing, MAPT 406R/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004065,GSM6346169,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346169_6mFB_337VV2_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004066,GSM6346170,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346170_6mFB_337VM2_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004067,GSM6346171,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346171_6mFB_337VV3B12_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004068,GSM6346172,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346172_6mFB_337VV3F02_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004069,GSM6346173,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346173_6mFB_337VM3_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004070,GSM6346174,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346174_6mFB_406WW1_1412_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 406W/W,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004071,GSM6346175,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346175_6mFB_337VV1_1513_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004072,GSM6346176,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346176_6mFB_337VM1_1513_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,6 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004073,GSM6346177,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346177_4mFB_337VV1_1313_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004074,GSM6346178,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346178_4mFB_337VM1_1313_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,4 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004075,GSM6346179,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346179_2mFB_337VV1_1113_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,no data available,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,wild type,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD004076,GSM6346180,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35985329/GSM6346180_2mFB_337VM1_1113_gene_exon_tagged.dge.txt.gz,txt.gz,,35985329,FTD,Disease,,	Human,cerebral organoid,no data avaliable,no data avaliable,no data avaliable,2 months,,drop-seq,Single-cell RNA sequencing,MAPT 337V/M,"3-4 organoids were pooled for each dissociation and dissociated using the Worthington Papain Dissociation System (Worthington). Solutions were prepared according to the Manufacturers instructions. Organoids in FB D media were cut into pieces with a sterile scalpel blade and washed twice in PBS prior to dissociation. Incubation in papain/DNaseI solution was performed in a 15 ml conical tube with untightened lid and at 37C and 5% CO2 with occasional agitation. After the first 30 min of incubation, organoids were triturated 10 times with a fire-polished glass Pasteur pipette, followed by further incubation and trituration every 15 min until dissociation was complete. The total incubation time in papain/DNaseI solution was 75 -90 min. After adding Inhibitor Solution and DNaseI in EBSS, the dissociated cells were pelleted by centrifugation for 5 min at 300 g. The cells were resuspended in ice-cold PBS/0.01% BSA and passed through a 35 m cell strainer.Following dissociation, cells were diluted to 110 cells/l in PBS/0.01% BSA. Drop-seq was performed as described (Macosko et al., 2015, DOI: 10.1016/j.cell.2015.05.002). Briefly, cells and barcoded beads (Chemgenes, 132 beads/ul in lysis buffer) were ran on an aquapel-treated microfluidic drop-seq device (FlowJEM) for co-encapsulation in nanoliter-sized droplets. After droplet-breakage, reverse transcription and Exonuclease I treatment, beads were counted, and 2000 beads were apportioned per PCR tube for cDNA amplification. The amplified cDNA libraries were purified using SPRI beads (Beckman Coulter) and quantified on a Fragment Analyzer (Agilent). Tagmentations were performed using the Illumina Nextera XT kit (Illumina), and the resulting libraries were purified in two consecutive rounds of SPRI beads-based size selection (0.6x beads to sample ratio followed by 1x beads to sample ratio).",,,
FTD005001,GSM6260246,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36322143/bac_ana/filtered_feature_bc_matrix/,10x,,36322143,ALS/FTD,Disease,,Mouse,	Cortex,no data avaliable,Female,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,C9-BAC,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
FTD005002,GSM6260247,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36322143/het_ana/filtered_feature_bc_matrix/,10x,,36322143,ALS/FTD,Disease,,Mouse, Cortex,no data avaliable,Female,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,C9-BAC;C9orf72+/-,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
FTD005003,GSM6260248,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36322143/hom_ana/filtered_feature_bc_matrix/,10x,,36322143,ALS/FTD,Disease,,Mouse, Cortex,no data avaliable,Female,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,C9-BAC;C9orf72-/-,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
FTD005004,GSM6260249,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36322143/wt_ana/filtered_feature_bc_matrix/,10x,,36322143,ALS/FTD,Healthy,,Mouse, Cortex,no data avaliable,Female,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,WT,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
FTD006001,GSM8208813,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39289761/GSM8208813_g007_,10x_matrix,,39289761,ALS/FTD,Disease,,Human,cerebral organoids,no data avaliable,no data avaliable,no data avaliable,day 90,,10X Genomics,Single-cell RNA sequencing,C9ORF72 hexanucleotide repeat expansion on one allele,,,,
FTD006002,GSM8208814,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39289761/GSM8208814_g008_,10x_matrix,,39289761,ALS/FTD,Healthy,Control,Human,cerebral organoids,no data avaliable,no data avaliable,no data avaliable,day 90,,10X Genomics,Single-cell RNA sequencing,,,,,
FTD006003,GSM8208815,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39289761/GSM8208815_g009_,10x_matrix,,39289761,ALS/FTD,Disease,,Human,cerebral organoids,no data avaliable,no data avaliable,no data avaliable,day 90,,10X Genomics,Single-cell RNA sequencing,C9ORF72 hexanucleotide repeat expansion on one allele,,,,
FTD006004,GSM8208816,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39289761/GSM8208816_g010_,10x_matrix,,39289761,ALS/FTD,Disease,,Human,cerebral organoids,no data avaliable,no data avaliable,no data avaliable,day 90,,10X Genomics,Single-cell RNA sequencing,C9ORF72 hexanucleotide repeat expansion on one allele,,,,
FTD006005,GSM8208817,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39289761/GSM8208817_g011_,10x_matrix,,39289761,ALS/FTD,Healthy,Control,Human,cerebral organoids,no data avaliable,no data avaliable,no data avaliable,day 90,,10X Genomics,Single-cell RNA sequencing,,,,,
FTD006006,GSM8208818,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39289761/GSM8208818_g012_,10x_matrix,,39289761,ALS/FTD,Healthy,Control,Human,cerebral organoids,no data avaliable,no data avaliable,no data avaliable,day 90,,10X Genomics,Single-cell RNA sequencing,,,,,
FTD007001,syn52074156,Unique,,rds,39265576,no data available,Disease,,Human,calcarine cortex ,no data avaliable,Male ,PSP-S,82 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007002,syn52074156,,,rds,39265576,AD,Disease,,Human,calcarine cortex ,no data avaliable,Female,AD,64 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007003,syn52074156,,,rds,39265576,FTD,Disease,,Human,calcarine cortex ,no data avaliable,Female,bvFTD,76 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007004,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,calcarine cortex ,no data avaliable,Male ,Control,61 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007005,syn52074156,,,rds,39265576,no data available,Disease,,Human,calcarine cortex ,no data avaliable,Female,PSP-S,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007006,syn52074156,,,rds,39265576,AD,Disease,,Human,calcarine cortex ,no data avaliable,Male ,AD,58 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007007,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,calcarine cortex ,no data avaliable,Male ,Control,67 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007008,syn52074156,,,rds,39265576,FTD,Disease,,Human,calcarine cortex ,no data avaliable,Female,bvFTD,60 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007009,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,calcarine cortex ,no data avaliable,Female,Control,60 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007010,syn52074156,,,rds,39265576,no data available,Disease,,Human,calcarine cortex ,no data avaliable,Female,PSP-S,64 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007011,syn52074156,,,rds,39265576,AD,Disease,,Human,calcarine cortex ,no data avaliable,Female,AD,65 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007012,syn52074156,,,rds,39265576,FTD,Disease,,Human,calcarine cortex ,no data avaliable,Female,bvFTD,84 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007013,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,calcarine cortex ,no data avaliable,Male ,Control,74 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007014,syn52074156,,,rds,39265576,no data available,Disease,,Human,calcarine cortex ,no data avaliable,Male ,PSP-S,59 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007015,syn52074156,,,rds,39265576,AD,Disease,,Human,calcarine cortex ,no data avaliable,Male ,AD,74 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007016,syn52074156,,,rds,39265576,FTD,Disease,,Human,calcarine cortex ,no data avaliable,Male ,bvFTD,72 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007017,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,calcarine cortex ,no data avaliable,Male ,Control,76 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007018,syn52074156,,,rds,39265576,FTD,Disease,,Human,calcarine cortex ,no data avaliable,Male ,bvFTD,66 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007019,syn52074156,,,rds,39265576,AD,Disease,,Human,calcarine cortex ,no data avaliable,Male ,AD,82 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007020,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,calcarine cortex ,no data avaliable,Female,Control,67 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007021,syn52074156,,,rds,39265576,no data available,Disease,,Human,calcarine cortex ,no data avaliable,Male ,PSP-S,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007022,syn52074156,,,rds,39265576,AD,Disease,,Human,calcarine cortex ,no data avaliable,Male ,AD,70 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007023,syn52074156,,,rds,39265576,AD,Disease,,Human,calcarine cortex ,no data avaliable,Female,AD,58 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007024,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,calcarine cortex ,no data avaliable,Female,Control,65 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007025,syn52074156,,,rds,39265576,no data available,Disease,,Human,calcarine cortex ,no data avaliable,Male ,PSP-S,71 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007026,syn52074156,,,rds,39265576,FTD,Disease,,Human,calcarine cortex ,no data avaliable,Male ,bvFTD,70 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007027,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Male ,PSP-S,82 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007028,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Female,AD,64 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007029,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Female,bvFTD,76 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007030,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Male ,Control,61 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007031,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Female,PSP-S,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007032,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Male ,AD,58 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007033,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Male ,Control,67 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007034,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Female,bvFTD,60 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007035,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Female,Control,60 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007036,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Female,PSP-S,64 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007037,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Female,AD,65 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007038,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Female,bvFTD,84 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007039,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Male ,Control,74 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007040,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Male ,PSP-S,59 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007041,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Male ,AD,74 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007042,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Female,Control,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007043,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Male ,PSP-S,77 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007044,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Male ,AD,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007045,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Female,PSP-S,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007046,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Male ,Control,76 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007047,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Female,AD,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007048,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Female,bvFTD,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007049,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Female,PSP-S,72 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007050,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Male ,PSP-S,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007051,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Male ,bvFTD,57 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007052,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Male ,bvFTD,70 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007053,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Male ,PSP-S,71 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007054,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Female,Control,65 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007055,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Female,AD,58 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007056,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Male ,AD,70 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007057,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Male ,bvFTD,72 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007058,syn52074156,,,rds,39265576,no data available,Disease,,Human,insular cortex ,no data avaliable,Female,PSP-S,56 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007059,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Male ,bvFTD,66 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007060,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Male ,AD,82 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007061,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,insular cortex ,no data avaliable,Female,Control,67 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007062,syn52074156,,,rds,39265576,FTD,Disease,,Human,insular cortex ,no data avaliable,Male ,bvFTD,74 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007063,syn52074156,,,rds,39265576,AD,Disease,,Human,insular cortex ,no data avaliable,Male ,AD,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007064,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Male ,PSP-S,82 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007065,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Female,AD,64 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007066,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Female,bvFTD,76 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007067,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Male ,Control,61 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007068,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Female,PSP-S,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007069,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Male ,AD,58 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007070,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Male ,Control,67 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007071,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Female,bvFTD,60 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007072,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Female,Control,60 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007073,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Female,PSP-S,64 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007074,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Female,AD,65 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007075,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Female,bvFTD,84 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007076,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Male ,Control,74 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007077,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Male ,PSP-S,59 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007078,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Male ,AD,74 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007079,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Male ,bvFTD,72 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007080,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Male ,Control,76 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007081,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Male ,bvFTD,66 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007082,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Male ,AD,82 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007083,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Female,Control,67 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007084,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Male ,PSP-S,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007085,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Male ,AD,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007086,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Male ,AD,70 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007087,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Female,AD,58 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007088,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Female,Control,65 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007089,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Male ,PSP-S,71 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007090,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Male ,bvFTD,70 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007091,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Male ,bvFTD,57 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007092,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Female,Control,56 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007093,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Female,PSP-S,72 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007094,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Female,Control,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007095,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Male ,PSP-S,77 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007096,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Male ,AD,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007097,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Female,PSP-S,68 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007098,syn52074156,,,rds,39265576,no data available,Healthy,Yes,Human,precentral gyrus,no data avaliable,Male ,Control,77 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007099,syn52074156,,,rds,39265576,no data available,Disease,,Human,precentral gyrus,no data avaliable,Female,PSP-S,75 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007100,syn52074156,,,rds,39265576,AD,Disease,,Human,precentral gyrus,no data avaliable,Female,AD,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
FTD007101,syn52074156,,,rds,39265576,FTD,Disease,,Human,precentral gyrus,no data avaliable,Female,bvFTD,69 years,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD001001,GSM6106340,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106340_HSDG07HC,10x,,39475571,PD,Healthy,Yes,Human,prefrontal cortex,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001002,GSM6106341,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106341_hsDG101HC,10x,,39475571,PD,Healthy,Yes,Human,prefrontal cortex,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001003,GSM6106342,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106342_HSDG10HC,10x,,39475571,PD,Healthy,Yes,Human,prefrontal cortex,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001004,GSM6106343,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106343_hsDG13HC,10x,,39475571,PD,Healthy,Yes,Human,prefrontal cortex,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001005,GSM6106344,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106344_hsDG142PD,10x,,39475571,PD,Disease,,Human,prefrontal cortex,no data avaliable,no data avaliable,late-stage,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001006,GSM6106345,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106345_HSDG148PD,10x,,39475571,PD,Disease,,Human,prefrontal cortex,no data avaliable,no data avaliable,late-stage,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001007,GSM6106346,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106346_hsDG151PD,10x,,39475571,PD,Disease,,Human,prefrontal cortex,no data avaliable,no data avaliable,late-stage,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001008,GSM6106347,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106347_hsDG197PD,10x,,39475571,PD,Disease,,Human,prefrontal cortex,no data avaliable,no data avaliable,late-stage,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001009,GSM6106348,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106348_HSDG199PD,10x,,39475571,PD,Disease,,Human,prefrontal cortex,no data avaliable,no data avaliable,late-stage,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001010,GSM6106349,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106349_hsDG208PD,10x,,39475571,PD,Disease,,Human,prefrontal cortex,no data avaliable,no data avaliable,late-stage,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001011,GSM6106350,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106350_hsDG30HC,10x,,39475571,PD,Healthy,Yes,Human,prefrontal cortex,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD001012,GSM6106351,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39475571/GSM6106351_hsDG99HC,10x,,39475571,PD,Healthy,Yes,Human,prefrontal cortex,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,,"Nuclei were isolated from post-mortem fresh frozen human brain tissue. Frozen tissue (50 to 100 mg) was homogenized in 15 ml of ice-cold nuclei homogenization buffer [2 M sucrose, 10 mM Hepes (pH 7.9), 25 mM KCl, 1 mM EDTA (pH 8.0), 10% glycerol, and ribonuclease (RNase) inhibitors freshly added (80 U/ml)] with Dounce tissue grinder (10 strokes with loose pestle and 10 strokes with tight pestle). The homogenate was transferred into an ultracentrifuge tube on top of 10 ml of fresh nuclei homogenization buffer and centrifuged at 25,000 rpm for 60 min at 4C on a ultracentrifuge. The supernatant was removed, and the pellet was resuspended in 1 ml of nuclei resuspension buffer [15 mM Hepes (pH 7.4), 15 mM NaCl, 60 mM KCl, 2 mM MgCl2, 3 mM CaCl2, and RNase inhibitors freshly added (80 U/ml)] and counted on a hemocytometer for 10x loading.The snRNA-seq libraries were prepared by the 10x Genomics Chromium Single Cell 3 Reagent Kit v3 chemistry according to the manufacturers instructions and sequenced using Illumina NovaSeq6000 S4.Single nucleus RNA sequencing, 10x Genomics Chromium Single Cell 3 Reagent Kit v3.",,,
PD003001,GSM6211038,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36142685/GSM6211038_CN_,10x_matrix,,36142685,PD,Healthy,,Mouse,"cerebral cortex, hippocampus, striatum and cerebellum",no data avaliable,Male,no data avaliable,8 weeks old,,10X Genomics,Single-nucleus RNA sequencing,C57BL/6J,"Eight-week-old male MPTP-induced Parkinson model mice (on a C57BL/6J background, MPTP-PD) and recommended control (C57BL/6J, CN) were purchased from the Shanghai Model Organisms Center, Inc. The animals were anesthetized with 500 mg/kg tribromoethanol (Sigma, Saint Louis, USA) and were killed by cervical dislocation. After the animals were sacrificed, brain tissues (cerebral cortex, hippocampus, striatum and cerebellum) were isolated, quickly frozen in liquid nitrogen and stored in liquid nitrogen until library construction. Nuclei were isolated by adapting the published 10X Genomics protocol for Isolation of Nuclei for Single Cell RNA Sequencing. In brief, the tissue was lysed in a chilled lysis buffer (10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl2, 0,1% NP-40). Then, the suspension was filtered and nuclei were pelleted by centrifugation. Nuclei pellets were then washed in nuclei wash and resuspension buffer (1x PBS, 1% BSA, 0.2 U/L RNase inhibitor, 2 mM DTT), filtered and pelleted again. Cell count was then performed to calculate the concentration of nuclear suspension.Sorted nuclei were processed using the 10x Chromium Next GEM Single Cell 3 Kit v3.1 to generate the cDNA libraries. The quality of cDNA was assessed using the Agilent 2100 Bioanalyzer System. Sequencing was performed on Illumina NovaSeq 6000-S2.",,,
PD003002,GSM6211039,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36142685/GSM6211039_PD_,10x_matrix,,36142685,PD,Disease,,Mouse,"cerebral cortex, hippocampus, striatum and cerebellum",no data avaliable,Male,no data avaliable,8 weeks old,,10X Genomics,Single-nucleus RNA sequencing,MPTP-PD,"Eight-week-old male MPTP-induced Parkinson model mice (on a C57BL/6J background, MPTP-PD) and recommended control (C57BL/6J, CN) were purchased from the Shanghai Model Organisms Center, Inc. The animals were anesthetized with 500 mg/kg tribromoethanol (Sigma, Saint Louis, USA) and were killed by cervical dislocation. After the animals were sacrificed, brain tissues (cerebral cortex, hippocampus, striatum and cerebellum) were isolated, quickly frozen in liquid nitrogen and stored in liquid nitrogen until library construction. Nuclei were isolated by adapting the published 10X Genomics protocol for Isolation of Nuclei for Single Cell RNA Sequencing. In brief, the tissue was lysed in a chilled lysis buffer (10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl2, 0,1% NP-40). Then, the suspension was filtered and nuclei were pelleted by centrifugation. Nuclei pellets were then washed in nuclei wash and resuspension buffer (1x PBS, 1% BSA, 0.2 U/L RNase inhibitor, 2 mM DTT), filtered and pelleted again. Cell count was then performed to calculate the concentration of nuclear suspension.Sorted nuclei were processed using the 10x Chromium Next GEM Single Cell 3 Kit v3.1 to generate the cDNA libraries. The quality of cDNA was assessed using the Agilent 2100 Bioanalyzer System. Sequencing was performed on Illumina NovaSeq 6000-S2.",,,
PD007001,GSM3891466,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891466_rat11_1a,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007002,GSM3891467,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891467_rat11_2a,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007003,GSM3891468,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891468_rat11_2b,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007004,GSM3891469,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891469_rat39_3a,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007005,GSM3891470,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891470_rat39_3b,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007006,GSM3891471,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891471_rat39_3c,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007007,GSM3891472,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891472_rat45_1a,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007008,GSM3891473,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32415072/GSM3891473_rat45_1b,10x_matrix,,32415072,PD,no data avaliable,,Human,Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,,"Grafted human ventral midbrain and grafted VM-patterned hESCs cells were dissected from rat striatum and dissociated into a single cell suspension using the papain kitsingle-cell suspensions were loaded onto 10x Genomics Single Cell 3 Chips along with the reverse transcription (RT) mastermix per the manufacturers protocol for the Chromium Single Cell 3 Library to generate single-cell gel beads in emulsion (GEMs). cDNA amplification was done as per the guidelines from 10X Genomics. Sequencing libraries were generated with unique sample indices (SI) for each sample with the following specifications Read1 28 cycles, Read2 98 cycles, Index1 8 cycles.Libraries for samples were multiplexed and sequenced on an Illumina NextSeq 500 machine using a 150-cycle NextSeq 500/550 High Output Reagent Kit v2.",,,
PD007009,RC17_after,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/0.h5ad/PD007009.h5ad,h5ad,"smart-seq,gene_ids",32415072,PD,Disease,,Human,Human graft in rat brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,iPS: RC17,,,,
PD007010,fetal_after,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/0.h5ad/PD007010.h5ad,h5ad,"smart-seq,gene_ids",32415072,PD,Disease,,Human,Human graft in rat brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,NPCs,,,,
PD007011,RC17_before,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/0.h5ad/PD007011.h5ad,h5ad,"smart-seq,gene_ids",32415072,PD,Healthy,,Human,Human graft in rat brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,iPS: RC17,,,,
PD007012,fetal_before,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/0.h5ad/PD007012.h5ad,h5ad,"smart-seq,gene_ids",32415072,PD,Healthy,,Human,Human graft in rat brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,NPCs,,,,
PD009001,GSM5928090,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38041169/GSM5928090_Sample_1-,10x_matrix,,38041169,PD,Disease,,Mouse,Substantia nigra,no data avaliable,no data avaliable,no data avaliable,10 month,,10X Genomics,Single-cell RNA sequencing,hA53T transgenic mice,"All procedures were carried out on the ice or at 4 C. Briefly, the frozen substantia nigra brain tissue was homogenized in 2 ml Homogenization Buffer (10 mM Tris-HCl, pH 8.0, 25 mM KCl, 5 mM MgCl2, 0.1% Triton X-100, 250 mM sucrose, 0.5 U/l SuperRNase inhibitor, and 0.5 U/l RNAse inhibitor), using a Wheaton Dounce Tissue Grinder (10 strokes with the loose pestle and 15 strokes with the tight pestle). Then, tissue homogenate was overlaid onto 10% iodixanol and centrifuged with an SW32 rotor at 10,000g for 20 minutes at 4 C. After ultracentrifugation, the supernatant was aspirated and discarded, and the remaining pellet was resuspended in 0.5 % BSA plus 50 ng/ul DAPI for nuclei isolation using a BD AriaFusion cell sorter (BD Biosciences).RNA libraries were prepared for sequencing using Chromium Single Cell 3 GEM, Library & Gel Bead Kit v3, 16 rxns PN-1000075Single nuclei RNA-Seq",,,
PD009002,GSM5928091,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38041169/GSM5928091_Sample_2-,10x_matrix,,38041169,PD,Disease,,Mouse,Substantia nigra,no data avaliable,no data avaliable,no data avaliable,10 month,,10X Genomics,Single-cell RNA sequencing,hA53T transgenic mice plus Mlkl-/-,"All procedures were carried out on the ice or at 4 C. Briefly, the frozen substantia nigra brain tissue was homogenized in 2 ml Homogenization Buffer (10 mM Tris-HCl, pH 8.0, 25 mM KCl, 5 mM MgCl2, 0.1% Triton X-100, 250 mM sucrose, 0.5 U/l SuperRNase inhibitor, and 0.5 U/l RNAse inhibitor), using a Wheaton Dounce Tissue Grinder (10 strokes with the loose pestle and 15 strokes with the tight pestle). Then, tissue homogenate was overlaid onto 10% iodixanol and centrifuged with an SW32 rotor at 10,000g for 20 minutes at 4 C. After ultracentrifugation, the supernatant was aspirated and discarded, and the remaining pellet was resuspended in 0.5 % BSA plus 50 ng/ul DAPI for nuclei isolation using a BD AriaFusion cell sorter (BD Biosciences).RNA libraries were prepared for sequencing using Chromium Single Cell 3 GEM, Library & Gel Bead Kit v3, 16 rxns PN-1000075Single nuclei RNA-Seq",,,
PD011001,GSM8219516,,,tsv,39218899,PD,Healthy,,Mouse,midbrain,PBS,Male,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,Line 61 mice,Mononuclear cells were isolated for sequencing as described above with 3-5 ventral midbrains pooled per sample and sorted for CD45+ live cells on a BD FACsAria. Sorted CD45+ cells were resuspended in DPBS supplemented with 0.04% w/v BSA.Single Cell 3 Reagent Kit V3.1 was used in conjunction with TotalSeqB antibodies to generate 3' gene expression library and HTO library. Single cells and beads containing barcoded DNA oligos were captured into oil droplets to generate the gel bead-in-emulsion (GEM) by 10x Chromium controller. The poly-A RNA from the cell lysate in GEM was reverse-transcripted to cDNA. Libraries were constructed according to the manufacturers instructions,,,
PD011002,GSM8219517,,,tsv,39218899,PD,Healthy,,Mouse,midbrain,Monomer,Male,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,Line 61 mice,Mononuclear cells were isolated for sequencing as described above with 3-5 ventral midbrains pooled per sample and sorted for CD45+ live cells on a BD FACsAria. Sorted CD45+ cells were resuspended in DPBS supplemented with 0.04% w/v BSA.Single Cell 3 Reagent Kit V3.1 was used in conjunction with TotalSeqB antibodies to generate 3' gene expression library and HTO library. Single cells and beads containing barcoded DNA oligos were captured into oil droplets to generate the gel bead-in-emulsion (GEM) by 10x Chromium controller. The poly-A RNA from the cell lysate in GEM was reverse-transcripted to cDNA. Libraries were constructed according to the manufacturers instructions,,,
PD011003,GSM8219518,,,tsv,39218899,PD,Disease,,Mouse,midbrain,PFF + VH,Male,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,Line 61 mice,Mononuclear cells were isolated for sequencing as described above with 3-5 ventral midbrains pooled per sample and sorted for CD45+ live cells on a BD FACsAria. Sorted CD45+ cells were resuspended in DPBS supplemented with 0.04% w/v BSA.Single Cell 3 Reagent Kit V3.1 was used in conjunction with TotalSeqB antibodies to generate 3' gene expression library and HTO library. Single cells and beads containing barcoded DNA oligos were captured into oil droplets to generate the gel bead-in-emulsion (GEM) by 10x Chromium controller. The poly-A RNA from the cell lysate in GEM was reverse-transcripted to cDNA. Libraries were constructed according to the manufacturers instructions,,,
PD011004,GSM8219519,,,tsv,39218899,PD,Disease,,Mouse,midbrain,PFF + VH,Male,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,Line 61 mice,Mononuclear cells were isolated for sequencing as described above with 3-5 ventral midbrains pooled per sample and sorted for CD45+ live cells on a BD FACsAria. Sorted CD45+ cells were resuspended in DPBS supplemented with 0.04% w/v BSA.Single Cell 3 Reagent Kit V3.1 was used in conjunction with TotalSeqB antibodies to generate 3' gene expression library and HTO library. Single cells and beads containing barcoded DNA oligos were captured into oil droplets to generate the gel bead-in-emulsion (GEM) by 10x Chromium controller. The poly-A RNA from the cell lysate in GEM was reverse-transcripted to cDNA. Libraries were constructed according to the manufacturers instructions,,,
PD011005,GSM8219520,,,tsv,39218899,PD,Disease,,Mouse,midbrain,PFF + AZD1480,Male,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,Line 61 mice,Mononuclear cells were isolated for sequencing as described above with 3-5 ventral midbrains pooled per sample and sorted for CD45+ live cells on a BD FACsAria. Sorted CD45+ cells were resuspended in DPBS supplemented with 0.04% w/v BSA.Single Cell 3 Reagent Kit V3.1 was used in conjunction with TotalSeqB antibodies to generate 3' gene expression library and HTO library. Single cells and beads containing barcoded DNA oligos were captured into oil droplets to generate the gel bead-in-emulsion (GEM) by 10x Chromium controller. The poly-A RNA from the cell lysate in GEM was reverse-transcripted to cDNA. Libraries were constructed according to the manufacturers instructions,,,
PD011006,GSM8219521,,,tsv,39218899,PD,Disease,,Mouse,midbrain,PFF + AZD1480,Male,no data avaliable,no data avaliable,,10X Genomics,Single-cell RNA sequencing,Line 61 mice,Mononuclear cells were isolated for sequencing as described above with 3-5 ventral midbrains pooled per sample and sorted for CD45+ live cells on a BD FACsAria. Sorted CD45+ cells were resuspended in DPBS supplemented with 0.04% w/v BSA.Single Cell 3 Reagent Kit V3.1 was used in conjunction with TotalSeqB antibodies to generate 3' gene expression library and HTO library. Single cells and beads containing barcoded DNA oligos were captured into oil droplets to generate the gel bead-in-emulsion (GEM) by 10x Chromium controller. The poly-A RNA from the cell lysate in GEM was reverse-transcripted to cDNA. Libraries were constructed according to the manufacturers instructions,,,
PD014001,GSM5386624,,,whole,35513515,PD,no data available,no data available,Tupaia belangeri,Substantia nigra pars compacta,no data available,Male,no data available,3 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge,,,
PD014002,GSM5386625,,,whole,35513515,PD,no data available,no data available,Rattus norvegicus,Substantia nigra pars compacta,no data available,Male,no data available,0.2 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge,,,
PD014003,GSM5386626,,,whole,35513515,PD,no data available,no data available,Macaca mulatta,Substantia nigra pars compacta,no data available,Male,no data available,3 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge,,,
PD014004,GSM5386627,,,whole,35513515,PD,no data available,no data available,Macaca mulatta,Substantia nigra pars compacta,no data available,Male,no data available,3 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge,,,
PD014005,GSM5386628,,,whole,35513515,PD,non-PD control ,Yes,	Human,Caudate nucleus,no data available,Male,no data available,47 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014006,GSM5386629,,,whole,35513515,PD,non-PD control ,Yes,	Human,Caudate nucleus,no data available,Male,no data available,47 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014007,GSM5386630,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,79 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014008,GSM5386631,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,91 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014009,GSM5386632,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,79 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014010,GSM5386633,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,91 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014011,GSM5386634,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014012,GSM5386635,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,49 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014013,GSM5386636,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014014,GSM5386637,,,whole,35513515,PD,non-PD control ,Yes,	Human, Substantia nigra pars compacta,no data available,Female,no data available,90 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014015,GSM5386638,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014016,GSM5386639,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,90 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014017,GSM5386640,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,91 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014018,GSM5386641,,,whole,35513515,PD,non-PD control ,Yes,	Human,Caudate nucleus,no data available,Male,no data available,59 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014019,GSM5386642,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014020,GSM5386643,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,79 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014021,GSM5386644,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available,92 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014022,GSM5386645,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Female,no data available, 79 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014023,GSM5386650,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,75 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014024,GSM5386652,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014025,GSM5386653,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014026,GSM5386654,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014027,GSM5386657,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014028,GSM5386660,,,whole,35513515,PD,Disease,No,	Human, Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014029,GSM5386661,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014030,GSM5386662,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014031,GSM5386663,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014032,GSM5386664,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014033,GSM5386665,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014034,GSM5386666,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,75 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014035,GSM5386667,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,76 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014036,GSM5386668,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,75 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014037,GSM5386670,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,75 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014038,GSM5386671,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014039,GSM5386673,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014040,GSM5386674,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,75 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014041,GSM5386677,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014042,GSM5386680,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,90 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014043,GSM5386681,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014044,GSM5386683,,,whole,35513515,PD,non-PD control ,Yes,	Human,Substantia nigra pars compacta,no data available,Male,no data available,25 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014045,GSM5386684,,,whole,35513515,PD,Disease,No,	Human, Substantia nigra pars compacta,no data available,Male,no data available,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014046,GSM5386685,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available, Female,no data available,83 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014047,GSM5386686,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014048,GSM5386688,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014049,GSM5386689,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014050,GSM5386690,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014051,GSM5386692,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014052,GSM5386694,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014053,GSM5386697,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,90 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014054,GSM5386712,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,90 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014055,GSM5386714,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014056,GSM5386716,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014057,GSM5386718,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014058,GSM5386720,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD014059,GSM5386723,,,whole,35513515,PD,Disease,No,	Human,Substantia nigra pars compacta,no data available,Male,no data available,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"Please see: https://www.protocols.io/view/frozen-tissue-nuclei-extraction-for-10xv3-snseq-bi62khge 10X Chromium Single Cell 3' (V3), manufacturer's protocol",,,
PD018001,GSM7384413,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37981650/GSM7384413_F9_filtered_feature_bc_matrix.h5,h5,,37981650,PD,Health,,Mouse,Spleen,EV,Male,no data available,10-12 wk,,10X Genomics,Single-cell RNA sequencing,C57Bl/6J or SNCAKO (JAX stock#016123),"Tissue was digested in with Accutase (Merck) at 37C for 30min and triturated through 70m cell strainers which were rinsed with 10% FCS in PBS. Cells were purified by a linear 40% Percoll (GE Healthcare) centrifugation step at 650xg without brakes for 25min and the supernatant were discarded. Mononuclear cells were resuspended in FACS buffer (1% BSA and 0.1% sodium azide in PBS) and stained for live cells, CD45, CD11c, CD8, and CD4. Cells from similar organs and treatment were pooled from five mice and single cell libraries prepared.Single cells were encapsulated in droplets using 10X Genomics GemCode Technology kit v2 and processed following manufacturer's specifications. Chromium single cell 3 v2 (10XGenomics)",,,
PD018002,GSM7384414,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37981650/GSM7384414_F10_raw_feature_bc_matrix.h5,h5,,37981650,PD,Disease,,Mouse,Spleen,A53T,Male,no data available,10-12 wk,,10X Genomics,Single-cell RNA sequencing,C57Bl/6J or SNCAKO (JAX stock#016123),"Tissue was digested in with Accutase (Merck) at 37C for 30min and triturated through 70m cell strainers which were rinsed with 10% FCS in PBS. Cells were purified by a linear 40% Percoll (GE Healthcare) centrifugation step at 650xg without brakes for 25min and the supernatant were discarded. Mononuclear cells were resuspended in FACS buffer (1% BSA and 0.1% sodium azide in PBS) and stained for live cells, CD45, CD11c, CD8, and CD4. Cells from similar organs and treatment were pooled from five mice and single cell libraries prepared.Single cells were encapsulated in droplets using 10X Genomics GemCode Technology kit v2 and processed following manufacturer's specifications. Chromium single cell 3 v2 (10XGenomics)",,,
PD018003,GSM7384415,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37981650/GSM7384415_F11_filtered_feature_bc_matrix.h5,h5,,37981650,PD,Health,,Mouse,Ileum,EV,Male,no data available,10-12 wk,,10X Genomics,Single-cell RNA sequencing,C57Bl/6J or SNCAKO (JAX stock#016123),"Tissue was digested in with Accutase (Merck) at 37C for 30min and triturated through 70m cell strainers which were rinsed with 10% FCS in PBS. Cells were purified by a linear 40% Percoll (GE Healthcare) centrifugation step at 650xg without brakes for 25min and the supernatant were discarded. Mononuclear cells were resuspended in FACS buffer (1% BSA and 0.1% sodium azide in PBS) and stained for live cells, CD45, CD11c, CD8, and CD4. Cells from similar organs and treatment were pooled from five mice and single cell libraries prepared.Single cells were encapsulated in droplets using 10X Genomics GemCode Technology kit v2 and processed following manufacturer's specifications. Chromium single cell 3 v2 (10XGenomics)",,,
PD018004,GSM7384416,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37981650/GSM7384416_F12_filtered_feature_bc_matrix.h5,h5,,37981650,PD,Disease,,Mouse,Ileum,A53T,Male,no data available,10-12 wk,,10X Genomics,Single-cell RNA sequencing,C57Bl/6J or SNCAKO (JAX stock#016123),"Tissue was digested in with Accutase (Merck) at 37C for 30min and triturated through 70m cell strainers which were rinsed with 10% FCS in PBS. Cells were purified by a linear 40% Percoll (GE Healthcare) centrifugation step at 650xg without brakes for 25min and the supernatant were discarded. Mononuclear cells were resuspended in FACS buffer (1% BSA and 0.1% sodium azide in PBS) and stained for live cells, CD45, CD11c, CD8, and CD4. Cells from similar organs and treatment were pooled from five mice and single cell libraries prepared.Single cells were encapsulated in droplets using 10X Genomics GemCode Technology kit v2 and processed following manufacturer's specifications. Chromium single cell 3 v2 (10XGenomics)",,,
PD018005,GSM7384417,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37981650/GSM7384417_G1_filtered_feature_bc_matrix.h5,h5,,37981650,PD,Health,,Mouse,Brain,EV,Male,no data available,10-12 wk,,10X Genomics,Single-cell RNA sequencing,C57Bl/6J or SNCAKO (JAX stock#016123),"Tissue was digested in with Accutase (Merck) at 37C for 30min and triturated through 70m cell strainers which were rinsed with 10% FCS in PBS. Cells were purified by a linear 40% Percoll (GE Healthcare) centrifugation step at 650xg without brakes for 25min and the supernatant were discarded. Mononuclear cells were resuspended in FACS buffer (1% BSA and 0.1% sodium azide in PBS) and stained for live cells, CD45, CD11c, CD8, and CD4. Cells from similar organs and treatment were pooled from five mice and single cell libraries prepared.Single cells were encapsulated in droplets using 10X Genomics GemCode Technology kit v2 and processed following manufacturer's specifications. Chromium single cell 3 v2 (10XGenomics)",,,
PD018006,GSM7384418,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37981650/GSM7384418_G2_filtered_feature_bc_matrix.h5,h5,,37981650,PD,Disease,,Mouse,Brain,A53T,Male,no data available,10-12 wk,,10X Genomics,Single-cell RNA sequencing,C57Bl/6J or SNCAKO (JAX stock#016123),"Tissue was digested in with Accutase (Merck) at 37C for 30min and triturated through 70m cell strainers which were rinsed with 10% FCS in PBS. Cells were purified by a linear 40% Percoll (GE Healthcare) centrifugation step at 650xg without brakes for 25min and the supernatant were discarded. Mononuclear cells were resuspended in FACS buffer (1% BSA and 0.1% sodium azide in PBS) and stained for live cells, CD45, CD11c, CD8, and CD4. Cells from similar organs and treatment were pooled from five mice and single cell libraries prepared.Single cells were encapsulated in droplets using 10X Genomics GemCode Technology kit v2 and processed following manufacturer's specifications. Chromium single cell 3 v2 (10XGenomics)",,,
PD019001,GSM7897844,,,"two, check",38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,21 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019002,GSM7897845,,,,38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,21 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019003,GSM7897846,,,,38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,30 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019004,GSM7897847,,,,38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,30 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019005,GSM7897848,,,,38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019006,GSM7897849,,,,38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019007,GSM7897850,,,,38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,65 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019008,GSM7897851,,,,38132179,PD,Health,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,65 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line; genetic modification: LMX1A Cre AAVS1 BFP,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019009,GSM7937469,,,,38132179,PD,Disease,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019010,GSM7937470,,,,38132179,PD,Disease,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019011,GSM7937471,,,,38132179,PD,Disease,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019012,GSM7937472,,,,38132179,PD,Disease,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing, KOLF2-C1 human iPSC line,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019013,GSM7937473,,,,38132179,PD,Disease,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD019014,GSM7937474,,,,38132179,PD,Disease,,Human,dopaminergic neurons,no data avaliable,no data avaliable,no data avaliable,45 days,,SMART-Seq,Single-nucleus RNA sequencing,KOLF2-C1 human iPSC line,"KOLF2-C1 (HPSI0114i-kolf_2) and genome edited KOLF2-C1 derivatives were maintained on Matrigel-coated plates in Essential 8 media (TeSR-E8, Stemcell Technologies). All PSCs were passaged via manual dissociation using Gentle Cell Dissociation Reagent (Stemcell Technologies) as described previously (Arber et al 2015). IPSC differentiation towards mDA fate follows a protocol combining key features of (Kriks et al 2019) and (Jagger et al 2019). Briefly, PSCs were pre-plated on growth factor-reduced matrigel in TeSR-E8. Neural differentiation was initiated when cells reached >80% confluence by switching to DMEM-F12/Neurobasal (2:1) supplemented with N2 and B27 (N2B27). For the first 7 days, cultures were supplemented with SB431542 (10M, 1614-10 Tocris), LDN-193189 (100nM, StemGene), SHH-C24II (200ng/ml, 1845-SH-500 BioTechne) and Purmorphamine (1M, 540220-5 VWR). LDN was kept until day 11. On day 3 CHIR99021 (3 M, SM13-10 Cambridge Bioscience) was added to the media until day 13. Cultures were treated with PD0325901 from day 5 to 9 (1M, SM26-10 Cambridge Bioscience). FGF8a was added from day 11 to day 20 (100ng/ml, 100-25A Peprotech). Cultures were dissociated at around day 16/17 to single cells using Accutase (00-4555-56 Thermo Fisher Scientific) and replated onto poly-D-lysine/laminin coated plates at a density of 250000 cells/cm2. B27 without vitamin A (125870 Thermo Fisher Scientific) was used for the first 25 days, followed by B27 (175040 Thermo Fisher Scientific) plus BDNF (10ng/ml, 450-02-1MG Peprotech), GDNF (10ng/ml, GFH2-100 Cell Guidance System), Ascorbic Acid (200M, A4544 Sigma-Aldrich) and DAPT (10M, 2634 Tocris) from day 21 onwards.We prepared single cell preparations from fresh cultures by incubation with Accutase 10 min at 37C followed by gently pipetting the cells 3-4 times and an extra 2 min incubation at 37C. After dissociation and pelleting, cells were pipetted to single cells in 500 ul PBS and incubated for staining with Hoechst and PI for 20 min at 37C (ReadyProbes Cell Viability Imaging Kit, Blue/Red, R37610 Invitrogen). After washing, we re-suspended the cells in 1ml PBS and filtered through a nylon membrane to remove cell clumps. We used Countess II Automated cell counter (Invitrogen) to quantify cell numbers and cells were dispensed at a concentration of 30.000 cells/ml into ICELL8 Single-Cell System (Takara).The cDNA libraries were generated using the SMART-Seq ICELL8 cx Application Kit protocol provided by the manufacturer",,,
PD020001,GSM7438331,,,whole,38587883,PD,Healthy,Yes,Mouse,midbrain,C57BL6,Female,no data avaliable,P90,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020002,GSM7438332,,,whole,38587883,PD,Healthy,Yes,Mouse,midbrain,C57BL7,Female,no data avaliable,P530,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020003,GSM7438333,,,whole,38587883,PD,Healthy,Yes,Mouse,midbrain,C57BL8,Female,no data avaliable,P90,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020004,GSM7438334,,,whole,38587883,PD,Healthy,Yes,Mouse,midbrain,C57BL9,Female,no data avaliable,P90,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020005,GSM7438335,,,whole,38587883,PD,Healthy,Yes,Mouse,midbrain,C57BL10,Female,no data avaliable,P530,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020006,GSM7438336,,,whole,38587883,PD,Healthy,Yes,Mouse,midbrain,C57BL11,Female,no data avaliable,P530,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020007,GSM7438337,,,whole,38587883,PD,Disease,,Mouse,midbrain,6-OHDA,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020008,GSM7438338,,,whole,38587883,PD,Disease,,Mouse,midbrain,no data avaliable,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020009,GSM7438339,,,whole,38587883,PD,Disease,,Mouse,midbrain,6-OHDA,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020010,GSM7438340,,,whole,38587883,PD,Disease,,Mouse,midbrain,no data avaliable,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020011,GSM7438341,,,whole,38587883,PD,Disease,,Mouse,midbrain,6-OHDA,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020012,GSM7438342,,,whole,38587883,PD,Disease,,Mouse,midbrain,no data avaliable,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020013,GSM7438343,,,whole,38587883,PD,Disease,,Mouse,midbrain,6-OHDA,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020014,GSM7438344,,,whole,38587883,PD,Disease,,Mouse,midbrain,no data avaliable,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020015,GSM7438345,,,whole,38587883,PD,Disease,,Mouse,midbrain,6-OHDA,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020016,GSM7438346,,,whole,38587883,PD,Disease,,Mouse,midbrain,no data avaliable,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020017,GSM7438347,,,whole,38587883,PD,Disease,,Mouse,midbrain,6-OHDA,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD020018,GSM7438348,,,whole,38587883,PD,Disease,,Mouse,midbrain,no data avaliable,Female,no data avaliable,P165,,10X Genomics,Single-nucleus RNA sequencing,C57BL6; DatCre TrapC fl/fl,"unilaterally injected, over 2 min, with 0.7 or 1.5 g of 6-OHDA in 0.01% ascorbate (SigmaAldrich) into the medial forebrain bundle (MFB) of the right hemisphere.single nuclei isolation and FANSSingle nucleus libraries were made using Single Cell 3' v3 on Chromium platform (10X Genomics & SciLifeLab, Stockholm) in accordance with the manufacturers protocols",,,
PD023001,GSM8385018,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40353820/GSM8385018_Control_922_,10x_matrix,,40353820,PD,Healthy,Yes,Mouse,Midbrain,no data avaliable,no data avaliable,no data avaliable,6 month,,10X Genomics,Single-nucleus RNA sequencing,Lrrk2 WT,"A 2mm thick block of ventral midbrain tissue was dissected out from each mouse and collected for isolation. Tissue was dounce homogenized in a nuclear extraction buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.1% NP-40, 40u/mL Protector RNAse inhibitor (Roche 3335399001). Dounce homogenizer was washed with 4mL of a washing buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.01% BSA, 40U/mL Protector RNAse inhibitor) and filtered through a 30uM cell strainer. After three rounds of washing by centrifugation at 500g for 5 minutes, nuclei pellets were resuspended resuspension buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 2% BSA, 0.02% Tween-20) and filtered through a 20uM strainer. This nuclei suspension was loaded onto a MACSQuant Tyto HS chip and diluted with 1x PBS. Nuclei were sorted using gates set for isolation of GFP+ singlet nuclei.The cDNA and library were generated using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (10X Genomics, PN-1000286) and Dual Index Kit TT Set A (10X Genomics, PN-1000215) according to the manufacturers manual with following modification: PCR cycle used for cDNA generation was 16 and the resulting PCR products was size-selected using 0.8X SPRI beads instead of 0.6X SPRI beads as stated in protocol.",,,
PD023002,GSM8385019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40353820/GSM8385019_Control_1123_,10x_matrix,,40353820,PD,Healthy,Yes,Mouse,Midbrain,no data avaliable,no data avaliable,no data avaliable,7 month,,10X Genomics,Single-nucleus RNA sequencing,Lrrk2 WT,"A 2mm thick block of ventral midbrain tissue was dissected out from each mouse and collected for isolation. Tissue was dounce homogenized in a nuclear extraction buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.1% NP-40, 40u/mL Protector RNAse inhibitor (Roche 3335399001). Dounce homogenizer was washed with 4mL of a washing buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.01% BSA, 40U/mL Protector RNAse inhibitor) and filtered through a 30uM cell strainer. After three rounds of washing by centrifugation at 500g for 5 minutes, nuclei pellets were resuspended resuspension buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 2% BSA, 0.02% Tween-20) and filtered through a 20uM strainer. This nuclei suspension was loaded onto a MACSQuant Tyto HS chip and diluted with 1x PBS. Nuclei were sorted using gates set for isolation of GFP+ singlet nuclei.The cDNA and library were generated using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (10X Genomics, PN-1000286) and Dual Index Kit TT Set A (10X Genomics, PN-1000215) according to the manufacturers manual with following modification: PCR cycle used for cDNA generation was 16 and the resulting PCR products was size-selected using 0.8X SPRI beads instead of 0.6X SPRI beads as stated in protocol.",,,
PD023003,GSM8385020,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40353820/GSM8385020_LRRK_113_,10x_matrix,,40353820,PD,Disease,,Mouse,Midbrain,no data avaliable,no data avaliable,no data avaliable,8 month,,10X Genomics,Single-nucleus RNA sequencing,LRRK2 G2019S,"A 2mm thick block of ventral midbrain tissue was dissected out from each mouse and collected for isolation. Tissue was dounce homogenized in a nuclear extraction buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.1% NP-40, 40u/mL Protector RNAse inhibitor (Roche 3335399001). Dounce homogenizer was washed with 4mL of a washing buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.01% BSA, 40U/mL Protector RNAse inhibitor) and filtered through a 30uM cell strainer. After three rounds of washing by centrifugation at 500g for 5 minutes, nuclei pellets were resuspended resuspension buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 2% BSA, 0.02% Tween-20) and filtered through a 20uM strainer. This nuclei suspension was loaded onto a MACSQuant Tyto HS chip and diluted with 1x PBS. Nuclei were sorted using gates set for isolation of GFP+ singlet nuclei.The cDNA and library were generated using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (10X Genomics, PN-1000286) and Dual Index Kit TT Set A (10X Genomics, PN-1000215) according to the manufacturers manual with following modification: PCR cycle used for cDNA generation was 16 and the resulting PCR products was size-selected using 0.8X SPRI beads instead of 0.6X SPRI beads as stated in protocol.",,,
PD023004,GSM8385021,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40353820/GSM8385021_LRRK_922_,10x_matrix,,40353820,PD,Disease,,Mouse,Midbrain,no data avaliable,no data avaliable,no data avaliable,9 month,,10X Genomics,Single-nucleus RNA sequencing,LRRK2 G2019S,"A 2mm thick block of ventral midbrain tissue was dissected out from each mouse and collected for isolation. Tissue was dounce homogenized in a nuclear extraction buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.1% NP-40, 40u/mL Protector RNAse inhibitor (Roche 3335399001). Dounce homogenizer was washed with 4mL of a washing buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 0.01% BSA, 40U/mL Protector RNAse inhibitor) and filtered through a 30uM cell strainer. After three rounds of washing by centrifugation at 500g for 5 minutes, nuclei pellets were resuspended resuspension buffer (10mM Tris, 146mM NaCl, 1mM CaCl2, 21mM MgCl2, 2% BSA, 0.02% Tween-20) and filtered through a 20uM strainer. This nuclei suspension was loaded onto a MACSQuant Tyto HS chip and diluted with 1x PBS. Nuclei were sorted using gates set for isolation of GFP+ singlet nuclei.The cDNA and library were generated using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (10X Genomics, PN-1000286) and Dual Index Kit TT Set A (10X Genomics, PN-1000215) according to the manufacturers manual with following modification: PCR cycle used for cDNA generation was 16 and the resulting PCR products was size-selected using 0.8X SPRI beads instead of 0.6X SPRI beads as stated in protocol.",,,
PD025001,GSM7140319,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_W1118CS_25d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Healthy,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,W1118CS,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025002,GSM7140320,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_W1118CS_25d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Healthy,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,W1118CS,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025003,GSM7140321,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_W1118CS_5d_3.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Healthy,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,W1118CS,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025004,GSM7140322,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_W1118CS_5d_4.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Healthy,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,W1118CS,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025005,GSM7140323,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dAux_5d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Healthy,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,W1118CS,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025006,GSM7140324,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_W1118CS_5d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Healthy,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,W1118CS,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025007,GSM7140325,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dAux_5d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dAux,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025008,GSM7140326,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dAux_5d_4.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dAux,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025009,GSM7140327,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dAux_5d_3.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dAux,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025010,GSM7140328,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dAux_5d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dAux,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025011,GSM7140329,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dSynj_5d_4.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dSynj,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025012,GSM7140330,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dSynj_5d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dSynj,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025013,GSM7140331,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dSynj_5d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dSynj,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025014,GSM7140332,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_dSynj_5d_3.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,dSynj,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025015,GSM7140337,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_4_25d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025016,GSM7140338,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_4_5d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025017,GSM7140339,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_2_5d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025018,GSM7140340,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_1_25d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025020,GSM7140341,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_3_5d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025021,GSM7140342,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_2_25d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025022,GSM7140343,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_1_5d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025023,GSM7140344,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_LRRK_3_25d.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,LRRK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025024,GSM7140345,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_EndoA_25d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad.,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025025,GSM7140346,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_EndoA_25d_3.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025026,GSM7140347,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_EndoA_25d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025027,GSM7140348,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_EndoA_25d_4.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025028,GSM7140349,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_GAL4_25d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025029,GSM7140350,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_GAL4_25d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025030,GSM7140351,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_GCAMP_25d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025031,GSM7140352,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hLRRK_OPN_GCAMP_25d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,25 day,,10X Genomics,Single-nucleus RNA sequencing,hLRRK_OPN>EndoA,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025032,GSM7140353,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hPINK_5d_1.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,hPINK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025033,GSM7140354,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hPINK_5d_3.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,hPINK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025034,GSM7140355,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hPINK_5d_4.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,hPINK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025035,GSM7140356,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hPINK_5d_2.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,hPINK,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025036,GSM7140357,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hRAB39B_5d_1_adult_brain.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,hRAB39B,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025037,GSM7140358,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hRAB39B_5d_3_adult_brain.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,hRAB39B,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025038,GSM7140359,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hRAB39B_5d_2_central_brain.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,5 day,,10X Genomics,Single-nucleus RNA sequencing,hRAB39B,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025039,GSM7140360,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE228843_hRAB39B_5d_4_adult_brain.CELDA_DECONTX_CORRECT_SCRUBLET.h5ad,h5ad,,40178224,PD,Disease,,Drosophila melanogaster,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,,10X Genomics,Single-nucleus RNA sequencing,hRAB39B,10x Genomics CHROMIUM Single Cell RNA Library 7 Gel Bead kit v3,,,
PD025040,GSE235330,C8_C23,,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40178224/GSE235330_PD_atlas_human_final_genotyped.h5ad,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025041,GSE235330,C4_C23,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025042,GSE235330,C10_C45,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025043,GSE235330,C2_C45,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025044,GSE235330,C6_C45,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025045,GSE235330,C11_C72,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025046,GSE235330,C0_C72,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025047,GSE235330,C1_C72,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025048,GSE235330,C1_C73,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025049,GSE235330,C4_C73,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025050,GSE235330,C9_C73,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025051,GSE235330,C3_C87,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025052,GSE235330,C5_C87,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025053,GSE235330,C9_C87,,,40178224,PD,Disease,Yes,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",,,
PD025054,GSE235330,C3_PD106,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus basalis of Meynert,Male,75 years
PD025055,GSE235330,C8_PD106,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Putamen,Male,75 years
PD025056,GSE235330,C6_PD106,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus accumbens,Male,75 years
PD025057,GSE235330,C7_PD188,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus accumbens,Female,81 years
PD025058,GSE235330,C1_PD188,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus basalis of Meynert,Female,81 years
PD025059,GSE235330,C9_PD188,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Putamen,Female,81 years
PD025060,GSE235330,C4_PD194,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus accumbens,Male,71 years
PD025061,GSE235330,C2_PD194,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus basalis of Meynert,Male,71 years
PD025062,GSE235330,C11_PD194,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Putamen,Male,71 years
PD025063,GSE235330,C10_PD348,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Putamen,Male,78 years
PD025064,GSE235330,C3_PD348,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus basalis of Meynert,Male,78 years
PD025065,GSE235330,C7_PD348,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus accumbens,Male,78 years
PD025066,GSE235330,C5_PD348,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus accumbens,Male,78 years
PD025067,GSE235330,C2_PD423,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus basalis of Meynert,Female,66 years
PD025068,GSE235330,C8_PD423,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Putamen,Female,66 years
PD025069,GSE235330,C7_PD423,,,40178224,PD,Disease,No,Human,Brain,no data avaliable,no data avaliable,no data avaliable,no data avaliable,no data available,10X Genomics,Single-nucleus RNA sequencing,no data avaliable,"Nuclei of human samples were prepared as described in Hodge et al., 2019; Slyper et al., 2020.",Nucleus accumbens,Female,66 years
PD026001,GSM7595892,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40246848/GSM7595892_C230131001_,10x_matrix,10x_matrix (error),40246848,PD,Healthy ,Yes,Human,midbrain organoid,no data avaliable,no data avaliable,no data avaliable,30 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, cat. nr. 10010-23). Organoids were digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, cat. nr. 1190062) in a 15 ml conical tube (Sarstedt, cat. nr. 62.5544.003) and placed in a thermal shaker at 50 rpm at 37C for 30 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, cat nr. 542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 500l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, cat. nr. F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, cat nr. 4161031) according to the manufacturers instructions. Briefly, for each library, the concentration of the single-cell suspension was adjusted to 3x105 cells/ml with PBS, and the suspension was loaded onto an SD microfluidic chip to capture 6000 cells. Paramagnetic beads conjugated to oligodT probes that carry a unique molecular identifier (UMI) and a barcode unique to each bead (from the same kit) were loaded, after which the cells were lysed. The beads bound to polyadenylated mRNA were extracted from the chip and reverse transcribed into cDNA at 42C for 1.5 hours, and the cDNA was amplified by PCR. The cDNA was then fragmented and ligated to indexed Illumina adapters. The fragment size distribution of the final amplified library was obtained on an Agilent Fragment Analyzer.",midbrain organoid,,
PD026002,GSM7595893,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40246848/GSM7595893_C230131003_,10x_matrix,10x_matrix (error),40246848,PD,Disease,No,Human,midbrain organoid,no data avaliable,no data avaliable,no data avaliable,30 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC; RhoT1 (Miro1 R272Q) mutation,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, cat. nr. 10010-23). Organoids were digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, cat. nr. 1190062) in a 15 ml conical tube (Sarstedt, cat. nr. 62.5544.003) and placed in a thermal shaker at 50 rpm at 37C for 30 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, cat nr. 542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 500l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, cat. nr. F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, cat nr. 4161031) according to the manufacturers instructions. Briefly, for each library, the concentration of the single-cell suspension was adjusted to 3x105 cells/ml with PBS, and the suspension was loaded onto an SD microfluidic chip to capture 6000 cells. Paramagnetic beads conjugated to oligodT probes that carry a unique molecular identifier (UMI) and a barcode unique to each bead (from the same kit) were loaded, after which the cells were lysed. The beads bound to polyadenylated mRNA were extracted from the chip and reverse transcribed into cDNA at 42C for 1.5 hours, and the cDNA was amplified by PCR. The cDNA was then fragmented and ligated to indexed Illumina adapters. The fragment size distribution of the final amplified library was obtained on an Agilent Fragment Analyzer.",,,
PD026003,GSM7595894,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40246848/GSM7595894_C230131004_,10x_matrix,10x_matrix (error),40246848,PD,Healthy ,Yes,Human,midbrain organoid,no data avaliable,no data avaliable,no data avaliable,30 days ,,GEXSCOPE,Single-cell RNA sequencing,iPSC; Isogenic control (corrected MIRO1 R272Q mutation),"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, cat. nr. 10010-23). Organoids were digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, cat. nr. 1190062) in a 15 ml conical tube (Sarstedt, cat. nr. 62.5544.003) and placed in a thermal shaker at 50 rpm at 37C for 30 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, cat nr. 542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 500l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, cat. nr. F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, cat nr. 4161031) according to the manufacturers instructions. Briefly, for each library, the concentration of the single-cell suspension was adjusted to 3x105 cells/ml with PBS, and the suspension was loaded onto an SD microfluidic chip to capture 6000 cells. Paramagnetic beads conjugated to oligodT probes that carry a unique molecular identifier (UMI) and a barcode unique to each bead (from the same kit) were loaded, after which the cells were lysed. The beads bound to polyadenylated mRNA were extracted from the chip and reverse transcribed into cDNA at 42C for 1.5 hours, and the cDNA was amplified by PCR. The cDNA was then fragmented and ligated to indexed Illumina adapters. The fragment size distribution of the final amplified library was obtained on an Agilent Fragment Analyzer.",,,
PD026004,GSM8210404,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40246848/GSM8210404_C230131002_,10x_matrix,10x_matrix (error),40246848,PD,Healthy ,Yes,Human,midbrain organoid,no data avaliable,no data avaliable,no data avaliable,60 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC; ,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, cat. nr. 10010-23). Organoids were digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, cat. nr. 1190062) in a 15 ml conical tube (Sarstedt, cat. nr. 62.5544.003) and placed in a thermal shaker at 50 rpm at 37C for 30 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, cat nr. 542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 500l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, cat. nr. F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, cat nr. 4161031) according to the manufacturers instructions. Briefly, for each library, the concentration of the single-cell suspension was adjusted to 3x105 cells/ml with PBS, and the suspension was loaded onto an SD microfluidic chip to capture 6000 cells. Paramagnetic beads conjugated to oligodT probes that carry a unique molecular identifier (UMI) and a barcode unique to each bead (from the same kit) were loaded, after which the cells were lysed. The beads bound to polyadenylated mRNA were extracted from the chip and reverse transcribed into cDNA at 42C for 1.5 hours, and the cDNA was amplified by PCR. The cDNA was then fragmented and ligated to indexed Illumina adapters. The fragment size distribution of the final amplified library was obtained on an Agilent Fragment Analyzer.",,,
PD026005,GSM8210405,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40246848/GSM8210405_C230131005_,10x_matrix,10x_matrix (error),40246848,PD,Disease,No,Human,midbrain organoid,no data avaliable,no data avaliable,no data avaliable,60 days ,,GEXSCOPE,Single-cell RNA sequencing,iPSC; RhoT1 (Miro1 R272Q) mutation,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, cat. nr. 10010-23). Organoids were digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, cat. nr. 1190062) in a 15 ml conical tube (Sarstedt, cat. nr. 62.5544.003) and placed in a thermal shaker at 50 rpm at 37C for 30 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, cat nr. 542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 500l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, cat. nr. F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, cat nr. 4161031) according to the manufacturers instructions. Briefly, for each library, the concentration of the single-cell suspension was adjusted to 3x105 cells/ml with PBS, and the suspension was loaded onto an SD microfluidic chip to capture 6000 cells. Paramagnetic beads conjugated to oligodT probes that carry a unique molecular identifier (UMI) and a barcode unique to each bead (from the same kit) were loaded, after which the cells were lysed. The beads bound to polyadenylated mRNA were extracted from the chip and reverse transcribed into cDNA at 42C for 1.5 hours, and the cDNA was amplified by PCR. The cDNA was then fragmented and ligated to indexed Illumina adapters. The fragment size distribution of the final amplified library was obtained on an Agilent Fragment Analyzer.",,,
PD026006,GSM8210406,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40246848/GSM8210406_C230131006_,10x_matrix,10x_matrix (error),40246848,PD,Healthy ,Yes,Human,midbrain organoid,no data avaliable,no data avaliable,no data avaliable,60 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC; Isogenic control (corrected MIRO1 R272Q mutation),"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, cat. nr. 10010-23). Organoids were digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, cat. nr. 1190062) in a 15 ml conical tube (Sarstedt, cat. nr. 62.5544.003) and placed in a thermal shaker at 50 rpm at 37C for 30 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, cat nr. 542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 500l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, cat. nr. F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, cat nr. 4161031) according to the manufacturers instructions. Briefly, for each library, the concentration of the single-cell suspension was adjusted to 3x105 cells/ml with PBS, and the suspension was loaded onto an SD microfluidic chip to capture 6000 cells. Paramagnetic beads conjugated to oligodT probes that carry a unique molecular identifier (UMI) and a barcode unique to each bead (from the same kit) were loaded, after which the cells were lysed. The beads bound to polyadenylated mRNA were extracted from the chip and reverse transcribed into cDNA at 42C for 1.5 hours, and the cDNA was amplified by PCR. The cDNA was then fragmented and ligated to indexed Illumina adapters. The fragment size distribution of the final amplified library was obtained on an Agilent Fragment Analyzer.",,,
PD027001,GSM8504093,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504093_C231212001_,10x_matrix,10x_matrix (error),40164620,PD,Healthy,Yes,Human,Midbrain organoids,no data avaliable,Female,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027002,GSM8504094,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504094_C231212002_,10x_matrix,10x_matrix (error),40164620,PD,Healthy,Yes,Human,Midbrain organoids,no data avaliable,Female,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027003,GSM8504095,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504095_C231212003_,10x_matrix,10x_matrix (error),40164620,PD,Healthy,Yes,Human,Midbrain organoids,no data avaliable,Female,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027004,GSM8504096,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504096_C231212004_,10x_matrix,10x_matrix (error),40164620,PD,Disease,No,Human,Midbrain organoids,no data avaliable,Female,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027005,GSM8504097,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504097_C231212005_,10x_matrix,10x_matrix (error),40164620,PD,Disease,No,Human,Midbrain organoids,no data avaliable,Female,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027006,GSM8504098,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504098_C231212006_,10x_matrix,10x_matrix (error),40164620,PD,Disease,No,Human,Midbrain organoids,no data avaliable,Female,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027007,GSM8504099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504099_C231212007_,10x_matrix,10x_matrix (error),40164620,PD,Healthy,Yes,Human,Midbrain organoids,no data avaliable,Male,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027008,GSM8504100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504100_C231212008_,10x_matrix,10x_matrix (error),40164620,PD,Healthy,Yes,Human,Midbrain organoids,no data avaliable,Male,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027009,GSM8504101,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504101_C231212009_,10x_matrix,10x_matrix (error),40164620,PD,Healthy,Yes,Human,Midbrain organoids,no data avaliable,Male,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027010,GSM8504102,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504102_C231212010_,10x_matrix,10x_matrix (error),40164620,PD,Disease,No,Human,Midbrain organoids,no data avaliable,Male,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027011,GSM8504103,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504103_C231212011_,10x_matrix,10x_matrix (error),40164620,PD,Disease,No,Human,Midbrain organoids,no data avaliable,Male,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD027012,GSM8504104,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40164620/GSM8504104_C231212012_,10x_matrix,10x_matrix (error),40164620,PD,Disease,No,Human,Midbrain organoids,no data avaliable,Male,no data avaliable,50 days,,GEXSCOPE,Single-cell RNA sequencing,iPSC,"Midbrain organoids were collected from their culture medium and washed with 1x PBS (phosphate-buffered saline, Gibco, Cat#10010-015). Organoids were transferred to a 1.5ml Eppendorf tube and digested in 1 ml sCelLive Tissue Dissociation Solution (Singleron Biotechnologies, Cat#1190062) diluted 1:2 with PBS. The organoids were placed in a thermal shaker at 750 rpm at 37C for 45 minutes. The state of dissociation was checked at regular intervals under a light microscope. Following digestion, the suspension was filtered using a 40-m sterile strainer (Greiner, Cat#542040). The cells were centrifuged at 350xg for 5 minutes at 4C, and the cell pellets were resuspended in 300l PBS. Cells were stained with Acridine Orange/Propidium Iodide Stain (Logos Biosystems, Cat#F23001), and the cell number and viability were calculated using LUNA-FX7 Automated Cell Counter (Logos Biosystems, Villeneuve dAscq, France).The single-cell RNA-seq libraries were constructed using GEXSCOPE Single Cell RNAseq Library Kit (Singleron Biotechnologies, Cat#4180011) according to the manufacturers instructions.",,,
PD030001,GSM7792123,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792123_s_0096_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,Female,braak stage_for_neurofibrillary_tangles: 4,90 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030002,GSM7792124,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792124_s_0098_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 4,99 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030003,GSM7792125,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792125_s_0100_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 4,89 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030004,GSM7792126,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792126_s_0102_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,Female,braak stage_for_neurofibrillary_tangles: 1,57 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030005,GSM7792127,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792127_s_0103_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 4,68 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030006,GSM7792128,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792128_s_0104_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 4,81 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030007,GSM7792129,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792129_s_0105_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 1,78 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030008,GSM7792130,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792130_s_0107_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 2,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030009,GSM7792131,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792131_s_0109_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 3,98 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030010,GSM7792132,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792132_s_0110_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 3,82 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030011,GSM7792133,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792133_s_0111_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 2,80 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030012,GSM7792134,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792134_s_0116_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 1,77 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030013,GSM7792135,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792135_s_0118_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,Female,braak stage_for_neurofibrillary_tangles: 4,85 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030014,GSM7792136,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792136_s_0119_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,male,braak stage_for_neurofibrillary_tangles: 4,84 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030015,GSM7792137,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792137_s_0120_,10x_matrix,,38245794,PD,Disease,no data available,Human,substantia nigra,no data available,Female,braak stage_for_neurofibrillary_tangles: 3,85 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030016,GSM7792138,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792138_s_0127_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,65 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030017,GSM7792139,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792139_s_0128_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,female,no data available,81 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030018,GSM7792140,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792140_s_0129_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,86 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030019,GSM7792141,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792141_s_0130_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,61 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030020,GSM7792142,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792142_s_0131_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,65 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030021,GSM7792143,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792143_s_0142_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,62 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030022,GSM7792144,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792144_s_0147_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,Female,no data available,30 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030023,GSM7792145,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792145_s_0151_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,Female,no data available,77 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030024,GSM7792146,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792146_s_0152_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,Female,no data available,93 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030025,GSM7792147,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792147_s_0153_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,91 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030026,GSM7792148,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792148_s_0154_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,93 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030027,GSM7792149,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792149_s_0158_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,89 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030028,GSM7792150,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792150_s_0159_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,Female,no data available,73 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD030029,GSM7792151,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38245794/GSM7792151_s_0165_,10x_matrix,,38245794,PD,Healthy,Yes,Human,substantia nigra,no data available,male,no data available,91 years,no data available,10X Genomics,Single-nucleus RNA sequencing,,"To identify the substantia nigra in Control and PD tissues, cryostat sections of 5m thickness were cut, haematoxylin and eosin (H&E) stained and viewed under the microscope by a neuropathologist (DRT) to identify region populated with melanin containing neurons. Based on this observation, the substantia nigra pars compacta region was manually annotated with a waterproof pen. H&E-guided 2 mm biopsy punches were collected from the SNpc of selected samples and nuclei were isolated to prepare the sequencing libraries.Libraries were prepared using the Chromium Single Cell 3 Reagent Kits v.3 according to the manufacturers protocol (10x Genomics).",,,
PD035001,GSM6459689,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459689_NOSN01_snRNA.molecule_info.h5,h5,"contains more than one genome. For legacy 10x h5 files you must specify the genome if more than one is present. Available genomes are: ['barcode_idx', 'barcode_info', 'barcodes', 'count', 'feature_idx', 'features', 'gem_group', 'library_idx', 'library_info', 'metrics', 'umi']",37058563,PD,Healthy,no data available,Human,Substantia nigra,no data available,Female,Braak combo: 1,63,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035002,GSM6459690,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459690_NOSN02_snRNA.molecule_info.h5,h5,,37058563,PD,Healthy,no data available,Human,Substantia nigra,no data available,Female,Braak combo: 0,79,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035003,GSM6459691,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459691_NOSN03_snRNA.molecule_info.h5,h5,,37058563,PD,Healthy,no data available,Human,Substantia nigra,no data available,Female,Braak combo: 1,80,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035004,GSM6459692,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459692_NOSN04_snRNA.molecule_info.h5,h5,,37058563,PD,Healthy,no data available,Human,Substantia nigra,no data available,Male,Braak combo: 1,71,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035005,GSM6459693,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459693_NOSN05_snRNA.molecule_info.h5,h5,,37058563,PD,Healthy,no data available,Human,Substantia nigra,no data available,Male,Braak combo: 1,91,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E3,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035006,GSM6459694,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459694_NOSN06_snRNA.molecule_info.h5,h5,,37058563,PD,Healthy,no data available,Human,Substantia nigra,no data available,Male,Braak combo: 0,69,no data available,10X Genomics,Single-nucleus RNA sequencing,E2/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035007,GSM6459695,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459695_PDSN01_snRNA.molecule_info.h5,h5,,37058563,PD,Disease,no data available,Human,Substantia nigra,no data available,Female,Braak combo: 2.1,82,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035008,GSM6459696,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459696_PDSN02_snRNA.molecule_info.h5,h5,,37058563,PD,Disease,no data available,Human,Substantia nigra,no data available,Female,Braak combo: 4.2,75,no data available,10X Genomics,Single-nucleus RNA sequencing,E4/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035009,GSM6459697,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459697_PDSN04_snRNA.molecule_info.h5,h5,,37058563,PD,Disease,no data available,Human,Substantia nigra,no data available,Female,Braak combo: 4.2,89,no data available,10X Genomics,Single-nucleus RNA sequencing,E4/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035010,GSM6459698,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459698_PDSN06_snRNA.molecule_info.h5,h5,,37058563,PD,Disease,no data available,Human,Substantia nigra,no data available,Male,Braak combo: 3.2,71,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035011,GSM6459699,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459699_PDSN07_snRNA.molecule_info.h5,h5,,37058563,PD,Disease,no data available,Human,Substantia nigra,no data available,Male,Braak combo: 2.1,77,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD035012,GSM6459700,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37058563/GSM6459700_PDSN09_snRNA.molecule_info.h5,h5,,37058563,PD,Disease,no data available,Human,Substantia nigra,no data available,Male,Braak combo: 4.2,76,no data available,10X Genomics,Single-nucleus RNA sequencing,E3/E4,"About 15 mg of tissue was placed in an extra-thick tissue processing tube (Covaris, 520140) while kept in liquid nitrogen, and repeatedly hammered to produce frozen tissue powder. The frozen tissue was transferred to lysis buffer of 0.2% Triton X-100, protease inhibitor (Roche, 04-693-159-001), 1 mM DTT (Sigma-Aldrich, D9779), 0.2 U/L RNAsin (Promega, N211B), and 2% BSA (Sigma-Aldrich, SRE0036) in PBS. Sample was pipetted 10 times, rotated for 5 min at 4C, and centrifuged at 500g for 5 min. The pellet was resuspended in sorting buffer of 1 mM EDTA, 0.2 U/L RNAsin, and 2% BSA in PBS, and passed through a 30 m strainer (Sysmex, 04-0042-2316) to remove excessive debris. The nuclei were stained with DRAQ7 (1:100, Cell Signaling, 7406) for snRNA-seq, and with DAPI (10 ug/mL, Sigma, 32670) for snATAC-seq. Between 100,000 and 150,000 nuclei were sorted using a MoFlo Astrios EQ sorter (Beckman coulter, laser/filter) into a collection tube with 1 U/ L RNAsin and 5% BSA in PBS. Sorted nuclei were centrifuged at 1000 g for 15 min at 4C, and supernatant was removed. Nuclei were resuspended in resuspension buffer (0.2 U/L RNAsin and 1% BSA in PBS) and counted using a cell counter (Cellometer Auto 2000, Nexcelom Biosicence) with AO/PI staining.We generated snRNA-seq libraries using the Chromium Single Cell 3 Library & Gel Bead Kit v3 (10x Genomics).",,,
PD040001,GSM7438575,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438575_seq067-rat2-12m-Seq067-hES-GFP-12m-rat2AF018.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040002,GSM7438576,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438576_seq069-rat10-12m-Seq069-1-hESgraft-12m-rat10.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,"10x Genomics, Cellranger count v3",10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040003,GSM7438577,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438577_seq069-rat10-12m-Seq069-2-hESgraft-12m-rat10.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040004,GSM7438578,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438578_seq069-rat11-12m-Seq069-1-hESgraft-12m-rat11-AF17.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040005,GSM7438579,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438579_seq069-rat5-12m-Seq069-1-hESgraft-12m-rat5.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040006,GSM7438580,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438580_seq069-rat6-12m-Seq069-1-hESgraft-12m-rat6.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040007,GSM7438581,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438581_seq069-rat6-12m-Seq069-2-hESgraft-12m-rat6.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040008,GSM7438582,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438582_seq069-rat6-12m-Seq069-3-hESgraft-12m-rat6.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040009,GSM7438583,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438583_seq103-rat7A-12m-hESgraft12months.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040010,GSM7438584,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438584_seq103-rat7B-12m-hESgraft12months.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040011,GSM7438585,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438585_seq103-rat7C-12m-hESgraft12months.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040012,GSM7438586,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438586_seq103-rat8A-12m-hESgraft12months.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040013,GSM7438587,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438587_seq103-rat8B-12m-hESgraft12months.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040014,GSM7438588,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438588_seq103-rat8C-12m-hESgraft12months.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,12 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040015,GSM7438589,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438589_seq113-rat3A-9m-hESgraft.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,9 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040016,GSM7438590,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438590_seq113-rat3B-9m-hESgraft.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,9 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040017,GSM7438591,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438591_seq113-rat3C-9m-hESgraft.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,9 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040018,GSM7438592,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438592_seq113-rat4-9m-hESgraft.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,9 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040019,GSM7438593,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438593_seq113-rat7A1-9m-hESgraft.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,9 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040020,GSM7438594,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438594_seq113-rat7A2-9m-hESgraft.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,9 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD040021,GSM7438595,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39541349/GSM7438595_seq113-rat7A4-9m-hESgraft.rds,,rds,39541349,PD,Disease,no data available,Human,Nigral graft of dopamine progenitors in nude rat,no data available,no data available,no data available,9 months,no data available,10X Genomics,Single-nucleus RNA sequencing,DA neurons driven DA neurons + 6-OHDA rat,"RC17 hESCs (Roslin Cells) were cultured at 37 C and 5% CO2 and used for all transplantation experiments. Regional patterning of hESCs toward a ventral midbrain (VM) fate was performed via dual SMAD inhibition to induce neuralization, GSK3 inhibitor-mediated caudalization, and SHH-mediated ventralization. VM progentior cells were transplanted into the nigral brain region of of athymic nude rats. Lesion of the nigrostriatal pathway in rats was induced by unilateral injection of 6-hydroxydopamine into the right medial forebrain bundle (MFB).Grafted VM patterned hESCs cells were dissected from rat nigra and transferred to a glass douncer containing 1ml of nuclei lysis buffer (consisted of sucrose, CaCl2, MgAc, EDTA, Tril-HCl, DTT, Triton X-100, RNase inhibitor and RNase-free water) on ice. Tissue was completely minced and homogenized to nuclei suspension by sample grinding with Dounce homogenizers with 10 strokes with loose pestle and then 10 strokes with tight pestle. The nuclei suspension was filtered by loading through a 35-m-diameter filter and followed by centrifuging for 10min at 900g and 4C.According to 10X protocols.",,,
PD056001,https://zenodo.org/record/3993994,N1,,rds,34282123,PD,Healthy,,	Human,Blood,no data available,Female,no data available,71,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056002,,N2,,rds,34282123,PD,Healthy,,	Human,Blood,no data available,Female,no data available,54,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056003,,N3,,rds,34282123,PD,Healthy,,	Human,Blood,no data available,Female,no data available,65,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056004,,N4,,rds,34282123,PD,Healthy,,	Human,Blood,no data available,Male,no data available,51,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056005,,N5,,rds,34282123,PD,Healthy,,	Human,Blood,no data available,Male,no data available,65,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056006,,N6,,rds,34282123,PD,Healthy,,	Human,Blood,no data available,Male,no data available,65,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056007,,P1,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Female,no data available,56,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056008,,P2,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Female,no data available,63,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056009,,P3,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Female,no data available,68,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056010,,P4,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Female,no data available,61,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056011,,P5,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Male,no data available,69,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056012,,P6,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Male,no data available,65,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056013,,P7,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Male,no data available,68,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD056014,,P8,,rds,34282123,PD,Disease,,	Human,Blood,no data available,Male,no data available,50,,10X Genomics,Single-cell RNA sequencing,,"Fresh blood samples from eight PD patients (P1P8) and six age-matched healthy controls (N1N6) were collected and followed by density gradient centrifugation on Percoll to isolate human peripheral blood mononuclear cells (PBMCs). CD3+ T cells were then isolated from PBMCs by fluorescence-activated cell sorting (FACS) analysis.Single-cell 5 and V(D)J libraries were prepared following the protocol provided by the 10 genomics Chromium Single Cell Immune Profiling Solution. Briefly, CD3+ T cell suspensions (4001000 living cells per microliter determined by CounterStar) were loaded on a Chromium Single Cell Controller (10 Genomics) to generate single-cell gel beads in emulsion (GEMs) using Chromium Single Cell V(D)J Reagent Kits. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Each single-cell 5 and V(D)J libraries were sequenced by the Illumina Novaseq 6000 using 150 paired-end reads.",,,
PD058001,GSM5359131,UKERiC99-R1-007,,,35974013,PD,no data available,no data available,Human,fibroblast-derived induced pluripotent stem cells,no data available,Male,no data available,68,no data available,10X Genomics,Single-cell RNA sequencing,," human induced pluripotent stem cells (hiPSCs) were differentiated into human small molecule neural progenitor cells (hNPCs) by embryoid body (EB) formation following the protocol described by (Reinhardt et al., 2013) with minor adaptations. At 70 % confluency, hiPSC colonies were detached using 2 mg/ml collagenase type IV (Thermo Fisher Scientific) for 40 min at 37 C, 5 % CO2, 21 % O2. Detached hiPSC colonies were harvested in knockout serum replacement medium (80 % KnockOut DMEM (Life Technologies) supplemented with 20 % Knockout serum replacement (Life Technologies), 10 M SB431542 (Miltenyi Biotec), 0.5 M purmorphamine (Tocris Bioscience), 1 M dorsomorphin (Tocris Bioscience), 3 M CHIR99021 (Tocris Bioscience), 4.44 nM FGF-8b (Miltenyi Biotec), 1 % non-essential amino acids (Life Technologies), 1 % L-glutamine (Life Technologies), 150 M ascorbic acid 2-phosphate (Sigma) and 0.02 % beta-mercaptoethanol (Life Technologies)). hiPSCs were cultivated for two days on an orbital shaker at 37 C, 5 % CO2, 21 % O2 and 80 rpm with daily media changes. At day 3, EBs were transferred into neuronal precursor medium (50 % DMEM/F12-GlutaMAX (Life Technologies), 50 % Neurobasal (Life Technologies) supplemented with 1 % B27 (minus vitamin A, 12587010, Life Technologies), 0.5 % N2 (Life Technologies), 10 M SB431542, 0.5 M purmorphamine, 1 M dorsomorphin, 3 M CHIR99021, 4.44 nM FGF-8b, 150 M ascorbic acid 2-phosphate and 0.02 % beta-mercaptoethanol). EBs were cultivated for 4 days at 37 C, 7 % CO2, 21 % O2 and 80 rpm with daily media changes. On day 6, EBs were transferred into neural precursor maintenance medium (neural precursor medium deprived of purmorphamine and CHIR99021). The following day, EBs were seeded unharmed on Geltrex coated plates and expanded for 3-4 days in neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2 with daily media changes. At day 10-11 hNPCs were dissociated using Accutase (Sigma) for 10 min at 37 C, 7 % CO2, 21 % O2, chopped with a 1000 l pipette tip and diluted in 5 ml neural precursor maintenance medium. hNPCs were harvested at 200 g for 5 min, resuspended in 1 ml neural precursor maintenance medium and seeded on Geltrex coated plates. Thereafter, hNPCs were cultivated at 37 C, 7 % CO2, 21 % O2 with daily medium changes and passaged with Accutase at 80 % confluency. After 2 passages, 0.5 M purmorphamine was added to the maintenance medium.hNPCs were maintained on Geltrex coated plates containing neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2. At 80% confluency, hNPCs were dissociated using Accutase for 10 min at 37 C, chopped with a 1000 l pipette tip and diluted in 5 ml PBS containing 10 % BSA (Sigma). hNPCs were harvested at 200 g for 5 min and resuspended in 1 ml PBS containing 10 % BSA. The hNPC solution was filtered through a 35 m cell strainer (Corning) and counted using a Neubauer improved cell counting chamber (Carl Roth).In total 6 libraries with 13,692 hNPCs each were generated in the 10X Genomics Chromium controller according to the manufacturer's instructions and using the Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN-120237, 10xGenomics) and Chromium i7 Multiplex Kit (PN-120262, 10xGenomics). Libraries were pooled and sequenced on a HiSeq4000 (Illumina) according to the Chromium Single Cell v.2 specifications and with an average read depth of 90,000 aligned reads per cell.Transcriptome of 16 cell lines was analyzed using single-cell RNA-seq. Cells from all doners where pooled and demultiplexed after sequencing due to the unique SNP patterns of donors.",,,
PD058002,GSM5359132,UKERi88H-R1-002,,,35974013,PD,no data available,no data available,Human,fibroblast-derived induced pluripotent stem cells,no data available,Female,no data available,63,no data available,10X Genomics,Single-cell RNA sequencing,," human induced pluripotent stem cells (hiPSCs) were differentiated into human small molecule neural progenitor cells (hNPCs) by embryoid body (EB) formation following the protocol described by (Reinhardt et al., 2013) with minor adaptations. At 70 % confluency, hiPSC colonies were detached using 2 mg/ml collagenase type IV (Thermo Fisher Scientific) for 40 min at 37 C, 5 % CO2, 21 % O2. Detached hiPSC colonies were harvested in knockout serum replacement medium (80 % KnockOut DMEM (Life Technologies) supplemented with 20 % Knockout serum replacement (Life Technologies), 10 M SB431542 (Miltenyi Biotec), 0.5 M purmorphamine (Tocris Bioscience), 1 M dorsomorphin (Tocris Bioscience), 3 M CHIR99021 (Tocris Bioscience), 4.44 nM FGF-8b (Miltenyi Biotec), 1 % non-essential amino acids (Life Technologies), 1 % L-glutamine (Life Technologies), 150 M ascorbic acid 2-phosphate (Sigma) and 0.02 % beta-mercaptoethanol (Life Technologies)). hiPSCs were cultivated for two days on an orbital shaker at 37 C, 5 % CO2, 21 % O2 and 80 rpm with daily media changes. At day 3, EBs were transferred into neuronal precursor medium (50 % DMEM/F12-GlutaMAX (Life Technologies), 50 % Neurobasal (Life Technologies) supplemented with 1 % B27 (minus vitamin A, 12587010, Life Technologies), 0.5 % N2 (Life Technologies), 10 M SB431542, 0.5 M purmorphamine, 1 M dorsomorphin, 3 M CHIR99021, 4.44 nM FGF-8b, 150 M ascorbic acid 2-phosphate and 0.02 % beta-mercaptoethanol). EBs were cultivated for 4 days at 37 C, 7 % CO2, 21 % O2 and 80 rpm with daily media changes. On day 6, EBs were transferred into neural precursor maintenance medium (neural precursor medium deprived of purmorphamine and CHIR99021). The following day, EBs were seeded unharmed on Geltrex coated plates and expanded for 3-4 days in neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2 with daily media changes. At day 10-11 hNPCs were dissociated using Accutase (Sigma) for 10 min at 37 C, 7 % CO2, 21 % O2, chopped with a 1000 l pipette tip and diluted in 5 ml neural precursor maintenance medium. hNPCs were harvested at 200 g for 5 min, resuspended in 1 ml neural precursor maintenance medium and seeded on Geltrex coated plates. Thereafter, hNPCs were cultivated at 37 C, 7 % CO2, 21 % O2 with daily medium changes and passaged with Accutase at 80 % confluency. After 2 passages, 0.5 M purmorphamine was added to the maintenance medium.hNPCs were maintained on Geltrex coated plates containing neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2. At 80% confluency, hNPCs were dissociated using Accutase for 10 min at 37 C, chopped with a 1000 l pipette tip and diluted in 5 ml PBS containing 10 % BSA (Sigma). hNPCs were harvested at 200 g for 5 min and resuspended in 1 ml PBS containing 10 % BSA. The hNPC solution was filtered through a 35 m cell strainer (Corning) and counted using a Neubauer improved cell counting chamber (Carl Roth).In total 6 libraries with 13,692 hNPCs each were generated in the 10X Genomics Chromium controller according to the manufacturer's instructions and using the Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN-120237, 10xGenomics) and Chromium i7 Multiplex Kit (PN-120262, 10xGenomics). Libraries were pooled and sequenced on a HiSeq4000 (Illumina) according to the Chromium Single Cell v.2 specifications and with an average read depth of 90,000 aligned reads per cell.Transcriptome of 16 cell lines was analyzed using single-cell RNA-seq. Cells from all doners where pooled and demultiplexed after sequencing due to the unique SNP patterns of donors.",,,
PD058003,GSM5359133,UKERiAY6-R1-003,,,35974013,PD,no data available,no data available,Human,fibroblast-derived induced pluripotent stem cells,no data available,Male,no data available,37,no data available,10X Genomics,Single-cell RNA sequencing,," human induced pluripotent stem cells (hiPSCs) were differentiated into human small molecule neural progenitor cells (hNPCs) by embryoid body (EB) formation following the protocol described by (Reinhardt et al., 2013) with minor adaptations. At 70 % confluency, hiPSC colonies were detached using 2 mg/ml collagenase type IV (Thermo Fisher Scientific) for 40 min at 37 C, 5 % CO2, 21 % O2. Detached hiPSC colonies were harvested in knockout serum replacement medium (80 % KnockOut DMEM (Life Technologies) supplemented with 20 % Knockout serum replacement (Life Technologies), 10 M SB431542 (Miltenyi Biotec), 0.5 M purmorphamine (Tocris Bioscience), 1 M dorsomorphin (Tocris Bioscience), 3 M CHIR99021 (Tocris Bioscience), 4.44 nM FGF-8b (Miltenyi Biotec), 1 % non-essential amino acids (Life Technologies), 1 % L-glutamine (Life Technologies), 150 M ascorbic acid 2-phosphate (Sigma) and 0.02 % beta-mercaptoethanol (Life Technologies)). hiPSCs were cultivated for two days on an orbital shaker at 37 C, 5 % CO2, 21 % O2 and 80 rpm with daily media changes. At day 3, EBs were transferred into neuronal precursor medium (50 % DMEM/F12-GlutaMAX (Life Technologies), 50 % Neurobasal (Life Technologies) supplemented with 1 % B27 (minus vitamin A, 12587010, Life Technologies), 0.5 % N2 (Life Technologies), 10 M SB431542, 0.5 M purmorphamine, 1 M dorsomorphin, 3 M CHIR99021, 4.44 nM FGF-8b, 150 M ascorbic acid 2-phosphate and 0.02 % beta-mercaptoethanol). EBs were cultivated for 4 days at 37 C, 7 % CO2, 21 % O2 and 80 rpm with daily media changes. On day 6, EBs were transferred into neural precursor maintenance medium (neural precursor medium deprived of purmorphamine and CHIR99021). The following day, EBs were seeded unharmed on Geltrex coated plates and expanded for 3-4 days in neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2 with daily media changes. At day 10-11 hNPCs were dissociated using Accutase (Sigma) for 10 min at 37 C, 7 % CO2, 21 % O2, chopped with a 1000 l pipette tip and diluted in 5 ml neural precursor maintenance medium. hNPCs were harvested at 200 g for 5 min, resuspended in 1 ml neural precursor maintenance medium and seeded on Geltrex coated plates. Thereafter, hNPCs were cultivated at 37 C, 7 % CO2, 21 % O2 with daily medium changes and passaged with Accutase at 80 % confluency. After 2 passages, 0.5 M purmorphamine was added to the maintenance medium.hNPCs were maintained on Geltrex coated plates containing neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2. At 80% confluency, hNPCs were dissociated using Accutase for 10 min at 37 C, chopped with a 1000 l pipette tip and diluted in 5 ml PBS containing 10 % BSA (Sigma). hNPCs were harvested at 200 g for 5 min and resuspended in 1 ml PBS containing 10 % BSA. The hNPC solution was filtered through a 35 m cell strainer (Corning) and counted using a Neubauer improved cell counting chamber (Carl Roth).In total 6 libraries with 13,692 hNPCs each were generated in the 10X Genomics Chromium controller according to the manufacturer's instructions and using the Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN-120237, 10xGenomics) and Chromium i7 Multiplex Kit (PN-120262, 10xGenomics). Libraries were pooled and sequenced on a HiSeq4000 (Illumina) according to the Chromium Single Cell v.2 specifications and with an average read depth of 90,000 aligned reads per cell.Transcriptome of 16 cell lines was analyzed using single-cell RNA-seq. Cells from all doners where pooled and demultiplexed after sequencing due to the unique SNP patterns of donors.",,,
PD058004,GSM5359134,UKERiR66-R1-007,,,35974013,PD,no data available,no data available,Human,fibroblast-derived induced pluripotent stem cells,no data available,Male,no data available,54,no data available,10X Genomics,Single-cell RNA sequencing,," human induced pluripotent stem cells (hiPSCs) were differentiated into human small molecule neural progenitor cells (hNPCs) by embryoid body (EB) formation following the protocol described by (Reinhardt et al., 2013) with minor adaptations. At 70 % confluency, hiPSC colonies were detached using 2 mg/ml collagenase type IV (Thermo Fisher Scientific) for 40 min at 37 C, 5 % CO2, 21 % O2. Detached hiPSC colonies were harvested in knockout serum replacement medium (80 % KnockOut DMEM (Life Technologies) supplemented with 20 % Knockout serum replacement (Life Technologies), 10 M SB431542 (Miltenyi Biotec), 0.5 M purmorphamine (Tocris Bioscience), 1 M dorsomorphin (Tocris Bioscience), 3 M CHIR99021 (Tocris Bioscience), 4.44 nM FGF-8b (Miltenyi Biotec), 1 % non-essential amino acids (Life Technologies), 1 % L-glutamine (Life Technologies), 150 M ascorbic acid 2-phosphate (Sigma) and 0.02 % beta-mercaptoethanol (Life Technologies)). hiPSCs were cultivated for two days on an orbital shaker at 37 C, 5 % CO2, 21 % O2 and 80 rpm with daily media changes. At day 3, EBs were transferred into neuronal precursor medium (50 % DMEM/F12-GlutaMAX (Life Technologies), 50 % Neurobasal (Life Technologies) supplemented with 1 % B27 (minus vitamin A, 12587010, Life Technologies), 0.5 % N2 (Life Technologies), 10 M SB431542, 0.5 M purmorphamine, 1 M dorsomorphin, 3 M CHIR99021, 4.44 nM FGF-8b, 150 M ascorbic acid 2-phosphate and 0.02 % beta-mercaptoethanol). EBs were cultivated for 4 days at 37 C, 7 % CO2, 21 % O2 and 80 rpm with daily media changes. On day 6, EBs were transferred into neural precursor maintenance medium (neural precursor medium deprived of purmorphamine and CHIR99021). The following day, EBs were seeded unharmed on Geltrex coated plates and expanded for 3-4 days in neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2 with daily media changes. At day 10-11 hNPCs were dissociated using Accutase (Sigma) for 10 min at 37 C, 7 % CO2, 21 % O2, chopped with a 1000 l pipette tip and diluted in 5 ml neural precursor maintenance medium. hNPCs were harvested at 200 g for 5 min, resuspended in 1 ml neural precursor maintenance medium and seeded on Geltrex coated plates. Thereafter, hNPCs were cultivated at 37 C, 7 % CO2, 21 % O2 with daily medium changes and passaged with Accutase at 80 % confluency. After 2 passages, 0.5 M purmorphamine was added to the maintenance medium.hNPCs were maintained on Geltrex coated plates containing neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2. At 80% confluency, hNPCs were dissociated using Accutase for 10 min at 37 C, chopped with a 1000 l pipette tip and diluted in 5 ml PBS containing 10 % BSA (Sigma). hNPCs were harvested at 200 g for 5 min and resuspended in 1 ml PBS containing 10 % BSA. The hNPC solution was filtered through a 35 m cell strainer (Corning) and counted using a Neubauer improved cell counting chamber (Carl Roth).In total 6 libraries with 13,692 hNPCs each were generated in the 10X Genomics Chromium controller according to the manufacturer's instructions and using the Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN-120237, 10xGenomics) and Chromium i7 Multiplex Kit (PN-120262, 10xGenomics). Libraries were pooled and sequenced on a HiSeq4000 (Illumina) according to the Chromium Single Cell v.2 specifications and with an average read depth of 90,000 aligned reads per cell.Transcriptome of 16 cell lines was analyzed using single-cell RNA-seq. Cells from all doners where pooled and demultiplexed after sequencing due to the unique SNP patterns of donors.",,,
PD058005,GSM5359135,UKERiJ2C-R1-015,,,35974013,PD,no data available,no data available,Human,fibroblast-derived induced pluripotent stem cells,no data available,Male,no data available,73,no data available,10X Genomics,Single-cell RNA sequencing,," human induced pluripotent stem cells (hiPSCs) were differentiated into human small molecule neural progenitor cells (hNPCs) by embryoid body (EB) formation following the protocol described by (Reinhardt et al., 2013) with minor adaptations. At 70 % confluency, hiPSC colonies were detached using 2 mg/ml collagenase type IV (Thermo Fisher Scientific) for 40 min at 37 C, 5 % CO2, 21 % O2. Detached hiPSC colonies were harvested in knockout serum replacement medium (80 % KnockOut DMEM (Life Technologies) supplemented with 20 % Knockout serum replacement (Life Technologies), 10 M SB431542 (Miltenyi Biotec), 0.5 M purmorphamine (Tocris Bioscience), 1 M dorsomorphin (Tocris Bioscience), 3 M CHIR99021 (Tocris Bioscience), 4.44 nM FGF-8b (Miltenyi Biotec), 1 % non-essential amino acids (Life Technologies), 1 % L-glutamine (Life Technologies), 150 M ascorbic acid 2-phosphate (Sigma) and 0.02 % beta-mercaptoethanol (Life Technologies)). hiPSCs were cultivated for two days on an orbital shaker at 37 C, 5 % CO2, 21 % O2 and 80 rpm with daily media changes. At day 3, EBs were transferred into neuronal precursor medium (50 % DMEM/F12-GlutaMAX (Life Technologies), 50 % Neurobasal (Life Technologies) supplemented with 1 % B27 (minus vitamin A, 12587010, Life Technologies), 0.5 % N2 (Life Technologies), 10 M SB431542, 0.5 M purmorphamine, 1 M dorsomorphin, 3 M CHIR99021, 4.44 nM FGF-8b, 150 M ascorbic acid 2-phosphate and 0.02 % beta-mercaptoethanol). EBs were cultivated for 4 days at 37 C, 7 % CO2, 21 % O2 and 80 rpm with daily media changes. On day 6, EBs were transferred into neural precursor maintenance medium (neural precursor medium deprived of purmorphamine and CHIR99021). The following day, EBs were seeded unharmed on Geltrex coated plates and expanded for 3-4 days in neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2 with daily media changes. At day 10-11 hNPCs were dissociated using Accutase (Sigma) for 10 min at 37 C, 7 % CO2, 21 % O2, chopped with a 1000 l pipette tip and diluted in 5 ml neural precursor maintenance medium. hNPCs were harvested at 200 g for 5 min, resuspended in 1 ml neural precursor maintenance medium and seeded on Geltrex coated plates. Thereafter, hNPCs were cultivated at 37 C, 7 % CO2, 21 % O2 with daily medium changes and passaged with Accutase at 80 % confluency. After 2 passages, 0.5 M purmorphamine was added to the maintenance medium.hNPCs were maintained on Geltrex coated plates containing neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2. At 80% confluency, hNPCs were dissociated using Accutase for 10 min at 37 C, chopped with a 1000 l pipette tip and diluted in 5 ml PBS containing 10 % BSA (Sigma). hNPCs were harvested at 200 g for 5 min and resuspended in 1 ml PBS containing 10 % BSA. The hNPC solution was filtered through a 35 m cell strainer (Corning) and counted using a Neubauer improved cell counting chamber (Carl Roth).In total 6 libraries with 13,692 hNPCs each were generated in the 10X Genomics Chromium controller according to the manufacturer's instructions and using the Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN-120237, 10xGenomics) and Chromium i7 Multiplex Kit (PN-120262, 10xGenomics). Libraries were pooled and sequenced on a HiSeq4000 (Illumina) according to the Chromium Single Cell v.2 specifications and with an average read depth of 90,000 aligned reads per cell.Transcriptome of 16 cell lines was analyzed using single-cell RNA-seq. Cells from all doners where pooled and demultiplexed after sequencing due to the unique SNP patterns of donors.",,,
PD058006,GSM5359136,UKERiPX7-R1-001,,,35974013,PD,no data available,no data available,Human,fibroblast-derived induced pluripotent stem cells,no data available,Male,no data available,49,no data available,10X Genomics,Single-cell RNA sequencing,," human induced pluripotent stem cells (hiPSCs) were differentiated into human small molecule neural progenitor cells (hNPCs) by embryoid body (EB) formation following the protocol described by (Reinhardt et al., 2013) with minor adaptations. At 70 % confluency, hiPSC colonies were detached using 2 mg/ml collagenase type IV (Thermo Fisher Scientific) for 40 min at 37 C, 5 % CO2, 21 % O2. Detached hiPSC colonies were harvested in knockout serum replacement medium (80 % KnockOut DMEM (Life Technologies) supplemented with 20 % Knockout serum replacement (Life Technologies), 10 M SB431542 (Miltenyi Biotec), 0.5 M purmorphamine (Tocris Bioscience), 1 M dorsomorphin (Tocris Bioscience), 3 M CHIR99021 (Tocris Bioscience), 4.44 nM FGF-8b (Miltenyi Biotec), 1 % non-essential amino acids (Life Technologies), 1 % L-glutamine (Life Technologies), 150 M ascorbic acid 2-phosphate (Sigma) and 0.02 % beta-mercaptoethanol (Life Technologies)). hiPSCs were cultivated for two days on an orbital shaker at 37 C, 5 % CO2, 21 % O2 and 80 rpm with daily media changes. At day 3, EBs were transferred into neuronal precursor medium (50 % DMEM/F12-GlutaMAX (Life Technologies), 50 % Neurobasal (Life Technologies) supplemented with 1 % B27 (minus vitamin A, 12587010, Life Technologies), 0.5 % N2 (Life Technologies), 10 M SB431542, 0.5 M purmorphamine, 1 M dorsomorphin, 3 M CHIR99021, 4.44 nM FGF-8b, 150 M ascorbic acid 2-phosphate and 0.02 % beta-mercaptoethanol). EBs were cultivated for 4 days at 37 C, 7 % CO2, 21 % O2 and 80 rpm with daily media changes. On day 6, EBs were transferred into neural precursor maintenance medium (neural precursor medium deprived of purmorphamine and CHIR99021). The following day, EBs were seeded unharmed on Geltrex coated plates and expanded for 3-4 days in neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2 with daily media changes. At day 10-11 hNPCs were dissociated using Accutase (Sigma) for 10 min at 37 C, 7 % CO2, 21 % O2, chopped with a 1000 l pipette tip and diluted in 5 ml neural precursor maintenance medium. hNPCs were harvested at 200 g for 5 min, resuspended in 1 ml neural precursor maintenance medium and seeded on Geltrex coated plates. Thereafter, hNPCs were cultivated at 37 C, 7 % CO2, 21 % O2 with daily medium changes and passaged with Accutase at 80 % confluency. After 2 passages, 0.5 M purmorphamine was added to the maintenance medium.hNPCs were maintained on Geltrex coated plates containing neural precursor maintenance medium at 37 C, 7 % CO2, 21 % O2. At 80% confluency, hNPCs were dissociated using Accutase for 10 min at 37 C, chopped with a 1000 l pipette tip and diluted in 5 ml PBS containing 10 % BSA (Sigma). hNPCs were harvested at 200 g for 5 min and resuspended in 1 ml PBS containing 10 % BSA. The hNPC solution was filtered through a 35 m cell strainer (Corning) and counted using a Neubauer improved cell counting chamber (Carl Roth).In total 6 libraries with 13,692 hNPCs each were generated in the 10X Genomics Chromium controller according to the manufacturer's instructions and using the Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN-120237, 10xGenomics) and Chromium i7 Multiplex Kit (PN-120262, 10xGenomics). Libraries were pooled and sequenced on a HiSeq4000 (Illumina) according to the Chromium Single Cell v.2 specifications and with an average read depth of 90,000 aligned reads per cell.Transcriptome of 16 cell lines was analyzed using single-cell RNA-seq. Cells from all doners where pooled and demultiplexed after sequencing due to the unique SNP patterns of donors.",,,
PD058007,,UKERiM89-R1-005,,,35974013,PD,no data available,no data available,Human,fibroblast-derived induced pluripotent stem cells,no data available,Male,no data available,64,,,,,,,,
PD065001,UU26392,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26392_,10x_matrix,,40069190,PD,Healthy,,Drosophila melanogaster,brain,no data available,female,no data available,1 day,,10X Genomics,Single-cell RNA sequencing,elav-gal4 F,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065002,UU26409,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26409_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,3 days,,10X Genomics,Single-cell RNA sequencing,FLHTT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065003,UU26399,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26399_,10x_matrix,,40069190,PD,Healthy,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,elav-gal4 F,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065004,UU26410,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26410_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,3 days,,10X Genomics,Single-cell RNA sequencing,NTHTT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065005,UU26404,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26404_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,TauWT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065006,UU26398,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26398_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,AB42,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065007,UU26395,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26395_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,1 day,,10X Genomics,Single-cell RNA sequencing,TauWT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065008,UU26396,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26396_,10x_matrix,,40069190,PD,Healthy,,Drosophila melanogaster,brain,no data available,female,no data available,1 day,,10X Genomics,Single-cell RNA sequencing,w1118,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065009,UU26393,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26393_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,1 day,,10X Genomics,Single-cell RNA sequencing,FLHTT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065010,UU26411,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26411_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,3 days,,10X Genomics,Single-cell RNA sequencing,AB42,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065011,UU26414,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26414_,10x_matrix,,40069190,PD,Healthy,,Drosophila melanogaster,brain,no data available,female,no data available,3 days,,10X Genomics,Single-cell RNA sequencing,w1118,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065012,UU26413,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26413_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,3 days,,10X Genomics,Single-cell RNA sequencing,TauWT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065013,UU26403,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26403_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,aSyn,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065014,UU26397,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26397_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,NTHTT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065015,UU26412,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26412_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,3 days,,10X Genomics,Single-cell RNA sequencing,aSyn,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065016,UU26407,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26407_,10x_matrix,,40069190,PD,Healthy,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,w1118,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065017,UU26401,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26401_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,NTHTT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065018,UU26408,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26408_,10x_matrix,,40069190,PD,Healthy,,Drosophila melanogaster,brain,no data available,female,no data available,3 days,,10X Genomics,Single-cell RNA sequencing,elav-gal4 F,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065019,UU26402,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26402_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,AB42,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065020,UU26394,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26394_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,1 day,,10X Genomics,Single-cell RNA sequencing,aSyn,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD065021,UU26400,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40069190/UU26400_,10x_matrix,,40069190,PD,Disease,,Drosophila melanogaster,brain,no data available,female,no data available,2 days,,10X Genomics,Single-cell RNA sequencing,FLHTT,"Three biological replicates of females at 10 days post-eclosion were generated per genotype (21 samples total). For each replicate, dissected brains (18 per replicate) were enzymatically dissociated into a single-cell suspension as previously described83. Single-cell RNA-seq libraries were prepared by the Baylor College of Medicine Single Cell Genomics Core using the Chromium Single Cell Gene Expression 3 v3.1 kit (10x Genomics) and then were sequenced by the Baylor Genomic and RNA Profiling Core. Sequencing was performed using the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample. Illumina BCL files were demultiplexed using the Cell Ranger 4.0.0 mkfastq function. The resultant FASTQ files were aligned to the Drosophila reference genome (BDGP6.22.98). Gene counts were quantified using the Cell Ranger 4.0.0 count pipeline and filtered count matrices were loaded into Seurat84 in R for additional quality control and downstream analyses. Cells were filtered from the data if the proportion of mitochondrial reads per cell was >20% or the total number of unique genes per cell was fewer than 200 or >3000.To predict and remove heterotypic doublets we used the DoubletFinder function within the Seurat package. Briefly, for each library, artificial doublets were generated from the existing data, and PCA was performed after merging the real and artificial data. Using the first 40 PCs, we generated a distance matrix to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. We estimated the PC neighborhood size for each library as previously described85, estimated the number of doublets per library, ranked the cells using pANN, and removed the suspected doublets.We used SCTransform86 to normalize gene expression independently per library using regularized negative binomial regression. All libraries normalized via SCTransform were integrated using the reciprocal principal component analysis (rPCA) pipeline in Seurat to correct for batch effects and identify similar cell identities across conditions. 3 elav-Gal4 controls were merged to create an integration reference, and anchors across libraries were computed over the first 100 rPCA dimensions in the combined dataset. We used the NormalizeData function in Seurat for the normalization of gene counts for computing cell cluster marker genes, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters. Unique molecular identifiers (UMI) for each gene in each cell were divided by the sum of UMIs in that cell, multiplied by a scalar (10,000), and log-transformed to create the final integrated and normalized dataset.",,,
PD066001,https://doi.org/10.6084/m9.figshare.26724526.v1, /fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40537664/blank_1,10x,,40537664,PD,Healthy,Yes,	Mouse,SN,no data available,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD066002,https://doi.org/10.6084/m9.figshare.26724526.v2, /fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40537664/blank_2,10x,,40537664,PD,Healthy,Yes,	Mouse,SN,no data available,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD066003,https://doi.org/10.6084/m9.figshare.26724526.v3, /fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40537664/blank_3,10x,,40537664,PD,Healthy,Yes,	Mouse,SN,no data available,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD066004,https://doi.org/10.6084/m9.figshare.26724526.v4, /fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40537664/model_1,10x,,40537664,PD,Disease,,	Mouse,SN,no data available,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,MPTP,,,,
PD066005,https://doi.org/10.6084/m9.figshare.26724526.v5, /fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40537664/model_2,10x,,40537664,PD,Disease,,	Mouse,SN,no data available,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,MPTP,,,,
PD066006,https://doi.org/10.6084/m9.figshare.26724526.v6, /fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40537664/model_3,10x,,40537664,PD,Disease,,	Mouse,SN,no data available,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,MPTP,,,,
PD067001,GSM8787529,,,multi,40368950,PD,Healthy,,	Human,PBMC,-synuclein not response positive,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD067002,GSM8787530,,,multi,40368950,PD,Healthy,,	Human,PBMC,-synuclein not responsive negative,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD067003,GSM8787531,,,multi,40368950,PD,Disease,,	Human,PBMC,-synuclein response positive,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD067004,GSM8787532,,,multi,40368950,PD,Disease,,	Human,PBMC,-synuclein response negative,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD067005,GSM8787533,,,,40368950,PD,Healthy,,	Human,PBMC,-synuclein not response positive,no data available,no data available,no data available,,,CITE-seq,,,,,
PD067006,GSM8787534,,,,40368950,PD,Healthy,,	Human,PBMC,-synuclein not responsive negative,no data available,no data available,no data available,,,CITE-seq,,,,,
PD067007,GSM8787535,,,,40368950,PD,Disease,,	Human,PBMC,-synuclein response positive,no data available,no data available,no data available,,,CITE-seq,,,,,
PD067008,GSM8787536,,,,40368950,PD,Disease,,	Human,PBMC,-synuclein response negative,no data available,no data available,no data available,,,CITE-seq,,,,,
PD068001,GSM6940192,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39366969/GSM6940192_16_,10x_matrix,,39366969,PD,Healthy,Yes,	Human,PBMC,no data available,Female,no data available,67,,10X Genomics,Single-cell RNA sequencing,,,,,
PD068002,GSM6940193,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39366969/GSM6940193_17_,10x_matrix,,39366969,PD,Healthy,Yes,	Human,PBMC,no data available,Female,no data available,73,,10X Genomics,Single-cell RNA sequencing,,,,,
PD068003,GSM6940194,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39366969/GSM6940194_19_,10x_matrix,,39366969,PD,Disease,,	Human,PBMC,no data available,Female,Early PD,66,,10X Genomics,Single-cell RNA sequencing,,,,,
PD068004,GSM6940195,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39366969/GSM6940195_20_,10x_matrix,,39366969,PD,Disease,,	Human,PBMC,no data available,Female,Early PD,66,,10X Genomics,Single-cell RNA sequencing,,,,,
PD068005,GSM6940196,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39366969/GSM6940196_25_,10x_matrix,,39366969,PD,Disease,,	Human,PBMC,no data available,Female,Advance PD,78,,10X Genomics,Single-cell RNA sequencing,,,,,
PD068006,GSM6940197,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39366969/GSM6940197_26_,10x_matrix,,39366969,PD,Disease,,	Human,PBMC,no data available,Female,Advance PD,76,,10X Genomics,Single-cell RNA sequencing,,,,,
PD069001,GSM5392891,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37365181/gfp1/filtered_feature_bc_matrix/,10x,,37365181,PD,Healthy,Yes,	Mouse,ventral midbrain,AAV-GFP,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD069002,GSM5392892,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37365181/gfp2/filtered_feature_bc_matrix/,10x,,37365181,PD,Healthy,Yes,	Mouse,ventral midbrain,AAV-GFP,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD069003,GSM5392893,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37365181/syn1/filtered_feature_bc_matrix/,10x,,37365181,PD,Disease,,	Mouse,ventral midbrain,AAV-SYN,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD069004,GSM5392894,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37365181/syn2/filtered_feature_bc_matrix/,10x,,37365181,PD,Disease,,	Mouse,ventral midbrain,AAV-SYN,no data available,no data available,no data available,,10X Genomics,Single-cell RNA sequencing,,,,,
PD072001,GSM5380921,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/C36_raw_feature_bc_matrix/,10x,,34309761,PD,Healthy,Yes,	Human,Anterior cingulate cortex,no data available,Male,aSN: 0,68,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072002,GSM5380922,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/C48_raw_feature_bc_matrix/,10x,,34309761,PD,Healthy,Yes,	Human,Anterior cingulate cortex,no data available,Male,aSN: 0,68,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072003,GSM5380930,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PD413_raw_feature_bc_matrix/,10x,,34309761,PD,Disease,,	Human,Anterior cingulate cortex,no data available,Female,aSN: 6,72,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072004,GSM5380932,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PD416_raw_feature_bc_matrix/,10x,,34309761,PD,Disease,,	Human,Anterior cingulate cortex,no data available,Female,aSN: 6,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072005,GSM5380934,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PD523_raw_feature_bc_matrix/,10x,,34309761,PD,Disease,,	Human,Anterior cingulate cortex,no data available,Female,aSN: 6,86,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072006,GSM5380938,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PD666_raw_feature_bc_matrix/,10x,,34309761,PD,Disease,,	Human,Anterior cingulate cortex,no data available,Female,aSN: 6,93,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072007,GSM5380940,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PD683_raw_feature_bc_matrix/,10x,,34309761,PD,Disease,,	Human,Anterior cingulate cortex,no data available,Female,aSN: 5,83,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072008,GSM5380942,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PD732_raw_feature_bc_matrix/,10x,,34309761,PD,Disease,,	Human,Anterior cingulate cortex,no data available,Male,aSN: 5,81,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072009,GSM5380943,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PD747_raw_feature_bc_matrix/,10x,,34309761,PD,Disease,,	Human,Anterior cingulate cortex,no data available,Male,aSN: 6,83,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072010,GSM5380944,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PDC05_raw_feature_bc_matrix/,10x,,34309761,PD,Healthy,Yes,	Human,Anterior cingulate cortex,no data available,Male,aSN: 0,58,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072011,GSM5380945,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PDC22_raw_feature_bc_matrix/,10x,,34309761,PD,Healthy,Yes,	Human,Anterior cingulate cortex,no data available,Male,aSN: 0,65,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072012,GSM5380946,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PDC34_raw_feature_bc_matrix/,10x,,34309761,PD,Healthy,Yes,	Human,Anterior cingulate cortex,no data available,Male,aSN: 0,90,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072013,GSM5380947,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PDC87_raw_feature_bc_matrix/,10x,,34309761,PD,Healthy,Yes,	Human,Anterior cingulate cortex,no data available,Female,aSN: 0,92,,10X Genomics,Single-nucleus RNA sequencing,,,,,
PD072014,GSM5380948,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34309761/PDC91_raw_feature_bc_matrix,10x,,34309761,PD,Healthy,Yes,	Human,Anterior cingulate cortex,no data available,Male,aSN: 0,85,,10X Genomics,Single-nucleus RNA sequencing,,,,,
MS001001,GSM8563681,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563681_CO37_,10x,,39501036,MS,Healthy,Yes,Human,Brain,no data available,Male,no data available ,84 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001002,GSM8563682,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563682_CO40_,10x,,39501036,MS,Healthy,Yes,Human,Brain,no data available,Female,no data available ,61 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001003,GSM8563683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563683_CO41_,10x,,39501036,MS,Healthy,Yes,Human,Brain,no data available,Male,no data available ,54 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001004,GSM8563684,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563684_CO45_,10x,,39501036,MS,Healthy,Yes,Human,Brain,no data available,Male,no data available ,77 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001005,GSM8563685,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563685_CO74_,10x,,39501036,MS,Healthy,Yes,Human,Brain,no data available,Female,no data available ,84 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001006,GSM8563686,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563686_CO85_,10x,,39501036,MS,Healthy,Yes,Human,Brain,no data available,Female,no data available ,81 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001007,GSM8563687,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563687_MS197D_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,52 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001008,GSM8563688,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563688_MS229_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,53 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001009,GSM8563689,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563689_MS377N_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,50 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001010,GSM8563690,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563690_MS377T_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,50 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001011,GSM8563691,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563691_MS377I_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,50 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001012,GSM8563692,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563692_MS411_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,61 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001013,GSM8563693,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563693_MS497I_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,60 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001014,GSM8563694,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563694_MS497T_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,60 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001015,GSM8563695,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563695_MS549H_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,50 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001016,GSM8563696,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563696_MS549T_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,50 years,,10x Genomics,single-nucleus RNA sequencing,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001017,GSM8563697,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563697_CO37_,10x,,39501036,MS,Healthy ,Yes,Human,Brain,no data available,Male,no data available ,84 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001018,GSM8563698,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563698_CO40_,10x,,39501036,MS,Healthy ,Yes,Human,Brain,no data available,Female,no data available ,61 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001019,GSM8563699,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563699_CO41_,10x,,39501036,MS,Healthy ,Yes,Human,Brain,no data available,Male,no data available ,54 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001020,GSM8563700,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563700_CO74_,10x,,39501036,MS,Healthy ,Yes,Human,Brain,no data available,Female,no data available ,84 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001021,GSM8563701,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563701_CO85_,10x,,39501036,MS,Healthy ,Yes,Human,Brain,no data available,Female,no data available ,81 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001022,GSM8563702,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563702_CO96_,10x,,39501036,MS,Healthy ,Yes,Human,Brain,no data available,Female,no data available ,68 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001023,GSM8563703,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563703_MS94_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,42 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001024,GSM8563704,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563704_MS197D_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,52 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001025,GSM8563705,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563705_MS197U_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,52 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001026,GSM8563706,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563706_MS229_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,53 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001027,GSM8563707,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563707_MS377N_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,50 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001028,GSM8563708,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563708_MS377T_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,50 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001029,GSM8563709,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563709_MS377I_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,50 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001030,GSM8563710,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563710_MS411_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,61 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001031,GSM8563711,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563711_MS497I_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,60 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001032,GSM8563712,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563712_MS497T_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Female,no data available ,60 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001033,GSM8563713,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563713_MS549H_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,50 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS001034,GSM8563714,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39501036/GSM8563714_MS549T_,10x,,39501036,MS,Disease,No,Human,Brain,no data available,Male,no data available ,50 years,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",10x Genomics Visium Spatial Gene Expression,,"For nuclei isolation, 20-30 mg of muscle tissue was chopped and homogenized using 2 ml lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 0.5% Triton X100 in DEPC-treated water) and a glass Dounce homogenizer with a tight pestle on ice.Libraries were generated according to the provided protocols according to the 10X Next GEM 3 Kit v3.1 protocol. After recommended quality control, all libraries were pooled and sequenced on an Illumina NovaSeq 6000 system. Sequencing was performed at Institute of Clinical Biology (IKMB, Kiel).",,,
MS003001,GSM3323805,,txt.gz,whole,30747918,MS,Non-MS control,Yes,Human,White Matter brain tissue,no data available,Female,no data available,60 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,,Original ID: CO28,
MS003002,GSM3323806,,txt.gz,whole,30747918,MS,Non-MS control,Yes,Human,White Matter brain tissue,no data available,Male,no data available,35 years ,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,,Original ID: CO25,
MS003003,GSM3323807,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Primary Progressive,37 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,normal appearing white matter,Original ID: MS176,
MS003004,GSM3323808,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Primary Progressive,37 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,remyelinating lesions,Original ID: MS176,
MS003005,GSM3323809,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Primary Progressive,37 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,chronic inactive lesions,Original ID: MS176,
MS003006,GSM3323810,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Primary Progressive,37 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,chronic active lesions,Original ID: MS176,
MS003007,GSM3323811,,txt.gz,whole,30747918,MS,Non-MS control,Yes,Human,White Matter brain tissue,no data available,Female ,not applicable ,82 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,,Original ID: CO39,
MS003008,GSM3323812,,txt.gz,whole,30747918,MS,Non-MS control,Yes,Human,White Matter brain tissue,no data available,Male ,no data available,64 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,,Original ID: CO14,
MS003009,GSM3323813,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Secondary Progressive,57 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,chronic active lesions,Original ID: MS242,
MS003010,GSM3323814,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Secondary Progressive,57 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,chronic inactive lesions,Original ID: MS242,
MS003011,GSM3323815,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Secondary Progressive,57 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,chronic active lesions,Original ID: MS242,
MS003012,GSM3323816,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male,Secondary Progressive,57 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,remyelinating lesions,Original ID: MS242,
MS003013,GSM3323817,,txt.gz,whole,30747918,MS,Non-MS control,Yes,Human,White Matter brain tissue,no data available,Male ,no data available,49 years ,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,,Original ID: SD48/16,
MS003014,GSM3323818,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male ,Secondary Progressive,44 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,normal appearing white matter,Original ID: MS122,
MS003015,GSM3323819,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male ,Secondary Progressive,44 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,chronic inactive lesions,Original ID: MS122,
MS003016,GSM3323820,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Male ,Secondary Progressive,44 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,active,Original ID: MS122,
MS003017,GSM3323821,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Female,Secondary Progressive,49 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,normal appearing white matter,Original ID: MS121,
MS003018,GSM3323822,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Female,Secondary Progressive,49 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,active,Original ID: MS121,
MS003019,GSM3323823,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Female,Secondary Progressive,49 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,active,Original ID: MS121,
MS003020,GSM3323824,,txt.gz,whole,30747918,MS,Disease,No,Human,White Matter brain tissue,no data available,Female,Secondary Progressive,49 years,,10x Genomics,single-nucleus RNA sequencing,,Nuclei were extracted with a Nuclei Isolation Buffer and the suspension was cleaned through density gradient centrifugation.cDNA libraries have been constructed with the kit from 10x Genomics Single Cell 3' v2 and were compatible with standard Illumina sequencing,chronic active lesions,Original ID: MS121,
MS005001,GSM4294777,HH-OX-01_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,18 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005002,GSM4294778,HH-OX-02_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,23 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005003,GSM4294779,HH-OX-03_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,26 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005004,GSM4294780,HH-OX-04_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,27 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005005,GSM4294781,HH-OX-05_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,31 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005006,GSM4294782,HH-OX-06_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,30 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005007,GSM4294783,HH-OX-07_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,20 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005008,GSM4294784,HH-OX-08_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,24 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005009,GSM4294785,HH-OX-09_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,31 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005010,GSM4294786,HH-OX-10_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,33 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005011,GSM4294787,HH-OX-11_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,44 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005012,GSM4294788,HH-OX-12_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,43 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005013,GSM4294789,HH-OX-13_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005014,GSM4294790,HH-OX-14_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,35 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005015,GSM4294791,HH-OX-15_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,44 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005016,GSM4294792,HH-OX-15_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,44 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005017,GSM4294793,HH-OX-16_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005018,GSM4294794,HH-OX-16_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005019,GSM4294795,HH-OX-17_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,33 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005020,GSM4294796,HH-OX-18_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005021,GSM4294797,HH-OX-19_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,30 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005022,GSM4294798,HH-OX-19_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,30 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005023,GSM4294799,HH-OX-20_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,28 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005024,GSM4294800,HH-OX-20_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,28 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005025,GSM4294801,HH-OX-21_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsing-Remitting,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005026,GSM4294802,HH-OX-22_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005027,GSM4294803,HH-OX-23B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Avonex, Rebif, Copaxone, Betaferon, Azathioprin",Female,Relapsing-Remitting,37 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005028,GSM4294804,HH-OX-23A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Avonex, Rebif, Copaxone, Betaferon, Azathioprin",Female,Relapsing-Remitting,36 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005029,GSM4294805,HH-OX-23B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Avonex, Rebif, Copaxone, Betaferon, Azathioprin",Female,Relapsing-Remitting,37 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005030,GSM4294806,HH-OX-23A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Avonex, Rebif, Copaxone, Betaferon, Azathioprin",Female,Relapsing-Remitting,36 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005031,GSM4294807,HH-OX-24_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,35 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005032,GSM4294808,HH-OX-24_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,35 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005033,GSM4294809,HH-OX-25B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Male,Relapsing-Remitting,28 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005034,GSM4294810,HH-OX-25A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Copaxone,Male,Relapsing-Remitting,27 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005035,GSM4294811,HH-OX-25B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Male,Relapsing-Remitting,28 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005036,GSM4294812,HH-OX-25A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Copaxone,Male,Relapsing-Remitting,27 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005037,GSM4294813,HH-OX-26_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,29 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005038,GSM4294814,HH-OX-26_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,29 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005039,GSM4294815,HH-OX-27B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Natalizumab,Male,Relapsing-Remitting,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005040,GSM4294816,HH-OX-27A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Relapsing-Remitting,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005041,GSM4294817,HH-OX-27B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Natalizumab,Male,Relapsing-Remitting,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005042,GSM4294818,HH-OX-27A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Relapsing-Remitting,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005043,GSM4294819,HH-OX-28_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005044,GSM4294820,HH-OX-28_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005045,GSM4294821,HH-OX-29B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Mitoxantron (1x, discontinued due to cardiomyopathie), Rebif, Azathioprin",Male,Relapsing-Remitting,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005046,GSM4294822,HH-OX-29A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Mitoxantron (1x, discontinued due to cardiomyopathie), Rebif, Azathioprin",Male,Relapsing-Remitting,27 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005047,GSM4294823,HH-OX-29B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Mitoxantron (1x, discontinued due to cardiomyopathie), Rebif, Azathioprin",Male,Relapsing-Remitting,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005048,GSM4294824,HH-OX-29A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Mitoxantron (1x, discontinued due to cardiomyopathie), Rebif, Azathioprin",Male,Relapsing-Remitting,27 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005049,GSM4294825,HH-OX-30_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,34 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005050,GSM4294826,HH-OX-30_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,34 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005051,GSM4294827,HH-OX-31_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Female,Relapsing-Remitting,35 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005052,GSM4294828,HH-OX-31_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Female,Relapsing-Remitting,35 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005053,GSM4294829,HH-OX-32_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,34 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005054,GSM4294830,HH-OX-32_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,34 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005055,GSM4294831,HH-OX-33B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Rebif, Copaxone, Betaferon",Male,Relapsing-Remitting,25 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005056,GSM4294832,HH-OX-33A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Rebif, Copaxone, Betaferon",Male,Relapsing-Remitting,22 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005057,GSM4294833,HH-OX-33B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Rebif, Copaxone, Betaferon",Male,Relapsing-Remitting,25 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005058,GSM4294834,HH-OX-33A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Rebif, Copaxone, Betaferon",Male,Relapsing-Remitting,21 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005059,GSM4294835,HH-OX-34_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,22 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005060,GSM4294836,HH-OX-34_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,22 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005061,GSM4294837,HH-OX-35B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Avonex, Copaxone",Female,Relapsing-Remitting,34 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005062,GSM4294838,HH-OX-35A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Avonex, Copaxone",Female,Relapsing-Remitting,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005063,GSM4294839,HH-OX-35B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Avonex, Copaxone",Female,Relapsing-Remitting,34 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005064,GSM4294840,HH-OX-35A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Avonex, Copaxone",Female,Relapsing-Remitting,32 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005065,GSM4294841,HH-OX-36_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,35 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005066,GSM4294842,HH-OX-36_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,35 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005067,GSM4294843,HH-OX-37B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Female,Relapsing-Remitting,44 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005068,GSM4294844,HH-OX-37A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Copaxone,Female,Relapsing-Remitting,39 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005069,GSM4294845,HH-OX-37B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Female,Relapsing-Remitting,44 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005070,GSM4294846,HH-OX-37A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Copaxone,Female,Relapsing-Remitting,39 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005071,GSM4294847,HH-OX-38_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005072,GSM4294848,HH-OX-38_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005073,GSM4294849,HH-OX-39B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Female,Relapsing-Remitting,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005074,GSM4294850,HH-OX-39A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Copaxone,Female,Relapsing-Remitting,36 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005075,GSM4294851,HH-OX-39B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Copaxone",Female,Relapsing-Remitting,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005076,GSM4294852,HH-OX-39A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,Copaxone,Female,Relapsing-Remitting,36 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005077,GSM4294853,HH-OX-40_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,39 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005078,GSM4294854,HH-OX-40_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,39 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005079,GSM4294855,HH-OX-41B_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Rebif, Interferon beta",Male,Relapsing-Remitting,37 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005080,GSM4294856,HH-OX-41A_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Rebif, Interferon beta",Male,Relapsing-Remitting,36 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005081,GSM4294857,HH-OX-41B_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Natalizumab, Rebif, Interferon beta",Male,Relapsing-Remitting,37 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005082,GSM4294858,HH-OX-41A_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Rebif, Interferon beta",Male,Relapsing-Remitting,36 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005083,GSM4294859,HH-OX-42_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,38 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005084,GSM4294860,HH-OX-42_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,38 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005085,GSM4294861,HH-OX-43_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,58 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005086,GSM4294862,HH-OX-43_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,58 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005087,GSM4294863,HH-OX-43_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,58 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005088,GSM4294864,HH-OX-43_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,58 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005089,GSM4294865,HH-OX-43_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,58 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005090,GSM4294866,HH-OX-43_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,58 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005091,GSM4294867,HH-OX-44_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,55 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005092,GSM4294868,HH-OX-44_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,55 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005093,GSM4294869,HH-OX-44_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,55 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005094,GSM4294870,HH-OX-44_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,55 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005095,GSM4294871,HH-OX-44_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,55 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005096,GSM4294872,HH-OX-44_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,55 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005097,GSM4294873,HH-OX-45_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005098,GSM4294874,HH-OX-45_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005099,GSM4294875,HH-OX-45_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005100,GSM4294876,HH-OX-45_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005101,GSM4294877,HH-OX-45_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005102,GSM4294878,HH-OX-45_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,42 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005103,GSM4294879,HH-OX-46_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005104,GSM4294880,HH-OX-46_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005105,GSM4294881,HH-OX-46_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005106,GSM4294882,HH-OX-46_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005107,GSM4294883,HH-OX-46_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005108,GSM4294884,HH-OX-46_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,41 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005109,GSM4294885,HH-OX-47_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005110,GSM4294886,HH-OX-47_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005111,GSM4294887,HH-OX-47_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005112,GSM4294888,HH-OX-47_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005113,GSM4294889,HH-OX-47_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005114,GSM4294890,HH-OX-47_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,53 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005115,GSM4294891,HH-OX-48_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,50 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005116,GSM4294892,HH-OX-48_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,50 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005117,GSM4294893,HH-OX-48_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,50 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005118,GSM4294894,HH-OX-48_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,50 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005119,GSM4294895,HH-OX-48_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,50 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005120,GSM4294896,HH-OX-48_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,50 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005121,GSM4294897,HH-OX-49_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005122,GSM4294898,HH-OX-49_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005123,GSM4294899,HH-OX-49_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005124,GSM4294900,HH-OX-49_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005125,GSM4294901,HH-OX-49_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005126,GSM4294902,HH-OX-49_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Primary Progressive,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005127,GSM4294903,HH-OX-50_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,46 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005128,GSM4294904,HH-OX-50_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,46 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005129,GSM4294905,HH-OX-50_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,46 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005130,GSM4294906,HH-OX-50_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,46 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005131,GSM4294907,HH-OX-50_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,46 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005132,GSM4294908,HH-OX-50_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,46 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005133,GSM4294909,HH-OX-51_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Endoxan, Betaferon, MTX, Mitoxantron",Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005134,GSM4294910,HH-OX-51_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Endoxan, Betaferon, MTX, Mitoxantron",Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005135,GSM4294911,HH-OX-51_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Endoxan, Betaferon, MTX, Mitoxantron",Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005136,GSM4294912,HH-OX-51_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Endoxan, Betaferon, MTX, Mitoxantron",Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005137,GSM4294913,HH-OX-51_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Endoxan, Betaferon, MTX, Mitoxantron",Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005138,GSM4294914,HH-OX-51_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,"Endoxan, Betaferon, MTX, Mitoxantron",Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005139,GSM4294915,HH-OX-52_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,42 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005140,GSM4294916,HH-OX-52_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,42 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005141,GSM4294917,HH-OX-52_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,42 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005142,GSM4294918,HH-OX-52_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,42 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005143,GSM4294919,HH-OX-52_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,42 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005144,GSM4294920,HH-OX-52_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,42 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005145,GSM4294921,HH-OX-53_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005146,GSM4294922,HH-OX-53_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005147,GSM4294923,HH-OX-53_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005148,GSM4294924,HH-OX-53_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005149,GSM4294925,HH-OX-53_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005150,GSM4294926,HH-OX-53_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005151,GSM4294927,HH-OX-54_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,52 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005152,GSM4294928,HH-OX-54_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,52 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005153,GSM4294929,HH-OX-54_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,52 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005154,GSM4294930,HH-OX-54_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,52 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005155,GSM4294931,HH-OX-54_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,52 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005156,GSM4294932,HH-OX-54_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,52 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005157,GSM4294933,HH-OX-55_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005158,GSM4294934,HH-OX-55_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005159,GSM4294935,HH-OX-55_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005160,GSM4294936,HH-OX-55_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005161,GSM4294937,HH-OX-55_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005162,GSM4294938,HH-OX-55_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,45 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005163,GSM4294939,HH-OX-56_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005164,GSM4294940,HH-OX-56_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005165,GSM4294941,HH-OX-56_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005166,GSM4294942,HH-OX-56_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005167,GSM4294943,HH-OX-56_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005168,GSM4294944,HH-OX-56_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,47 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005169,GSM4294945,HH-OX-57_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,intrathecal steroids,Female,Primary Progressive,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005170,GSM4294946,HH-OX-57_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,intrathecal steroids,Female,Primary Progressive,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005171,GSM4294947,HH-OX-57_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,intrathecal steroids,Female,Primary Progressive,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005172,GSM4294948,HH-OX-57_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,intrathecal steroids,Female,Primary Progressive,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005173,GSM4294949,HH-OX-57_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,intrathecal steroids,Female,Primary Progressive,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005174,GSM4294950,HH-OX-57_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,intrathecal steroids,Female,Primary Progressive,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005175,GSM4294951,HH-OX-58_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005176,GSM4294952,HH-OX-58_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005177,GSM4294953,HH-OX-58_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005178,GSM4294954,HH-OX-58_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005179,GSM4294955,HH-OX-58_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005180,GSM4294956,HH-OX-58_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Female,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005181,GSM4294957,HH-OX-59_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005182,GSM4294958,HH-OX-59_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005183,GSM4294959,HH-OX-59_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005184,GSM4294960,HH-OX-59_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005185,GSM4294961,HH-OX-59_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005186,GSM4294962,HH-OX-59_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005187,GSM4294963,HH-OX-60_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005188,GSM4294964,HH-OX-60_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005189,GSM4294965,HH-OX-60_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005190,GSM4294966,HH-OX-60_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005191,GSM4294967,HH-OX-60_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005192,GSM4294968,HH-OX-60_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,36 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005193,GSM4294969,HH-OX-61_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005194,GSM4294970,HH-OX-61_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005195,GSM4294971,HH-OX-61_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005196,GSM4294972,HH-OX-61_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005197,GSM4294973,HH-OX-61_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005198,GSM4294974,HH-OX-61_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Male,Primary Progressive,51 years ,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005199,GSM4294975,HH-OX-62_4,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005200,GSM4294976,HH-OX-62_3,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005201,GSM4294977,HH-OX-62_2,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005202,GSM4294978,HH-OX-62_1,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005203,GSM4294979,HH-OX-62_6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS005204,GSM4294980,HH-OX-62_5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33748804/RNA_counts/,whole,33748804,MS,Healthy ,Yes,Human,Peripheral blood mononuclear cells,none,Male,no data available,56 years,,10x Genomics,single-cell RNA sequencing,,"Labeled single cell suspensions were mixed and 5,00010,000 cells per sample were loaded onto a Chromium 10x controller (total load of 25,00050,000 cells per well). All samples for a given donor and their matched control were loaded together and processed simultaneously. Samples were processed using the Chromium 3 v3 (cohorts HI1 and MS1), v2 and v3 (cohorts HI2 and MS2), and v3 (cohorts HI3 and MS3) kits according to the manufacturers instructions with modifications as described previously in the CITE-seq and cell hashing protocols.53,54 Processed libraries were run on a Nextseq500 using an Illumina 75 cycle kit (R1 = 26, R2 = 55, i7 = 8, i5 = 0).",,,
MS008001,GSM3442006,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442006_E14_F_B10.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008002,GSM3442007,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442007_E14_M_B11.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008003,GSM3442008,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442008_E14_F_B12.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008004,GSM3442009,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442009_E14_F_C1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008005,GSM3442010,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442010_E14_M_B9.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008006,GSM3442011,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442011_E14_F_B6.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008007,GSM3442012,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442012_E14_M_B7.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008008,GSM3442013,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442013_E14_M_B8.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,E14.5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008009,GSM3442014,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442014_P5_M_A1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008010,GSM3442015,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442015_P5_F_A2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P5,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008011,GSM3442016,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442016_P4_M_A4.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P4,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008012,GSM3442017,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442017_P4_M_A5.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P4,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008013,GSM3442018,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442018_P4_F_A6.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P4,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008014,GSM3442019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442019_P4_F_B3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P4,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008015,GSM3442020,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442020_P4_F_B4.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P4,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008016,GSM3442021,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442021_P4_M_B5.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P4,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008017,GSM3442022,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442022_P30_Male_1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P30,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008018,GSM3442023,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442023_P30_Male_2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P30,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008019,GSM3442024,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442024_P30_male_3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P30,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008020,GSM3442025,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442025_P30_male_4.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P30,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008021,GSM3442026,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442026_P100_Male_1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008022,GSM3442027,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442027_P100_Male_2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008023,GSM3442028,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442028_P100_female_1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008024,GSM3442029,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442029_P100_female_2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008025,GSM3442030,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442030_P100_male_3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008026,GSM3442031,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442031_P100_male_4.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008027,GSM3442032,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442032_P100_female_3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008028,GSM3442033,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442033_P100_female_4.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008029,GSM3442034,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442034_Old_male_1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P540,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008030,GSM3442035,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442035_Old_male_2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P540,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008031,GSM3442036,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442036_Old_male_3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P540,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008032,GSM3442037,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442037_Old_male_4.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P540,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008033,GSM3442038,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442038_P100_M_A1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008034,GSM3442039,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442039_P100_M_A2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008035,GSM3442040,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442040_P100_M_B5.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,C57BL/6J,"FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008036,GSM3442041,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442041_P100_M_SALINE_A3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Subcortical White Matter,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Saline injection","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008037,GSM3442042,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442042_P100_M_SALINE_A5.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Subcortical White Matter,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Saline injection","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008038,GSM3442043,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442043_P100_M_SALINE_B9.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Subcortical White Matter   ,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Saline injection","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008039,GSM3442044,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442044_P100_M_LPC_A4.dge.txt.gz,txt.gz,,30471926,MS,Disease,No,Mouse,Subcortical White Matter,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Lysolecithin-induced demyelination","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008040,GSM3442045,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442045_P100_M_LPC_A6.dge.txt.gz,txt.gz,,30471926,MS,Disease,No,Mouse,Subcortical White Matter,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Lysolecithin-induced demyelination","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008041,GSM3442046,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442046_P100_M_LPC_B10.dge.txt.gz,txt.gz,,30471926,MS,Disease,No,Mouse,Subcortical White Matter,none,Male,no data available,P100,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Lysolecithin-induced demyelination","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008042,GSM3442047,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442047_P5_female_nopercoll_1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P5,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Purified without Percoll ","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008043,GSM3442048,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442048_P5_female_nopercoll_2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P5,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Purified without Percoll ","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008044,GSM3442049,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442049_P5_female_nopercoll_3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P5,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Purified without Percoll","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008045,GSM3442050,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442050_P5_female_percoll_1.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P5,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Purified with Percoll ","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008046,GSM3442051,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442051_P5_female_percoll_2.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P5,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Purified with Percoll ","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS008047,GSM3442052,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30471926/GSM3442052_P5_female_percoll_3.dge.txt.gz,txt.gz,,30471926,MS,Healthy ,Yes,Mouse,Whole Brain,none,Female,no data available,P5,,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Purified with Percoll ","FACS purified microglia were sequenced using the Chromium single cell gene expression platform (10 Genomics). Approximately 10,000-13,000 microglia from each sample were directly loaded into each sample well following manufacturer instructions and combined into droplets with barcoded beads using the Chromium controller. Manufacturer specifications were followed for generation of the barcoded libraries and then the samples were sequenced to an average depth of 40,000-60,000 reads on an Illumina Nextseq 500 sequencer.",,,
MS010001,GSE180759,09_034,,whole,34497421,MS,Disease,No,Human,Chronic active edge,IFNb-1a (between age 37-44),Male,Progressive,45 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_active_MS_lesion_edge,
MS010002,GSE180759,09_034,,whole,34497421,MS,Disease,No,Human,Periplaque white matter,IFNb-1a (between age 37-44),Male,Progressive,45 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,MS_periplaque_white_matter,
MS010003,GSE180759,09_034,,whole,34497421,MS,Disease,No,Human,Chronic inactive edge,IFNb-1a (between age 37-44),Male,Progressive,45 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_inactive_MS_lesion_edge,
MS010004,GSE180759,12_078,,whole,34497421,MS,Disease,No,Human,Chronic active edge,none,Male,Progressive,58 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_active_MS_lesion_edge,
MS010005,GSE180759,12_078,,whole,34497421,MS,Disease,No,Human,Periplaque white matter,none,Male,Progressive,58 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,MS_periplaque_white_matter,
MS010006,GSE180759,12_078,,whole,34497421,MS,Disease,No,Human,Chronic inactive edge,none,Male,Progressive,58 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_inactive_MS_lesion_edge,
MS010007,GSE180759,09_067,,whole,34497421,MS,Disease,No,Human,Chronic active edge,none,Male,Progressive,44 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_active_MS_lesion_edge,
MS010008,GSE180759,09_067,,whole,34497421,MS,Disease,No,Human,Periplaque white matter,none,Male,Progressive,44 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,MS_periplaque_white_matter,
MS010009,GSE180759,09_067,,whole,34497421,MS,Disease,No,Human,Lesion core,none,Male,Progressive,44 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,MS_lesion_core,
MS010010,GSE180759,13_047,,whole,34497421,MS,Disease,No,Human,Chronic active edge,none,Female,Progressive,48 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_active_MS_lesion_edge,
MS010011,GSE180759,13_047,,whole,34497421,MS,Disease,No,Human,Lesion core,none,Female,Progressive,48 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,MS_lesion_core,
MS010012,GSE180759,13_047,,whole,34497421,MS,Disease,No,Human,Chronic inactive edge,none,Female,Progressive,48 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_inactive_MS_lesion_edge,
MS010013,GSE180759,13_047,,whole,34497421,MS,Disease,No,Human,Chronic active edge,none,Female,Progressive,48 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_active_MS_lesion_edge,
MS010014,GSE180759,13_047,,whole,34497421,MS,Disease,No,Human,Chronic active edge,none,Female,Progressive,48 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_active_MS_lesion_edge,
MS010015,GSE180759,13_015,,whole,34497421,MS,Disease,No,Human,Chronic inactive edge,none,Male,Progressive,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_inactive_MS_lesion_edge,
MS010016,GSE180759,13_015,,whole,34497421,MS,Disease,No,Human,Chronic inactive edge,none,Male,Progressive,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,chronic_inactive_MS_lesion_edge,
MS010017,GSE180759,13_015,,whole,34497421,MS,Disease,No,Human,Periplaque white matter,none,Male,Progressive,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,MS_periplaque_white_matter,
MS010018,GSE180759,14_043,,whole,34497421,MS,Healthy,Yes,Human,Normal frontal white matter,none,Female,no data available,60 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,control_white_matter,
MS010019,GSE180759,11_069,,whole,34497421,MS,Healthy,Yes,Human,Normal frontal white matter,none,Male,no data available,49 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,control_white_matter,
MS010020,GSE180759,12_002,,whole,34497421,MS,Healthy,Yes,Human,Normal frontal white matter,none,Male,no data available,55 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Snap-frozen autopsy human brain tissue sampling used a 3mm-punch biopsy tool and a cold blade. Nuclei extraction from snap-frozen human autopsy brains was performed according to the following protocol. On wet ice, the frozen, dissected tissue was lysed using a Dounce homogenizer (10 strokes with the loose pestle followed by 20 strokes with the tight pestle) in 600-l of freshly made cold lysis buffer (low sucrose buffer, Triton X-100 20%, Rnase inhibitor 40U/l). Part of the homogenate (200 l) was collected for bulk RNA extraction (Qiagen RNAeasy kit) and stored at -80C for future applications. The remaining homogenate was filtered through a 40-m cell strainer for nuclei extraction with 4-ml of low sucrose buffer (0.64M sucrose, HEPES pH8, CaCl2, MgAc, EDTA, DTT, nuclease-free water). Sonication of the homogenate was performed for 10 sec. To remove cellular and myelin debris, a sucrose gradient (12-ml of high sucrose buffer [2M sucrose, HEPES pH8, MgAc, DTT, nuclease-free water] underneath the low sucrose buffer) was centrifuged at 3,200 g for 30 minutes, and the supernatant was discarded. Nuclei were resuspended in 1-ml resuspension solution (PBS, 5% BSA and RNAse inhibitor 40U/l) and centrifuged for 12-min at 3,200 g. Nuclei were again resuspended in 50-l cold resuspension solution. Nuclei were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 nuclei/l per sample was targeted. Immediately after extraction, 5,000 nuclei/sample were loaded onto a Chromium Single Cell 3 Chip (10X Genomics) and processed for the single-nucleus cDNA library preparation (Chromium Single Cell 3 version 3, 10X Genomics) according to the manufacturers instructions without modifications.Chromium Single Cell 3 version 3, 10X Genomics",,control_white_matter,
MS014001,GSM7108087,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108087_MS-5023_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Grey matter,no data available,Female,no data available,50 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014002,GSM7108088,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108088_MS-5023_Plaque_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Brain plaque,no data available,Female,no data available,50 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014003,GSM7108089,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108089_MS-5023_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,White matter,no data available,Female,no data available,50 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014004,GSM7108090,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108090_MS-5024_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Grey matter,no data available,Female,no data available,67 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014005,GSM7108091,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108091_MS-5024_Plaque_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Brain plaque,no data available,Female,no data available,67 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014006,GSM7108092,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108092_MS-5024_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,White matter,no data available,Female,no data available,67 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014007,GSM7108093,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108093_MS-5068_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Grey matter,no data available,Male,no data available,62 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014008,GSM7108094,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108094_MS-5068_Plaque_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Brain plaque,no data available,Male,no data available,62 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014009,GSM7108095,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108095_MS-5068_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,White matter,no data available,Male,no data available,62 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014010,GSM7108096,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108096_MS-5072_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,Grey matter,no data available,Male,no data available,83 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014011,GSM7108097,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108097_MS-5072_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,White matter,no data available,Male,no data available,83 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014012,GSM7108098,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108098_MS-5086_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,Grey matter,no data available,Female,no data available,63 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014013,GSM7108099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108099_MS-5086_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,White matter,no data available,Female,no data available,63 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014014,GSM7108100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108100_MS-5090_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Grey matter,no data available,Male,no data available,65 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014015,GSM7108101,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108101_MS-5090_Plaque_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Brain plaque,no data available,Male,no data available,65 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014016,GSM7108102,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108102_MS-5090_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,White matter,no data available,Male,no data available,65 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014017,GSM7108103,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108103_MS-5093_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Grey matter,no data available,Male,no data available,74 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014018,GSM7108104,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108104_MS-5093_Plaque_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Brain plaque,no data available,Male,no data available,74 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014019,GSM7108105,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108105_MS-5093_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,White matter,no data available,Male,no data available,74 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014020,GSM7108106,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108106_MS-5095_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Grey matter,no data available,Male,no data available,60 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014021,GSM7108107,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108107_MS-5095_Plaque_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,Brain plaque,no data available,Male,no data available,60 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014022,GSM7108108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108108_MS-5095_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Disease,No,Human,White matter,no data available,Male,no data available,60 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014023,GSM7108109,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108109_MS-5116_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,Grey matter,no data available,Male,no data available,55 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014024,GSM7108110,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108110_MS-5116_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,White matter,no data available,Male,no data available,55 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014025,GSM7108111,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108111_MS-5144_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,Grey matter,no data available,Male,no data available,74 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014026,GSM7108112,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108112_MS-5144_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,White matter,no data available,Male,no data available,74 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014027,GSM7108113,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108113_MS-5185_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,Grey matter,no data available,Female,no data available,41 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014028,GSM7108114,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108114_MS-5185_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,White matter,no data available,Female,no data available,41 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014029,GSM7108115,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108115_MS-5190_Grey_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,Grey matter,no data available,Male,no data available,68 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS014030,GSM7108116,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37160117/GSM7108116_MS-5190_White_filtered_feature_bc_matrix.h5,h5,,37160117,MS,Non-MS control,Yes,Human,White matter,no data available,Male,no data available,68 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Isolation and fluorescence-activated nuclear sorting (FANS) of nuclei for frozen human postmortem brain: Samples were processed in batches consisting of 2 individuals; 1 case and 1 control. For each case, we processed 3 dissections; 1 of gray matter, 1 white matter, and 1 containing an MS plaque. For each Control we processed 2 dissections; 1 gray matter and 1 white matter. Approximately 25 mg of frozen postmortem human brain tissue from each dissection was homogenized in cold lysis buffer (0.32M Sucrose, 5 mM CaCl2, 3 mM Magnesium acetate, 0.1 mM, EDTA, 10 mM Tris-HCl, pH8, 1 mM DTT, 0.1% Triton X-100) and filtered through a 40 m cell strainer. All buffers were supplemented with RNAse inhibitors (Takara). The flow-through was underlaid with sucrose solution (1.8 M Sucrose, 3 mM Magnesium acetate, 1 mM DTT, 10 mM Tris-HCl, pH8) and centrifuged at 107,000 g for 1 hour at 4C. Pellets were resuspended in PBS supplemented with 0.5% bovine serum albumin (BSA). Prior to FANS, volumes were brought up to 500 l with PBS and DAPI (Thermoscientific) added to a final concentration of 1 g/ml. DAPI-positive nuclei were sorted into tubes pre-coated with 5% BSA using a FACSAria flow cytometer (BD Biosciences).Single-nuclei gene expression library preparation: Following FANS, nuclei were quantified (Countess II, Life Technologies) and 8,000 from each sample loaded on a single 10x lane using single cell 3' v3 reagents (10x Genomics). cDNA libraries were prepared according to the manufacturer's protocol. Libraries were sequenced at New York Genome Center using the Novaseq platform (Illumina).snRNA-seq",,,
MS015001,GSM6190636,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190636_A1_raw_feature_bc_matrix.h5,h5,,36952346,MS,Healthy,Yes,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,WT C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS015002,GSM6190637,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190637_A2_raw_feature_bc_matrix.h5,h5,,36952346,MS,Healthy,Yes,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,WT C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS015003,GSM6190638,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190638_A3_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone treatment,
MS015004,GSM6190639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190639_A4_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone treatment,
MS015005,GSM6190640,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190640_A5_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone treatment,
MS015006,GSM6190641,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190641_B7_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone treatment, followed by 2-week regular chow",
MS015007,GSM6190642,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190642_B8_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone treatment, followed by 2-week regular chow",
MS015008,GSM6190643,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190643_B9_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone treatment, followed by 2-week regular chow",
MS015009,GSM6190829,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190829_1_raw_feature_bc_matrix.h5,h5,,36952346,MS,Healthy,Yes,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,WT C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS015010,GSM6190830,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190830_2_raw_feature_bc_matrix.h5,h5,,36952346,MS,Healthy,Yes,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,WT C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS015011,GSM6190831,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190831_3_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,Trem2/ C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS015012,GSM6190832,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190832_4_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,Trem2/ C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS015013,GSM6190833,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190833_5_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone, followed by 2-week regular chow",
MS015014,GSM6190834,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190834_6_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone, followed by 2-week regular chow",
MS015015,GSM6190835,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190835_7_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone, followed by 2-week regular chow",
MS015016,GSM6190836,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190836_8_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Trem2/ C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone, followed by 2-week regular chow",
MS015017,GSM6190837,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190837_9_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Trem2/ C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone, followed by 2-week regular chow",
MS015018,GSM6190838,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190838_10_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Trem2/ C57BL/6J, Cuprizone model + 2 week remyelination","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,"5-week cuprizone, followed by 2-week regular chow",
MS015019,GSM6190839,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190839_11_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone,
MS015020,GSM6190840,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190840_12_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone,
MS015021,GSM6190841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190841_13_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"WT C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone,
MS015022,GSM6190842,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190842_14_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Trem2/ C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone,
MS015023,GSM6190843,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190843_15_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Trem2/ C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone,
MS015024,GSM6190844,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190844_16_raw_feature_bc_matrix.h5,h5,,36952346,MS,Disease,No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Trem2/ C57BL/6J, Cuprizone model","Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,5-week cuprizone,
MS015025,GSM6190845,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190845_17_raw_feature_bc_matrix.h5,h5,,36952346,MS,Healthy,Yes,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,WT C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS015026,GSM6190846,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36952346/GSM6190846_18_raw_feature_bc_matrix.h5,h5,,36952346,MS,Genetic model (Trem2 KO),No,Mouse,Cortex and corpus callosum,none,Male,no data available,8 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,Trem2/ C57BL/6J,"Eight-week-old male wild-type (WT) mice were fed with 0.2% CPZ or regular chow and three experimental groups were set up: a) demyelination (5-week CPZ treatment); b) remyelination (5-week CPZ treatment, followed by 2-week regular chow); c) control (regular chow throughout the time course)Flash frozen brain tissues were homogenized in a Dounce homogenizer in Lysis Buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl, 3mM MgCl2, and 0.025% NP-40), and incubated on ice for 15min. The suspension was filtered through a 30-m filter to remove debris and pelleted at 500g for 5min at 4oC. Nuclei were washed and filtered twice with Nuclei Wash buffer (1%BSA in PBS with 0.2U l1 RNasin (Promega)). Nuclei pellets were resuspended in 500l nuclei wash buffer and 900 l 1.8M sucrose. This 1,400 l mixture was carefully layered on top of 500l 1.8M sucrose and centrifuged at 13,000g for 45min at 4oC to separate the nuclei from myelin debris. The nuclei pellet was resuspended in nuclei wash buffer at 1,000 nuclei l1 and filtered through a 40-m FlowMi Cell Strainer.Chromium Single Cell 5' Reagent Kit (v1)single nucleus RNA sequencing",,,
MS016001,GSM5420999,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5420999_S1_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,none,Male,Relapsing-Remitting,43 years ,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS016002,GSM5421000,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5421000_S10_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,Avonex between 7-16 years prior to death; intermittently for 7 years prior to death,Male,Relapsing-Remitting,57 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS016003,GSM5421001,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5421001_S2_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,none,Male,Secondary Progressive,52 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS016004,GSM5421002,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5421002_S3_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,none,Female,Secondary Progressive,66 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS016005,GSM5421003,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5421003_S4_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,"Methylprednisolone, last dose during the year of death. Prior Avonex, mitoxantrone (was on the year of death)",Female,Secondary Progressive,50 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS016006,GSM5421004,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5421004_S5_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,none,Female,Relapsing-Remitting,58 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS016007,GSM5421005,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5421005_S7_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,none,Female,Secondary Progressive,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS016008,GSM5421006,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35783097/GSM5421006_S8_filtered_feature_bc_,10x,,35783097,MS,Disease,No,Human,Prefrontal cortex,"Avonex and Copaxone 5 years prior to death, mitoxantrone (4 years prior to death), methotrexate (was on the year of death), methylprednisolone intermittently.",Male,Secondary Progressive,61 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Post-mortem prefrontal cortices (BA10) from donors who suffered from RRMS or SPMS were cryo-sectioned at 300 m and were processed for nuclei isolation. Single-nucleus capture (target capture of 5,000 nuclei per sample) and library preparation was conducted using Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3 (10x Genomics) and Chromium Single Cell B Chip Kit (10X Genomics) according to the manufacturer's instruction. Single-nucleus libraries were sequenced on the Illumina NovaSeq 6000 machine at GENEWIZ, Inc. Raw FASTQ files were input into the cellranger count pipeline (Cell Ranger V3.0.2, 10x Genomics) to align reads to the GRCh38 human genome.",,,
MS017001,GSM8296320,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40057769/GSM8296320_R1_H_,10x,,40057769,MS,Healthy,Yes,Mouse,Olfactory bulb,none,Female,no data available,10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6 J,"Olfactory bulb tissue was harvested and snap-frozen in 80C until further analysis. For nuclei isolation olfactory bulb tissues were homogenized in EZ lysis buffer (Sigma Aldrich, NUC101) with a glass douncer ((Sigma-Aldrich, D9063). After 3-min incubation on ice cell suspension was then centrifuged by 500  g for 4 min at 4C. Nuclei were washed once with the EZ lysis buffer and twice in the nucleus incubation buffer (MgCl2 2 mM, KCl 25 mM, Glycerophosphate 65 mM, Sucrose 340 mM, glycerol 5%, ethylenediaminetetraacetic acid 1 mM, bovine serum albumin (BSA) 1%) and filtered through a 30 m pre-separation filter (Miltenyi Biotech, 130-041-407). The nuclei suspensions were stained in nucleus incubation buffer for ten minutes with anti-HuC/D labeled to Alexa647 (1:300, rabbit, Abcam; Cat# ab237235, RRID: AB_2864321) and propidium iodide (PI) (1:1000, Thermo Fisher Scientific, Cat# P1304MP). PI-positive HuC/D positive nuclei were sorted in PBS containing 0.4% BSA using a BD Aria III cell sorter (BD Biosciences).mRNA library preparation is performed according to the standard 10X Genomics protocol with the Chromium Next GEM Single Cell 3GEM, Library & Gel Bead Kit v3.1 (Cat# 1000075, 10x Genomics). Briefly, gel bead emulsion (GEMs) was generated containing single nuclei and a master mix with reagents in the Chromium Controller followed by cell lysis and reverse transcription of RNA, cDNA amplification, enzymatic fragmentation, 5adaptor attachment and sample indexing. On average around 25,000 nuclei were loaded on each channel of the Chromium instrument. To minimize batch effects, EAE and control samples were distributed evenly in the Chromium controller. Libraries were pooled and sequenced on an Illumina NovaSeq6000 platform (paired end sequencing, 2 x 100 bp read length, 500 million reads per sample).",,,
MS017002,GSM8296321,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40057769/GSM8296321_R1_EAE_,10x,,40057769,MS,Disease,No,Mouse,Olfactory bulb,none,Female,Acute Experimental Autoimmune Encephalomyelitis,10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6 J, Experimental Autoimmune Encephalomyelitis","Olfactory bulb tissue was harvested and snap-frozen in 80C until further analysis. For nuclei isolation olfactory bulb tissues were homogenized in EZ lysis buffer (Sigma Aldrich, NUC101) with a glass douncer ((Sigma-Aldrich, D9063). After 3-min incubation on ice cell suspension was then centrifuged by 500  g for 4 min at 4C. Nuclei were washed once with the EZ lysis buffer and twice in the nucleus incubation buffer (MgCl2 2 mM, KCl 25 mM, Glycerophosphate 65 mM, Sucrose 340 mM, glycerol 5%, ethylenediaminetetraacetic acid 1 mM, bovine serum albumin (BSA) 1%) and filtered through a 30 m pre-separation filter (Miltenyi Biotech, 130-041-407). The nuclei suspensions were stained in nucleus incubation buffer for ten minutes with anti-HuC/D labeled to Alexa647 (1:300, rabbit, Abcam; Cat# ab237235, RRID: AB_2864321) and propidium iodide (PI) (1:1000, Thermo Fisher Scientific, Cat# P1304MP). PI-positive HuC/D positive nuclei were sorted in PBS containing 0.4% BSA using a BD Aria III cell sorter (BD Biosciences).mRNA library preparation is performed according to the standard 10X Genomics protocol with the Chromium Next GEM Single Cell 3GEM, Library & Gel Bead Kit v3.1 (Cat# 1000075, 10x Genomics). Briefly, gel bead emulsion (GEMs) was generated containing single nuclei and a master mix with reagents in the Chromium Controller followed by cell lysis and reverse transcription of RNA, cDNA amplification, enzymatic fragmentation, 5adaptor attachment and sample indexing. On average around 25,000 nuclei were loaded on each channel of the Chromium instrument. To minimize batch effects, EAE and control samples were distributed evenly in the Chromium controller. Libraries were pooled and sequenced on an Illumina NovaSeq6000 platform (paired end sequencing, 2 x 100 bp read length, 500 million reads per sample).",,,
MS017003,GSM8296322,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40057769/GSM8296322_R2_H_,10x,,40057769,MS,Healthy,Yes,Mouse,Olfactory bulb,none,Female,no data available,10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6 J,"Olfactory bulb tissue was harvested and snap-frozen in 80C until further analysis. For nuclei isolation olfactory bulb tissues were homogenized in EZ lysis buffer (Sigma Aldrich, NUC101) with a glass douncer ((Sigma-Aldrich, D9063). After 3-min incubation on ice cell suspension was then centrifuged by 500  g for 4 min at 4C. Nuclei were washed once with the EZ lysis buffer and twice in the nucleus incubation buffer (MgCl2 2 mM, KCl 25 mM, Glycerophosphate 65 mM, Sucrose 340 mM, glycerol 5%, ethylenediaminetetraacetic acid 1 mM, bovine serum albumin (BSA) 1%) and filtered through a 30 m pre-separation filter (Miltenyi Biotech, 130-041-407). The nuclei suspensions were stained in nucleus incubation buffer for ten minutes with anti-HuC/D labeled to Alexa647 (1:300, rabbit, Abcam; Cat# ab237235, RRID: AB_2864321) and propidium iodide (PI) (1:1000, Thermo Fisher Scientific, Cat# P1304MP). PI-positive HuC/D positive nuclei were sorted in PBS containing 0.4% BSA using a BD Aria III cell sorter (BD Biosciences).mRNA library preparation is performed according to the standard 10X Genomics protocol with the Chromium Next GEM Single Cell 3GEM, Library & Gel Bead Kit v3.1 (Cat# 1000075, 10x Genomics). Briefly, gel bead emulsion (GEMs) was generated containing single nuclei and a master mix with reagents in the Chromium Controller followed by cell lysis and reverse transcription of RNA, cDNA amplification, enzymatic fragmentation, 5adaptor attachment and sample indexing. On average around 25,000 nuclei were loaded on each channel of the Chromium instrument. To minimize batch effects, EAE and control samples were distributed evenly in the Chromium controller. Libraries were pooled and sequenced on an Illumina NovaSeq6000 platform (paired end sequencing, 2 x 100 bp read length, 500 million reads per sample).",,,
MS017004,GSM8296323,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40057769/GSM8296323_R2_EAE_,10x,,40057769,MS,Disease,No,Mouse,Olfactory bulb,none,Female,Acute Experimental Autoimmune Encephalomyelitis,10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6 J, Experimental Autoimmune Encephalomyelitis","Olfactory bulb tissue was harvested and snap-frozen in 80C until further analysis. For nuclei isolation olfactory bulb tissues were homogenized in EZ lysis buffer (Sigma Aldrich, NUC101) with a glass douncer ((Sigma-Aldrich, D9063). After 3-min incubation on ice cell suspension was then centrifuged by 500  g for 4 min at 4C. Nuclei were washed once with the EZ lysis buffer and twice in the nucleus incubation buffer (MgCl2 2 mM, KCl 25 mM, Glycerophosphate 65 mM, Sucrose 340 mM, glycerol 5%, ethylenediaminetetraacetic acid 1 mM, bovine serum albumin (BSA) 1%) and filtered through a 30 m pre-separation filter (Miltenyi Biotech, 130-041-407). The nuclei suspensions were stained in nucleus incubation buffer for ten minutes with anti-HuC/D labeled to Alexa647 (1:300, rabbit, Abcam; Cat# ab237235, RRID: AB_2864321) and propidium iodide (PI) (1:1000, Thermo Fisher Scientific, Cat# P1304MP). PI-positive HuC/D positive nuclei were sorted in PBS containing 0.4% BSA using a BD Aria III cell sorter (BD Biosciences).mRNA library preparation is performed according to the standard 10X Genomics protocol with the Chromium Next GEM Single Cell 3GEM, Library & Gel Bead Kit v3.1 (Cat# 1000075, 10x Genomics). Briefly, gel bead emulsion (GEMs) was generated containing single nuclei and a master mix with reagents in the Chromium Controller followed by cell lysis and reverse transcription of RNA, cDNA amplification, enzymatic fragmentation, 5adaptor attachment and sample indexing. On average around 25,000 nuclei were loaded on each channel of the Chromium instrument. To minimize batch effects, EAE and control samples were distributed evenly in the Chromium controller. Libraries were pooled and sequenced on an Illumina NovaSeq6000 platform (paired end sequencing, 2 x 100 bp read length, 500 million reads per sample).",,,
MS017005,GSM8296324,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40057769/GSM8296324_R3_H_,10x,,40057769,MS,Healthy,Yes,Mouse,Olfactory bulb,none,Female,no data available,10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6 J,"Olfactory bulb tissue was harvested and snap-frozen in 80C until further analysis. For nuclei isolation olfactory bulb tissues were homogenized in EZ lysis buffer (Sigma Aldrich, NUC101) with a glass douncer ((Sigma-Aldrich, D9063). After 3-min incubation on ice cell suspension was then centrifuged by 500  g for 4 min at 4C. Nuclei were washed once with the EZ lysis buffer and twice in the nucleus incubation buffer (MgCl2 2 mM, KCl 25 mM, Glycerophosphate 65 mM, Sucrose 340 mM, glycerol 5%, ethylenediaminetetraacetic acid 1 mM, bovine serum albumin (BSA) 1%) and filtered through a 30 m pre-separation filter (Miltenyi Biotech, 130-041-407). The nuclei suspensions were stained in nucleus incubation buffer for ten minutes with anti-HuC/D labeled to Alexa647 (1:300, rabbit, Abcam; Cat# ab237235, RRID: AB_2864321) and propidium iodide (PI) (1:1000, Thermo Fisher Scientific, Cat# P1304MP). PI-positive HuC/D positive nuclei were sorted in PBS containing 0.4% BSA using a BD Aria III cell sorter (BD Biosciences).mRNA library preparation is performed according to the standard 10X Genomics protocol with the Chromium Next GEM Single Cell 3GEM, Library & Gel Bead Kit v3.1 (Cat# 1000075, 10x Genomics). Briefly, gel bead emulsion (GEMs) was generated containing single nuclei and a master mix with reagents in the Chromium Controller followed by cell lysis and reverse transcription of RNA, cDNA amplification, enzymatic fragmentation, 5adaptor attachment and sample indexing. On average around 25,000 nuclei were loaded on each channel of the Chromium instrument. To minimize batch effects, EAE and control samples were distributed evenly in the Chromium controller. Libraries were pooled and sequenced on an Illumina NovaSeq6000 platform (paired end sequencing, 2 x 100 bp read length, 500 million reads per sample).",,,
MS017006,GSM8296325,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40057769/GSM8296325_R3_EAE_,10x,,40057769,MS,Disease,No,Mouse,Olfactory bulb,none,Female,Acute Experimental Autoimmune Encephalomyelitis,10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6 J, Experimental Autoimmune Encephalomyelitis","Olfactory bulb tissue was harvested and snap-frozen in 80C until further analysis. For nuclei isolation olfactory bulb tissues were homogenized in EZ lysis buffer (Sigma Aldrich, NUC101) with a glass douncer ((Sigma-Aldrich, D9063). After 3-min incubation on ice cell suspension was then centrifuged by 500  g for 4 min at 4C. Nuclei were washed once with the EZ lysis buffer and twice in the nucleus incubation buffer (MgCl2 2 mM, KCl 25 mM, Glycerophosphate 65 mM, Sucrose 340 mM, glycerol 5%, ethylenediaminetetraacetic acid 1 mM, bovine serum albumin (BSA) 1%) and filtered through a 30 m pre-separation filter (Miltenyi Biotech, 130-041-407). The nuclei suspensions were stained in nucleus incubation buffer for ten minutes with anti-HuC/D labeled to Alexa647 (1:300, rabbit, Abcam; Cat# ab237235, RRID: AB_2864321) and propidium iodide (PI) (1:1000, Thermo Fisher Scientific, Cat# P1304MP). PI-positive HuC/D positive nuclei were sorted in PBS containing 0.4% BSA using a BD Aria III cell sorter (BD Biosciences).mRNA library preparation is performed according to the standard 10X Genomics protocol with the Chromium Next GEM Single Cell 3GEM, Library & Gel Bead Kit v3.1 (Cat# 1000075, 10x Genomics). Briefly, gel bead emulsion (GEMs) was generated containing single nuclei and a master mix with reagents in the Chromium Controller followed by cell lysis and reverse transcription of RNA, cDNA amplification, enzymatic fragmentation, 5adaptor attachment and sample indexing. On average around 25,000 nuclei were loaded on each channel of the Chromium instrument. To minimize batch effects, EAE and control samples were distributed evenly in the Chromium controller. Libraries were pooled and sequenced on an Illumina NovaSeq6000 platform (paired end sequencing, 2 x 100 bp read length, 500 million reads per sample).",,,
MS018001,GSM8032585,,,whole,39560646,MS,Disease,No,Mouse,Brain,none,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Ifng fl/fl, CD4-Cre/ Ifng fl/fl, Experimental Autoimmune Encephalomyelitis","Sinlge cell droplets were generated by 10x Genomics Chromium Controller, and cDNAs with UMIs were generated at single-cell level.The single cell libraries were prepared following the protocol outlined in the Chromium Next GEM Single Cell 5' Reagent Kits v2 User Guide.",,,
MS018002,GSM8032586,,,whole,39560646,MS,Disease,No,Mouse,Brain,none,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Ifng fl/fl, CD4-Cre/ Ifng fl/fl, Experimental Autoimmune Encephalomyelitis","Sinlge cell droplets were generated by 10x Genomics Chromium Controller, and cDNAs with UMIs were generated at single-cell level.The single cell libraries were prepared following the protocol outlined in the Chromium Next GEM Single Cell 5' Reagent Kits v2 User Guide.",,,
MS018003,GSM8032587,,,whole,39560646,MS,Disease,No,Mouse,"Spleen, brain",none,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6N, Experimental Autoimmune Encephalomyelitis","Sinlge cell droplets were generated by 10x Genomics Chromium Controller, and cDNAs with UMIs were generated at single-cell level.The single cell libraries were prepared following the protocol outlined in the Chromium Next GEM Single Cell 5' Reagent Kits v2 User Guide.",,,
MS018004,GSM8032588,,,whole,39560646,MS,Disease,No,Mouse,"Spleen, brain",none,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6N, Experimental Autoimmune Encephalomyelitis","Sinlge cell droplets were generated by 10x Genomics Chromium Controller, and cDNAs with UMIs were generated at single-cell level.The single cell libraries were prepared following the protocol outlined in the Chromium Next GEM Single Cell 5' Reagent Kits v2 User Guide.",,,
MS019001,GSM7549677,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549677_Il12rb2fl_EAE_1_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019002,GSM7549678,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549678_Il12rb2fl_EAE_2_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019003,GSM7549679,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549679_Il12rb2fl_EAE_3_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019004,GSM7549680,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549680_NestinCre_Il12rb2fl_EAE_1_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"NestinCre/+Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019005,GSM7549681,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549681_NestinCre_Il12rb2fl_EAE_2_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"NestinCre/+Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019006,GSM7549682,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549682_NestinCre_Il12rb2fl_EAE_3_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"NestinCre/+Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019007,GSM7549683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549683_Il12rb2fl_EAE_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019008,GSM7549684,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549684_Il12rb2fl_naive_2_,10x,,37749256,MS,Healthy,Yes,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,no data available,8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,Il12rb2fl/fl,"EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019009,GSM7549685,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549685_NestinCre_Il12rb2fl_EAE_,10x,,37749256,MS,Disease,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,Experimental Autoimmune Encephalomyelitis (10 dpi),8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"NestinCre/+Il12rb2fl/fl, Experimental Autoimmune Encephalomyelitis","EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019010,GSM7549686,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549686_Il12rb2fl_naive_3_,10x,,37749256,MS,Healthy,Yes,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,no data available,8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,Il12rb2fl/fl,"EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS019011,GSM7549687,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37749256/GSM7549687_NestinCre_Il12rb2fl_naive_2_,10x,,37749256,MS,Healthy,No,Mouse,"Cerebellum, brainstem, and cervical spinal cord ",none,Male,no data available,8-12 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,NestinCre/+Il12rb2fl/fl,"EAE was induced by injection of 200 g of myelin oligodendrocyte glycoprotein epitope MOG35-55 (#RP10245, Genscript) emulsified in complete Freunds adjuvant (CFA) (#231131, BD). All mice received two subcutaneous (s.c.) injections into the flank, each of 100 l of the freshly prepared MOG-CFA mixture and a single intraperitoneal injection (i.p.) of 50-100 ng pertussis toxin (PT) (List Biological Laboratories, #179A).Mouse cerebellum and brainstem (of one brain hemisphere) and cervical spinal cord (C1-C2) were harvested from adult male mice (8-12 weeks old) and immediately snap-frozen in liquid nitrogen and stored at -80oC until further processing. Nuclei were isolated with the EZ PREP lysis buffer (#NUC-101, Sigma). Tissue samples were homogenized using a glass dounce tissue grinder (#D8938, Sigma) (25 strokes with pastel A, 25 strokes with pastel B) in 2 ml of ice-cold EZ prep lysis buffer and incubated on ice with an additional 2 ml of ice-cold EZ PREP lysis buffer. During incubation, 1  of Hoechst (#H3570, Thermo Fisher Scientific) dye and 40 U/l of RiboLock inhibitors (#EO0382, Thermo Fisher Scientific) were added to the homogenate. Following incubation, the homogenate was filtered through a 30 M FACS tube filter. Nuclei were sorted based on the fluorescent Hoechst signal using a BD FACS Aria sorter III with an 85 m nozzle configuration at 4oC, directly into PBS + 4% BSA + RiboLock inhibitors (40 U/l) (Cat # EO0382). As CNS nuclei vary strongly in size, no doublet exclusion was performed based on FSC or SSC to avoid bias against nucleus size. Nuclei were then counted based on brightfield image and Trypan Blue staining (Cat # 15250061) using a Neubauer counting chamber and a Keyence BZX-710 microscope.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS022001,GSM6641992,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 WT","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS022002,GSM6641993,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 WT","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS022003,GSM6641994,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 WT","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS022004,GSM6641995,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 WT","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS022005,GSM6641996,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 R150H","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS022006,GSM6641997,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 R150H","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS022007,GSM6641998,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 R150H","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS022008,GSM6641999,,h5,whole,36516268,MS,Disease,No,Mouse,Central Nervous System,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, HDAC7 R150H","Resected brains were homogenized and digested by a 30 minute incubation at 37 C with 1mg/mL of collagenase IV (Worthington) and 100ug/mL DNase (Roche). Mononuclear cells were isolated with a triple Percoll gradient (90, 60, 40%) after centrifugation at 1700 RPM for 20 minutes at 4C, and stained with flow cytometry antibodies for 30 minutes at 4C, followed by DAPI staining (Thermofisher) to exclude dead cells.        At day 14 post-immunization, mice were injected with 2ug of CD45 flow antibody (Biolegend) via intravenous injection (CD45iv) at least 5 minutes prior to sacrifice and perfusion. Following anesthesia induction with isoflurane, mice were transcardially perfused with 15-20 ml of PBS supplemented with 2 mM EDTA before sacrifice.Live CD45ivCD11bCD45+CD3+ cells were sorted on a FACSAria (BD Biosciences). Cells were resuspended in PBS 2% FBS and counted on a hemocytometer, before being loaded on the 10x genomics instrument using the Chromium Single Cell 5 kit v2 (10x genomics).Single-cell libraries were generated according to the manufacturers protocol (10 Genomics). Single-cell library size and quality were confirmed on the Fragment Analyzer (Agilent). KAPA Quantification Kit for Illumina platforms (KAPA Biosystems, Roche) was used to quantify libraries.The libraries were sequenced on a NovaSeq (Illumina) in pair-end sequencing 150bp",,,
MS023001,GSM4476524,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476524_SAM24359737.txt.gz,txt.gz,whole,33691116,MS,Healthy,Yes,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Mertk-WT,"No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,,
MS023002,GSM4476525,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476525_SAM24359738.txt.gz,txt.gz,whole,33691116,MS,Healthy,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Mertk_KO,"No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,,
MS023003,GSM4476526,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476526_SAM24360680.txt.gz,txt.gz,whole,33691116,MS,Healthy,Yes,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Mertk-WT,"No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,,
MS023004,GSM4476527,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476527_SAM24360681.txt.gz,txt.gz,whole,33691116,MS,Healthy,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Mertk_KO,"No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,,
MS023005,GSM4476528,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476528_SAM24360682.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk-WT, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023006,GSM4476529,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476529_SAM24360683.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk_KO, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023007,GSM4476530,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476530_SAM24360684.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk-WT, Cuprizone model + 3 week remyelination","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow,
MS023008,GSM4476531,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476531_SAM24360685.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk_KO, Cuprizone model + 3 week remyelination","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow,
MS023009,GSM4476532,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476532_SAM24360686.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk-WT, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023010,GSM4476533,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476533_SAM24360687.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk_KO, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023011,GSM4476534,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476534_SAM24360688.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk-WT, Cuprizone model + 3 week remyelination","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow,
MS023012,GSM4476535,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476535_SAM24360689.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk_KO, Cuprizone model + 3 week remyelination","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow,
MS023013,GSM4476536,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476536_SAM24369063.txt.gz,txt.gz,whole,33691116,MS,Healthy,Yes,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Mertk-WT,"No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,,
MS023014,GSM4476537,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476537_SAM24369064.txt.gz,txt.gz,whole,33691116,MS,Healthy,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Mertk_KO,"No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,,
MS023015,GSM4476538,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476538_SAM24369065.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk-WT, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023016,GSM4476539,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476539_SAM24369066.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk_KO, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023017,GSM4476540,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476540_SAM24369067.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk-WT, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023018,GSM4476541,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476541_SAM24369068.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk_KO, Cuprizone model","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2% Cuprizone chow,
MS023019,GSM4476542,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476542_SAM24369069.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk-WT, Cuprizone model + 3 week remyelination","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow,
MS023020,GSM4476543,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33691116/GSM4476543_SAM24369070.txt.gz,txt.gz,whole,33691116,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Mertk_KO, Cuprizone model + 3 week remyelination","No treatment (Baseline), 4 weeks of 0.2% Cuprizone chow (Cuprizone_4w), 4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow (Cuprizone_4+3w)Mice were perfused with cold PBS and the corpus callosum dissected from the brain. Tissues were dissociated with Miltenyi Neural Tissue Dissociation Kit (P).10X libraries were prepared using Chromium Single Cell 3' Library Prep Kit (v2)",,4 weeks of 0.2 Cuprizone chow followed by 3 weeks of normal chow,
MS024001,GSM8200513,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39264698/Normal_brain/filtered_feature_bc_matrix/,10x,,39264698,MS,Healthy,Yes,Mouse,Brain,none,Female,no data available,8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,C57BL/6,"Brain tissue was minced and centrifuged at 300g for 5 min at 4C. The supernatant was discarded. Add enzyme I mixture, resuspend and then add enzyme II mixture, incubate at 37C, 90 rpm, 3 times for 10 min each time, filter through a 70 m filter. Then centrifuge and discard the supernatant, add pre-cooled D-PBS and resuspend, and afterwards add debris remover, mix well and slowly add pre-cooled D-PBS, thoroughly remove the upper two layers, add pre-cooled D-PBS, resuspended and centrifuge for 10 min. Centrifuge for 10 min, completely remove the upper two layers, add pre-cooled D-PBS and resuspend, centrifuge and discard the supernatant, and resuspend the cells in PBS containing 0.1% BSA and pass through a 30 m sterile cell strainer.Library was performd accordiing to the manufacter's instructions10Genomics Chromium Single Cell 3 Reagent Guidelines v3 Chemistry; https://support.10genomics.com/single-cell-gene-expression.Cells were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsionGEM.The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an llumina R1 primer sequence, Unique Molecular IdentifierUMIand the 10 Barcode. The pooled barcode cDNA was then cleaned up with Silane DynaBeads, amplifiled by PCR and the apropiated sized fragments were selected for subsequent library construction. Read 2 is used for downstream analysis in Cell ranger, which is added during library construction by end repair, adenine tailing, junction ligation and PCR.",,,
MS024002,GSM8200514,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39264698/EAE-peak-Brain_CD45-/filtered_feature_bc_matrix/,10x,,39264698,MS,Disease,No,Mouse,Brain,none,Female,Peak Experimental Autoimmune Encephalomyelitis,8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Brain tissue was minced and centrifuged at 300g for 5 min at 4C. The supernatant was discarded. Add enzyme I mixture, resuspend and then add enzyme II mixture, incubate at 37C, 90 rpm, 3 times for 10 min each time, filter through a 70 m filter. Then centrifuge and discard the supernatant, add pre-cooled D-PBS and resuspend, and afterwards add debris remover, mix well and slowly add pre-cooled D-PBS, thoroughly remove the upper two layers, add pre-cooled D-PBS, resuspended and centrifuge for 10 min. Centrifuge for 10 min, completely remove the upper two layers, add pre-cooled D-PBS and resuspend, centrifuge and discard the supernatant, and resuspend the cells in PBS containing 0.1% BSA and pass through a 30 m sterile cell strainer.Library was performd accordiing to the manufacter's instructions10Genomics Chromium Single Cell 3 Reagent Guidelines v3 Chemistry; https://support.10genomics.com/single-cell-gene-expression.Cells were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsionGEM.The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an llumina R1 primer sequence, Unique Molecular IdentifierUMIand the 10 Barcode. The pooled barcode cDNA was then cleaned up with Silane DynaBeads, amplifiled by PCR and the apropiated sized fragments were selected for subsequent library construction. Read 2 is used for downstream analysis in Cell ranger, which is added during library construction by end repair, adenine tailing, junction ligation and PCR.",,,
MS024003,GSM8200515,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39264698/EAE-peak-Brain_CD45+/filtered_feature_bc_matrix/,10x,,39264698,MS,Disease,No,Mouse,Brain,none,Female,Peak Experimental Autoimmune Encephalomyelitis,8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Brain tissue was minced and centrifuged at 300g for 5 min at 4C. The supernatant was discarded. Add enzyme I mixture, resuspend and then add enzyme II mixture, incubate at 37C, 90 rpm, 3 times for 10 min each time, filter through a 70 m filter. Then centrifuge and discard the supernatant, add pre-cooled D-PBS and resuspend, and afterwards add debris remover, mix well and slowly add pre-cooled D-PBS, thoroughly remove the upper two layers, add pre-cooled D-PBS, resuspended and centrifuge for 10 min. Centrifuge for 10 min, completely remove the upper two layers, add pre-cooled D-PBS and resuspend, centrifuge and discard the supernatant, and resuspend the cells in PBS containing 0.1% BSA and pass through a 30 m sterile cell strainer.Library was performd accordiing to the manufacter's instructions10Genomics Chromium Single Cell 3 Reagent Guidelines v3 Chemistry; https://support.10genomics.com/single-cell-gene-expression.Cells were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsionGEM.The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an llumina R1 primer sequence, Unique Molecular IdentifierUMIand the 10 Barcode. The pooled barcode cDNA was then cleaned up with Silane DynaBeads, amplifiled by PCR and the apropiated sized fragments were selected for subsequent library construction. Read 2 is used for downstream analysis in Cell ranger, which is added during library construction by end repair, adenine tailing, junction ligation and PCR.",,,
MS024004,GSM8200516,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39264698/EAE-chronic-Brain_CD45-/filtered_feature_bc_matrix/,10x,,39264698,MS,Disease,No,Mouse,Brain,none,Female,Chronic Experimental Autoimmune Encephalomyelitis,8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Brain tissue was minced and centrifuged at 300g for 5 min at 4C. The supernatant was discarded. Add enzyme I mixture, resuspend and then add enzyme II mixture, incubate at 37C, 90 rpm, 3 times for 10 min each time, filter through a 70 m filter. Then centrifuge and discard the supernatant, add pre-cooled D-PBS and resuspend, and afterwards add debris remover, mix well and slowly add pre-cooled D-PBS, thoroughly remove the upper two layers, add pre-cooled D-PBS, resuspended and centrifuge for 10 min. Centrifuge for 10 min, completely remove the upper two layers, add pre-cooled D-PBS and resuspend, centrifuge and discard the supernatant, and resuspend the cells in PBS containing 0.1% BSA and pass through a 30 m sterile cell strainer.Library was performd accordiing to the manufacter's instructions10Genomics Chromium Single Cell 3 Reagent Guidelines v3 Chemistry; https://support.10genomics.com/single-cell-gene-expression.Cells were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsionGEM.The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an llumina R1 primer sequence, Unique Molecular IdentifierUMIand the 10 Barcode. The pooled barcode cDNA was then cleaned up with Silane DynaBeads, amplifiled by PCR and the apropiated sized fragments were selected for subsequent library construction. Read 2 is used for downstream analysis in Cell ranger, which is added during library construction by end repair, adenine tailing, junction ligation and PCR.",,,
MS024005,GSM8200517,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39264698/EAE-chronic-Brain_CD45+/filtered_feature_bc_matrix/,10x,,39264698,MS,Disease,No,Mouse,Brain,none,Female,Chronic Experimental Autoimmune Encephalomyelitis,8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Brain tissue was minced and centrifuged at 300g for 5 min at 4C. The supernatant was discarded. Add enzyme I mixture, resuspend and then add enzyme II mixture, incubate at 37C, 90 rpm, 3 times for 10 min each time, filter through a 70 m filter. Then centrifuge and discard the supernatant, add pre-cooled D-PBS and resuspend, and afterwards add debris remover, mix well and slowly add pre-cooled D-PBS, thoroughly remove the upper two layers, add pre-cooled D-PBS, resuspended and centrifuge for 10 min. Centrifuge for 10 min, completely remove the upper two layers, add pre-cooled D-PBS and resuspend, centrifuge and discard the supernatant, and resuspend the cells in PBS containing 0.1% BSA and pass through a 30 m sterile cell strainer.Library was performd accordiing to the manufacter's instructions10Genomics Chromium Single Cell 3 Reagent Guidelines v3 Chemistry; https://support.10genomics.com/single-cell-gene-expression.Cells were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsionGEM.The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an llumina R1 primer sequence, Unique Molecular IdentifierUMIand the 10 Barcode. The pooled barcode cDNA was then cleaned up with Silane DynaBeads, amplifiled by PCR and the apropiated sized fragments were selected for subsequent library construction. Read 2 is used for downstream analysis in Cell ranger, which is added during library construction by end repair, adenine tailing, junction ligation and PCR.",,,
MS025001,GSM7244785,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37640028/GSM7244785_HA843_Control_,10x_matrix,,37640028,MS,Healthy,Yes,Human,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"OLs were isolated from fresh non-pathological brain tissue from surgical resections for non-tumoral intractable focal epilepsy as previously published (Rone MB et al., 2016). OLs were harvested and plated on poly-L-lysine and extracellular matrix coated wells. During the first 4 days, OLs were allowed to grow in enriched cell medium containing 2ng/mL T3 , 1/50 N1 supplement , 1/50 B27 , 10ng/mL basic fibroblast growth factor and 10ng/mL platelet derived growth factor  AA as previously published (Rone MB et al., 2016). After cell process extension, fresh medium without basic fibroblast growth factor and platelet derived growth factor  AA was used. Cells were treated with the experimental conditions after 8-10 days in vitroIn brief, media was collected and cells were treated with PBS-EDTA to detach the oligodendrocytes from the bottom of the well. Once cells were visibly detached, the suspension was combined with the collected media and the wells were washed twice with PBS to collect any residual cells and transferred to the same sample tube. The samples were centrifuged at 800rpm for 10min to pellet the live cells and then resuspended in PBS at a concentration of 350 thousand cells per milliliter. Approximately 10,000 cells were used for library construction.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics).",,,
MS025002,GSM7244786,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37640028/GSM7244786_HA843_TCM_,10x_matrix,,37640028,MS,Healthy,No,Human,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Oligodendrocyte co-cultured with T cells separated by insert (TCM),"OLs were isolated from fresh non-pathological brain tissue from surgical resections for non-tumoral intractable focal epilepsy as previously published (Rone MB et al., 2016). OLs were harvested and plated on poly-L-lysine and extracellular matrix coated wells. During the first 4 days, OLs were allowed to grow in enriched cell medium containing 2ng/mL T3 , 1/50 N1 supplement , 1/50 B27 , 10ng/mL basic fibroblast growth factor and 10ng/mL platelet derived growth factor  AA as previously published (Rone MB et al., 2016). After cell process extension, fresh medium without basic fibroblast growth factor and platelet derived growth factor  AA was used. Cells were treated with the experimental conditions after 8-10 days in vitroIn brief, media was collected and cells were treated with PBS-EDTA to detach the oligodendrocytes from the bottom of the well. Once cells were visibly detached, the suspension was combined with the collected media and the wells were washed twice with PBS to collect any residual cells and transferred to the same sample tube. The samples were centrifuged at 800rpm for 10min to pellet the live cells and then resuspended in PBS at a concentration of 350 thousand cells per milliliter. Approximately 10,000 cells were used for library construction.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics).",,,
MS025003,GSM7244787,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37640028/GSM7244787_HA843_TCO_,10x_matrix,,37640028,MS,Healthy,No,Human,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Oligodendrocyte co-cultured in direct with T cells (TCO),"OLs were isolated from fresh non-pathological brain tissue from surgical resections for non-tumoral intractable focal epilepsy as previously published (Rone MB et al., 2016). OLs were harvested and plated on poly-L-lysine and extracellular matrix coated wells. During the first 4 days, OLs were allowed to grow in enriched cell medium containing 2ng/mL T3 , 1/50 N1 supplement , 1/50 B27 , 10ng/mL basic fibroblast growth factor and 10ng/mL platelet derived growth factor  AA as previously published (Rone MB et al., 2016). After cell process extension, fresh medium without basic fibroblast growth factor and platelet derived growth factor  AA was used. Cells were treated with the experimental conditions after 8-10 days in vitroIn brief, media was collected and cells were treated with PBS-EDTA to detach the oligodendrocytes from the bottom of the well. Once cells were visibly detached, the suspension was combined with the collected media and the wells were washed twice with PBS to collect any residual cells and transferred to the same sample tube. The samples were centrifuged at 800rpm for 10min to pellet the live cells and then resuspended in PBS at a concentration of 350 thousand cells per milliliter. Approximately 10,000 cells were used for library construction.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics).",,,
MS025004,GSM7244788,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37640028/GSM7244788_HA844_Control_,10x_matrix,,37640028,MS,Healthy,Yes,Human,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"OLs were isolated from fresh non-pathological brain tissue from surgical resections for non-tumoral intractable focal epilepsy as previously published (Rone MB et al., 2016). OLs were harvested and plated on poly-L-lysine and extracellular matrix coated wells. During the first 4 days, OLs were allowed to grow in enriched cell medium containing 2ng/mL T3 , 1/50 N1 supplement , 1/50 B27 , 10ng/mL basic fibroblast growth factor and 10ng/mL platelet derived growth factor  AA as previously published (Rone MB et al., 2016). After cell process extension, fresh medium without basic fibroblast growth factor and platelet derived growth factor  AA was used. Cells were treated with the experimental conditions after 8-10 days in vitroIn brief, media was collected and cells were treated with PBS-EDTA to detach the oligodendrocytes from the bottom of the well. Once cells were visibly detached, the suspension was combined with the collected media and the wells were washed twice with PBS to collect any residual cells and transferred to the same sample tube. The samples were centrifuged at 800rpm for 10min to pellet the live cells and then resuspended in PBS at a concentration of 350 thousand cells per milliliter. Approximately 10,000 cells were used for library construction.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics).",,,
MS025005,GSM7244789,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37640028/GSM7244789_HA844_TCM_,10x_matrix,,37640028,MS,Healthy,No,Human,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Oligodendrocyte co-cultured with T cells separated by insert (TCM),"OLs were isolated from fresh non-pathological brain tissue from surgical resections for non-tumoral intractable focal epilepsy as previously published (Rone MB et al., 2016). OLs were harvested and plated on poly-L-lysine and extracellular matrix coated wells. During the first 4 days, OLs were allowed to grow in enriched cell medium containing 2ng/mL T3 , 1/50 N1 supplement , 1/50 B27 , 10ng/mL basic fibroblast growth factor and 10ng/mL platelet derived growth factor  AA as previously published (Rone MB et al., 2016). After cell process extension, fresh medium without basic fibroblast growth factor and platelet derived growth factor  AA was used. Cells were treated with the experimental conditions after 8-10 days in vitroIn brief, media was collected and cells were treated with PBS-EDTA to detach the oligodendrocytes from the bottom of the well. Once cells were visibly detached, the suspension was combined with the collected media and the wells were washed twice with PBS to collect any residual cells and transferred to the same sample tube. The samples were centrifuged at 800rpm for 10min to pellet the live cells and then resuspended in PBS at a concentration of 350 thousand cells per milliliter. Approximately 10,000 cells were used for library construction.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics).",,,
MS025006,GSM7244790,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37640028/GSM7244790_HA844_TCO_,10x_matrix,,37640028,MS,Healthy,No,Human,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,Oligodendrocyte co-cultured in direct with T cells (TCO),"OLs were isolated from fresh non-pathological brain tissue from surgical resections for non-tumoral intractable focal epilepsy as previously published (Rone MB et al., 2016). OLs were harvested and plated on poly-L-lysine and extracellular matrix coated wells. During the first 4 days, OLs were allowed to grow in enriched cell medium containing 2ng/mL T3 , 1/50 N1 supplement , 1/50 B27 , 10ng/mL basic fibroblast growth factor and 10ng/mL platelet derived growth factor  AA as previously published (Rone MB et al., 2016). After cell process extension, fresh medium without basic fibroblast growth factor and platelet derived growth factor  AA was used. Cells were treated with the experimental conditions after 8-10 days in vitroIn brief, media was collected and cells were treated with PBS-EDTA to detach the oligodendrocytes from the bottom of the well. Once cells were visibly detached, the suspension was combined with the collected media and the wells were washed twice with PBS to collect any residual cells and transferred to the same sample tube. The samples were centrifuged at 800rpm for 10min to pellet the live cells and then resuspended in PBS at a concentration of 350 thousand cells per milliliter. Approximately 10,000 cells were used for library construction.Library was performed according to the manufacters instructions (single cell 3 v2 protocol, 10x Genomics).",,,
MS026001,GSM5417499,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417499_Cup1_,10x,,35090578,MS,Disease,No,Mouse,Brain,none,Male,no data available,4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J-Cx3cr1tm2.1(cre/ERT2)LittGt(ROSA)26Sortm14(CAG-tdTomato)Hze, Cuprizone model",[diet protocol mice] Mice were fed 0.2% cuprizone in their diet ad libitum. Control animals received similarly prepared chow but without cuprizone [Macrophage isolation mouse] Enzymatic isolation at 4C using protease from Bacillus lichenformis and L-cysteine. FACS sorted on tdTomato Red cells.Qiagen Rneasy lipid mini kit3 3 single cell RNAseq v2 from 10x Genomics for single cell.,,3 weeks cuprizone,
MS026002,GSM5417500,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417500_Cup3_,10x,,35090578,MS,Disease,No,Mouse,Brain,none,Male,no data available,4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J-Cx3cr1tm2.1(cre/ERT2)LittGt(ROSA)26Sortm14(CAG-tdTomato)Hze, Cuprizone model",[diet protocol mice] Mice were fed 0.2% cuprizone in their diet ad libitum. Control animals received similarly prepared chow but without cuprizone [Macrophage isolation mouse] Enzymatic isolation at 4C using protease from Bacillus lichenformis and L-cysteine. FACS sorted on tdTomato Red cells.Qiagen Rneasy lipid mini kit3 3 single cell RNAseq v2 from 10x Genomics for single cell.,,5 weeks cuprizone,
MS026003,GSM5417501,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417501_Cup5_,10x,,35090578,MS,Disease,No,Mouse,Brain,none,Male,no data available,4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J-Cx3cr1tm2.1(cre/ERT2)LittGt(ROSA)26Sortm14(CAG-tdTomato)Hze, Cuprizone model + 2 weeks remyelination",[diet protocol mice] Mice were fed 0.2% cuprizone in their diet ad libitum. Control animals received similarly prepared chow but without cuprizone [Macrophage isolation mouse] Enzymatic isolation at 4C using protease from Bacillus lichenformis and L-cysteine. FACS sorted on tdTomato Red cells.Qiagen Rneasy lipid mini kit3 3 single cell RNAseq v2 from 10x Genomics for single cell.,,2 weeks remyelination,
MS026004,GSM5417502,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417502_Cup7_,10x,,35090578,MS,Healthy,Yes,Mouse,Brain,none,Male,no data available,4 months,no data available,10x Genomics,single-cell RNA sequencing,C57BL/6J-Cx3cr1tm2.1(cre/ERT2)LittGt(ROSA)26Sortm14(CAG-tdTomato)Hze,[diet protocol mice] Mice were fed 0.2% cuprizone in their diet ad libitum. Control animals received similarly prepared chow but without cuprizone [Macrophage isolation mouse] Enzymatic isolation at 4C using protease from Bacillus lichenformis and L-cysteine. FACS sorted on tdTomato Red cells.Qiagen Rneasy lipid mini kit3 Quantseq FWD kit from Lexogen for bulk RNAseq. 3 single cell RNAseq v2 from 10x Genomics for single cell.,,,
MS026005,GSM5417503,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417503_MS115NAGM_,10x,,35090578,MS,Disease,No,Human,Gray matter,no data available,Male,no data available,56 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026006,GSM5417504,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417504_MS115NAWM_,10x,,35090578,MS,Disease,No,Human,White matter,no data available,Male,no data available,56 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026007,GSM5417505,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417505_MS115LESION_,10x,,35090578,MS,Disease,No,Human,Brain,no data available,Male,no data available,56 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026008,GSM5417506,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417506_MS116NAGM_,10x,,35090578,MS,Disease,No,Human,Gray matter,no data available,Female,no data available,66 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026009,GSM5417507,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417507_MS116NAWM_,10x,,35090578,MS,Disease,No,Human,White matter,no data available,Female,no data available,66 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026010,GSM5417508,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417508_MS116LESION_,10x,,35090578,MS,Disease,No,Human,Brain,no data available,Female,no data available,66 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026011,GSM5417509,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417509_MS011NAGM_,10x,,35090578,MS,Disease,No,Human,Gray matter,no data available,Male,no data available,63 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026012,GSM5417510,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417510_MS011NAWM_,10x,,35090578,MS,Disease,No,Human,White matter,no data available,Male,no data available,63 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026013,GSM5417511,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417511_MS011LESION_,10x,,35090578,MS,Disease,No,Human,Brain,no data available,Male,no data available,63 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026014,GSM5417512,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417512_MS043NAGM_,10x,,35090578,MS,Disease,No,Human,Gray matter,no data available,Female,no data available,61 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026015,GSM5417513,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417513_MS043NAWM_,10x,,35090578,MS,Disease,No,Human,White matter,no data available,Female,no data available,61 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026016,GSM5417514,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417514_MS043LESION_,10x,,35090578,MS,Disease,No,Human,Brain,no data available,Female,no data available,61 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026017,GSM5417515,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417515_MS069NAGM_,10x,,35090578,MS,Disease,No,Human,Gray matter,no data available,Female,no data available,67 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026018,GSM5417516,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417516_MS069NAWM_,10x,,35090578,MS,Disease,No,Human,White matter,no data available,Female,no data available,67 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS026019,GSM5417517,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35090578/GSM5417517_MS069LESION_,10x,,35090578,MS,Disease,No,Human,Brain,no data available,Female,no data available,67 years,no data available,10x Genomics,single-cell RNA sequencing,,[Macrophage isolation human] Mechanical tissue dissociation followed by percoll gradient centrifugation. FACS sorting for CD45posCD11Bpos cells.,,,
MS027001,GSM6241065,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36883849/GSM6241065_15454X1_,10x,error,36883849,MS,Disease,No,Mouse,Brain,none,no data available,Experimental Autoimmune Encephalomyelitis (0 dpi),8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"WT, Experimental Autoimmune Encephalomyelitis ","Brain and spinal cord tissues were dissociated using scissors and forceps and processed on ice. After a percoll gradient, cells were stained with DAPI and APC-conjugated CD45 for 15 minutes on ice in PBS containing 2 mM EDTA and 0.5% BSA. Live CD45+ cells were sorted via BD FACSAria cell sorter and washed once in PBS containing 0.04% BSA. Samples were then processed for SCseq via a 10 platform according to the manufacturers instructions (10 Genomics).Single-cell 3' RNA-Sequencing",,,
MS027002,GSM6241066,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36883849/GSM6241066_15454X2_,10x,error,36883849,MS,Disease,No,Mouse,Brain,none,no data available,Experimental Autoimmune Encephalomyelitis (0 dpi),8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"miR-155KO, Experimental Autoimmune Encephalomyelitis ","Brain and spinal cord tissues were dissociated using scissors and forceps and processed on ice. After a percoll gradient, cells were stained with DAPI and APC-conjugated CD45 for 15 minutes on ice in PBS containing 2 mM EDTA and 0.5% BSA. Live CD45+ cells were sorted via BD FACSAria cell sorter and washed once in PBS containing 0.04% BSA. Samples were then processed for SCseq via a 10 platform according to the manufacturers instructions (10 Genomics).Single-cell 3' RNA-Sequencing",,,
MS027003,GSM6241067,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36883849/GSM6241067_15203X1_,10x,error,36883849,MS,Disease,No,Mouse,Brain,none,no data available,Experimental Autoimmune Encephalomyelitis (13 dpi),8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"WT, Experimental Autoimmune Encephalomyelitis ","Brain and spinal cord tissues were dissociated using scissors and forceps and processed on ice. After a percoll gradient, cells were stained with DAPI and APC-conjugated CD45 for 15 minutes on ice in PBS containing 2 mM EDTA and 0.5% BSA. Live CD45+ cells were sorted via BD FACSAria cell sorter and washed once in PBS containing 0.04% BSA. Samples were then processed for SCseq via a 10 platform according to the manufacturers instructions (10 Genomics).Single-cell 3' RNA-Sequencing",,,
MS027004,GSM6241068,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36883849/GSM6241068_15203X2_,10x,error,36883849,MS,Disease,No,Mouse,Brain,none,no data available,Experimental Autoimmune Encephalomyelitis (13 dpi),8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"miR-155KO, Experimental Autoimmune Encephalomyelitis ","Brain and spinal cord tissues were dissociated using scissors and forceps and processed on ice. After a percoll gradient, cells were stained with DAPI and APC-conjugated CD45 for 15 minutes on ice in PBS containing 2 mM EDTA and 0.5% BSA. Live CD45+ cells were sorted via BD FACSAria cell sorter and washed once in PBS containing 0.04% BSA. Samples were then processed for SCseq via a 10 platform according to the manufacturers instructions (10 Genomics).Single-cell 3' RNA-Sequencing",,,
MS027005,GSM6241069,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36883849/GSM6241069_15232X1_,10x,error,36883849,MS,Disease,No,Mouse,Brain,none,no data available,Experimental Autoimmune Encephalomyelitis (21 dpi),8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"WT, Experimental Autoimmune Encephalomyelitis ","Brain and spinal cord tissues were dissociated using scissors and forceps and processed on ice. After a percoll gradient, cells were stained with DAPI and APC-conjugated CD45 for 15 minutes on ice in PBS containing 2 mM EDTA and 0.5% BSA. Live CD45+ cells were sorted via BD FACSAria cell sorter and washed once in PBS containing 0.04% BSA. Samples were then processed for SCseq via a 10 platform according to the manufacturers instructions (10 Genomics).Single-cell 3' RNA-Sequencing",,,
MS027006,GSM6241070,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36883849/GSM6241070_15232X2_,10x,error,36883849,MS,Disease,No,Mouse,Brain,none,no data available,Experimental Autoimmune Encephalomyelitis (21 dpi),8-13 weeks,no data available,10x Genomics,single-cell RNA sequencing,"miR-155KO, Experimental Autoimmune Encephalomyelitis ","Brain and spinal cord tissues were dissociated using scissors and forceps and processed on ice. After a percoll gradient, cells were stained with DAPI and APC-conjugated CD45 for 15 minutes on ice in PBS containing 2 mM EDTA and 0.5% BSA. Live CD45+ cells were sorted via BD FACSAria cell sorter and washed once in PBS containing 0.04% BSA. Samples were then processed for SCseq via a 10 platform according to the manufacturers instructions (10 Genomics).Single-cell 3' RNA-Sequencing",,,
MS029001,GSM7473560,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37934060/GSM7473560_FL_NAIVE_,10x,error,37934060,MS,Healthy,Yes,Mouse,Central nervous system,none,no data available,no data available,8-20 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Bhlhe40fl/fl","Live CD45+ central nervous system cells were FACS sorted from either nave mice or immunized Bhlhe40fl/fl, Cd4-Cre+ Bhlhe40fl/fl, or Il17a-Cre+ Bhlhe40fl/fl mice.10x Genomics protocolsSingle cell libraries were prepared using standard 10x Genomics protocols with the v2 Chromium Single Cell 3' Library Kit.",,,
MS029002,GSM7473561,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37934060/GSM7473561_FL_IMM_,10x,error,37934060,MS,Disease,No,Mouse,Central nervous system,none,no data available,Experimental Autoimmune Encephalomyelitis (14 dpi),8-20 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Cd4-Cre+ Bhlhe40fl/fl, Experimental Autoimmune Encephalomyelitis ","Live CD45+ central nervous system cells were FACS sorted from either nave mice or immunized Bhlhe40fl/fl, Cd4-Cre+ Bhlhe40fl/fl, or Il17a-Cre+ Bhlhe40fl/fl mice.10x Genomics protocolsSingle cell libraries were prepared using standard 10x Genomics protocols with the v2 Chromium Single Cell 3' Library Kit.",,,
MS029003,GSM7473562,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37934060/GSM7473562_Cd4Cre_IMM_,10x,error,37934060,MS,Disease,No,Mouse,Central nervous system,none,no data available,Experimental Autoimmune Encephalomyelitis (14 dpi),8-20 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Cd4-Cre+ Bhlhe40fl/fl, Experimental Autoimmune Encephalomyelitis ","Live CD45+ central nervous system cells were FACS sorted from either nave mice or immunized Bhlhe40fl/fl, Cd4-Cre+ Bhlhe40fl/fl, or Il17a-Cre+ Bhlhe40fl/fl mice.10x Genomics protocolsSingle cell libraries were prepared using standard 10x Genomics protocols with the v2 Chromium Single Cell 3' Library Kit.",,,
MS029004,GSM7473563,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37934060/GSM7473563_Il17aCre_IMM_,10x,error,37934060,MS,Disease,No,Mouse,Central nervous system,none,no data available,Experimental Autoimmune Encephalomyelitis (14 dpi),8-20 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Cd4-Cre+ Bhlhe40fl/fl, Experimental Autoimmune Encephalomyelitis ","Live CD45+ central nervous system cells were FACS sorted from either nave mice or immunized Bhlhe40fl/fl, Cd4-Cre+ Bhlhe40fl/fl, or Il17a-Cre+ Bhlhe40fl/fl mice.10x Genomics protocolsSingle cell libraries were prepared using standard 10x Genomics protocols with the v2 Chromium Single Cell 3' Library Kit.",,,
MS030001,GSM5975315,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35705491/GSM5975315_,10x_matrix,,35705491,MS,Disease,No,Mouse,Brain ,none,no data available,no data available,5-6 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6 WT, Cuprizone Model","Cuprizone 0.2% diet was given to 5-6weeks old mice for 5 weeksscRNA libraries were generated using the GemCode Single- Cell Instrument (10x Genomics, Pleasanton, CA, USA) and Single Cell 3 Library & Gel Bead Kit v2 and Chip Kit (P/N 120236 P/N 120237 10x Genomics). The sequencing ready libraries were purified with SPRIselect, quality controlled for sized distribution and yield (LabChip GX Perkin Elmer), and quantified using qPCR (KAPA Biosystems Library Quantification Kit for Illumina platforms P/N KK4824) as previously described(Couturier et al., 2020). Libraries were subsequently shipped and sequenced using Illumina NovaSeq6000 at IGM Genomics Center, UCSD, San Diego, CA.",,5 week Cuprizone 0.2% diet,
MS030002,GSM5975316,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35705491/GSM5975316_,10x_matrix,,35705491,MS,Disease,No,Mouse,Brain ,none,no data available,no data available,5-6 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6 WT, Cuprizone Model","Cuprizone 0.2% diet was given to 5-6weeks old mice for 5 weeksscRNA libraries were generated using the GemCode Single- Cell Instrument (10x Genomics, Pleasanton, CA, USA) and Single Cell 3 Library & Gel Bead Kit v2 and Chip Kit (P/N 120236 P/N 120237 10x Genomics). The sequencing ready libraries were purified with SPRIselect, quality controlled for sized distribution and yield (LabChip GX Perkin Elmer), and quantified using qPCR (KAPA Biosystems Library Quantification Kit for Illumina platforms P/N KK4824) as previously described(Couturier et al., 2020). Libraries were subsequently shipped and sequenced using Illumina NovaSeq6000 at IGM Genomics Center, UCSD, San Diego, CA.",,5 week Cuprizone 0.2% diet,
MS030003,GSM5975317,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35705491/GSM5975317_,10x_matrix,,35705491,MS,Disease,No,Mouse,Brain ,none,no data available,no data available,5-6 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6 PRMT1-KO, Cuprizone Model","Cuprizone 0.2% diet was given to 5-6weeks old mice for 5 weeksscRNA libraries were generated using the GemCode Single- Cell Instrument (10x Genomics, Pleasanton, CA, USA) and Single Cell 3 Library & Gel Bead Kit v2 and Chip Kit (P/N 120236 P/N 120237 10x Genomics). The sequencing ready libraries were purified with SPRIselect, quality controlled for sized distribution and yield (LabChip GX Perkin Elmer), and quantified using qPCR (KAPA Biosystems Library Quantification Kit for Illumina platforms P/N KK4824) as previously described(Couturier et al., 2020). Libraries were subsequently shipped and sequenced using Illumina NovaSeq6000 at IGM Genomics Center, UCSD, San Diego, CA.",,5 week Cuprizone 0.2% diet,
MS030004,GSM5975318,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID35705491/GSM5975318_,10x_matrix,,35705491,MS,Disease,No,Mouse,Brain ,none,no data available,no data available,5-6 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6 PRMT1-KO, Cuprizone Model","Cuprizone 0.2% diet was given to 5-6weeks old mice for 5 weeksscRNA libraries were generated using the GemCode Single- Cell Instrument (10x Genomics, Pleasanton, CA, USA) and Single Cell 3 Library & Gel Bead Kit v2 and Chip Kit (P/N 120236 P/N 120237 10x Genomics). The sequencing ready libraries were purified with SPRIselect, quality controlled for sized distribution and yield (LabChip GX Perkin Elmer), and quantified using qPCR (KAPA Biosystems Library Quantification Kit for Illumina platforms P/N KK4824) as previously described(Couturier et al., 2020). Libraries were subsequently shipped and sequenced using Illumina NovaSeq6000 at IGM Genomics Center, UCSD, San Diego, CA.",,5 week Cuprizone 0.2% diet,
MS031001,GSM4104122,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104122_MS19270_CSF_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Cerebrospinal fluid,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031002,GSM4104123,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104123_MS58637_CSF_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Cerebrospinal fluid,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031003,GSM4104124,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104124_MS71658_CSF_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Cerebrospinal fluid,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031004,GSM4104125,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104125_MS49131_CSF_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Cerebrospinal fluid,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031005,GSM4104126,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104126_MS60249_CSF_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Cerebrospinal fluid,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031006,GSM4104127,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104127_MS74594_CSF_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Cerebrospinal fluid,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031007,GSM4104134,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104134_MS19270_PBMCs_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Peripheral blood mononuclear cell,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031008,GSM4104135,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104135_MS71658_PBMCs_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Peripheral blood mononuclear cell,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031009,GSM4104136,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104136_MS49131_PBMCs_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Peripheral blood mononuclear cell,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031010,GSM4104137,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104137_MS60249_PBMCs_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Peripheral blood mononuclear cell,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS031011,GSM4104138,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID31937773/GSM4104138_MS74594_PBMCs_GRCh38_,10x_matrix,,31937773,MS,Disease,No,Human,Peripheral blood mononuclear cell,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"Patient Inclusion Criterior: 1) treatment naive patients with a first episode suggestive of MS (i.e. clinically isolated syndrome (CIS)) or with relapsing-remitting (RR)MS diagnosed based on MAGNIMS criteria86, 2) patients receiving LP for diagnostic purposes and consenting to participate.Patient Exclusion Criterior: 1) questionable diagnosis of MS by clinical signs or magnetic resonance imaging (MRI) findings, 2) secondary chronic progressive MS or primary progressive MS. IIH patients were included, if they gave informed consent. Exclusion criteria for all patients were: 1) immunologically relevant co-morbidities (e.g. rheumatologic diseases), 2) severe concomitant infectious diseases (e.g. HIV, meningitis, encephalitis), 3) pregnancy or breastfeeding, 4) younger than 18 years, 5) mental illness impairing the ability to give informed consent, 6) artificial blood contamination during the lumbar puncture resulting in >200 red blood cells / l.Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2AMPure beads (Beckman Coulter) Illumina Nextseq 500 using the High-Out 75 cycle kit with a 26-8-0-57 read setup",,,
MS032001,GSM5677715,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677715_batch1_SPL_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Spleen,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032002,GSM5677716,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677716_batch1_MLN_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Mesenteric lymph nodes,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032003,GSM5677717,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677717_batch1_PP_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Peyer's patches,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032004,GSM5677718,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677718_batch1_SI_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Small intestine,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032005,GSM5677719,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677719_batch1_COL_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Colon,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032006,GSM5677720,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677720_batch2_SPL_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Spleen,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032007,GSM5677721,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677721_batch2_SPL_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Spleen,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032008,GSM5677722,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677722_batch2_MLN_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Mesenteric lymph nodes,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032009,GSM5677723,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677723_batch2_PP_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Peyer's patches,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032010,GSM5677724,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677724_batch2_PP_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Peyer's patches,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032011,GSM5677725,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677725_batch2_SI_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Small intestine,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032012,GSM5677726,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677726_batch2_COL_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Colon,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032013,GSM5677727,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677727_batch2_COL_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Colon,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032014,GSM5677728,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677728_batch2_CNS_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Central nervous system,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032015,GSM5677729,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677729_batch3_SPL_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Spleen,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032016,GSM5677730,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677730_batch3_SPL_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Spleen,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032017,GSM5677731,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677731_batch3_SI_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Small intestine,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032018,GSM5677732,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677732_batch3_SI_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Small intestine,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032019,GSM5677733,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677733_batch3_COL_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,No,Mouse,Colon,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032020,GSM5677734,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677734_batch3_COL_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Colon,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032021,GSM5677735,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677735_batch3_CNS_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Central nervous system,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032022,GSM5677736,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677736_batch4_MLN_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Mesenteric lymph nodes,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032023,GSM5677737,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677737_batch4_PP_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Peyer's patches,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032024,GSM5677738,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677738_batch4_SI_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Small intestine,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032025,GSM5677739,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677739_batch4_SI_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Small intestine,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032026,GSM5677740,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677740_batch4_COL_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,No,Mouse,Colon,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032027,GSM5677741,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677741_batch4_COL_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Colon,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032028,GSM5677742,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677742_batch4_CNS_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Central nervous system,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032029,GSM5677743,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677743_batch5_MLN_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Mesenteric lymph nodes,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032030,GSM5677744,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677744_batch5_MLN_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Mesenteric lymph nodes,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032031,GSM5677745,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677745_batch5_PP_UT_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,Peyer's patches,no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032032,GSM5677746,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677746_batch5_PP_EAE_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,Peyer's patches,no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032033,GSM5677747,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677747_batch6_hashed_EAE_mouse1_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon, central nervous system, inguinal draining lymph nodes ",no data available,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032034,GSM5677750,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677750_batch6_hashed_EAE_mouse2_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon, central nervous system, inguinal draining lymph nodes ",Experimental Autoimmune Encephalomyelitis,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032035,GSM5677753,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677753_batch7_hashed_EAE_mouse1_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon, central nervous system, inguinal draining lymph nodes ",Experimental Autoimmune Encephalomyelitis,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032036,GSM5677756,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677756_batch7_hashed_EAE_mouse2_GFP_raw_,10x_matrix,,34875227,MS,Disease,No,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon, central nervous system, inguinal draining lymph nodes ",Experimental Autoimmune Encephalomyelitis,no data available,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Il17aCreGFP X Rosa26tdTomato, Experimental Autoimmune Encephalomyelitis","For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032037,GSM5677759,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677759_batch8_hashed_UT_mouse1_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon",no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032038,GSM5677762,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677762_batch8_hashed_UT_mouse2_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon",no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032039,GSM5677765,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677765_batch9_hashed_UT_mouse1_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon",no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS032040,GSM5677768,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID34875227/GSM5677768_batch9_hashed_UT_mouse2_GFP_raw_,10x_matrix,,34875227,MS,Healthy,Yes,Mouse,"Spleen, mesenteric lymph nodes, Peyers patches, small intestine, colon",no data available,Female,no data available,8-12 weeks,no data available,10x Genomics,single-cell RNA sequencing,Il17aCreGFP X Rosa26tdTomato,"For tissue harvest, mice were perfused intracardially with cold PBS. Lymphoid tissues, spleen and mesenteric lymph nodes were harvested and smashed through 40 um sterile strainers. ACK lysis (Buffer from Lonza) was performed with the spleen for 5 min at RT. Peyers patches were digested for 20 min at 37C in a water bath in digestion buffer (5% fetal bovine serum, 50 g/ml DNase I (Sigma Aldrich), 1 mg/ml Collagenase Type VIII (Sigma Aldrich), 2 mM CaCl2 (Sigma Aldrich), 5 mM MgCl2 (Sigma Aldrich) in RPMI 1640 medium (Thermo Fisher Scientific)) and smashed through a 40 um sterile strainer. To isolate cells from the small intestine and the colon, intestinal tissues were harvested and cleaned. Epithelial cells and intraepithelial lymphocytes were removed by incubating the tissues for 20 min at 37C with constant stirring at 350 rpm in extraction buffer (5% fetal bovine serum, 1 mM DTT (Thermo Fischer Scientific), 5 mM EDTA (Thermo Fisher Scientific) in RPMI 1640 medium (Thermo Fisher Scientific)). Tissues were minced and incubated in digestion buffer for 40 min at 37C with constant stirring at 550 rpm and smashed through a 40 um sterile strainer. To isolate CNS-infiltrating lymphocytes from EAE mice, brain and spinal cord were flushed out with PBS by hydrostatic pressure. The CNS was minced and digested in 2.5 mg/ml Collagenase D (Roche Diagnostics) in RPMI 1640 medium (Thermo Fisher Scientific) for 20 min at 37C. Cells were smashed through a 40 um sterile cell strainer and mononuclear cells were enriched on a discontinuous (37% and 70%) Percoll gradient (Cytiva). After tissue cell isolation, cells were stained for flow cytometry. Single-cell suspensions were stained in flow buffer (2% fetal bovine serum in PBS) with antibodies for surface proteins. Viable CD4+ TCR+ tdTomato+ tissue Th17 cells were sorted by FACS for sequencing. Cell hashing was performed with samples for scRNA/TCR-Seq in order to process all tissues of one mouse together in one 10x channel. After the sort, cells were resuspended in flow buffer with the TotalSeqTM-antibody pool (Biolegend) at 1:1000 final dilution for each antibody, followed by incubation for 30 min on ice. Next, cells were washed for a total of three washes with flow buffer. Samples for scRNA/TCR-Seq with 5' feature barcoding were then separated into droplet emulsions using the Chromium Single Cell 5' V2 Solution, according to manufacturers instructions (10x Genomics). For samples that did not include scTCR-seq and 5' feature barcoding, sorted cells were separated into droplet emulsions using the Chromium Single Cell 3 Solution (v2 or v3) according to manufacturers instructions (10x Genomics).ScRNA-seq, scTCR-seq and 5' feature barcoding library preparations were performed according to manufacturers instructions (10x Genomics). Single Cell 3' v2 chemistry was used for non-cell-hashing samples (batch 1-5), and Single Cell 5' chemistry was used for cell-hashing samples (batch6-9).",,,
MS033001,GSM3529822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529822_MS_case1_3.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033002,GSM3529823,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529823_MS_case1_4.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033003,GSM3529824,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529824_MS_case1_Pl1_1_9.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033004,GSM3529825,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529825_MS_case1_Pl1_2_10.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033005,GSM3529826,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529826_MS_case1_Pl2_1_9.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033006,GSM3529827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529827_MS_case1_Pl2_2_10.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033008,GSM3529828,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529828_MS_case2_Plate1_1_3.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Frontal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033009,GSM3529829,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529829_MS_case2_Plate1_2_4.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Frontal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033010,GSM3529830,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529830_MS_case2_Plate2_1_7.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Frontal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033011,GSM3529831,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529831_MS_case2_Plate2_2_8.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Frontal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033012,GSM3529832,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529832_MS_case4_18_Plate1_2.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033013,GSM3529833,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529833_MS_case4_18_Plate2_1.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033014,GSM3529834,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529834_MS_case4_18_Plate2_2.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033015,GSM3529835,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529835_MS_case5_18_Plate1_2.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033016,GSM3529836,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529836_MS_case5_18_Plate2_1.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,Disease,No,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033017,GSM3529837,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529837_MS_case5_18_Plate2_2.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Parietal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033018,GSM3529838,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529838_Pat1_GM_1_5.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033019,GSM3529839,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529839_Pat1_GM_2_6.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033020,GSM3529840,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529840_Pat1_WM_1_11.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033021,GSM3529841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529841_Pat1_WM_1_12.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033022,GSM3529842,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529842_Pat2_GM_2_2.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033024,GSM3529843,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529843_Pat2_WM_1_3.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033025,GSM3529844,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529844_Pat2_WM_2_4.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033026,GSM3529845,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529845_Pat3_GM_1_5.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033027,GSM3529846,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529846_Pat3_GM_2_6.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033028,GSM3529847,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529847_Pat3_WM_2_8.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033029,GSM3529848,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529848_Pat4_Pl1_1_5.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033030,GSM3529849,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529849_Pat4_Pl1_2_6.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033031,GSM3529850,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529850_Pat4_Pl2_1_7.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033032,GSM3529851,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529851_Pat4_Pl2_1_8.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033033,GSM3529852,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529852_Pat5_1_1.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS033034,GSM3529853,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID30760929/GSM3529853_Pat5_2_2.coutt.csv.gz,csv.gz,index 0 is out of bounds for axis 0 with size 0,30760929,MS,non-MS control,Yes,Human,Temporal lobe,no data available,no data available,no data available,no data available,no data available,mCEL-Seq2,single-cell RNA sequencing,,"All subjects underwent brain surgery, the healthy samples were located at least 2 cm from the lesion the patients underwent surgery for; the MS samples were taken from the center of an active lesionIsolated myeloid cells were stained with antibodies for surface markers (CD45, CD3, CD19, CD20). All CD45+ cells were FACS-sorted in 384-well plates.As described in mCEL-Seq2 protocol (Hashimshony et al. 2016 and Herman et al. 2018)Adapted from TruSeq Small RNA Library Preparation Protocol",,,
MS036001,GSM3993135,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33526922/GSM3993135_WholeEAE.txt.gz,txt.gz,,33526922,MS,Disease,No,Mouse,Spinal cord,none,no data available,no data available,2-6 months,no data available,10x Genomics,single-cell RNA sequencing,"C57/BL6, Experimental Autoimmune Encephalomyelitis",Spinal cords were dissociated using both chemical and mechanical dissociation methods and single cells were sorted using FACS sortingRNA libraries were prepared for sequencing using the 10x Genomics v2 standard protocols,,,
MS036002,GSM3993136,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33526922/GSM3993136_Healthy1.txt.gz,txt.gz,,33526922,MS,Healthy,Yes,Mouse,Spinal cord,none,no data available,no data available,2-6 months,no data available,10x Genomics,single-cell RNA sequencing,Col1a1GFP; C57/BL6 background,Spinal cords were dissociated using both chemical and mechanical dissociation methods and single cells were sorted using FACS sortingRNA libraries were prepared for sequencing using the 10x Genomics v2 standard protocols,,,
MS036003,GSM3993137,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33526922/GSM3993137_Healthy2.txt.gz,txt.gz,,33526922,MS,Healthy,Yes,Mouse,Spinal cord,none,no data available,no data available,2-6 months,no data available,10x Genomics,single-cell RNA sequencing,Col1a1GFP; C57/BL6 background,Spinal cords were dissociated using both chemical and mechanical dissociation methods and single cells were sorted using FACS sortingRNA libraries were prepared for sequencing using the 10x Genomics v2 standard protocols,,,
MS036004,GSM3993138,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33526922/GSM3993138_EAE.txt.gz,txt.gz,,33526922,MS,Disease,No,Mouse,Spinal cord,none,no data available,no data available,2-6 months,no data available,10x Genomics,single-cell RNA sequencing,"Col1a1GFP; C57/BL6 background, Experimental Autoimmune Encephalomyelitis",Spinal cords were dissociated using both chemical and mechanical dissociation methods and single cells were sorted using FACS sortingRNA libraries were prepared for sequencing using the 10x Genomics v2 standard protocols,,,
MS036005,GSM4751220,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33526922/GSM4751220_health3.txt.gz,txt.gz,,33526922,MS,Healthy,Yes,Mouse,Spinal cord,none,no data available,no data available,2-6 months,no data available,10x Genomics,single-cell RNA sequencing,Col1a1GFP; C57/BL6 background,Spinal cords were dissociated using both chemical and mechanical dissociation methods and single cells were sorted using FACS sortingRNA libraries were prepared for sequencing using the 10x Genomics v2 standard protocols,,,
MS036006,GSM4751221,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33526922/GSM4751221_EAE2.txt.gz,txt.gz,,33526922,MS,Disease,No,Mouse,Spinal cord,none,no data available,no data available,2-6 months,no data available,10x Genomics,single-cell RNA sequencing,"Col1a1GFP; C57/BL6 background, Experimental Autoimmune Encephalomyelitis",Spinal cords were dissociated using both chemical and mechanical dissociation methods and single cells were sorted using FACS sortingRNA libraries were prepared for sequencing using the 10x Genomics v2 standard protocols,,,
MS037001,GSM7660669,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660669_HC01_,10x_matrix,,39191254,MS,Healthy,Yes,Human,iPSC-derived culture,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037002,GSM7660670,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660670_HC02_,10x_matrix,,39191254,MS,Healthy,Yes,Human,iPSC-derived culture,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037003,GSM7660671,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660671_HC03_,10x_matrix,,39191254,MS,Healthy,Yes,Human,iPSC-derived culture,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037004,GSM7660672,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660672_HC04_,10x_matrix,,39191254,MS,Healthy,Yes,Human,iPSC-derived culture,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037005,GSM7660673,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660673_RR01_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Relapsing remitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037006,GSM7660674,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660674_RR02_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Relapsing remitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037007,GSM7660675,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660675_RR03_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Relapsing remitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037008,GSM7660676,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660676_RR04_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Relapsing remitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037009,GSM7660677,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660677_SP01_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Secondary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037010,GSM7660678,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660678_SP02_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Secondary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037011,GSM7660679,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660679_SP03_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Secondary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037012,GSM7660680,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660680_SP04_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Secondary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037013,GSM7660681,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660681_PP01_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Primary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037014,GSM7660682,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660682_PP02_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Primary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037015,GSM7660683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660683_PP03_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Primary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS037016,GSM7660684,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39191254/GSM7660684_PP04_,10x_matrix,,39191254,MS,Disease,No,Human,iPSC-derived culture,no data available,no data available,Primary progressive,no data available,no data available,10x Genomics,single-cell RNA sequencing,iPSC,Day 85 cultures from 16 lines were detached enzymatically in parallel using papain (Worthington; LK003153) and were filtered through 40m Flowmi Cell Strainers (Scienceware; H13680-0040) to obtain a single cell suspension. The ran on a 10x Chromium Controller followed by RNA extraction in GEMs according to manufacturer's instructions (10x Genomics Single Cell 3' v3)Library was prepared according to manufacturer's instructions (10x Genomics Single Cell 3' v3),,,
MS038001,GSM6437085,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS001,10x,,39256571,MS,Non-MS control,Yes,Mouse,Spinal cord,none,Female,no data available,10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038002,GSM6437086,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS002,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038003,GSM6437087,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS003,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (28 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038004,GSM6437088,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS004,10x,,39256571,MS,Non-MS control,Yes,Mouse,Spinal cord,none,Female,no data available,10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038005,GSM6437089,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS005,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038006,GSM6437090,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS006,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (28 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038007,GSM6437091,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS007,10x,,39256571,MS,Healthy,Yes,Mouse,Spinal cord,none,Female,no data available,10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038008,GSM6437092,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS008,10x,,39256571,MS,Healthy,Yes,Mouse,Spinal cord,none,Female,no data available,10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038009,GSM6437093,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS009,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (28 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038010,GSM6437094,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS010,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (28 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038011,GSM6437095,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS011,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038012,GSM6437096,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS012,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038013,GSM6437097,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS013,10x,,39256571,MS,Healthy,Yes,Mouse,Spinal cord,none,Female,no data available,10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038014,GSM6437098,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/DS014,10x,,39256571,MS,Non-MS control,Yes,Mouse,Spinal cord,none,Female,no data available,10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038015,GSM6437099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/BEVAC001,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,5 mg/kg Bevacizumab,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038016,GSM6437100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/BEVAC002,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,5 mg/kg Bevacizumab,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038017,GSM6437101,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/BEVAC003,10x,,39256571,MS,Disease,No,Mouse,Spinal cord,5 mg/kg Bevacizumab,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038018,GSM7912367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/GSM7912367_DSA003_raw_feature_bc_matrix.h5,h5,,39256571,MS,Disease,No,Mouse,Spinal cord,IgG (immunoglobulin G),Female,Experimental Autoimmune Encephalomyelitis (6 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038019,GSM7912368,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/GSM7912368_DSA004_raw_feature_bc_matrix.h5,h5,,39256571,MS,Disease,No,Mouse,Spinal cord,IgG (immunoglobulin G),Female,Experimental Autoimmune Encephalomyelitis (6 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038020,GSM7912369,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/GSM7912369_DSA005_raw_feature_bc_matrix.h5,h5,,39256571,MS,Disease,No,Mouse,Spinal cord,IgG (immunoglobulin G),Female,Experimental Autoimmune Encephalomyelitis (6 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038021,GSM7912370,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/GSM7912370_DSA006_raw_feature_bc_matrix.h5,h5,,39256571,MS,Disease,No,Mouse,Spinal cord,5 mg/kg r84,Female,Experimental Autoimmune Encephalomyelitis (6 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038022,GSM7912371,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/GSM7912371_DSA007_raw_feature_bc_matrix.h5,h5,,39256571,MS,Disease,No,Mouse,Spinal cord,5 mg/kg r84,Female,Experimental Autoimmune Encephalomyelitis (6 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS038023,GSM7912372,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39256571/GSM7912372_DSA008_raw_feature_bc_matrix.h5,h5,,39256571,MS,Disease,No,Mouse,Spinal cord,5 mg/kg r84,Female,Experimental Autoimmune Encephalomyelitis (6 dpi),10-12 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, TCF/LEF1::H2B::eGFP, Experimental Autoimmune Encephalomyelitis + Complete Freund's adjuvant + Pertussis Toxin","The neural dissociation kit (P) was used to dissociate the spinal cords into a single cell suspension. Following myelin removal using Miltenyi Biotec Myelin Removal Beads II, the samples were stained with CD31-APC and PI, and live endothelial cells were FACS sorted for single cell RNA sequencing",,,
MS039001,GSM7328912,,,csv,37709997,MS,Mixed,Mixed,Human,Blood,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"After collection of blood into tubes containing EDTA, samples were diluted 1:1 with PBS and added to a SepMate tube containing human Pancoll. During centrifugation (1200 g for 10 min at 4C) PBMCs were isolated by density gradient. The isolated cells in plasma were transferred to a tube and centrifuged again at 300g 10 min at 4C. The isolated PBMCs were either used freshly or cryopreserved in liquid nitrogen, using serum-free cryopreservation medium (CTL-Cryo ABC Media Kit, Immunospot). For analysis, samples were thawed quickly, washed twice with 1% BSA/PBS (300g for 10min at 4C) and labelled using the following procedure: 10min at 4C with Fc-block (Miltenyi) at 1/50 dilution in FACS buffer (PBS + 2% FBS), followed by the surface antibody mix. The mix comprised: ThermoFisher anti-human CD45RO-FITC (1:40), CCR7-APC (1:40), CD3-AF700 (1:50), Fixable Viability Dye eFluor 780 at 1:1000, CD4-Pacific Blue (1:25) and BioLegend: CD8-PerCP (1:25), in a total volume of 100l FACS buffer and incubated for 30 min at 4C. Antigen-experienced CD4+ T cells consisting of CD3+CD4+CD8- effector memory (CD45RO+CCR7-), effector (CD45RO-CCR7-) and central memory (CD45RO+CCR7+) cells were collected using a FACS Aria Fusion flow cytometer (BD Biosciences). After, cells were washed in 0.04% BSA/PBS and approximately 16,500 cells per sample were loaded onto the 10x Chip.Further processing followed the manufacturer's protocol using the Chromium Next GEM Single Cell VDJ v1.1. For CSF samples, the Feature Barcoding technology for Cell Surface Protein steps were also performed. Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150 bp read 1, 8 bp i7 index, 150 bp read 2",,,
MS039002,GSM7328913,,,csv,37709997,MS,Mixed,Mixed,Human,Cerebrospinal fluid,no data available,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"After collection of blood into tubes containing EDTA, samples were diluted 1:1 with PBS and added to a SepMate tube containing human Pancoll. During centrifugation (1200 g for 10 min at 4C) PBMCs were isolated by density gradient. The isolated cells in plasma were transferred to a tube and centrifuged again at 300g 10 min at 4C. The isolated PBMCs were either used freshly or cryopreserved in liquid nitrogen, using serum-free cryopreservation medium (CTL-Cryo ABC Media Kit, Immunospot). For analysis, samples were thawed quickly, washed twice with 1% BSA/PBS (300g for 10min at 4C) and labelled using the following procedure: 10min at 4C with Fc-block (Miltenyi) at 1/50 dilution in FACS buffer (PBS + 2% FBS), followed by the surface antibody mix. The mix comprised: ThermoFisher anti-human CD45RO-FITC (1:40), CCR7-APC (1:40), CD3-AF700 (1:50), Fixable Viability Dye eFluor 780 at 1:1000, CD4-Pacific Blue (1:25) and BioLegend: CD8-PerCP (1:25), in a total volume of 100l FACS buffer and incubated for 30 min at 4C. Antigen-experienced CD4+ T cells consisting of CD3+CD4+CD8- effector memory (CD45RO+CCR7-), effector (CD45RO-CCR7-) and central memory (CD45RO+CCR7+) cells were collected using a FACS Aria Fusion flow cytometer (BD Biosciences). After, cells were washed in 0.04% BSA/PBS and approximately 16,500 cells per sample were loaded onto the 10x Chip.Further processing followed the manufacturer's protocol using the Chromium Next GEM Single Cell VDJ v1.1. For CSF samples, the Feature Barcoding technology for Cell Surface Protein steps were also performed. Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150 bp read 1, 8 bp i7 index, 150 bp read 2",,,
MS041001,GSM7421795,,,tsv,39121861,MS,Healthy,No,Human,hipSC-derived forebrain organoids,none,Female,no data available,35 years,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Exposed to inflamed cerebrospinal fluid (CSF) from MS patients","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041002,GSM7421796,,,tsv,39121861,MS,Healthy ,Yes,Human,hipSC-derived forebrain organoids,none,Female,no data available,35 years,no data available,10x Genomics,single-cell RNA sequencing,hiPSC,"For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041003,GSM7421797,,,tsv,39121861,MS,Disease,No,Human,hipSC-derived forebrain organoids,none,Female,Relapsing MS,32 years,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Expressing SOX10-eGFP, Exposed to inflamed cerebrospinal fluid (CSF) from MS patients","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041004,GSM7421798,,,tsv,39121861,MS,Disease ,No,Human,hipSC-derived forebrain organoids,none,Female,Relapsing MS,32 years,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Expressing SOX10-eGFP","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041005,GSM7421799,,,tsv,39121861,MS,Mixed ,No,Human,hipSC-derived forebrain organoids,none,Mixed ,Mixed,Mixed,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Expressing SOX10-eGFP, no doxycycline","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041006,GSM7421800,,,tsv,39121861,MS,Healthy,No,Human,hipSC-derived forebrain organoids,none,Female ,no data available,32 years,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Expressing SOX10-eGFP, incorporating iPSC-derived human microglia","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041007,GSM7421801,,,tsv,39121861,MS,Disease,No,Human,hipSC-derived forebrain organoids,none,Male,Relapsing MS,35 years,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Expressing SOX10-eGFP, incorporating iPSC-derived human microglia","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041008,GSM7421802,,,tsv,39121861,MS,Healthy,No,Human,hipSC-derived forebrain organoids,none,Female,no data available,32 years,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Expressing SOX10-eGFP, incorporating iPSC-derived human microglia, Exposed to inflamed cerebrospinal fluid (CSF) from MS patients","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS041009,GSM7421803,,,tsv,39121861,MS,Disease,No,Human,hipSC-derived forebrain organoids,none,Female ,Relapsing MS,35 years,no data available,10x Genomics,single-cell RNA sequencing,"hiPSC, Expressing SOX10-eGFP, incorporating iPSC-derived human microglia, Exposed to inflamed cerebrospinal fluid (CSF) from MS patients","For the enzymatic cellular dissociation, 30 organoids, for each experiment, were first washed in Hanks balanced salt solution (HBSS) and, then, incubated with a freshly prepared dissociation solution (HBSS, papain and DNAase I) for 45 min at 37C on an orbital shaker (90 rpm), and gently triturated using a P1000 pipette. Cells were incubated again for 15 min at 37C on an orbital shaker (90 rpm) centrifuged and gently triturated using a P1000 pipette. After the single cell dissociation, the cell suspension was mixed (1:1) with 10 mg/mL ovomucoid protease inhibitor solution and centrifuged at 300g for 5 min. The pellet was resuspended in 1X PBS containing BSA (1:50). Cells were counted using trypan blue and a haemocytometer under bright field. A yield of 7001,200 cells per L per sample was targeted.Library was performed according to the manufacters instructions (single cell 3 v3 protocol, 10x Genomics). Briefly, GCs were resuspended in the master mix and loaded together with partitioning oil and gel beads into the chip to generate the gel bead-in-emulsion (GEM). The poly-A RNA from the cell lysate contained in every single GEM was retrotranscripted to cDNA, which contains an Ilumina R1 primer sequence, Unique Molecular Identifier (UMI) and the 10x Barcode. The pooled barcoded cDNA was then cleaned up with Silane DynaBeads, amplified by PCR and the apropiated sized fragments were selected with SPRIselect reagent for subsequent library construction. During the library construction Ilumina R2 primer sequence, paired-end constructs with P5 and P7 sequences and a sample index were added.",,,
MS042001,GSM8541677,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042002,GSM8541678,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042003,GSM8541679,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042004,GSM8541680,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042005,GSM8541681,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042006,GSM8541682,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042007,GSM8541683,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042008,GSM8541684,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042009,GSM8541685,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042010,GSM8541686,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042011,GSM8541687,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042012,GSM8541688,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042013,GSM8541689,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042014,GSM8541690,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042015,GSM8541691,,,rds,39446583,MS,Healthy,Yes,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6,"Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042016,GSM8541692,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042017,GSM8541693,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042018,GSM8541694,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042019,GSM8541695,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042020,GSM8541696,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042021,GSM8541697,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042022,GSM8541698,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042023,GSM8541699,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042024,GSM8541700,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042025,GSM8541701,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042026,GSM8541702,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042027,GSM8541703,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042028,GSM8541704,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042029,GSM8541705,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042030,GSM8541706,,,rds,39446583,MS,Disease,No,Mouse,Cortex,none,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model, Saline-treated","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042031,GSM8541707,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042032,GSM8541708,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042033,GSM8541709,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042034,GSM8541710,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042035,GSM8541711,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042036,GSM8541712,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042037,GSM8541713,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042038,GSM8541714,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042039,GSM8541715,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042040,GSM8541716,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042041,GSM8541717,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042042,GSM8541718,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042043,GSM8541719,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042044,GSM8541720,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS042045,GSM8541721,,,rds,39446583,MS,Disease,No,Mouse,Cortex,XPro1595,Male,no data available,8-10 weeks,no data available,10x Genomics,single-nucleus RNA sequencing,"C57BL/6, Cuprizone model","Brain cortex tissue was suspended in 500 L homogenization buffer (Nuclei Isolation Kit, Sigma-Aldrich, NUC201) and homogenised in a pre-cooled 2 mL dounce homogeniser. The homogenate was filtered through a cell strainer cap (70M) and centrifuged at 600g for 5 min. Thereafter, nuclei were subjected to an additional clean-up step by resuspending in freshly prepared nuclei wash buffer and density centrifugation for the gradient of the layered nuclei/29% iodixanol solution at 5000g for 15 mins at 4 C. Nuclei pellets were collected. SnRNA-Seq performed in samples processed as per 10 Genomics Chromium Single Cell Reagent Kits Protocol (chemistry: Single Cell 3 v2). The samples were processed to target 10,000 nuclei per sample.SnRNA-Seq was performed according to the manufacturers instructions (10 Genomics Chromium Single Cell 3' v3). The samples were processed to target 10,000 nuclei per sample. Briefly, 12 cycles of cDNA amplification were performed, and 12 cycles of final indexing PCR. cDNA concentrations were measured using Qubit dsDNA HS Assay Kit (ThermoFisher, Q32851). cDNA and library preparations were assessed using the Bioanalyzer High-Sensitivity DNA Kit. All samples were pooled to equimolar concentration and sequenced together on an Illumina NovaSeq 6000.",,,
MS046001,GSM4743024,,,,34099917,MS,Disease,No,Mouse,photoconverted CD4+ T cells isolated from inguinal lymph node + mesenteric lymph node + spleen + brain,none,no data available,no data available,post natal 8 to 12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Two single-cell RNA experiments were performed. In the first, scRNA-seq and Cell Hashing libraries were prepared using the 10x Chromium Single Cell 3' Solution (Chromium Single Cell 3' v3 combined with Cell Hashing as per established protocols (doi: 10.1186/s13059-018-1603-1). In the second, scRNA-seq, scTCR-seq and Cell Hashing libraries were prepared using the 10x Chromium Single Cell 5' Solution (Chromium Next GEM Single Cell VDJ v1.1 with Feature Barcoding technology for Cell Surface Protein)",,,
MS046003,GSM4743026,,,,34099917,MS,Disease,No,Mouse,photoconverted CD4+ T cells isolated from inguinal lymph node + spleen + brain,none,no data available,no data available,post natal 8 to 12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Two single-cell RNA experiments were performed. In the first, scRNA-seq and Cell Hashing libraries were prepared using the 10x Chromium Single Cell 3' Solution (Chromium Single Cell 3' v3 combined with Cell Hashing as per established protocols (doi: 10.1186/s13059-018-1603-1). In the second, scRNA-seq, scTCR-seq and Cell Hashing libraries were prepared using the 10x Chromium Single Cell 5' Solution (Chromium Next GEM Single Cell VDJ v1.1 with Feature Barcoding technology for Cell Surface Protein)",,,
MS046006,GSM4743029,,,,34099917,MS,Disease,No,Mouse,photoconverted CD4+ T cells isolated from mesenteric lymph node + spleen + brain,none,no data available,no data available,post natal 8 to 12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Two single-cell RNA experiments were performed. In the first, scRNA-seq and Cell Hashing libraries were prepared using the 10x Chromium Single Cell 3' Solution (Chromium Single Cell 3' v3 combined with Cell Hashing as per established protocols (doi: 10.1186/s13059-018-1603-1). In the second, scRNA-seq, scTCR-seq and Cell Hashing libraries were prepared using the 10x Chromium Single Cell 5' Solution (Chromium Next GEM Single Cell VDJ v1.1 with Feature Barcoding technology for Cell Surface Protein)",,,
MS046009,GSM5239642,,,,34099917,MS,Disease,No,Human,Cerobrospinal fluid,no data available,Male,Relapsing-remitting,29 years,no data available,10x Genomics,single-cell RNA sequencing,,"Fresh human CSF samples were processed within 1h after collection. CSF samples (36ml) were centrifuged at 300g for 10min. The pellet was then transferred to a 2-ml tube and stained with TotalSeq-C anti-human CD4, CD8A and mouse IgG1 isotype control (Biolegend, 300567, 301071, 400187; 0.5g of each) according to the cell surface labeling protocol available from 10x Genomics, with the difference that all centrifugations were done at 300g for 10min. The human CSF scRNA-seq and scTCR-seq libraries were prepared using the 10x Chromium Single Cell 5 Solution (Chromium Next GEM Single Cell VDJ v1.1, 10x Genomics with feature barcoding technology for cell surface protein, 1000167, 1000020 and 1000005) as per the manufacturers protocol. CSF cells were loaded in total (with a maximum target cell number of 10,000). Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150bp read 1, 8bp i7 index and 150bp read 2.",,,
MS046010,GSM5239643,,,,34099917,MS,Disease,No,Human,Cerobrospinal fluid,no data available,Female,Relapsing-remitting,31 years,no data available,10x Genomics,single-cell RNA sequencing,,"Fresh human CSF samples were processed within 1h after collection. CSF samples (36ml) were centrifuged at 300g for 10min. The pellet was then transferred to a 2-ml tube and stained with TotalSeq-C anti-human CD4, CD8A and mouse IgG1 isotype control (Biolegend, 300567, 301071, 400187; 0.5g of each) according to the cell surface labeling protocol available from 10x Genomics, with the difference that all centrifugations were done at 300g for 10min. The human CSF scRNA-seq and scTCR-seq libraries were prepared using the 10x Chromium Single Cell 5 Solution (Chromium Next GEM Single Cell VDJ v1.1, 10x Genomics with feature barcoding technology for cell surface protein, 1000167, 1000020 and 1000005) as per the manufacturers protocol. CSF cells were loaded in total (with a maximum target cell number of 10,000). Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150bp read 1, 8bp i7 index and 150bp read 2.",,,
MS046011,GSM5239644,,,,34099917,MS,Disease,No,Human,Cerobrospinal fluid,no data available,Female,Relapsing-remitting,36 years,no data available,10x Genomics,single-cell RNA sequencing,,"Fresh human CSF samples were processed within 1h after collection. CSF samples (36ml) were centrifuged at 300g for 10min. The pellet was then transferred to a 2-ml tube and stained with TotalSeq-C anti-human CD4, CD8A and mouse IgG1 isotype control (Biolegend, 300567, 301071, 400187; 0.5g of each) according to the cell surface labeling protocol available from 10x Genomics, with the difference that all centrifugations were done at 300g for 10min. The human CSF scRNA-seq and scTCR-seq libraries were prepared using the 10x Chromium Single Cell 5 Solution (Chromium Next GEM Single Cell VDJ v1.1, 10x Genomics with feature barcoding technology for cell surface protein, 1000167, 1000020 and 1000005) as per the manufacturers protocol. CSF cells were loaded in total (with a maximum target cell number of 10,000). Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150bp read 1, 8bp i7 index and 150bp read 2.",,,
MS046012,GSM5239645,,,,34099917,MS,Disease,No,Human,Cerobrospinal fluid,no data available,Female,Relapsing-remitting,26 years,no data available,10x Genomics,single-cell RNA sequencing,,"Fresh human CSF samples were processed within 1h after collection. CSF samples (36ml) were centrifuged at 300g for 10min. The pellet was then transferred to a 2-ml tube and stained with TotalSeq-C anti-human CD4, CD8A and mouse IgG1 isotype control (Biolegend, 300567, 301071, 400187; 0.5g of each) according to the cell surface labeling protocol available from 10x Genomics, with the difference that all centrifugations were done at 300g for 10min. The human CSF scRNA-seq and scTCR-seq libraries were prepared using the 10x Chromium Single Cell 5 Solution (Chromium Next GEM Single Cell VDJ v1.1, 10x Genomics with feature barcoding technology for cell surface protein, 1000167, 1000020 and 1000005) as per the manufacturers protocol. CSF cells were loaded in total (with a maximum target cell number of 10,000). Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150bp read 1, 8bp i7 index and 150bp read 2.",,,
MS046013,GSM5239646,,,,34099917,MS,Disease,No,Human,Cerobrospinal fluid,no data available,Female,Relapsing-remitting,28 years,no data available,10x Genomics,single-cell RNA sequencing,,"Fresh human CSF samples were processed within 1h after collection. CSF samples (36ml) were centrifuged at 300g for 10min. The pellet was then transferred to a 2-ml tube and stained with TotalSeq-C anti-human CD4, CD8A and mouse IgG1 isotype control (Biolegend, 300567, 301071, 400187; 0.5g of each) according to the cell surface labeling protocol available from 10x Genomics, with the difference that all centrifugations were done at 300g for 10min. The human CSF scRNA-seq and scTCR-seq libraries were prepared using the 10x Chromium Single Cell 5 Solution (Chromium Next GEM Single Cell VDJ v1.1, 10x Genomics with feature barcoding technology for cell surface protein, 1000167, 1000020 and 1000005) as per the manufacturers protocol. CSF cells were loaded in total (with a maximum target cell number of 10,000). Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150bp read 1, 8bp i7 index and 150bp read 2.",,,
MS046014,GSM5239647,,,,34099917,MS,Disease,No,Human,Cerobrospinal fluid,no data available,Female,Relapsing-remitting,40 years,no data available,10x Genomics,single-cell RNA sequencing,,"Fresh human CSF samples were processed within 1h after collection. CSF samples (36ml) were centrifuged at 300g for 10min. The pellet was then transferred to a 2-ml tube and stained with TotalSeq-C anti-human CD4, CD8A and mouse IgG1 isotype control (Biolegend, 300567, 301071, 400187; 0.5g of each) according to the cell surface labeling protocol available from 10x Genomics, with the difference that all centrifugations were done at 300g for 10min. The human CSF scRNA-seq and scTCR-seq libraries were prepared using the 10x Chromium Single Cell 5 Solution (Chromium Next GEM Single Cell VDJ v1.1, 10x Genomics with feature barcoding technology for cell surface protein, 1000167, 1000020 and 1000005) as per the manufacturers protocol. CSF cells were loaded in total (with a maximum target cell number of 10,000). Libraries were sequenced on an Illumina NovaSeq6000 S4 using read lengths of 150bp read 1, 8bp i7 index and 150bp read 2.",,,
MS051001,GSM8253373,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Temporal white matter,none,Female,no data available,2456 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051002,GSM8253374,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Parietal white matter,none,Female,no data available,2456 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051003,GSM8253375,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Parietal white matter,none,Female,no data available,2503 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051004,GSM8253376,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Parietal white matter,none,Female,no data available,2456 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051005,GSM8253377,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Optic tract ,none,Female,no data available,4102 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051006,GSM8253378,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Optic tract ,none,Female,no data available,2670 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051007,GSM8253379,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Optic tract ,none,Female,no data available,2810 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051008,GSM8253380,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Posterior corpus callosum,none,Female,no data available,2670 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051009,GSM8253381,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Temporal white matter,none,Male,no data available,3246 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051010,GSM8253382,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Parietal white matter,none,Female,no data available,2810 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051011,GSM8253383,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Parietal white matter,none,Female,no data available,2670 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051012,GSM8253384,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Posterior cortex ,none,Female,no data available,2810 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051013,GSM8253385,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Posterior cortex ,none,Female,no data available,2670 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051014,GSM8253386,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Parietal white matter,none,Female,no data available,4102 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051015,GSM8253387,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Parietal white matter,none,Female,no data available,4102 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051016,GSM8253388,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Temporal white matter,none,Male,no data available,3246 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051017,GSM8253389,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Temporal white matter,none,Female,no data available,2810 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051018,GSM8253390,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Temporal white matter,none,Female,no data available,4102 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051019,GSM8253391,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Temporal white matter,none,Female,no data available,4102 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051020,GSM8253392,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Frontal white matter,none,Female,no data available,2670 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051021,GSM8253393,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Frontal white matter,none,Female,no data available,4102 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051022,GSM8253394,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Frontal white matter,none,Female,no data available,2503 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051023,GSM8253395,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Lateral geniculate nucleus,none,Female,no data available,2670 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051024,GSM8253396,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Lateral geniculate nucleus,none,Female,no data available,2810 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051025,GSM8253397,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Frontal white matter,none,Female,no data available,2456 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS051026,GSM8253398,,,RData,40014701,MS,Disease,No,Callithrix jacchus,Posterior cortex ,none,Female,no data available,2810 days,no data available,10x Genomics,single-nucleus RNA sequencing,Experimental Autoimmune Encephalomyelitis,"Tissue dissection for cryosection and nuclei isolation: Before the day of tissue harvest, a custom-made brain holder was generated for each marmoset brain by 3D printing (Ultimaker 2+) to guide tissue sampling (141). Tissue dissection was carried out as described (34). Briefly, marmosets were deeply anesthetized with 5% isoflurane until no signs of breathing, then were transcardially perfused with ice-cold artificial cerebrospinal fluid (aCSF) for 5 min. After skull and meninges removal, each brain was quickly positioned into the designated brain holder submerged in ice-cold aCSF solution within 10 min post-perfusion. The brain was sectioned into 1213 slabs at 3 mm with a homemade blade-separator set submerged in aCSF solution. Each brain slab was transferred into a tissue cassette (70078-15, Electron Microscopy Sciences) with the anterior side of the brain slab facing the biopsy foam pad (62325-06, Electron Microscopy Sciences). The cassettes were then submerged into a jar full of RNAlater (RNAlater Stabilization Solution, AM7021, Invitrogen) and stored at 4C overnight. The following day, brain slabs were transferred to 25 x 20 x 5 mm3 molds (Tissue-Tek Cryomold, 4557, Sakura Finetek) on ice to facilitate targeted sampling. Slabs were matched to terminal MRI and informed by marmoset 3D MRI atlases (139,140) for region annotation. For nuclei dissociation, a cylinder of tissue 2 mm in diameter and 3 mm in height for each area was collected with a tissue punch (EMS-core sampling tool, 69039-20, EMS), and ejected into PCR tubes filled with 100 L of RNAlater and kept at 80C for long-term storage. For cryosection, a 6.5 x 6.5 x 3 mm3 block of tissue per region of interest (ROI) was prepared by a customized 3D-printed brain cutter and stored in cryomold filled with RNAlater at 80C or proceeded immediately to OCT (Tissue-Tek O.C.T. Compound, 4583, Sakura) embedding. The quality of RNAlater-preserved tissue was assessed by measuring RNA Integrity Number (RIN) on the Agilent 2100 Bioanalyzer (G2939BA, Agilent). Bulk RNA was isolated with TRIzol Reagent (15596026, Invitrogen) and measured with Agilent RNA 6000 Pico Kit (5067-1513, Agilent); samples with RIN >8.5 were used in the study.10x Genomics Chromium Single Cell 3 Library & Gel Bead Kit v3.1",,,
MS054001,GSM8059225,,,,38702968,MS,Disease,No,Mouse,Brain,none,"3 males, 4 females",Experimental Autoimmune Encephalomyelitis (19 dpi),12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, C3-tdTomato Reporter homozygous, Experimental Autoimmune Encephalomyelitis","Brains were extracted, chopped into small pieces, then digested with 20U/mL Papain and 100U/mL DNAse I in digestion buffer (EBSS with 22.5mM D(+)-glucose, 26mM NaHCO3, 0.5mM EDTA, and 1mM L-cysteine at pH 7.4) under slow rotation at 37c for 45 minutes with manual trituration steps every 15 minutes. After filtering, myelin debris was removed with 30% percoll solution. Cells from 7 animals (3 male, 4 female) were pooled and stained for viability (L/D Fixable NIR) and CD45 (anti-CD45 Pacific Blue) then two populations were sorted: viable;CD45-;C3-tdTomato+ and CD45-;C3-tdTomato-. Following sorting, cells were washed, counted, and loaded onto 2 seperate lanes (Pos cells in 1 lane, Neg cells in the other) of a 10X Chromium Chip G then partitioned into GEMs on a Chromium Controller following manufacturer's recommended protocol.Libraries were constructed and sequenced using 10X 3' 3.1 chemistry according to manufacturer's recommendations",,,
MS054002,GSM8059226,,,,38702968,MS,Disease,No,Mouse,Brain,none,"3 males, 4 females",Experimental Autoimmune Encephalomyelitis (19 dpi),12 weeks,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, C3-tdTomato Reporter homozygous, Experimental Autoimmune Encephalomyelitis","Brains were extracted, chopped into small pieces, then digested with 20U/mL Papain and 100U/mL DNAse I in digestion buffer (EBSS with 22.5mM D(+)-glucose, 26mM NaHCO3, 0.5mM EDTA, and 1mM L-cysteine at pH 7.4) under slow rotation at 37c for 45 minutes with manual trituration steps every 15 minutes. After filtering, myelin debris was removed with 30% percoll solution. Cells from 7 animals (3 male, 4 female) were pooled and stained for viability (L/D Fixable NIR) and CD45 (anti-CD45 Pacific Blue) then two populations were sorted: viable;CD45-;C3-tdTomato+ and CD45-;C3-tdTomato-. Following sorting, cells were washed, counted, and loaded onto 2 seperate lanes (Pos cells in 1 lane, Neg cells in the other) of a 10X Chromium Chip G then partitioned into GEMs on a Chromium Controller following manufacturer's recommended protocol.Libraries were constructed and sequenced using 10X 3' 3.1 chemistry according to manufacturer's recommendations",,,
MS056043,GSM4285758,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285758_AB1935.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (30 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056044,GSM4285759,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285759_AB1936.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (30 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056045,GSM4285760,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285760_AB1937.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (30 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056046,GSM4285761,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285761_AB1939.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (30 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056047,GSM4285762,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285762_AB1940.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (30 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056048,GSM4285763,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285763_AB1941.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056049,GSM4285764,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285764_AB1942.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056050,GSM4285765,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285765_AB1943.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056051,GSM4285766,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285766_AB1944.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056052,GSM4285767,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285767_AB1945.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056053,GSM4285768,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285768_AB1946.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056054,GSM4285769,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285769_AB5800.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6 Zbtb46-GFP, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056055,GSM4285770,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285770_AB5801.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6 Zbtb46-GFP, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056056,GSM4285771,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285771_AB5805.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (30 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6 Zbtb46-GFP, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056057,GSM4285772,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285772_AB5806.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Chronic Experimental Autoimmune Encephalomyelitis (30 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6 Zbtb46-GFP, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056058,GSM4285773,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285773_AB5810.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody isotype control,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056059,GSM4285774,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285774_AB5814.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056060,GSM4285775,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285775_AB6006.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody isotype control,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056061,GSM4285776,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285776_AB6007.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody isotype control,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056062,GSM4285777,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285777_AB6008.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody isotype control,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056063,GSM4285778,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285778_AB6009.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody isotype control,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056064,GSM4285779,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285779_AB6010.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody isotype control,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056065,GSM4285780,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285780_AB6011.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody isotype control,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056066,GSM4285781,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285781_AB6012.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056067,GSM4285782,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285782_AB6013.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056068,GSM4285783,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285783_AB6014.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056069,GSM4285784,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285784_AB6015.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056070,GSM4285785,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285785_AB6016.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056071,GSM4285786,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285786_AB6017.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,MC21 blocking antibody,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056072,GSM4285787,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285787_AB6018.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis, Adoptive transfer of MDPs from CD45.1/1 mice and monocytes from GFP mice","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056073,GSM4285788,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285788_AB6019.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis, Adoptive transfer of MDPs from CD45.1/1 mice and monocytes from GFP mice","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056074,GSM4285789,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285789_AB7789.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis, Adoptive transfer of GMPs from GFP mice","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056075,GSM4285790,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285790_AB8111.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis, Adoptive transfer of monocytes from GFP mice 6 days post EAE immunization","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS056076,GSM4285791,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32313246/GSM4285791_AB8112.txt.gz,txt.gz,txt,32313246,MS,Disease,No,Mouse,Spinal cord,none,Female,Acute Experimental Autoimmune Encephalomyelitis (16 dpi),8-12 weeks,no data available,MARS-seq,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis, Adoptive transfer of cMoPs from GFP mice","Mice were immunized subcutaneously with 200g of MOG35-55 peptide emulsified in CFA containing 1mg of Mycobacterium tuberculosis as described previously. Mice received intraperitonal injections of 250ng pertussis toxin at the time of immunization and 48 hours later.All mice were maintained under specific pathogen-free conditionsMice were perfused with 5 ml PBS via the left ventricle and spinal cord samples were harvested from individual mice. CNS tissues were cut into small pieces and homogenized through a 100m mesh filter without tissue digestion. After washing, the cell pellet was resuspended in 40% Percoll and the myelin fraction was separated from mononuclear cells by density centrifugation (2200rpm, 20 min at 14C with low acceleration and no brake).Samples were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva Software) cell sorter.3' end mRNA libraries were prepared for sequencing using MARS-seq (Jaitin et al, Science 2014)",,,
MS060001,GSM4365517,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32284594/GSM4365517_EAE1a_,10x_matrix,,32284594,MS,Disease,No,Mouse,Spinal cord,none,Female,Onset Experimental Autoimmune Encephalomyelitis,10 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were perfused with ice-cold phosphate-buffered saline (PBS) and spinal cords were flushed out from the spinal column with PBS. Tissues were incubated in HBSS with 0.2% collagenase, type 3 (Worthington) gently shaking for 30 min at 37 C, and then mechanically dissociated and passed through a 40-um strainer (Falcon). Cells were collected in complete RPMI-1640 medium (without phenol red supplemented with 25 mM HEPES pH 7.4, 1% Penicillin/Streptavidin and 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific)) and myelin was depleted following the myelin removal beads II manufactures guidelines (Miltenyi Biotec). Myelin-depleted cell suspensions were treated for 5 min at 4 C with Fc-block in BSA staining buffer (BD Biosciences) and then incubated for 30 min at 4 C with CD11b APC-Cy7 (M1/70) antibodies. Live cells isolated from spinal cord were stained for intracellular ROS in vitro using membrane permeable, fluorescent reagent 2,7dichlorofluorescein diacetate (DCFDA; Abcam). Cells were incubated with 10 uM DCFDA in PBS supplemented with 2% FBS without EDTA at 4 C for 30 min prior to cell sorting. Cells were incubated for 5 min at 4C with 1 uM sytox blue live/dead stain and then sorted using FACSAria II. Sorted cells were kept on ice until all samples were collected and then resuspended in cold PBS supplemented with 2% FBS at 233 cells/uL and immediately processed for single cell RNA-sequencing.Libraries were prepared following manufactures instructions for the Chromium Single Cell 3 v2 Reagent Kit (10X Genomics)",,,
MS060002,GSM4365518,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32284594/GSM4365518_EAE1b_,10x_matrix,,32284594,MS,Disease,No,Mouse,Spinal cord,none,Female,Onset Experimental Autoimmune Encephalomyelitis,10 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were perfused with ice-cold phosphate-buffered saline (PBS) and spinal cords were flushed out from the spinal column with PBS. Tissues were incubated in HBSS with 0.2% collagenase, type 3 (Worthington) gently shaking for 30 min at 37 C, and then mechanically dissociated and passed through a 40-um strainer (Falcon). Cells were collected in complete RPMI-1640 medium (without phenol red supplemented with 25 mM HEPES pH 7.4, 1% Penicillin/Streptavidin and 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific)) and myelin was depleted following the myelin removal beads II manufactures guidelines (Miltenyi Biotec). Myelin-depleted cell suspensions were treated for 5 min at 4 C with Fc-block in BSA staining buffer (BD Biosciences) and then incubated for 30 min at 4 C with CD11b APC-Cy7 (M1/70) antibodies. Live cells isolated from spinal cord were stained for intracellular ROS in vitro using membrane permeable, fluorescent reagent 2,7dichlorofluorescein diacetate (DCFDA; Abcam). Cells were incubated with 10 uM DCFDA in PBS supplemented with 2% FBS without EDTA at 4 C for 30 min prior to cell sorting. Cells were incubated for 5 min at 4C with 1 uM sytox blue live/dead stain and then sorted using FACSAria II. Sorted cells were kept on ice until all samples were collected and then resuspended in cold PBS supplemented with 2% FBS at 233 cells/uL and immediately processed for single cell RNA-sequencing.Libraries were prepared following manufactures instructions for the Chromium Single Cell 3 v2 Reagent Kit (10X Genomics)",,,
MS060003,GSM4365519,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32284594/GSM4365519_EAE2a_,10x_matrix,,32284594,MS,Disease,No,Mouse,Spinal cord,none,Female,Onset Experimental Autoimmune Encephalomyelitis,10 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were perfused with ice-cold phosphate-buffered saline (PBS) and spinal cords were flushed out from the spinal column with PBS. Tissues were incubated in HBSS with 0.2% collagenase, type 3 (Worthington) gently shaking for 30 min at 37 C, and then mechanically dissociated and passed through a 40-um strainer (Falcon). Cells were collected in complete RPMI-1640 medium (without phenol red supplemented with 25 mM HEPES pH 7.4, 1% Penicillin/Streptavidin and 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific)) and myelin was depleted following the myelin removal beads II manufactures guidelines (Miltenyi Biotec). Myelin-depleted cell suspensions were treated for 5 min at 4 C with Fc-block in BSA staining buffer (BD Biosciences) and then incubated for 30 min at 4 C with CD11b APC-Cy7 (M1/70) antibodies. Live cells isolated from spinal cord were stained for intracellular ROS in vitro using membrane permeable, fluorescent reagent 2,7dichlorofluorescein diacetate (DCFDA; Abcam). Cells were incubated with 10 uM DCFDA in PBS supplemented with 2% FBS without EDTA at 4 C for 30 min prior to cell sorting. Cells were incubated for 5 min at 4C with 1 uM sytox blue live/dead stain and then sorted using FACSAria II. Sorted cells were kept on ice until all samples were collected and then resuspended in cold PBS supplemented with 2% FBS at 233 cells/uL and immediately processed for single cell RNA-sequencing.Libraries were prepared following manufactures instructions for the Chromium Single Cell 3 v2 Reagent Kit (10X Genomics)",,,
MS060004,GSM4365520,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32284594/GSM4365520_EAE2b_,10x_matrix,,32284594,MS,Disease,No,Mouse,Spinal cord,none,Female,Onset Experimental Autoimmune Encephalomyelitis,10 weeks ,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice were perfused with ice-cold phosphate-buffered saline (PBS) and spinal cords were flushed out from the spinal column with PBS. Tissues were incubated in HBSS with 0.2% collagenase, type 3 (Worthington) gently shaking for 30 min at 37 C, and then mechanically dissociated and passed through a 40-um strainer (Falcon). Cells were collected in complete RPMI-1640 medium (without phenol red supplemented with 25 mM HEPES pH 7.4, 1% Penicillin/Streptavidin and 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific)) and myelin was depleted following the myelin removal beads II manufactures guidelines (Miltenyi Biotec). Myelin-depleted cell suspensions were treated for 5 min at 4 C with Fc-block in BSA staining buffer (BD Biosciences) and then incubated for 30 min at 4 C with CD11b APC-Cy7 (M1/70) antibodies. Live cells isolated from spinal cord were stained for intracellular ROS in vitro using membrane permeable, fluorescent reagent 2,7dichlorofluorescein diacetate (DCFDA; Abcam). Cells were incubated with 10 uM DCFDA in PBS supplemented with 2% FBS without EDTA at 4 C for 30 min prior to cell sorting. Cells were incubated for 5 min at 4C with 1 uM sytox blue live/dead stain and then sorted using FACSAria II. Sorted cells were kept on ice until all samples were collected and then resuspended in cold PBS supplemented with 2% FBS at 233 cells/uL and immediately processed for single cell RNA-sequencing.Libraries were prepared following manufactures instructions for the Chromium Single Cell 3 v2 Reagent Kit (10X Genomics)",,,
MS060005,GSM4365521,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32284594/GSM4365521_Healthy1_,10x_matrix,,32284594,MS,Healthy,Yes,Mouse,Spinal cord,none,Female,no data available,10 weeks ,no data available,10x Genomics,single-cell RNA sequencing,C57BL/6,"Mice were perfused with ice-cold phosphate-buffered saline (PBS) and spinal cords were flushed out from the spinal column with PBS. Tissues were incubated in HBSS with 0.2% collagenase, type 3 (Worthington) gently shaking for 30 min at 37 C, and then mechanically dissociated and passed through a 40-um strainer (Falcon). Cells were collected in complete RPMI-1640 medium (without phenol red supplemented with 25 mM HEPES pH 7.4, 1% Penicillin/Streptavidin and 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific)) and myelin was depleted following the myelin removal beads II manufactures guidelines (Miltenyi Biotec). Myelin-depleted cell suspensions were treated for 5 min at 4 C with Fc-block in BSA staining buffer (BD Biosciences) and then incubated for 30 min at 4 C with CD11b APC-Cy7 (M1/70) antibodies. Live cells isolated from spinal cord were stained for intracellular ROS in vitro using membrane permeable, fluorescent reagent 2,7dichlorofluorescein diacetate (DCFDA; Abcam). Cells were incubated with 10 uM DCFDA in PBS supplemented with 2% FBS without EDTA at 4 C for 30 min prior to cell sorting. Cells were incubated for 5 min at 4C with 1 uM sytox blue live/dead stain and then sorted using FACSAria II. Sorted cells were kept on ice until all samples were collected and then resuspended in cold PBS supplemented with 2% FBS at 233 cells/uL and immediately processed for single cell RNA-sequencing.Libraries were prepared following manufactures instructions for the Chromium Single Cell 3 v2 Reagent Kit (10X Genomics)",,,
MS060006,GSM4365522,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32284594/GSM4365522_Healthy2_,10x_matrix,,32284594,MS,Healthy,Yes,Mouse,Spinal cord,none,Female,no data available,10 weeks ,no data available,10x Genomics,single-cell RNA sequencing,C57BL/6,"Mice were perfused with ice-cold phosphate-buffered saline (PBS) and spinal cords were flushed out from the spinal column with PBS. Tissues were incubated in HBSS with 0.2% collagenase, type 3 (Worthington) gently shaking for 30 min at 37 C, and then mechanically dissociated and passed through a 40-um strainer (Falcon). Cells were collected in complete RPMI-1640 medium (without phenol red supplemented with 25 mM HEPES pH 7.4, 1% Penicillin/Streptavidin and 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific)) and myelin was depleted following the myelin removal beads II manufactures guidelines (Miltenyi Biotec). Myelin-depleted cell suspensions were treated for 5 min at 4 C with Fc-block in BSA staining buffer (BD Biosciences) and then incubated for 30 min at 4 C with CD11b APC-Cy7 (M1/70) antibodies. Live cells isolated from spinal cord were stained for intracellular ROS in vitro using membrane permeable, fluorescent reagent 2,7dichlorofluorescein diacetate (DCFDA; Abcam). Cells were incubated with 10 uM DCFDA in PBS supplemented with 2% FBS without EDTA at 4 C for 30 min prior to cell sorting. Cells were incubated for 5 min at 4C with 1 uM sytox blue live/dead stain and then sorted using FACSAria II. Sorted cells were kept on ice until all samples were collected and then resuspended in cold PBS supplemented with 2% FBS at 233 cells/uL and immediately processed for single cell RNA-sequencing.Libraries were prepared following manufactures instructions for the Chromium Single Cell 3 v2 Reagent Kit (10X Genomics)",,,
MS062001,GSM5603823,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, sp38alphaf/f Cre-, Experimental Autoimmune Encephalomyelitis","Female p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining. Cell hashing was used to mark biological samples using barcoded antibodies for CD45 (clone 30-F11), MHC class I (clone M1/42), and control Rat IgG2a following CITE-seq and TotalSeq-B protocols(Stoeckius et al, 2017).        10x Genomics single cell 3 V3 systemRNA and HTO libraries were prepared following 10X 3' system manufacturer instuctions and CITE-seq protocols (Stoeckius et al, 2017)",,,
MS062002,GSM5603824,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, p38alphaf/f Cre-, Experimental Autoimmune Encephalomyelitis","Female p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining. Cell hashing was used to mark biological samples using barcoded antibodies for CD45 (clone 30-F11), MHC class I (clone M1/42), and control Rat IgG2a following CITE-seq and TotalSeq-B protocols(Stoeckius et al, 2017).        10x Genomics single cell 3 V3 systemRNA and HTO libraries were prepared following 10X 3' system manufacturer instuctions and CITE-seq protocols (Stoeckius et al, 2017)",,,
MS062003,GSM5603825,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, p38alphaCKOCx3cr1-ER, Experimental Autoimmune Encephalomyelitis","Female p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining. Cell hashing was used to mark biological samples using barcoded antibodies for CD45 (clone 30-F11), MHC class I (clone M1/42), and control Rat IgG2a following CITE-seq and TotalSeq-B protocols(Stoeckius et al, 2017).        10x Genomics single cell 3 V3 systemRNA and HTO libraries were prepared following 10X 3' system manufacturer instuctions and CITE-seq protocols (Stoeckius et al, 2017)",,,
MS062004,GSM5603826,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, p38alphaCKOCx3cr1-ER, Experimental Autoimmune Encephalomyelitis","Female p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining. Cell hashing was used to mark biological samples using barcoded antibodies for CD45 (clone 30-F11), MHC class I (clone M1/42), and control Rat IgG2a following CITE-seq and TotalSeq-B protocols(Stoeckius et al, 2017).        10x Genomics single cell 3 V3 systemRNA and HTO libraries were prepared following 10X 3' system manufacturer instuctions and CITE-seq protocols (Stoeckius et al, 2017)",,,
MS062005,GSM5603827,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, sp38alphaf/f Cre-, Experimental Autoimmune Encephalomyelitis","Male p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining.10x Genomics single cell 3 V3 system RNA libraries were prepared following 10X 3' system manufacturer instuctions.",,,
MS062006,GSM5603828,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, sp38alphaf/f Cre-, Experimental Autoimmune Encephalomyelitis","Male p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining.10x Genomics single cell 3 V3 system RNA libraries were prepared following 10X 3' system manufacturer instuctions.",,,
MS062007,GSM5603829,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, sp38alphaf/f Cre-, Experimental Autoimmune Encephalomyelitis","Male p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining.10x Genomics single cell 3 V3 system RNA libraries were prepared following 10X 3' system manufacturer instuctions.",,,
MS062008,GSM5603830,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, p38alphaCKOCx3cr1-ER, Experimental Autoimmune Encephalomyelitis","Male p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining.10x Genomics single cell 3 V3 system RNA libraries were prepared following 10X 3' system manufacturer instuctions.",,,
MS062009,GSM5603831,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, p38alphaCKOCx3cr1-ER, Experimental Autoimmune Encephalomyelitis","Male p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining.10x Genomics single cell 3 V3 system RNA libraries were prepared following 10X 3' system manufacturer instuctions.",,,
MS062010,GSM5603832,,,whole 10x,34707603,MS,Disease,No,Mouse,Spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, p38alphaCKOCx3cr1-ER, Experimental Autoimmune Encephalomyelitis","Male p38CKOCx3cr1-ER and WT control littermates were treated with tamoxifen to induce Cre activity, followed by EAE induction at 4 weeks post tamoxifen treatment. On day 20 post-EAE induction, microglia were isolated from the brain and spinal cord using FACS based on CD11b+ CD45int/lo CX3CR1+ Ly6C- Ly6G- TCRb- CD19- staining.10x Genomics single cell 3 V3 system RNA libraries were prepared following 10X 3' system manufacturer instuctions.",,,
MS063001,GSM4726540,,,,40574973,MS,Disease,No,Mouse,Brainstem and spinal cord,none,no data available,Acute Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","At the designated chronic or acutetimepoint mice received a lethal dose of a Ketamine-Xylazine mixture (Ketamine320 mg/kg; Xylazine 5 mg/kg) i.p. and were transcardially perfused with 50ml ofice cold PBS. spinal cord tissue was removed and placed in a small petri dishand fully covered with ice cold D-PBS (with Ca2+, Mg2+,glucose and pyruvate, Gibco). Now under sterile conditions, tissues werechopped into smaller pieces and transferred into C-tubes containing enzyme mix 1 and 2 (for furtherdetails please refer to manufactures protocol). The tissue was homogenized onthe gentleMACS Octo Dissociator with Heaters (Miltenyi), program 37C_ABDK_01. Followinghomogenization, C-tubes containing homogenate were briefly centrifuged, resuspendedin 10 ml of cold D-PBS then passed through a 100 m cell strainer placed on anew 50 ml tube. The cell suspension was centrifuged at 300 x g and 4 C for[TC1] 10 min. The supernatant was completely aspirated and the cell pelletwas at first resuspended with 3.1 ml cold D-PBS and 900 l Percoll, transferredinto a new 15 ml tube and then overlaid with 4 ml cold D-PBS. To remove most ofthe cell debris and myelin a density gradient centrifugation step was performedat 3,000 x g and 4 C for 10 min with a soft acceleration and brake. The twotop phases were aspirated, the 15 ml tube was filled with cold D-PBS, gentlyinverted, centrifuged at 1,000 x g and 4 C for 10 min with full accelerationand brake. Again, the supernatant was aspirated and now an erythrolysis wasperformed by adding 10 ml of 1X Red Blood Cell Removal Solution followed by anincubation of 10 min at 4 C. The lysis was stopped by adding 10 ml of coldD-PBS/BSA buffer (0.5 % BSA, pH 7.2). A final washing step at 300 x g and 4 Cfor 10 min prepared the single cell suspension for the following immunostainingprocedure. Libraries were prepared as per manufacturer's insturctions provided by 10X Genomics platform for the Single Cell 3-prime Gene Expression v3 workflow.",,,
MS063002,GSM4726541,,,,40574973,MS,Disease,No,Mouse,Brainstem and spinal cord,none,no data available,Acute Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","At the designated chronic or acutetimepoint mice received a lethal dose of a Ketamine-Xylazine mixture (Ketamine320 mg/kg; Xylazine 5 mg/kg) i.p. and were transcardially perfused with 50ml ofice cold PBS. spinal cord tissue was removed and placed in a small petri dishand fully covered with ice cold D-PBS (with Ca2+, Mg2+,glucose and pyruvate, Gibco). Now under sterile conditions, tissues werechopped into smaller pieces and transferred into C-tubes containing enzyme mix 1 and 2 (for furtherdetails please refer to manufactures protocol). The tissue was homogenized onthe gentleMACS Octo Dissociator with Heaters (Miltenyi), program 37C_ABDK_01. Followinghomogenization, C-tubes containing homogenate were briefly centrifuged, resuspendedin 10 ml of cold D-PBS then passed through a 100 m cell strainer placed on anew 50 ml tube. The cell suspension was centrifuged at 300 x g and 4 C for[TC1] 10 min. The supernatant was completely aspirated and the cell pelletwas at first resuspended with 3.1 ml cold D-PBS and 900 l Percoll, transferredinto a new 15 ml tube and then overlaid with 4 ml cold D-PBS. To remove most ofthe cell debris and myelin a density gradient centrifugation step was performedat 3,000 x g and 4 C for 10 min with a soft acceleration and brake. The twotop phases were aspirated, the 15 ml tube was filled with cold D-PBS, gentlyinverted, centrifuged at 1,000 x g and 4 C for 10 min with full accelerationand brake. Again, the supernatant was aspirated and now an erythrolysis wasperformed by adding 10 ml of 1X Red Blood Cell Removal Solution followed by anincubation of 10 min at 4 C. The lysis was stopped by adding 10 ml of coldD-PBS/BSA buffer (0.5 % BSA, pH 7.2). A final washing step at 300 x g and 4 Cfor 10 min prepared the single cell suspension for the following immunostainingprocedure. Libraries were prepared as per manufacturer's insturctions provided by 10X Genomics platform for the Single Cell 3-prime Gene Expression v3 workflow.",,,
MS063003,GSM4726542,,,,40574973,MS,Disease,No,Mouse,Brainstem and spinal cord,none,no data available,Chronic Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","At the designated chronic or acutetimepoint mice received a lethal dose of a Ketamine-Xylazine mixture (Ketamine320 mg/kg; Xylazine 5 mg/kg) i.p. and were transcardially perfused with 50ml ofice cold PBS. spinal cord tissue was removed and placed in a small petri dishand fully covered with ice cold D-PBS (with Ca2+, Mg2+,glucose and pyruvate, Gibco). Now under sterile conditions, tissues werechopped into smaller pieces and transferred into C-tubes containing enzyme mix 1 and 2 (for furtherdetails please refer to manufactures protocol). The tissue was homogenized onthe gentleMACS Octo Dissociator with Heaters (Miltenyi), program 37C_ABDK_01. Followinghomogenization, C-tubes containing homogenate were briefly centrifuged, resuspendedin 10 ml of cold D-PBS then passed through a 100 m cell strainer placed on anew 50 ml tube. The cell suspension was centrifuged at 300 x g and 4 C for[TC1] 10 min. The supernatant was completely aspirated and the cell pelletwas at first resuspended with 3.1 ml cold D-PBS and 900 l Percoll, transferredinto a new 15 ml tube and then overlaid with 4 ml cold D-PBS. To remove most ofthe cell debris and myelin a density gradient centrifugation step was performedat 3,000 x g and 4 C for 10 min with a soft acceleration and brake. The twotop phases were aspirated, the 15 ml tube was filled with cold D-PBS, gentlyinverted, centrifuged at 1,000 x g and 4 C for 10 min with full accelerationand brake. Again, the supernatant was aspirated and now an erythrolysis wasperformed by adding 10 ml of 1X Red Blood Cell Removal Solution followed by anincubation of 10 min at 4 C. The lysis was stopped by adding 10 ml of coldD-PBS/BSA buffer (0.5 % BSA, pH 7.2). A final washing step at 300 x g and 4 Cfor 10 min prepared the single cell suspension for the following immunostainingprocedure. Libraries were prepared as per manufacturer's insturctions provided by 10X Genomics platform for the Single Cell 3-prime Gene Expression v3 workflow.",,,
MS063004,GSM4726543,,,,40574973,MS,Disease,No,Mouse,Brainstem and spinal cord,none,no data available,Chronic Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","At the designated chronic or acutetimepoint mice received a lethal dose of a Ketamine-Xylazine mixture (Ketamine320 mg/kg; Xylazine 5 mg/kg) i.p. and were transcardially perfused with 50ml ofice cold PBS. spinal cord tissue was removed and placed in a small petri dishand fully covered with ice cold D-PBS (with Ca2+, Mg2+,glucose and pyruvate, Gibco). Now under sterile conditions, tissues werechopped into smaller pieces and transferred into C-tubes containing enzyme mix 1 and 2 (for furtherdetails please refer to manufactures protocol). The tissue was homogenized onthe gentleMACS Octo Dissociator with Heaters (Miltenyi), program 37C_ABDK_01. Followinghomogenization, C-tubes containing homogenate were briefly centrifuged, resuspendedin 10 ml of cold D-PBS then passed through a 100 m cell strainer placed on anew 50 ml tube. The cell suspension was centrifuged at 300 x g and 4 C for[TC1] 10 min. The supernatant was completely aspirated and the cell pelletwas at first resuspended with 3.1 ml cold D-PBS and 900 l Percoll, transferredinto a new 15 ml tube and then overlaid with 4 ml cold D-PBS. To remove most ofthe cell debris and myelin a density gradient centrifugation step was performedat 3,000 x g and 4 C for 10 min with a soft acceleration and brake. The twotop phases were aspirated, the 15 ml tube was filled with cold D-PBS, gentlyinverted, centrifuged at 1,000 x g and 4 C for 10 min with full accelerationand brake. Again, the supernatant was aspirated and now an erythrolysis wasperformed by adding 10 ml of 1X Red Blood Cell Removal Solution followed by anincubation of 10 min at 4 C. The lysis was stopped by adding 10 ml of coldD-PBS/BSA buffer (0.5 % BSA, pH 7.2). A final washing step at 300 x g and 4 Cfor 10 min prepared the single cell suspension for the following immunostainingprocedure. Libraries were prepared as per manufacturer's insturctions provided by 10X Genomics platform for the Single Cell 3-prime Gene Expression v3 workflow.",,,
MS064001,GSM8800100,,,,40022134,MS,Disease,No,Mouse,Spleen + Inguinal lymph nodes,none,Female,no data available,8-10 weeks,no data available,Parse Biosciences,single-cell RNA sequencing,"C57B/6 J, Experimental Autoimmune Encephalomyelitis, received CD8+ T cells from mice immunized with PLP178-191","Splenic DC were isolated from CD8 recipients, PLP-CD8-DC and OVA-CD8-DC, on day 12 post-EAE induction as described before. The enrichment procedure efficiently removes non-DC antigen presenting cells (APC) and other cell types. DC were strained through a 40-m filter, fixed using the Cell Fixation Kit and processed with the Evercode Whole Transcriptome Mini Kit from Parse Biosciences (Seattle, Washington, USA) according to the manufacturers guidelines. Sub-libraries were evaluated for adequacy (Agilent BioAnalyzer RNA integrity number>8) and sent for Next Generation Sequencing on the Illumina NovaSeq 6000 using 100 bp paired-end reads (Iowa Institute of Human Genetics, University of Iowa). Resulting FASTQ files were further processed using the Parse Biosciences pipeline to identify the barcodes, align the reads, and create a gene-cell count matrix. Downstream data analysis and visualization were performed using the R package Seurat (Version 5.1.0) [46]. Quality control thresholds were applied to retain cells with 2001,250 detected genes and<10% mitochondrial gene expression; cells failing these criteria were excluded from further analysis. Principal component analysis (PCA) was performed on the top 2,000 variable features identified using the FindVariableFeatures function. Seurat objects corresponding to DC isolated from PLP-CD8 and OVA-CD8 recipients were integrated into a single dataset using the FindIntegrationAnchors and IntegrateData functions. Nearest-neighbor graphs were constructed using the FindNeighbors function with k=20 and 30 principal components as input. Clustering was conducted using the Louvain algorithm (FindClusters function) with a resolution parameter of 0.5. Uniform Manifold Approximation and Projection (UMAP) was used for visualization with default settings. Canonical gene expression was analyzed to annotate clusters.",,,
MS065001,GSM7780658,,,,39088391,MS,Disease,No,Mouse,Central nervous system,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Stat4fl/flCD11cCre, Experimental Autoimmune Encephalomyelitis","Mice from the two strains WT and Stat4fl/flCD11cCre were immunized for EAE. On day 15 post-immunization, mice were euthanized and mononuclear cells were recovered from the CNS of EAE mice. Cells were pooled from each group and stained with viability stain for 15 minutes, preincubated with FC block for 10 minutes at 4C, followed by staining with fluorescent conjugated-antibodies for 30 minutes at 4C, and then washed with 1% BSA in PBS. Cells were FACS sorted for all MHCII+ CD11c+ populations. Sorted cells suspension were partitioned into an emulsion of nanoliter-sized droplets using 10x Genomics Chromium Single Cell Controller",,,
MS065002,GSM7780659,,,,39088391,MS,Disease,No,Mouse,Central nervous system,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis","Mice from the two strains WT and Stat4fl/flCD11cCre were immunized for EAE. On day 15 post-immunization, mice were euthanized and mononuclear cells were recovered from the CNS of EAE mice. Cells were pooled from each group and stained with viability stain for 15 minutes, preincubated with FC block for 10 minutes at 4C, followed by staining with fluorescent conjugated-antibodies for 30 minutes at 4C, and then washed with 1% BSA in PBS. Cells were FACS sorted for all MHCII+ CD11c+ populations. Sorted cells suspension were partitioned into an emulsion of nanoliter-sized droplets using 10x Genomics Chromium Single Cell Controller",,,
MS066001,GSM5503739,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066002,GSM5503740,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066003,GSM5503741,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066004,GSM5503742,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066005,GSM5503743,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066006,GSM5503744,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066007,GSM5503745,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066008,GSM5503746,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066009,GSM5503747,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066010,GSM5503748,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066011,GSM5503749,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066012,GSM5503750,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066013,GSM5503751,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066014,GSM5503752,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066015,GSM5503753,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066016,GSM5503754,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066017,GSM5503755,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS066018,GSM5503756,,,,38933267,MS,Disease,No,Mouse,Cerebrospinal fluid and mELT (meningeal leukocyte tissue),anti-CD20 mAb,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"Thx2D2, Experimental Autoimmune Encephalomyelitis","Anesthetized mice underwent an intravascular staining procedure [20] with 0,75 g of TotalSeq-A0096 anti-mouse CD45 Antibody (clone 30-F11, Biolegend) in 300 l PBS, 3-10 minutes before CSF aspiration from the cisterna magna, to be able to discriminate CSF from blood leukocytes. After thorough perfusion with PBS the spinal cord was dissected, and meninges were detached from the spinal cord using fine forceps. Meninges were passed through a cell strainer to collect mELT cells. Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067001,GSM5504566,,,,38100739,MS,Disease,No,Mouse,Meningeal Ectopic Lymphoid Tissue from spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS lumbar lymph nodes, and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301).",,,
MS067002,GSM5504567,,,,38100739,MS,Disease,No,Mouse,Lumbar lymph node,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS lumbar lymph nodes, and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301).",,,
MS067003,GSM5504568,,,,38100739,MS,Disease,No,Mouse,Meningeal Ectopic Lymphoid Tissue from spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS lumbar lymph nodes, and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301).",,,
MS067004,GSM5504569,,,,38100739,MS,Disease,No,Mouse,Lumbar lymph node,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS lumbar lymph nodes, and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301).",,,
MS067005,GSM5504570,,,,38100739,MS,Disease,No,Mouse,Meningeal Ectopic Lymphoid Tissue from spinal cord,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS lumbar lymph nodes, and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301).",,,
MS067006,GSM5504571,,,,38100739,MS,Disease,No,Mouse,Lumbar lymph node,none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS lumbar lymph nodes, and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301).",,,
MS067016,GSM5536807,,,,38100739,MS,Disease,No,Mouse,"Cerebrospinal fluid, meningeal ectopic lymphoid tissue",none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067017,GSM5536808,,,,38100739,MS,Disease,No,Mouse,"Lumbar lymph node, Inguinal lymph node",none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067018,GSM5536809,,,,38100739,MS,Disease,No,Mouse,"Spleen, Blood",none,Male,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067019,GSM5536810,,,,38100739,MS,Disease,No,Mouse,"Cerebrospinal fluid, meningeal ectopic lymphoid tissue",none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067020,GSM5536811,,,,38100739,MS,Disease,No,Mouse,"Lumbar lymph node, Inguinal lymph node",none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067021,GSM5536812,,,,38100739,MS,Disease,No,Mouse,"Spleen, Blood",none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067022,GSM5536813,,,,38100739,MS,Disease,No,Mouse,"Cerebrospinal fluid, meningeal ectopic lymphoid tissue",none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067023,GSM5536814,,,,38100739,MS,Disease,No,Mouse,"Lumbar lymph node, Inguinal lymph node",none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS067024,GSM5536815,,,,38100739,MS,Disease,No,Mouse,"Spleen, Blood",none,Female,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"2D2xTh, Experimental Autoimmune Encephalomyelitis","Blood was collected by cardiac puncture. After thorough perfusion with PBS the spleen, inguinal lymph nodes, lumbar lymph nodes and spinal cord were dissected, and meninges were detached from the spinal cord using fine forceps. Organs were passed through cell strainers. Erythrocyte lysis was performed for spleen and blood. Samples were enriched for CD45+ cells using a MACS (Miltenyi Biotech) with antiCD45 mouse MAbconjugated microbeads (Miltenyi Biotech, #130-052-301). Fc receptors were blocked and samples were incubatedwith DNA barcoded TotalSeq antibodies against CD4 (TotalSeq-C0001 anti-mouse CD4, clone RM4-5, Biolegend), CD8a (TotalSeq-C0002 anti-mouse CD8a , clone 53-6.7, Biolegend), CD19 (TotalSeq-C0093 anti-mouse CD19, clone 6D5, Biolegend), Ly6G (TotalSeq-C0015 anti-mouse Ly6G , clone 1A8, Biolegend), and NK1.1 (TotalSeq-C0118 anti-mouse NK-1.1, clone PK136, Biolegend), and one of 2 TotalSeq Hashtag antibodies (TotalSeq-C0301 anti-mouse Hashtag 1 Antibody, clones M1/42; 30-F11, Biolegend or TotalSeq-C0302 anti-mouse Hashtag 2 Antibody, clones M1/42; 30-F11, Biolegend), to allow pooling of 2 samples per experiment.",,,
MS068001,GSM5827377,,,,37414380,MS,Healthy,Yes,Human,Cerebrospinal fluid,no data available,Male,no data available,20 years ,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068002,GSM5827378,,,,37414380,MS,Healthy,Yes,Human,Peripheral blood mononuclear cells,no data available,Male,no data available,20 years ,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068003,GSM5827379,,,,37414380,MS,Disease,No,Human,Cerebrospinal fluid,no data available,Female,no data available,47 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068004,GSM5827380,,,,37414380,MS,Disease,No,Human,Peripheral blood mononuclear cells,no data available,Female,no data available,47 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068005,GSM5827383,,,,37414380,MS,Disease,No,Human,Cerebrospinal fluid,no data available,Male,no data available,25 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068006,GSM5827384,,,,37414380,MS,Disease,No,Human,Peripheral blood mononuclear cells,no data available,Male,no data available,25 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068007,GSM5827387,,,,37414380,MS,Healthy,Yes,Human,Cerebrospinal fluid,no data available,Female,no data available,55 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068008,GSM5827388,,,,37414380,MS,Healthy,Yes,Human,Peripheral blood mononuclear cells,no data available,Female,no data available,55 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068009,GSM5827395,,,,37414380,MS,Disease,No,Human,Cerebrospinal fluid,no data available,Female,no data available,31 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS068010,GSM5827396,,,,37414380,MS,Disease,No,Human,Peripheral blood mononuclear cells,no data available,Female,no data available,31 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF was quickly transported and centrifuged at 700g for 10 min. After centrifugation, the supernatant was removed, and then the pellet was resuspended with 30 uL of CSF. A total of 10 L of the single-cell suspension was counted in a Cellometer counting chamber (PD100, Nexcelom, MA, USA) through staining with acridine orange and propidium iodide (AO/PI) reagent (CS2-0106, Nexcelom, MA, USA). Only samples having more than 2,000 cells were selected for scRNA-seq.PBMCs were isolated using Lymphoprep (07861, STEMCELL Technologies, BC, Canada) and SepMate-50 tubes (ST86450, STEMCELL Technologies, BC, Canada) according to the manufacturers protocol. Briefly, the enriched PBMCs were obtained from density gradientmedium centrifugation. The red blood cells were removed with an ACK lysing buffer (A1049201, Gibco, MA, USA). Cells were resuspended in complete RPMI medium containing 10% fetal bovine serum, 1% GlutaMax, and 1% penicillin/streptomycin up to 10 mL. All CSF/PBMC samples were processed without freezing in the RNA workflow.Single-cell cDNA synthesis, amplification, and sequencing libraries were generated using the Single Cell 3 Reagent Kit (10X Genomics) following the manufacturers instructions. Sequencing was carried out on an Illumina HiSeqXten and sequenced using the following parameters: Read1: 28 cycles, i7: 8 cycles, i5: 0 cycles, Read2: 91 cycles to generate paired-end reads.",,,
MS069001,GSM7439052,,,,37339207,MS,Disease,No,Human,Blood,no data available,Female,Relapsingremitting,63 years,no data available,10x Genomics,single-cell RNA sequencing,,"Blood samples from three recently diagnosed untreated RRMS patients were lysed with RBC lysis buffer (eBioscience) following manufacturers instructions. Cells stained for IL-11R and sorted using FACS Aria fusion were stimulated with 100 ng/ml rh IL-11 (R&D Systems) for 1 hour or kept unstimulated. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069002,GSM7439053,,,,37339207,MS,Disease,No,Human,Blood,Stimulated with IL-11,Female,Relapsingremitting,63 years,no data available,10x Genomics,single-cell RNA sequencing,,"Blood samples from three recently diagnosed untreated RRMS patients were lysed with RBC lysis buffer (eBioscience) following manufacturers instructions. Cells stained for IL-11R and sorted using FACS Aria fusion were stimulated with 100 ng/ml rh IL-11 (R&D Systems) for 1 hour or kept unstimulated. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069003,GSM7439054,,,,37339207,MS,Disease,No,Human,Blood,no data available,Female,Relapsingremitting,40 years,no data available,10x Genomics,single-cell RNA sequencing,,"Blood samples from three recently diagnosed untreated RRMS patients were lysed with RBC lysis buffer (eBioscience) following manufacturers instructions. Cells stained for IL-11R and sorted using FACS Aria fusion were stimulated with 100 ng/ml rh IL-11 (R&D Systems) for 1 hour or kept unstimulated. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069004,GSM7439055,,,,37339207,MS,Disease,No,Human,Blood,Stimulated with IL-11,Female,Relapsingremitting,40 years,no data available,10x Genomics,single-cell RNA sequencing,,"Blood samples from three recently diagnosed untreated RRMS patients were lysed with RBC lysis buffer (eBioscience) following manufacturers instructions. Cells stained for IL-11R and sorted using FACS Aria fusion were stimulated with 100 ng/ml rh IL-11 (R&D Systems) for 1 hour or kept unstimulated. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069005,GSM7439056,,,,37339207,MS,Disease,No,Human,Blood,no data available,Female,Relapsingremitting,45 years,no data available,10x Genomics,single-cell RNA sequencing,,"Blood samples from three recently diagnosed untreated RRMS patients were lysed with RBC lysis buffer (eBioscience) following manufacturers instructions. Cells stained for IL-11R and sorted using FACS Aria fusion were stimulated with 100 ng/ml rh IL-11 (R&D Systems) for 1 hour or kept unstimulated. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069006,GSM7439057,,,,37339207,MS,Disease,No,Human,Blood,Stimulated with IL-11,Female,Relapsingremitting,45 years,no data available,10x Genomics,single-cell RNA sequencing,,"Blood samples from three recently diagnosed untreated RRMS patients were lysed with RBC lysis buffer (eBioscience) following manufacturers instructions. Cells stained for IL-11R and sorted using FACS Aria fusion were stimulated with 100 ng/ml rh IL-11 (R&D Systems) for 1 hour or kept unstimulated. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069007,GSM7439058,,,,37339207,MS,Disease,No,Human,Blood,none,Female,Relapsingremitting,55 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood samples from two RRMS patients were sorted for IL-11R+ cells following RBC lysis for blood samples. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069008,GSM7439059,,,,37339207,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,55 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood samples from two RRMS patients were sorted for IL-11R+ cells following RBC lysis for blood samples. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069009,GSM7439060,,,,37339207,MS,Disease,No,Human,Peripheral blood mononuclear cells,none,Female,Relapsingremitting,26 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood samples from two RRMS patients were sorted for IL-11R+ cells following RBC lysis for blood samples. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS069010,GSM7439061,,,,37339207,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,26 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood samples from two RRMS patients were sorted for IL-11R+ cells following RBC lysis for blood samples. In order to decrease batch-to-batch variations, all samples from each experiment were submitted for scRNAseq on the same day. Next-generation sequencing libraries were prepared using the 10x Genomics Chromium Single Cell 3' Reagent kit v3 as per manufacturers instructions. Library quality control was assessed using Agilent TapeStation for sizing (bp) and KAPA qPCR for concentration. Libraries were uniquely indexed using the Chromium i7 Sample Index Kit, pooled, and sequenced on the Illumina NovaSeq6000 sequencer in a paired-end, single indexing run. Sequencing depth targeted 20000 mean reads per cell.",,,
MS070001,GSM7111364	,,,,37062182,MS,Disease,No,Human,Cerebrospinal fluid,Alemtuzumab,no data available,Relapsingremitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"CSF samples were centrifuged for 5 min at 400 g and resuspended in 40 l of X-Vivo 15 medium. 6 l were used for counting in a Fuchs-Rosenthal chamber. The maximum of CSF cells used was 10,000 cells and if less than 10,000 cells were available, all cells were used. To carry out scRNA-seq with blood samples, gradient centrifugation was performed with blood using Lymphoprep (Stemcell). The cells in the interphase were extracted and washed in 10 ml of X-Vivo 15 media. After manual cell counting (Fuchs-Rosenthal chamber), we used up to 10,000 cells for subsequent steps (see Table S1 for details). Single cell suspensions were loaded onto the Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2 (both from 10X Genomics). Sample processing and library preparation were performed according to the manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out commercially on an Illumina Nextseq500 with 26-8-0-57 read setup.",,,
MS070002,GSM7111364	,,,,37062182,MS,Disease,No,Human,Peripheral blood mononuclear cells,Alemtuzumab,no data available,Relapsingremitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"CSF samples were centrifuged for 5 min at 400 g and resuspended in 40 l of X-Vivo 15 medium. 6 l were used for counting in a Fuchs-Rosenthal chamber. The maximum of CSF cells used was 10,000 cells and if less than 10,000 cells were available, all cells were used. To carry out scRNA-seq with blood samples, gradient centrifugation was performed with blood using Lymphoprep (Stemcell). The cells in the interphase were extracted and washed in 10 ml of X-Vivo 15 media. After manual cell counting (Fuchs-Rosenthal chamber), we used up to 10,000 cells for subsequent steps (see Table S1 for details). Single cell suspensions were loaded onto the Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2 (both from 10X Genomics). Sample processing and library preparation were performed according to the manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out commercially on an Illumina Nextseq500 with 26-8-0-57 read setup.",,,
MS070003,GSM7111364	,,,,37062182,MS,Disease,No,Human,Cerebrospinal fluid,Alemtuzumab,no data available,Relapsingremitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"CSF samples were centrifuged for 5 min at 400 g and resuspended in 40 l of X-Vivo 15 medium. 6 l were used for counting in a Fuchs-Rosenthal chamber. The maximum of CSF cells used was 10,000 cells and if less than 10,000 cells were available, all cells were used. To carry out scRNA-seq with blood samples, gradient centrifugation was performed with blood using Lymphoprep (Stemcell). The cells in the interphase were extracted and washed in 10 ml of X-Vivo 15 media. After manual cell counting (Fuchs-Rosenthal chamber), we used up to 10,000 cells for subsequent steps (see Table S1 for details). Single cell suspensions were loaded onto the Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2 (both from 10X Genomics). Sample processing and library preparation were performed according to the manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out commercially on an Illumina Nextseq500 with 26-8-0-57 read setup.",,,
MS070004,GSM7111364	,,,,37062182,MS,Disease,No,Human,Peripheral blood mononuclear cells,Alemtuzumab,no data available,Relapsingremitting,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"CSF samples were centrifuged for 5 min at 400 g and resuspended in 40 l of X-Vivo 15 medium. 6 l were used for counting in a Fuchs-Rosenthal chamber. The maximum of CSF cells used was 10,000 cells and if less than 10,000 cells were available, all cells were used. To carry out scRNA-seq with blood samples, gradient centrifugation was performed with blood using Lymphoprep (Stemcell). The cells in the interphase were extracted and washed in 10 ml of X-Vivo 15 media. After manual cell counting (Fuchs-Rosenthal chamber), we used up to 10,000 cells for subsequent steps (see Table S1 for details). Single cell suspensions were loaded onto the Chromium Single Cell Controller using the Chromium Single Cell 3' Library & Gel Bead Kit v2 (both from 10X Genomics). Sample processing and library preparation were performed according to the manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out commercially on an Illumina Nextseq500 with 26-8-0-57 read setup.",,,
MS071001,GSM6424225,,,,36730207,MS,Disease,No,Mouse,Central nervous system,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6 CD45.1+ > CD45.2+ Bone Marrow Chimera Mice, Experimental Autoimmune Encephalomyelitis","Bone marrow chimeric mice (BL/6) were generated by injecting CD45.1+ bone marrow cells into irradiated CD45.2+ mice. These subsequently underwent induction with active experimental autoimmune encephalopathy (EAE). At peak of disease (day 15 post induction), cell suspensions from brain and spinal cord were sorted for CD88, CD317, and either CD45.1 or CD45.2 expression. Cell populations were subjected to single cell analysis using the 10X Multiomics platform.",,,
MS071002,GSM6424226,,,,36730207,MS,Disease,No,Mouse,Central nervous system,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6 CD45.1+ > CD45.2+ Bone Marrow Chimera Mice, Experimental Autoimmune Encephalomyelitis","Bone marrow chimeric mice (BL/6) were generated by injecting CD45.1+ bone marrow cells into irradiated CD45.2+ mice. These subsequently underwent induction with active experimental autoimmune encephalopathy (EAE). At peak of disease (day 15 post induction), cell suspensions from brain and spinal cord were sorted for CD88, CD317, and either CD45.1 or CD45.2 expression. Cell populations were subjected to single cell analysis using the 10X Multiomics platform.",,,
MS072001,GSM5973615,,,,36446612,MS,Disease,No,Mouse,Brain,none,no data available,Peak Experimental Autoimmune Encephalomyelitis ,no data available,no data available,10x Genomics,single-cell RNA sequencing,Experimental Autoimmune Encephalomyelitis,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072002,GSM5973616,,,,36446612,MS,Disease,No,Mouse,Brain,none,no data available,Peak Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,Experimental Autoimmune Encephalomyelitis,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072003,GSM5973617,,,,36446612,MS,Healthy,Yes,Mouse,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072004,GSM5973618,,,,36446612,MS,Disease,No,Mouse,Brain,none,no data available,Peak Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,Experimental Autoimmune Encephalomyelitis,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072005,GSM5973619,,,,36446612,MS,Healthy,Yes,Mouse,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072006,GSM5973620,,,,36446612,MS,Disease,No,Mouse,Brain,none,no data available,Peak Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,Experimental Autoimmune Encephalomyelitis,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072007,GSM5973621,,,,36446612,MS,Healthy,Yes,Mouse,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072008,GSM5973622,,,,36446612,MS,Healthy,Yes,Mouse,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072009,GSM5973623,,,,36446612,MS,Disease,No,Mouse,Brain,none,no data available,Peak Experimental Autoimmune Encephalomyelitis,no data available,no data available,10x Genomics,single-cell RNA sequencing,Experimental Autoimmune Encephalomyelitis,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072010,GSM5973624,,,,36446612,MS,Healthy,Yes,Mouse,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS072011,GSM5973625,,,,36446612,MS,Healthy,Yes,Mouse,Brain,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,,"cells were harvested, filtered and processed for single cell capture (1 sample per chip) cDNA libraries were created using the Chromium Single Cell 3' technology",,,
MS073001,GSM5538188 ,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (Baseline),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073002,GSM5538189,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (5 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073003,GSM5538190,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (Baseline),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073004,GSM5538191,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (5 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073005,GSM5538192,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (14 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073006,GSM5538193,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (28 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073007,GSM5538194,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (5 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073008,GSM5538195,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (28 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073009,GSM5538196,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (Baseline),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073010,GSM5538197,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (5 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073011,GSM5538198,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (14 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS073012,GSM5538199,,,,36001972,MS,Disease,No,Mouse,Corpus Callosum,none,no data available,Lysolecithin-induced lesion (28 dpi),3-4 months,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Lysolecithin-induced demyelination","Single cell suspensions were processed using Chromium Next GEM Single Cell 3 GEM, Library & Gel Bead Kit v3.1 (10X Genomics, PN-1000121) and Chromium Next GEM Chip G Single Cell Kit (10X GEnomics, PN-1000120) following manufacturers user guide. Cell-RT mix was prepared to aim 1,000 cells per sample and applied to Chromium Controller for GEM generation and barcoding. Then samples were subjected to post GEM-RT cleanup, cDNA amplification (11 cycles), and library construction according to the user guide. Sample index PCR was done with 12 cycles. Libraries were then quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Q33230) and profiled by Bioanalyzer High Sensitivity DNA kit (Agilent Technologies 5067-4626). Libraries were sequenced following 10X Genomics sequencing specification.",,,
MS074001,GSM5671167,,,,34873037,MS,Disease,No,Mouse,Spinal cord,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Experimental Autoimmune Encephalomyelitis",CNS infiltrated CD4+ T cells were purified by flow cytometry sorting and performed single cell sequencing.,,,
MS074002,GSM5671168,,,,34873037,MS,Disease,No,Mouse,Spinal cord,none,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,"C57BL/6, Tnfr2-/-, Experimental Autoimmune Encephalomyelitis",CNS infiltrated CD4+ T cells were purified by flow cytometry sorting and performed single cell sequencing.,,,
MS075001,GSM5379855,,,,34479995,MS,Disease,No,Mouse,Spinal cord meninges,none,no data available,no data available,8-14 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Donor: 2D2tg (=wt), Recipient: C57BL/6, Adoptive Transfer EAE, Recipient of wt-Th17 cells","After fluorescent labeling of blood leukocytes, peak of disease AT-EAE recipient mice (of either wt-Th17 or Bcl6KO-Th17 donor cells) were anesthetized and intracardially perfused, and spinal cord (SC) meninges and parenchyma were extracted separately. Parenchymal tissue was flushed out from the spinal canal with hydrostatic pressure. SC meninges remained attached to the vertebrae and were peeled of under the binocular. Parenchymal tissue was digested with collagenase D/DNase I and cells were isolated via 70%/37% percoll gradient as described before. Meningeal cell were extracted using collagenase D for digestion. Isolated cells were sorted either for CD45highCD45iv- cells or V11+CD4+CD45highCD45iv- cells. In vitro differentiated Th17 cultures were sorted for V11+CD4+ cells. Single cell suspensions of CD45highCD45iv- cells (5 l each) were manually counted in a Fuchs-Rosenthal chamber and the cell concentration was adjusted to achieve a cell recovery of approx. 5000-6000 cells. In total, 5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice were used to generate single cell RNA sequencing data from SC meningeal vs. parenchymal tissues. Per tissue, an average of 4,017  132 SEM cells were used for analysis. 57,846  1,060 SEM reads per cell were sequenced and this resulted in 2136  176 SEM median genes detected per cell. In addition, we did bulk RNA sequencing on sorted V11+CD4+CD45highCD45iv- cells of SC meninges (5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice) or parenchyma (4 wt-R AT-EAE mice vs. 4 Bcl6KO-R AT-EAE mice) or on sorted V11+CD4+ of in vitro differentiated Th17 cells (5 wt-Th17 vs. 5 Bcl6KO-Th17 in vitro cultures). On average, 15,19  0,65 SEM M reads were sequenced and used for bulk-seq analysis.",,,
MS075002,GSM5379856,,,,34479995,MS,Disease,No,Mouse,Spinal cord parenchyma,none,no data available,no data available,8-14 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Donor: 2D2tg (=wt), Recipient: C57BL/6, Adoptive Transfer EAE, Recipient of wt-Th17 cells","After fluorescent labeling of blood leukocytes, peak of disease AT-EAE recipient mice (of either wt-Th17 or Bcl6KO-Th17 donor cells) were anesthetized and intracardially perfused, and spinal cord (SC) meninges and parenchyma were extracted separately. Parenchymal tissue was flushed out from the spinal canal with hydrostatic pressure. SC meninges remained attached to the vertebrae and were peeled of under the binocular. Parenchymal tissue was digested with collagenase D/DNase I and cells were isolated via 70%/37% percoll gradient as described before. Meningeal cell were extracted using collagenase D for digestion. Isolated cells were sorted either for CD45highCD45iv- cells or V11+CD4+CD45highCD45iv- cells. In vitro differentiated Th17 cultures were sorted for V11+CD4+ cells. Single cell suspensions of CD45highCD45iv- cells (5 l each) were manually counted in a Fuchs-Rosenthal chamber and the cell concentration was adjusted to achieve a cell recovery of approx. 5000-6000 cells. In total, 5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice were used to generate single cell RNA sequencing data from SC meningeal vs. parenchymal tissues. Per tissue, an average of 4,017  132 SEM cells were used for analysis. 57,846  1,060 SEM reads per cell were sequenced and this resulted in 2136  176 SEM median genes detected per cell. In addition, we did bulk RNA sequencing on sorted V11+CD4+CD45highCD45iv- cells of SC meninges (5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice) or parenchyma (4 wt-R AT-EAE mice vs. 4 Bcl6KO-R AT-EAE mice) or on sorted V11+CD4+ of in vitro differentiated Th17 cells (5 wt-Th17 vs. 5 Bcl6KO-Th17 in vitro cultures). On average, 15,19  0,65 SEM M reads were sequenced and used for bulk-seq analysis.",,,
MS075003,GSM5379857,,,,34479995,MS,Disease,No,Mouse,Spinal cord meninges,none,no data available,no data available,8-14 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Donor: 2D2tg CD4cre Bcl6flox (=Bcl6KO), Recipient: C57BL/6, Adoptive Transfer EAE, Recipients of Bcl6KO-Th17 cells","After fluorescent labeling of blood leukocytes, peak of disease AT-EAE recipient mice (of either wt-Th17 or Bcl6KO-Th17 donor cells) were anesthetized and intracardially perfused, and spinal cord (SC) meninges and parenchyma were extracted separately. Parenchymal tissue was flushed out from the spinal canal with hydrostatic pressure. SC meninges remained attached to the vertebrae and were peeled of under the binocular. Parenchymal tissue was digested with collagenase D/DNase I and cells were isolated via 70%/37% percoll gradient as described before. Meningeal cell were extracted using collagenase D for digestion. Isolated cells were sorted either for CD45highCD45iv- cells or V11+CD4+CD45highCD45iv- cells. In vitro differentiated Th17 cultures were sorted for V11+CD4+ cells. Single cell suspensions of CD45highCD45iv- cells (5 l each) were manually counted in a Fuchs-Rosenthal chamber and the cell concentration was adjusted to achieve a cell recovery of approx. 5000-6000 cells. In total, 5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice were used to generate single cell RNA sequencing data from SC meningeal vs. parenchymal tissues. Per tissue, an average of 4,017  132 SEM cells were used for analysis. 57,846  1,060 SEM reads per cell were sequenced and this resulted in 2136  176 SEM median genes detected per cell. In addition, we did bulk RNA sequencing on sorted V11+CD4+CD45highCD45iv- cells of SC meninges (5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice) or parenchyma (4 wt-R AT-EAE mice vs. 4 Bcl6KO-R AT-EAE mice) or on sorted V11+CD4+ of in vitro differentiated Th17 cells (5 wt-Th17 vs. 5 Bcl6KO-Th17 in vitro cultures). On average, 15,19  0,65 SEM M reads were sequenced and used for bulk-seq analysis.",,,
MS075004,GSM5379858,,,,34479995,MS,Disease,No,Mouse,Spinal cord parenchyma,none,no data available,no data available,8-14 weeks,no data available,10x Genomics,single-cell RNA sequencing,"Donor: 2D2tg CD4cre Bcl6flox (=Bcl6KO), Recipient: C57BL/6, Adoptive Transfer EAE, Recipients of Bcl6KO-Th17 cells","After fluorescent labeling of blood leukocytes, peak of disease AT-EAE recipient mice (of either wt-Th17 or Bcl6KO-Th17 donor cells) were anesthetized and intracardially perfused, and spinal cord (SC) meninges and parenchyma were extracted separately. Parenchymal tissue was flushed out from the spinal canal with hydrostatic pressure. SC meninges remained attached to the vertebrae and were peeled of under the binocular. Parenchymal tissue was digested with collagenase D/DNase I and cells were isolated via 70%/37% percoll gradient as described before. Meningeal cell were extracted using collagenase D for digestion. Isolated cells were sorted either for CD45highCD45iv- cells or V11+CD4+CD45highCD45iv- cells. In vitro differentiated Th17 cultures were sorted for V11+CD4+ cells. Single cell suspensions of CD45highCD45iv- cells (5 l each) were manually counted in a Fuchs-Rosenthal chamber and the cell concentration was adjusted to achieve a cell recovery of approx. 5000-6000 cells. In total, 5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice were used to generate single cell RNA sequencing data from SC meningeal vs. parenchymal tissues. Per tissue, an average of 4,017  132 SEM cells were used for analysis. 57,846  1,060 SEM reads per cell were sequenced and this resulted in 2136  176 SEM median genes detected per cell. In addition, we did bulk RNA sequencing on sorted V11+CD4+CD45highCD45iv- cells of SC meninges (5 wt-R AT-EAE mice vs. 5 Bcl6KO-R AT-EAE mice) or parenchyma (4 wt-R AT-EAE mice vs. 4 Bcl6KO-R AT-EAE mice) or on sorted V11+CD4+ of in vitro differentiated Th17 cells (5 wt-Th17 vs. 5 Bcl6KO-Th17 in vitro cultures). On average, 15,19  0,65 SEM M reads were sequenced and used for bulk-seq analysis.",,,
MS076001,GSM3659281,,,,31566584,MS,Non-inflammatory control,Yes,Human,Cerebrospinal fluid,no data available,Female,no data available,22 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076002,GSM3659282,,,,31566584,MS,Non-inflammatory control,Yes,Human,Cerebrospinal fluid,no data available,Female,no data available,30 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076003,GSM3659283,,,,31566584,MS,subclinical neuro-inflammation,No,Human,Cerebrospinal fluid,no data available,Male,no data available,38 years,no data available,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.","Smart-seq2, Illumina HiSeq 1500",,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076004,GSM3659284,,,,31566584,MS,subclinical neuro-inflammation,No,Human,Cerebrospinal fluid,no data available,Female,no data available,69 years,no data available,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.","Smart-seq2, Illumina HiSeq 1500",,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076005,GSM3659285,,,,31566584,MS,subclinical neuro-inflammation,No,Human,Cerebrospinal fluid,no data available,Female,no data available,28 years,no data available,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.","Smart-seq2, Illumina HiSeq 1500",,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076006,GSM3659286,,,,31566584,MS,subclinical neuro-inflammation,No,Human,Cerebrospinal fluid,no data available,Female,no data available,32 years,no data available,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.","Smart-seq2, Illumina HiSeq 1500",,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076007,GSM3659287,,,,31566584,MS,Disease,No,Human,Cerebrospinal fluid,no data available,Female,no data available,40 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076008,GSM3659288,,,,31566584,MS,Subclinical neuro-inflammation,No,Human,Cerebrospinal fluid,no data available,Female,no data available,40 years,no data available,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.","Smart-seq2, Illumina HiSeq 1500",,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076009,GSM3659289,,,,31566584,MS,Disease,No,Human,Cerebrospinal fluid,no data available,Female,no data available,21 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076010,GSM3659290,,,,31566584,MS,Subclinical neuro-inflammation,No,Human,Cerebrospinal fluid,no data available,Female,no data available,21 years,no data available,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.","Smart-seq2, Illumina HiSeq 1500",,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076011,GSM3659291,,,,31566584,MS,Disease,No,Human,Cerebrospinal fluid,no data available,Female,no data available,50 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076012,GSM3659292,,,,31566584,MS,Non-inflammatory control,Yes,Human,Cerebrospinal fluid,no data available,Female,no data available,50 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076013,GSM3659293,,,,31566584,MS,Disease,No,Human,Cerebrospinal fluid,no data available,Female,no data available,45 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS076014,GSM3659294,,,,31566584,MS,Non-inflammatory control,Yes,Human,Cerebrospinal fluid,no data available,Female,no data available,45 years,no data available,Smart-Seq2,single-cell RNA sequencing,,"The Smart-Seq2 protocol was performed on sorted single cells as described previously (47), with minor modifications. Briefly, PCR preamplification products were purified using Ampure XP beads in a 0.6:1 ratio. For the tagmentation reaction (48), 0.8 ng DNA was used as input. Then, PCR purification was carried out using Ampure XP beads in a 0.75:1 ratio. Multiplex sequencing of 96 single-cell libraries was performed on a Hiseq 1500 lane in 150-bp paired-end mode, giving an average sequence depth of 2 million reads per cell. A total of 3362 CSF cells and 384 PMBCs were sequenced, and 2752 and 332 passed quality control. scRNA-Seq raw data were deposited in the NCBIs Sequence Read Archive database (SRA), and processed gene expression data can be accessed from the Gene Expression Omnibus (GEO) database under accession numbers SRP180896 and GSE127969.",,,
MS077001,GSM3717013,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717013_1_HG37GDMXX.1.TAAGGCGA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Priming (early disease stage),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077002,GSM3717014,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717014_1_HG37GDMXX.1.CGTACTAG.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Priming (early disease stage),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077003,GSM3717015,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717015_1_HG37GDMXX.1.AGGCAGAA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Priming (early disease stage),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077004,GSM3717016,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717016_1_HG37GDMXX.1.TCCTGAGC.dge.txt.gz,txt.gz,,32051591,MS,Inflammation control ,Yes,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Complete Freunds Adjuvant","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077005,GSM3717017,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717017_1_HG37GDMXX.1.GGACTCCT.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Peak Experimental Autoimmune Encephalomyelitis ,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077006,GSM3717018,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717018_1_HG37GDMXX.1.TAGGCATG.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Peak Experimental Autoimmune Encephalomyelitis ,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077007,GSM3717019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717019_1_HG37GDMXX.1.CTCTCTAC.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Peak Experimental Autoimmune Encephalomyelitis ,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077008,GSM3717020,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717020_1_HG37GDMXX.1.CAGAGAGG.dge.txt.gz,txt.gz,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077009,GSM3717021,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717021_1_HG37GDMXX.1.GCTACGCT.dge.txt.gz,txt.gz,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Male ,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077010,GSM3717022,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717022_1_HG37GDMXX.1.CGAGGCTG.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (Remission phase),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077011,GSM3717023,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717023_2_HG37GDMXX.2.AAGAGGCA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (Remission phase),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077012,GSM3717024,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717024_2_HG37GDMXX.2.GTAGAGGA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (Remission phase),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077013,GSM3717025,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717025_2_HG37GDMXX.2.GCTCATGA.dge.txt.gz,txt.gz,,32051591,MS,Inflammation control ,No,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Complete Freunds Adjuvant","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077014,GSM3717026,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717026_2_HG37GDMXX.2.ATCTCAGG.dge.txt.gz,txt.gz,,32051591,MS,Inflammation control ,No,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Complete Freunds Adjuvant","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077015,GSM3717027,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM3717027_2_HG37GDMXX.2.ACTCGCTA.dge.txt.gz,txt.gz,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077016,GSM4002707,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002707_2_H7NF2DRXX.2.TAAGGCGA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Peak Experimental Autoimmune Encephalomyelitis ,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077017,GSM4002708,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002708_2_H7NF2DRXX.2.CGTACTAG.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Peak Experimental Autoimmune Encephalomyelitis ,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077018,GSM4002709,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002709_2_H7NF2DRXX.2.AGGCAGAA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Peak Experimental Autoimmune Encephalomyelitis ,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077019,GSM4002710,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002710_2_H7NF2DRXX.2.TCCTGAGC.dge.txt.gz,txt.gz,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077020,GSM4002711,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002711_2_H7NF2DRXX.2.GCTACGCT.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (Remission phase),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077021,GSM4002712,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002712_2_H7NF2DRXX.2.CGAGGCTG.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (Remission phase),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077022,GSM4002713,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002713_2_H7NF2DRXX.2.AAGAGGCA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (Remission phase),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077023,GSM4002714,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002714_1_H7NF2DRXX.1.GTAGAGGA.dge.txt.gz,txt.gz,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077024,GSM4002715,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002715_1_H7NF2DRXX.1.GCTCATGA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Priming (early disease stage),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077025,GSM4002716,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002716_1_H7NF2DRXX.1.ATCTCAGG.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Priming (early disease stage),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077026,GSM4002717,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002717_1_H7NF2DRXX.1.ACTCGCTA.dge.txt.gz,txt.gz,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Priming (early disease stage),74-96 days,no data available,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077027,GSM4002718,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32051591/GSM4002718_1_H7NF2DRXX.1.GGAGCTAC.dge.txt.gz,txt.gz,,32051591,MS,Healthy ,Yes,Mouse,Central nervous system,none,Male,no data available,74-96 days,no data available,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077028,GSM3721791,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (peak phase),Postnatal day 122,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077029,GSM3721792,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Female,Experimental Autoimmune Encephalomyelitis (peak phase),Postnatal day 122,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077030,GSM3721793,,,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Male,no data available,Postnatal day 144,,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077031,GSM3721794,,,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Male,no data available,Postnatal day 144,,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077032,GSM3721795,,,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Female,no data available,Postnatal day 144,,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077033,GSM3721796,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Female,Experimental Autoimmune Encephalomyelitis (Remission phase),Postnatal day 144,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077034,GSM3721797,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Female,Experimental Autoimmune Encephalomyelitis (Remission phase),Postnatal day 144,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077035,GSM4002805,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Female,Experimental Autoimmune Encephalomyelitis (Remission phase),Postnatal day 126,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077036,GSM4002806,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Female,Experimental Autoimmune Encephalomyelitis (peak phase),Postnatal day 104,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077037,GSM4002807,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Female,Experimental Autoimmune Encephalomyelitis (peak phase),Postnatal day 104,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077038,GSM4002808,,,,32051591,MS,Disease,No,Mouse,Central nervous system,none,Male,Experimental Autoimmune Encephalomyelitis (Remission phase),Postnatal day 126,,Drop-seq,single-cell RNA sequencing,"C57BL/6J, Experimental Autoimmune Encephalomyelitis","Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS077039,GSM4002809,,,,32051591,MS,Healthy,Yes,Mouse,Central nervous system,none,Female,no data available,Postnatal day 126,,Drop-seq,single-cell RNA sequencing,C57BL/6J,"Each CNS was isolated per mouse. A cell suspension was generated by papain digestion, neutralization, and 70um filtration of cell extract. Cells were centrifuged, resuspended in 30% Percoll, centrifuged, washed in PBS, and cell density was quantified. Cells were suspended in PBS and 16% Opti-prep. Libraries were created according to the Drop-seq protocol in Macosko et al. Cell 2015. Following reverse transcription, exonuclease I treatment, and PCR, cDNA libraries were quantified and 600 pg of cDNA was tagmented using Nextera XT library prep kit.",,,
MS078061,GSM5264634,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264634_2_t4_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Healthy,Yes,Human,Cerebrospinal fluid,none,Male,no data available,33 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078062,GSM5264635,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264635_2_t4_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Healthy,Yes,Human,Peripheral blood,none,Male,no data available,33 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078063,GSM5264636,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264636_3_t2_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Healthy,Yes,Human,Cerebrospinal fluid,none,Female,no data available,27 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078064,GSM5264637,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264637_3_t2_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Healthy,Yes,Human,Peripheral blood,none,Female,no data available,27 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078065,GSM5264638,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264638_5_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Neuromyelitis optica ),Yes,Human,Peripheral blood,Remicade and Dexamethasone,Female,no data available,47 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078066,GSM5264639,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264639_6_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Male,Relapsingremitting,44 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078067,GSM5264640,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264640_6_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Male,Relapsingremitting,44 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078068,GSM5264641,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264641_7_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Male,Relapsingremitting,37 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078069,GSM5264642,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264642_7_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Male,Relapsingremitting,37 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078070,GSM5264643,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264643_8_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Male,Relapsingremitting,32 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078071,GSM5264644,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264644_8_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Male,Relapsingremitting,32 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078072,GSM5264645,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264645_9_t1_CSF_uns_5pGEX_2.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,27 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078073,GSM5264646,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264646_9_t1_PB_uns_5pGEX_2.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Female,Relapsingremitting,27 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078074,GSM5264647,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264647_10_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,45 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078075,GSM5264648,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264648_10_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Female,Relapsingremitting,45 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078076,GSM5264649,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264649_16_t1_CSF_uns_3pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Male,Relapsingremitting,22 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078077,GSM5264650,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264650_16_t1_PB_uns_3pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Male,Relapsingremitting,22 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078078,GSM5264651,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264651_18_t1_CSF_uns_3pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,Steroids,Female,Relapsingremitting,29 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078079,GSM5264652,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264652_18_t1_PB_uns_3pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,Steroids,Female,Relapsingremitting,29 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078080,GSM5264653,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264653_21_t3_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Uveitis),Yes,Human,Cerebrospinal fluid,none,Female,no data available,21 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078081,GSM5264654,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264654_21_t3_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Uveitis),Yes,Human,Peripheral blood,none,Female,no data available,21 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078082,GSM5264655,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264655_22_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Clinically isolated syndrome),Yes,Human,Cerebrospinal fluid,no data available,Female,no data available,35 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078083,GSM5264656,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264656_22_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Clinically isolated syndrome),Yes,Human,Peripheral blood,no data available,Female,no data available,35 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078084,GSM5264657,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264657_24_t2_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,45 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078085,GSM5264658,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264658_24_t2_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Female,Relapsingremitting,45 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078086,GSM5264659,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264659_25_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,42 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078087,GSM5264660,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264660_25_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Female,Relapsingremitting,42 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078088,GSM5264661,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264661_27_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,37 years ,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078089,GSM5264662,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264662_27_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Female,Relapsingremitting,37 years ,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078090,GSM5264663,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264663_28_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Female,Relapsingremitting,50 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078091,GSM5264664,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264664_28_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Female,Relapsingremitting,50 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078092,GSM5264665,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264665_29_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Cerebrospinal fluid,none,Male,Relapsingremitting,54 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078093,GSM5264666,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264666_29_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Disease,No,Human,Peripheral blood,none,Male,Relapsingremitting,54 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078094,GSM5264667,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264667_31_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Clinically isolated syndrome),Yes,Human,Cerebrospinal fluid,none,Female,no data available,53 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078095,GSM5264668,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264668_31_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Clinically isolated syndrome),Yes,Human,Peripheral blood,none,Female,no data available,53 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078096,GSM5264669,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264669_31_t1_PB_uns_5pGEX_2.rawCounts.csv.gz,txt.gz,,32859762,MS,Not-healthy control (Clinically isolated syndrome),Yes,Human,Cerebrospinal fluid,none,Female,no data available,53 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078097,GSM5264670,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264670_32_t1_CSF_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Healthy,Yes,Human,Peripheral blood,none,Male,no data available,41 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
MS078098,GSM5264671,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32859762/GSM5264671_32_t1_PB_uns_5pGEX.rawCounts.csv.gz,txt.gz,,32859762,MS,Healthy,Yes,Human,Peripheral blood,none,Male,no data available,41 years,no data available,10x Genomics,single-cell RNA sequencing,,"CSF and blood were obtained during diagnostic and research procedures after subjects had provided informed consent; 20 to 30 mL of CSF was centrifuged immediately after collection at 400  g for 15 min at 4 C. The pellet was resuspended in 80 L of residual supernatant, and lymphocytes were counted using a hemocytometer. Peripheral blood mononuclear cells (PBMCs) were isolated using cell preparation tubes and resuspended in 2% fetal bovine serum. All experiments were performed immediately with freshly collected, unsorted cells.Sequencing libraries were prepared using 3 or 5 library preparation kits (10x Genomics).",,,
,,,,,,,,,,,,,,,,,,,,,,
ALS001001,GSM6781906,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781906_snRNA_C9ALS_A1_FrontalCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,Human,frontal cortex,no data available,Male,no data available,72 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001002,GSM6781907,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781907_snRNA_C9ALS_A1_MotorCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,	motor cortex,no data available,Male,no data available,72 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001003,GSM6781908,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781908_snRNA_C9ALS_A2_FrontalCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,frontal cortex,no data available, Female,no data available,66 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001004,GSM6781909,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781909_snRNA_C9ALS_A2_MotorCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,motor cortex,no data available, Female,no data available,66 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001005,GSM6781910,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781910_snRNA_C9ALS_A3_FrontalCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,frontal cortex,no data available, Female,no data available,72 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001006,GSM6781911,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781911_snRNA_C9ALS_A3_MotorCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,	motor cortex,no data available, Female,no data available,72 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001007,GSM6781912,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781912_snRNA_C9ALS_A4_FrontalCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,frontal cortex,no data available, Female,no data available,59 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001008,GSM6781913,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781913_snRNA_C9ALS_A4_MotorCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,motor cortex,no data available, Female,no data available,59 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001009,GSM6781914,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781914_snRNA_C9ALS_A5_FrontalCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,frontal cortex,no data available,Male,no data available,63 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001010,GSM6781915,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781915_snRNA_C9ALS_A5_MotorCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,motor cortex,no data available,Male,no data available,63 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001011,GSM6781916,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781916_snRNA_C9ALS_A6_FrontalCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,frontal cortex,no data available,Male,no data available,61 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001012,GSM6781917,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781917_snRNA_C9ALS_A6_MotorCortex_raw_,10x_matrix,,37714849,ALS,Disease,No,	Human,motor cortex,no data available,Male,no data available,61 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001013,GSM6781918,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781918_snRNA_C9FTD_F1_FrontalCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,frontal cortex,no data available, Female,no data available,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001014,GSM6781919,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781919_snRNA_C9FTD_F1_MotorCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,motor cortex,no data available, Female,no data available,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001015,GSM6781920,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781920_snRNA_C9FTD_F2_FrontalCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,frontal cortex,no data available, Female,no data available,73 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001016,GSM6781921,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781921_snRNA_C9FTD_F2_MotorCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,motor cortex,no data available, Female,no data available,73 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001017,GSM6781922,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781922_snRNA_C9FTD_F3_FrontalCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,frontal cortex,no data available,Male,no data available,64 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001018,GSM6781923,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781923_snRNA_C9FTD_F3_MotorCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,motor cortex,no data available,Male,no data available,64 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001020,GSM6781924,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781924_snRNA_C9FTD_F4_FrontalCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,frontal cortex,no data available,Male,no data available,66 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001021,GSM6781925,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781925_snRNA_C9FTD_F4_MotorCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,motor cortex,no data available,Male,no data available,66 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001022,GSM6781926,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781926_snRNA_C9FTD_F5_FrontalCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,	frontal cortex,no data available,Male,no data available,71 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001023,GSM6781927,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781927_snRNA_C9FTD_F5_MotorCortex_raw_,10x_matrix,,37714849,FTD,Disease,No,	Human,motor cortex,no data available,Male,no data available,71 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001024,GSM6781928,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781928_snRNA_Control_C1_FrontalCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,frontal cortex,no data available, Female,no data available,67 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001025,GSM6781929,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781929_snRNA_Control_C1_MotorCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,motor cortex,no data available, Female,no data available,67 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001026,GSM6781930,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781930_snRNA_Control_C2_FrontalCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,frontal cortex,no data available,Male,no data available,64 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001027,GSM6781931,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781931_snRNA_Control_C2_MotorCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,motor cortex,no data available,Male,no data available,64 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001028,GSM6781932,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781932_snRNA_Control_C3_FrontalCortex_raw_,10x_matrix,,37714849,FTD; ALS,not-healthy control (old cerebrovascular accident),Yes,	Human,frontal cortex,no data available,Male,no data available,70 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001029,GSM6781933,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781933_snRNA_Control_C3_MotorCortex_raw_,10x_matrix,,37714849,FTD; ALS,not-healthy control (old cerebrovascular accident),Yes,	Human,motor cortex,no data available,Male,no data available,70 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001030,GSM6781934,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781934_snRNA_Control_C4_FrontalCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,frontal cortex,no data available,Male,no data available,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001031,GSM6781935,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781935_snRNA_Control_C4_MotorCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,motor cortex,no data available,Male,no data available,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001032,GSM6781936,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781936_snRNA_Control_C5_FrontalCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,	frontal cortex,no data available, Female,no data available,73 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001033,GSM6781937,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781937_snRNA_Control_C5_MotorCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human, motor cortex,no data available, Female,no data available,73 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001034,GSM6781938,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781938_snRNA_Control_C6_FrontalCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,frontal cortex,no data available, Female,no data available,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS001035,GSM6781939,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37714849/GSM6781939_snRNA_Control_C6_MotorCortex_raw_,10x_matrix,,37714849,FTD; ALS,Healthy,Yes,	Human,motor cortex,no data available, Female,no data available,56 years,no data available,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from 50-70 mg frozen brain tissue mostly as described in Velmeshev et al. (Science 2019). For each donor, brain tissues from the motor cortex and frontal cortex were dissected with a scalpel blade. The tissues were then homogenized on ice in 5mL lysis buffer (0.32 M sucrose, 3 mM Mg(Ac)2, 3 mM CaCl2, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water), containing 0.4 U/l freshly added Recombinant RNase Inhibitor (RRI; Takara, Cat. # 2313A) until no chunks of tissue were visible in the tissue suspension (~20 strokes) using a glass Dounce homogenizer (Thomas Scientific; Cat. # 3431D76; size A). The homogenized tissues were filtered through a 40 m strainer (Thermofisher; Cat. # 22-363-547) and transferred to a 30 mL thick polycarbonate ultracentrifuge tube (Beckman Coulter; Cat. # 355631). Nine mL of the sucrose buffer (1.8 M Sucrose, 3 mM Mg(Ac)2, 1 mM DTT, and 10 mM Tris-HCl pH 8.0 in DEPC-treated water) were added to the bottom of the tubes with the tissue homogenate, and the tubes were centrifuged at 34,400 RPM (107,164 FCF) for 2.5 hours at 4C, using a swing bucket rotor (SW28). The supernatant was aspirated, and the nuclear pellet was submerged on ice for 20 min in 250 uL of DEPC-treated water-based PBS, containing 1% BSA and 0.4 U/L RRI. The nuclear pellet was then resuspended and filtered twice through a 30 m cell strainer (Miltenyi Pre-separation Filters; Cat. # 130-041-407).Nuclei were counted using a hemocytometer and diluted to ~2,000 nuclei/L before performing single-nucleus capture on the 10X Genomics Single-Cell 3 system. The 10X capture and library preparation protocols were used without modification. Matched control, C9-ALS and C9-FTD samples were loaded on the same 10X chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pooled and sequenced on the NovaSeq 6000 machine with an average depth of ~10,870 unique molecular identifiers (UMIs) per nucleus.",,,
ALS002001,201019_ALS_101_snRNA-B1,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1 (Braak stage); 0 (Thal phase),54.85,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002002,201019_ALS_102_snRNA-B2,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1 (Braak stage); 0 (Thal phase),58.5,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002003,201019_ALS_103_snRNA-B3,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 0 (Thal phase),59.37,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002004,201019_ALS_104_snRNA-B4,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1 (Braak stage); 0 (Thal phase),60.29,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002005,201019_ALS_106_snRNA-B5,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 1 (Thal phase),61.97,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002006,201019_ALS_108_snRNA-B6,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 0 (Thal phase),64.21,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002007,191112_ALS_110_snRNA-B9,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,3 (Braak stage); 2 (Thal phase),71.62,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002008,191112_ALS_111_snRNA-B10,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 1 (Thal phase),71.16,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002009,191112_ALS_112_snRNA-D1,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 2 (Thal phase),79.49,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002010,201019_ALS_113_snRNA-B7,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 0 (Thal phase),58.87,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002011,191112_ALS_114_snRNA-B12,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,4 (Braak stage); 0 (Thal phase),62.2,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002012,191112_ALS_115_snRNA-C1,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2.5 (Braak stage); 2 (Thal phase),66.33,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002013,191112_ALS_116_snRNA-C2,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,0 (Braak stage); 1 (Thal phase),52.32,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002014,191112_ALS_117_snRNA-C3,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,1.5 (Braak stage); 0 (Thal phase),60.35,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002015,191112_ALS_118_snRNA-C4,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),64.28,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002016,191112_ALS_120_snRNA-A1,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),66.74,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002017,191112_ALS_122_snRNA-D2,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),70.83,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002018,191112_ALS_124_snRNA-A3,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 2 (Thal phase),71.88,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002019,191112_ALS_126_snRNA-A6,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,5 (Braak stage),76.33,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002020,191112_ALS_127_snRNA-A4,,,,38521060,ALS,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 1 (Thal phase),79.67,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002021,191112_ALS_128_snRNA-A7,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),58.7,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002022,191112_ALS_129_snRNA-A2,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,1 (Braak stage); 0 (Thal phase),63.01,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002023,191112_ALS_130_snRNA-A5,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),67.95,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002024,210910_MCX_ALS_131_snRNA-C2,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 0 (Thal phase),71,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002025,210910_MCX_ALS_132_snRNA-C3,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),63,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002026,210910_MCX_ALS_133_snRNA-C4,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 1 (Thal phase),59,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002027,210910_MCX_ALS_134_snRNA-C5,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 0 (Thal phase),60,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002028,210910_MCX_ALS_135_snRNA-C6,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 0 (Thal phase),62,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002029,210910_MCX_ALS_136_snRNA-C7,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 3 (Thal phase),70,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002030,210910_MCX_ALS_137_snRNA-C8,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,0 (Braak stage); 0 (Thal phase),68,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002031,210910_MCX_ALS_138_snRNA-C9,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 0 (Thal phase),67,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002032,210910_MCX_ALS_139_snRNA-D6,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 1 (Thal phase),70,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002033,210910_MCX_ALS_140_snRNA-D7,,,,38521060,ALS,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 0 (Thal phase),57,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002034,191113_FTLD_202_snRNA-D3,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1 (Braak stage); 0 (Thal phase),63.26,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002035,191113_FTLD_204_snRNA-D4,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1 (Braak stage); 1 (Thal phase),71.28,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002036,200721_FTLD_206_snRNA-A10,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0.5 (Braak stage); 1 (Thal phase),73.75,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002037,191113_FTLD_207_snRNA-D5,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2.5 (Braak stage); 0 (Thal phase),74.79,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002038,191113_FTLD_209_snRNA-D6,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2.5 (Braak stage); 2 (Thal phase),79.83,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002039,200721_FTLD_210_snRNA-A11,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,3.5 (Braak stage); 1 (Thal phase),75.24,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002040,191113_FTLD_211_snRNA-D7,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 0 (Thal phase),71.01,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002041,191113_FTLD_214_snRNA-D9,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0.5 (Braak stage); 1 (Thal phase),74.43,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002042,191113_FTLD_216_snRNA-H3,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),65.71,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002043,191113_FTLD_217_snRNA-D11,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,0 (Braak stage); 0 (Thal phase),70.54,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002044,191113_FTLD_218_snRNA-H4,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),73.79,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002045,191113_FTLD_222_snRNA-E1,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,1 (Braak stage); 0 (Thal phase),77.37,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002046,191113_FTLD_225_snRNA-H5,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,0.5 (Braak stage); 0 (Thal phase),70.88,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002047,191113_FTLD_226_snRNA-E4,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2.5 (Braak stage); 0 (Thal phase),no data available,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002048,191113_FTLD_228_snRNA-E5,,,,38521060,FTLD,Disease (sporadic),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,3 (Braak stage),66.36,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002049,191113_FTLD_229_snRNA-E6,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2.5 (Braak stage); 0 (Thal phase),65.88,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002050,201025_FTLD_232_snRNA-C5,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,2 (Braak stage); 2 (Thal phase),90,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002051,201025_FTLD_234_snRNA-C6,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 4 (Thal phase),70,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002052,201025_FTLD_235_snRNA-C7,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,3 (Braak stage); 3 (Thal phase),89,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002053,210526_FTLD_236_snRNA-D2,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,prefrontal cortex (Brodmann area 9),no data available,Female,1 (Braak stage); 0 (Thal phase),70,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002054,201025_FTLD_237_snRNA-C9,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),77,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002055,201025_FTLD_238_snRNA-C10,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Female,4 (Braak stage); 2 (Thal phase),80,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002056,201025_FTLD_239_snRNA-C11,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 0 (Thal phase),62,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002057,201025_FTLD_240_snRNA-C12,,,,38521060,FTLD,Disease (C9orf72 familial),No,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2 (Braak stage); 2 (Thal phase),75,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002058,191114_PN_301_snRNA-E7,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1 Braak stage); 0 (Thal phase),54.37,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002059,200721_PN_302_snRNA-B4,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,0 (Braak stage); 0 (Thal phase),58.64,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002060,191114_PN_303_snRNA-E8,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1 (Braak stage); 2 (Thal phase),61.19,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002061,191114_PN_304_snRNA-E9,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,4 (Braak stage); 2 (Thal phase),67.4,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002062,191114_PN_306_snRNA-E10,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,3.5 (Braak stage),89.64,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002063,191114_PN_307_snRNA-E11,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,3 (Braak stage); 3 (Thal phase),89.59,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002064,191114_PN_309_snRNA-F1,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,3 (Braak stage); 1 (Thal phase),92.15,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002065,201019_PN_311_snRNA-B8,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Female,1.5 (Braak stage); 2 (Thal phase),93.97,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002066,191114_PN_317_snRNA-F2,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,3 (Braak stage); 0 (Thal phase),62,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002067,191114_PN_318_snRNA-F3,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,1.5 (Braak stage); 0 (Thal phase),64.98,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002068,191114_PN_319_snRNA-F4,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,1 (Braak stage); 0 (Thal phase),73.91,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002069,191114_PN_322_snRNA-F5,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,3 (Braak stage); 0 (Thal phase),80.08,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002070,191114_PN_323_snRNA-F6,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2.5 (Braak stage); 2 (Thal phase),80.25,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002071,191114_PN_324_snRNA-F7,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,2.5 (Braak stage); 3 (Thal phase),84.79,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002072,191114_PN_325_snRNA-F8,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,3 (Braak stage); 2 (Thal phase),84.29,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS002073,191114_PN_328_snRNA-F9,,,,38521060,ALS; FLTD,Healthy,Yes,	Human,primary motor cortex (Brodmann area 4),no data available,Male,3 (Braak stage); 1 (Thal phase),85.16,no data available,10x Genomics,single-nucleus RNA sequencing,,"All cases underwent standard neuroanatomic sampling by a single neuropathologist (D.W.D) who performed the cutting of all autopsied procured brains (Mayo Clinic IRB 15009452). For all brains harvested and received at the Mayo Clinic Neuropathology Laboratory, the right hemibrain was frozen (80C) and the left hemibrain was fixed for long-term preservation. For the single-nucleus study, BA9 (dorsolateral prefrontal) and BA4 (primary motor) were sampled from frozen tissue stored at 80C. To maintain tissue integrity, tissue was stored at 20C for 30 min and subsequently at room temperature for 45 min to allow gradual thawing prior to sampling. BA9 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the head of the caudate in coronal slabs. BA4 was sampled from the lateral surface in cases with an intact hemisphere, or at the level of the pulvinar in coronal slabs. For IHC, sections of BA4 and BA9 from the fixed hemibrain were used.Nuclei isolation was performed as reported in Lee et al. (Neuron 2020).98 All procedures were performed on ice. For the human tissue samples, 150 mg of grey matter was sectioned and homogenized. Briefly, each tissue was homogenized in 700 L of homogenization buffer with a 2 mL tissue grinder using 10 strokes with a loose pestle, followed by 10 strokes with a tight pestle. Homogenized tissue was filtered through a 40 m cell strainer and mixed with 450 L of working solution. The mixture was then slowly pipetted onto the top of an iodixanol density gradient (300 L 40% solution and 750 L of 30% solution) inside a dolphin microcentrifuge tube. Nuclei were pelleted at the 30%40% interface of the density gradient by centrifugation at 10,000  g for 5 min at 4C using a fixed angle rotor. The nuclear pellet was collected by aspirating ~100L from the interface and transferring to a 1.5 mL siliconized microcentrifuge tube. The pellet was washed with in PBS with 2% BSA containing 0.12 U/L SUPERase-In RNase Inhibitor (Thermo Fisher Scientific). The nuclei were pelleted by centrifugation at 300  g for 3 min at 4C using a swing-bucket rotor. The nuclei were again pelleted and washed twice more under the same conditions. The nuclear pellet was resuspended in 100 L of PBS with 2% BSA.",,,
ALS003001,GSM6251277,,,preprocessed_data,37085528,ALS,Healthy,Yes,	Mouse,cortex,none,no data available,no data available,1 month,812,10x Genomics,single-cell RNA sequencing,WT,"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS003002,GSM6251278,,,,37085528,ALS,Disease,No,	Mouse,cortex,,no data available,no data available,1 month,2285,10x Genomics,single-cell RNA sequencing,SOD1(G93A),"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS003003,GSM6251279,,,,37085528,ALS,Healthy,Yes,	Mouse,cortex,none,no data available,no data available,2 months,3173,10x Genomics,single-cell RNA sequencing,WT,"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS003004,GSM6251280,,,,37085528,ALS,Disease,No,	Mouse,cortex,,no data available,no data available,2 months,3193,10x Genomics,single-cell RNA sequencing,SOD1(G93A),"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS003005,GSM6251281,,,,37085528,ALS,Healthy,Yes,	Mouse,cortex,none,no data available,no data available,3 months,3110,10x Genomics,single-cell RNA sequencing,WT,"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS003006,GSM6251282,,,,37085528,ALS,Disease,No,	Mouse,cortex,,no data available,no data available,3 months,3327,10x Genomics,single-cell RNA sequencing,SOD1(G93A),"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS003007,GSM6251283,,,,37085528,ALS,Healthy,Yes,	Mouse,cortex,none,no data available,no data available,4 months,1178,10x Genomics,single-cell RNA sequencing,WT,"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS003008,GSM6251284,,,,37085528,ALS,Disease,No,	Mouse,cortex,,no data available,no data available,4 months,4502,10x Genomics,single-cell RNA sequencing,SOD1(G93A),"The cortical tissue was isolated and dissociated following the Adult Brain dissociation protocol for mice and rats (Milteyni-Biotec, Germany), omitting the red blood cell removal. The cells were treated with actinomycin D to prevent activation of immediate early genes. After the debris removal, cells were layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, NJ) and harvested by centrifugation (300g for 6 min). Potential cell aggregates were removed by 70 m cell strainers (Becton Dickinson, NJ). The final suspension was labeled with ACSA-2, Cd11b and O4 antibodies conjugated with allophycocyanin and phycoerythrin respectively to allow for enrichment of astrocytes, microglia and oligodendrocytes using FACS. The cells were collected into 200 l of Advanced Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum (ThermoFisher Scientific Waltham, MA). Four animals per condition (2 males and 2 females) were pooled for the preparation of cell suspension.Chromium Next GEM Single Cell 3' Reagent Kits v3.1 (10x Genomics, Pleasanton, CA) was used to prepare the sequencing libraries and the protocol was performed according to the manufacturers instructions. Briefly, 10x Chromium platform was used to encapsulate individual cells into droplets along with beads covered in cell-specific 10x Barcodes, UMIs and poly(dT) sequences. After reverse transcription the cDNA libraries were amplified (13-14 cycles), fragmented and ligated to sequencing adaptors. SPRISelect magnetic beads were used for purification of the cDNA suspension and size selection of fragments. Concentration and quality of the libraries was measured using Qubit dsDNA HS Assay Kit (Invitrogen) and Fragment Analyzer HS NGS Fragment Kit (#DNF-474, Agilent). The libraries were pooled and sequenced in paired-end mode using Illumina NovaSeq 6000 SP Reagent Kit, Read 1 containing a barcode and a UMI and Read 2 covering the sequence of interest. Sequencing data comprised of approx. 100-200 million reads per sample.",,,
ALS004001,GSM6260246,,,,36322143,ALS,Disease,No,	Mouse,frontal cortex,,no data available,no data available,10 month,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6; C9-BAC,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
ALS004002,GSM6260247,,,,36322143,ALS,Disease,No,	Mouse,frontal cortex,,no data available,no data available,10 month,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6;C9-BAC;C9orf72+/-,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
ALS004003,GSM6260248,,,,36322143,ALS,Disease,No,	Mouse,frontal cortex,,no data available,no data available,10 month,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6;C9-BAC;C9orf72+/-,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
ALS004004,GSM6260249,,,,36322143,ALS,Healthy,Yes,	Mouse,frontal cortex,none,no data available,no data available,10 month,no data available,10x Genomics,single-nucleus RNA sequencing,C57BL/6; WT,"Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500  g for 5 min at 4 C. After centrifugation, the nuclei were resuspended in 1 ml of nuclei suspension buffer (NSB) consisting of 1XPBS, 1%BSA (#AM2618, Thermo Fisher Scientific) and 0.2U/ul RNAse inhibitor (#AM2694, Thermo Fisher Scientific) and were filtered through a 40-m Flowmi Cell Strainer (#H13680-0040, Bel-Art). Nuclei concentration was determined using 0.4% Trypan Blue (#15250061, Thermo Fisher Scientific). Final concentration of 1000 nuclei/l was adjusted with NSB.Droplet-based snRNA-seq libraries were prepared using the Chromium Single Cell 3 v2 according to the manufacturers protocol. ",,,
ALS005001,GSM4100677,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),none,Female,no data available,21 years (tissue collection); 0 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005002,GSM4100678,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),none,Female,no data available,21 years (tissue collection); 6 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005003,GSM4100679,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),none,Female,no data available,21 years (tissue collection); 12 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005004,GSM4100680,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),none,Female,no data available,21 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005005,GSM4100681,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),none,Female,no data available,21 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005006,GSM4100682,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),none,Male,no data available,57 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005007,GSM4100683,,,,33382996,ALS,Disease (sporadic),No,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),no data available,Male,no data available,37 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005008,GSM4100684,,,,33382996,ALS,Disease (sporadic),No,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),no data available,Male,no data available,51 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005009,GSM4100685,,,,33382996,ALS,Disease (C9orf72),No,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,47 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005010,GSM4100686,,,,33382996,ALS,Disease (C9orf72),No,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,47 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005011,GSM4100687,,,,33382996,ALS,Disease (C9orf72),No,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,49 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005012,GSM4100688,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),none,Male,no data available,76 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005013,GSM4100689,,,,33382996,ALS,Disease (C9orf72),No,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,47 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005014,GSM4100690,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),none,Male,no data available,76 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005015,GSM4100691,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),none,Male,no data available,57 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005016,GSM4100692,,,,33382996,ALS,Disease,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,47 years (tissue collection); 18 days (differentiaiton),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005017,GSM4100693,,,,33382996,ALS,Disease (sporadic),No,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),no data available,Male,no data available,37 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005018,GSM4100694,,,,33382996,ALS,Disease (C9orf72),No,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,47 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005019,GSM4100695,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),none,Male,no data available,57 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005020,GSM4100696,,,,33382996,ALS,Disease,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,47 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005021,GSM4100697,,,,33382996,ALS,Disease (sporadic),No,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),no data availabe,Male,no data available,37 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005022,GSM4100698,,,,33382996,ALS,Disease (C9orf72),No,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Male,no data available,49 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005023,GSM4100699,,,,33382996,ALS,Disease (C9orf72),No,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),no data available,Female,no data available,64 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005024,GSM4100700,,,,33382996,ALS,Healthy,Yes,	Human,iPSC-derived motor neurons; Peripheral Blood Mononuclear Cells (tissue source for iPSC),none,Female,no data available,78.68 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS005025,GSM4100701,,,,33382996,ALS,Disease,Yes,	Human,iPSC-derived motor neurons; fibroblast (tissue source for iPSC),,Male,no data available,49 years (tissue collection); 18 days (differentiation),no data available,10x Genomics,single-cell RNA sequencing,iPSC,"Growth protocol Differentiation was performed essentially as described in Maury et al. Nat Biotechnol, 2015Extracted molecule        polyA RNAExtraction protocol        Live cells were dissociated with 0.25% Trypsin-EDTA, filtered, and counted. Single cell capture was performed using the Illumina Bio-Rad ddSEQ System or 10X Genomics Chromium Controller. Sample specific information can be found in the 'Capture Platform' column in the Samples section.cDNA libraries were prepared following the manufacturer's instructions using the Illumina Bio-Rad SureCell WTA 3 Library Prep Kit or 10X Chromium Single Cell 3 Library & Gel Bead Kit v2. Sample specific information can be found under the 'Library Construction Kit' column in the Samples section.",,,
ALS006001,1312,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples (Brodmann Area 10),no treatment,F,no data available,87,44,10x Genomics,single-nucleus RNA sequencing,,"For human tissues, nuclei from 4 to 5 human donors were pooled to a final volume of 42l. We aimed for each 10x reaction to include two control groups (one from an older healthy individual and another from a younger individual) and two groups representing different disease states (AD, ALS or FTD), each uniquely tagged with a nuclear pore hashtag for subsequent identification using DemuxEM. We aimed for total nuclei count in each mixture to be ~8,000 nuclei. These mixtures were then loaded onto a Chromium single-cell V3 3 chip (10x Genomics) and processed according to the manufacturers protocol. In brief, after GEM generation, they were subjected to reverse cross-linking and reverse transcription by heating at 53C for 45min and then at 85C for 5min. The samples were subsequently stored at 4C until GEM recovery. For cDNA amplification, the standard 10x Genomics protocol was used, adding Feature cDNA primer 2 into the mix. Following amplification, an SPRI-based size selection was carried out to separate antibodyoligonucleotide-derived cDNA from mRNA-derived cDNA. The antibodyoligonucleotide cDNA, contained in the supernatant, was set aside for antibody capture library construction. Meanwhile, the mRNA-derived cDNA, attached to SPRI beads, was processed for gene expression library construction. Gene expression libraries were prepared from the mRNA-derived cDNA using enzymatic fragmentation, adaptor ligation and sample indexing, following the 10x Genomics protocol. These libraries were stored at 20C until quantification and sequencing. For antibody capture library, the antibodyoligonucleotide-derived cDNA underwent mixing with 1.4 SPRIselect, magnetic separation and ethanol washes, followed by elution in sterile water. PCR amplification of the cDNA with distinct TotalSeq-B index primer mixes generated the protein capture libraries. Subsequently, these libraries underwent purification, elution, and were stored at 4C. Quantification and sequencing were performed on a NovaSeq, utilizing v.1.5 chemistry.",,,
ALS006002,1439,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples (Brodmann Area 10),no treatment,F,no data available,85,811,10x Genomics,single-nucleus RNA sequencing,,"For human tissues, nuclei from 4 to 5 human donors were pooled to a final volume of 42l. We aimed for each 10x reaction to include two control groups (one from an older healthy individual and another from a younger individual) and two groups representing different disease states (AD, ALS or FTD), each uniquely tagged with a nuclear pore hashtag for subsequent identification using DemuxEM. We aimed for total nuclei count in each mixture to be ~8,000 nuclei. These mixtures were then loaded onto a Chromium single-cell V3 3 chip (10x Genomics) and processed according to the manufacturers protocol. In brief, after GEM generation, they were subjected to reverse cross-linking and reverse transcription by heating at 53C for 45min and then at 85C for 5min. The samples were subsequently stored at 4C until GEM recovery. For cDNA amplification, the standard 10x Genomics protocol was used, adding Feature cDNA primer 2 into the mix. Following amplification, an SPRI-based size selection was carried out to separate antibodyoligonucleotide-derived cDNA from mRNA-derived cDNA. The antibodyoligonucleotide cDNA, contained in the supernatant, was set aside for antibody capture library construction. Meanwhile, the mRNA-derived cDNA, attached to SPRI beads, was processed for gene expression library construction. Gene expression libraries were prepared from the mRNA-derived cDNA using enzymatic fragmentation, adaptor ligation and sample indexing, following the 10x Genomics protocol. These libraries were stored at 20C until quantification and sequencing. For antibody capture library, the antibodyoligonucleotide-derived cDNA underwent mixing with 1.4 SPRIselect, magnetic separation and ethanol washes, followed by elution in sterile water. PCR amplification of the cDNA with distinct TotalSeq-B index primer mixes generated the protein capture libraries. Subsequently, these libraries underwent purification, elution, and were stored at 4C. Quantification and sequencing were performed on a NovaSeq, utilizing v.1.5 chemistry.",,,
ALS006003,1630,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,83,1803,10x Genomics,single-nucleus RNA sequencing,,"For human tissues, nuclei from 4 to 5 human donors were pooled to a final volume of 42l. We aimed for each 10x reaction to include two control groups (one from an older healthy individual and another from a younger individual) and two groups representing different disease states (AD, ALS or FTD), each uniquely tagged with a nuclear pore hashtag for subsequent identification using DemuxEM. We aimed for total nuclei count in each mixture to be ~8,000 nuclei. These mixtures were then loaded onto a Chromium single-cell V3 3 chip (10x Genomics) and processed according to the manufacturers protocol. In brief, after GEM generation, they were subjected to reverse cross-linking and reverse transcription by heating at 53C for 45min and then at 85C for 5min. The samples were subsequently stored at 4C until GEM recovery. For cDNA amplification, the standard 10x Genomics protocol was used, adding Feature cDNA primer 2 into the mix. Following amplification, an SPRI-based size selection was carried out to separate antibodyoligonucleotide-derived cDNA from mRNA-derived cDNA. The antibodyoligonucleotide cDNA, contained in the supernatant, was set aside for antibody capture library construction. Meanwhile, the mRNA-derived cDNA, attached to SPRI beads, was processed for gene expression library construction. Gene expression libraries were prepared from the mRNA-derived cDNA using enzymatic fragmentation, adaptor ligation and sample indexing, following the 10x Genomics protocol. These libraries were stored at 20C until quantification and sequencing. For antibody capture library, the antibodyoligonucleotide-derived cDNA underwent mixing with 1.4 SPRIselect, magnetic separation and ethanol washes, followed by elution in sterile water. PCR amplification of the cDNA with distinct TotalSeq-B index primer mixes generated the protein capture libraries. Subsequently, these libraries underwent purification, elution, and were stored at 4C. Quantification and sequencing were performed on a NovaSeq, utilizing v.1.5 chemistry.",,,
ALS006004,1705,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,95,951,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006005,1720,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,63,1270,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006006,4587,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,81,1119,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006007,4976,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,104,1804,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006008,5000,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,78,717,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006009,5222,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,80,1168,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006010,5390,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,61,1685,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006011,5501,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,78,286,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006012,5525,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,89,1732,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006013,5680,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,83,71,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006014,4513,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,87,1184,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006015,4522,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,83,791,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006016,4535,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,87,1047,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006017,4559,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,87,779,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006018,4632,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,84,1004,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006019,4737,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,80,549,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006020,5195,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,80,1373,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006021,5598,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,80,826,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006022,5732,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,85,1453,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006023,6270,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,74,1740,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006024,6342,,h5ad,whole,40087396,AD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,71,2586,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006025,845,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,72,1538,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006026,1016,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,66,3805,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006027,1081,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,46,2016,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006028,4872,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,71,1171,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006029,5148,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,62,1502,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006030,5740,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,86,1441,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006031,5951,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,54,1318,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006032,5952,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,74,709,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006033,6314,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,68,3905,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006034,925,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,54,1746,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006035,4600,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,68,119,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006036,4762,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,59,460,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006037,5388,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,61,912,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006038,5549,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,45,1186,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006039,5675,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,53,1418,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006040,5678,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,55,2751,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006041,6044,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,68,1014,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006042,6101,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,88,2559,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006043,6350,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,60,1136,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006044,-3461,,h5ad,whole,40087396,ALS,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,77,588,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006045,5954,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,73,1216,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006046,6199,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,73,1605,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006047,6207,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,73,1887,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006048,6316,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,77,2885,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006049,5151,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,65,1400,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006050,5729,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,60,1983,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006051,6019,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,65,3530,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006052,6047,,h5ad,whole,40087396,FTD,Disease,,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,79,1991,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006053,1819,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,82,1900,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006054,4921,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,73,1753,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006055,5511,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,80,168,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006056,5823,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,82,1272,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006057,6332,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,95,505,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006058,6371,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,90,1738,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006059,946,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,69,3324,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006060,5028,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,67,850,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006061,5082,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,68,1480,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006062,5089,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,89,902,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006063,5171,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,79,3086,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006064,5352,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,81,966,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006065,5497,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,68,1188,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006066,5657,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,82,1170,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006067,5661,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,70,4661,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006068,5697,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,67,1479,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006069,5824,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,74,1144,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006070,5830,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,75,3152,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006071,5840,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,75,1276,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006072,6054,,h5ad,whole,40087396,OldCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,76,480,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006073,689,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,19,852,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006074,1486,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,22,2633,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006075,1710,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,26,748,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006076,1843,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,15,1341,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006077,4641,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,24,532,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006078,5125,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,24,2028,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006079,5337,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,28,1101,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006080,5344,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,25,2978,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006081,5575,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,19,1638,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006082,5602,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,F,no data available,22,1592,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006083,1025,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,21,2382,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006084,1026,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,28,556,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006085,1259,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,24,737,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006086,1429,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,18,596,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006087,1712,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,20,1898,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006088,4916,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,19,221,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006089,5242,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,15,1834,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006090,5532,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,18,1311,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006091,5580,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,29,1291,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS006092,6096,,h5ad,whole,40087396,YngCtrl,Healthy,Yes,	Human,cortical samples  (Brodmann Area 10),no treatment,M,no data available,28,165,10x Genomics,single-nucleus RNA sequencing,,,,,
ALS007001,GSM7083181,,,txt,38907103,ALS,Mixed,Mixed,	Human,cortical samples,,no data available,no data available,no data available,,Drop-Seq,single-nucleus RNA sequencing,,"RNA quality of brain samples was assessed by running bulk nuclear RNA on an Agilent TapeStation for RIN scores. Extraction of nuclei from frozen samples was performed as previously described85. Briefly, tissue was dissected and minced with a razor blade on ice and then placed in 4 ml ice-cold extraction buffer (Wash buffer (82 mM Na2SO4, 30 mM K2SO4, 5 mM MgCl2, 10 mM glucose, and 10 mM HEPES, pH adjusted to 7.4 with NaOH) containing 1% Triton X-100 and 5% Kollidon VA64). Tissue was homogenized with repeated pipetting, followed by passing the homogenized suspension twice through a 26  gauge needle on a 3 ml syringe (pre-chilled), once through a 20 mm mesh filter, and once through a 5 mm filter using vacuum. The nuclei were then diluted in 50 ml ice-cold wash buffer, split across four 50 ml tubes, and centrifuged at 500xg for 10 minutes at 4C. The supernatant was discarded, the nuclei pellet was resuspended in 1 ml cold wash buffer. Nuclei were DAPI-stained with Hoechst, loaded onto a hemocytometer, and counted using brightfield and fluorescence microscopy. The solution was diluted to ~176 nuclei/ul before proceeding with Drop-seq as described in ref.1528. cDNA amplification was performed using around 6000 beads per reaction with 16 PCR cycles. The integrity of both the cDNA and tagmented libraries were assessed for quality control on the Agilent Bioanalyzer as in ref86. Libraries were sequenced on a Nova-seq S2, with a 60 bp genomic read. Reads were aligned to the human genome assembly (hg19). Digital Gene Expression files were generated with the Zamboni Drop-seq analysis pipeline, designed by the McCarroll group85,87.",,,
ALS008001,GSM8370898,,,txt,40067829,ALS,Disease (sporadic),No,	Human,motor cortex,,Male,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Single nuclei were extracted from archived human postmortem motor cortex tissue using a Dounce homogenizer After removing cell debris, the lysed, filtered homogenate was then promptly centrifuged and supernatant decanted without disrupting the nuclei pellet. Following wash processes, the nucleus suspension was purified via gradient centrifugation, and sorted by FACS. Nuclei were loaded onto 10x Chromium chips, with library preparation performed using the Single Cell 3' Gene Expression kit v3.1 according to the manufacturer's instructions. Single nuclei RNA-seq",,,
ALS008002,GSM8370899,,,txt,40067829,ALS,Disease (sporadic),No,	Human,motor cortex,,Male,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Single nuclei were extracted from archived human postmortem motor cortex tissue using a Dounce homogenizer After removing cell debris, the lysed, filtered homogenate was then promptly centrifuged and supernatant decanted without disrupting the nuclei pellet. Following wash processes, the nucleus suspension was purified via gradient centrifugation, and sorted by FACS. Nuclei were loaded onto 10x Chromium chips, with library preparation performed using the Single Cell 3' Gene Expression kit v3.1 according to the manufacturer's instructions. Single nuclei RNA-seq",,,
ALS008003,GSM8370900,,,txt,40067829,ALS,Disease (sporadic),No,	Human,motor cortex,,Female,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Single nuclei were extracted from archived human postmortem motor cortex tissue using a Dounce homogenizer After removing cell debris, the lysed, filtered homogenate was then promptly centrifuged and supernatant decanted without disrupting the nuclei pellet. Following wash processes, the nucleus suspension was purified via gradient centrifugation, and sorted by FACS. Nuclei were loaded onto 10x Chromium chips, with library preparation performed using the Single Cell 3' Gene Expression kit v3.1 according to the manufacturer's instructions. Single nuclei RNA-seq",,,
ALS008004,GSM8370901,,,txt,40067829,ALS; FTD,Disease (sporadic ALS),No,	Human,motor cortex,,Female,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Single nuclei were extracted from archived human postmortem motor cortex tissue using a Dounce homogenizer After removing cell debris, the lysed, filtered homogenate was then promptly centrifuged and supernatant decanted without disrupting the nuclei pellet. Following wash processes, the nucleus suspension was purified via gradient centrifugation, and sorted by FACS. Nuclei were loaded onto 10x Chromium chips, with library preparation performed using the Single Cell 3' Gene Expression kit v3.1 according to the manufacturer's instructions. Single nuclei RNA-seq",,,
ALS008005,GSM8370902,,,txt,40067829,ALS,Healthy,Yes,	Human,motor cortex,,Male,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Single nuclei were extracted from archived human postmortem motor cortex tissue using a Dounce homogenizer After removing cell debris, the lysed, filtered homogenate was then promptly centrifuged and supernatant decanted without disrupting the nuclei pellet. Following wash processes, the nucleus suspension was purified via gradient centrifugation, and sorted by FACS. Nuclei were loaded onto 10x Chromium chips, with library preparation performed using the Single Cell 3' Gene Expression kit v3.1 according to the manufacturer's instructions. Single nuclei RNA-seq",,,
ALS008006,GSM8370903,,,txt,40067829,ALS,Healthy,Yes,	Human,motor cortex,,Male,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Single nuclei were extracted from archived human postmortem motor cortex tissue using a Dounce homogenizer After removing cell debris, the lysed, filtered homogenate was then promptly centrifuged and supernatant decanted without disrupting the nuclei pellet. Following wash processes, the nucleus suspension was purified via gradient centrifugation, and sorted by FACS. Nuclei were loaded onto 10x Chromium chips, with library preparation performed using the Single Cell 3' Gene Expression kit v3.1 according to the manufacturer's instructions. Single nuclei RNA-seq",,,
ALS009001,GSM8178791,,,rds,40216746,ALS,Disease ,No,Mouse,hippocampus,Vehicle ,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,GA-Nes,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009002,GSM8178792,,,rds,40216746,ALS,Disease,No,Mouse,hippocampus,Vehicle,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,GA-Nes,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009003,GSM8178793,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,Vehicle,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009004,GSM8178794,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,Vehicle,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009005,GSM8178795,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,Vehicle,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009006,GSM8178796,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,Vehicle,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009007,GSM8178797,,,rds,40216746,ALS,Disease,No,Mouse,hippocampus,Vehicle,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,GA-Nes,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009008,GSM8178798,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,HPbCD,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009009,GSM8178799,,,rds,40216746,ALS,Disease,No,Mouse,hippocampus,HPbCD ,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,GA-Nes,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009010,GSM8178800,,,rds,40216746,ALS,Disease,No,Mouse,hippocampus,HPbCD ,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,GA-Nes,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009011,GSM8178801,,,rds,40216746,ALS,Disease,No,Mouse,hippocampus,HPbCD ,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,GA-Nes,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009012,GSM8178802,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,HPbCD,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009013,GSM8178803,,,rds,40216746,ALS,Disease,No,Mouse,hippocampus,HPbCD,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,GA-Nes,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009014,GSM8178804,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,HPbCD,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS009015,GSM8178805,,,rds,40216746,ALS,Healthy,Yes,Mouse,hippocampus,HPbCD,no data available,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Treatment protocol  (2-Hydroxypropyl)--cyclodextrin (CAS #128446-35-5, referred to here as CD, Sigma-Aldrich H107-100G, Degree of Substitution=5) was dissolved in 30 mM citric buffer (pH 5.0) in normal saline (vehicle) to achieve a 20% concentration. Starting from P21, wildtype and transgenic mice received daily subcutaneous injections of 2 g/kg CD solution or an equivalent volume of the vehicle. Extracted molecule        total RNA Extraction protocol        Animals were perfused with ice-cold PBS prior to brain dissection and snap frozen. Nuclei from P40 female hippocampi with acceptable RNA quality (RNA Integrity Number (RIN) > 7 with Agilent RNA 6000 Nano kit (Agilent, 50671511)) were isolated according to Frankenstein protocol for nuclei isolation from fresh and frozen tissue. Nuclei were sorted via fluorescence-activated nuclei sorting (FANS) by a DAPI+ gate and two further gates of NeuN positive and NeuN negative nuclei (anti-NeuN antibody from Abcam, ab190195), in order to obtain 5000 neurons and 5000 glia per sample, respectively.The nuclei were processed with Chromium Next GEM Single Cell 3 Kit v3.1 (10x Genomics, 1000268) generate the cDNA libraries for this study. Gel Bead-in-Emulsions (GEMs) were generated with chip G (10x Genomics, 1000120) on the microfluidic platform 10x Genomics Chromium Single Cell Controller. Next, the samples were uniquely barcoded to distinguish the mRNAs (each having unique molecular identifier (UMI)) from different nuclei. The cDNA was extracted with Dynabeads MyOne SILANE beads (Invitrogen, 370-12D) and amplified by PCR. The PCR product was purified with SPRIselect reagent (Beckman Coulter, Cat #B23318). Subsequently, the 3 gene expression library was constructed with primers for Illumina NGS platform and Dual Index Kit TT set A (10x Genomics, 1000215) which allows individual sample identification.",,,
ALS010001,GSM8742363,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742363_29_control_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,Yes,Human,cervical spinal cord,none,male,no data available,57 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010002,GSM8742364,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742364_32_control_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,Yes,Human,cervical spinal cord,none,female,no data available,68 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010003,GSM8742365,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742365_35_control_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,Yes,Human,cervical spinal cord,none,female,no data available,65 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010004,GSM8742366,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742366_37_control_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,Yes,Human,cervical spinal cord,none,female,no data available,59 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010005,GSM8742367,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742367_39_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease (sporadic),No,Human,cervical spinal cord,none,male,no data available,65 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010006,GSM8742368,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742368_40_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease (sporadic),No,Human,cervical spinal cord,none,female,no data available,61 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010007,GSM8742369,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742369_41_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease (sporadic),No,Human,cervical spinal cord,none,male,no data available,51 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010008,GSM8742370,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742370_42_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease (sporadic),No,Human,cervical spinal cord,none,female,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010009,GSM8742371,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742371_44_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease (sporadic),No,Human,cervical spinal cord,none,male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010010,GSM8742372,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742372_45_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,"Disease (familial, no known mutation)",No,Human,cervical spinal cord,none,male,no data available,61 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010011,GSM8742373,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742373_46_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease (sporadic),No,Human,cervical spinal cord,none,female,no data available,68 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010012,GSM8742374,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8742374_47_ALS_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease (C9orf72),No,Human,cervical spinal cord,none,male,no data available,60 years,,10x Genomics,single-nucleus RNA sequencing,,Extracted molecule polyA RNA Extraction protocol Nuclei isolation kit followed by DAPI+ FACS isolation10x Genomics Next GEM Single Cell 3 v3.1,,,
ALS010013,GSM8748142,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748142_SOD1_s1_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,Yes,Mouse,spinal cord,,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing,SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010014,GSM8748143,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748143_SOD1_s2_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,Yes,Mouse,spinal cord,,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing,SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010015,GSM8748144,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748144_SOD1_s3_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,vehicle ,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010016,GSM8748145,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748145_SOD1_s4_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,vehicle ,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010017,GSM8748146,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748146_SOD1_s5_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,RIPK1i,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010018,GSM8748147,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748147_SOD1_s6_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,RIPK1i,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010019,GSM8748148,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748148_SOD1_s7_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,Yes,Mouse,spinal cord,,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing,SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010020,GSM8748149,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748149_SOD1_s8_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,Yes,Mouse,spinal cord,,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing,SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010021,GSM8748150,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748150_SOD1_s9_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,vehicle ,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010022,GSM8748151,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748151_SOD1_s10_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,vehicle ,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010023,GSM8748152,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748152_SOD1_s11_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,RIPK1i,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010024,GSM8748153,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8748153_SOD1_s12_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Disease,No,Mouse,spinal cord,RIPK1i,female,no data available,120 days,,10x Genomics,single-cell RNA sequencing, SOD1G93A,"At 120 days of age, C57BL/6 mice along with vehicle and RIPK1i-treated SOD1G93A mice were sacrificed and perfused with HBSS supplemented with 5g/mL actinomycin D and 10M triptolide. Whole spinal cords were isolated, cut sagitally, and placed in 10 mL pre-incubation solution (HBSS (Gibco, 14025-092) supplemented with transcription/translation inhibitor cocktail: 5g/mL actinomycin D, 10M triptolide, and 27.1g/mL anisomycin) on ice and protected from light. Spinal cords were minced on ice with a razor blade then digested for 15 minutes on a shaker at 37 C in 5 mL papain solution (300 U papain solution (Worthington, LS003126) was diluted in HBSS supplemented with 1:100 DNAse and the transcription/translation inhibitor cocktail). Every 5 minutes samples were triturated with a glass pipette and the papain reaction was quenched with 5 mL HBSS supplemented with 10% FBS. After filtering through a 70 m strainer and pelleting cells for 5 minutes at 300 g and 4 C, samples were resuspended in 3 mL HBSS with 10% FBS and 7 mL of 25% BSA solution in HBSS supplemented with the transcription and translation inhibitor cocktail. Cells were centrifuged for 10 minutes at 1200 g and the supernatant and myelin were aspirated prior to addition of 1 mL cold HBSS and a 2 minute spin at 500 g. Finally, the solution was decanted and cells were quantified after resuspending in 500 L HBSS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010025,GSM8745655,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745655_triculture_s1_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,DMSO,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010026,GSM8745656,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745656_triculture_s2_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,GSK547,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010027,GSM8745657,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745657_triculture_s3_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,TSZ,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010028,GSM8745658,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745658_triculture_s4_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,TSZ,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010029,GSM8745659,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745659_triculture_s5_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,TSZ; GSK547,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010030,GSM8745660,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745660_triculture_s6_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,DMSO,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010031,GSM8745661,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745661_triculture_s7_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,GSK547,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010032,GSM8745662,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745662_triculture_s8_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,TSZ,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010033,GSM8745663,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745663_triculture_s9_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,TSZ; GSK547,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS010034,GSM8745664,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40132594/GSM8745664_triculture_s10_filtered_feature_bc_matrix.h5,h5,,40132594,ALS,Healthy,,Human,iPSC tri-culture,TSZ; GSK547,male,no data available,55-59 days (tissue collection); 15 days ,,10x Genomics,single-cell RNA sequencing,iPSC,"Four hours after treatment, cells were washed twice with PBS then treated with 0.25% trypsin-EDTA solution (Sigma-Aldrich, T4049) and transcription/translation inhibitors: 5 g/mL actinomycin D (Sigma-Aldrich, A1410), 10 M triptolide (Sigma-Aldrich, T3652), and 27.1 g/mL anisomycin (Sigma-Aldrich, A9789) for 6 minutes at 37 C in a 5% CO2 incubator. Then, 1 volume of PBS with 2% FBS (Gibco, A38400-01), the transcription/translation inhibitors, and 1:100 DNAse (Worthington, LS002007) was added to quench. Cells from two wells were combined for each technical replicate and put through 40 m cell strainers (BD Falcon, 352235). Cells were counted and spun at 4 C for 5 minutes at 1500 rpm. Supernatant was removed and cells were resuspended at 1,000 cells/L in ice-cold PBS. Cells were loaded onto the 10x Genomics Next GEM Single Cell 3 v3.1 sample chip and run following the manufacturers protocols.10x Genomics Next GEM Single Cell 3 v3.1",,,
ALS011001,GSM7810083,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810083_ALS3.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011002,GSM7810084,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810084_ALS6.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011003,GSM7810085,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810085_ALS7.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011004,GSM7810086,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810086_ALS8.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011005,GSM7810087,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810087_ALS9.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011006,GSM7810088,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810088_ALS10.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011007,GSM7810089,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810089_ALS11.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011008,GSM7810090,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810090_ALS13.txt.gz,txt.gz,,39731185,ALS,Disease (rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011009,GSM7810091,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810091_ALS14.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011010,GSM7810092,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810092_ALS16.txt.gz,txt.gz,,39731185,ALS,Disease (rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011011,GSM7810093,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810093_ALS17.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011012,GSM7810094,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810094_ALS18.txt.gz,txt.gz,,39731185,ALS,Disease (rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011013,GSM7810095,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810095_ALS19.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011014,GSM7810096,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810096_ALS20.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011015,GSM7810097,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810097_ALS21.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011016,GSM7810098,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810098_ALS22.txt.gz,txt.gz,,39731185,ALS,Disease (rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011017,GSM7810099,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810099_ALS23.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011018,GSM7810100,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810100_ALS24.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011019,GSM7810101,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810101_ALS25.txt.gz,txt.gz,,39731185,ALS,Disease (rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011020,GSM7810102,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810102_ALS26.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011021,GSM7810103,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810103_ALS27.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011022,GSM7810104,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810104_ALS28.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011023,GSM7810105,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810105_ALS29.txt.gz,txt.gz,,39731185,ALS,Disease (rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011024,GSM7810106,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810106_ALS30.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011025,GSM7810107,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810107_ALS31.txt.gz,txt.gz,,39731185,ALS,Disease (rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011026,GSM7810108,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810108_ALS32.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011027,GSM7810109,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810109_ALS33.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011028,GSM7810110,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810110_ALS34.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011029,GSM7810111,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810111_ALS35.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011030,GSM7810112,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810112_ALS36.txt.gz,txt.gz,,39731185,ALS,Disease (Non-rapid),No,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011031,GSM7810113,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810113_C1.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011032,GSM7810114,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810114_C2.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011033,GSM7810115,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810115_C3.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011034,GSM7810116,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810116_C4.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011035,GSM7810117,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810117_C5.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011036,GSM7810118,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810118_C6.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011037,GSM7810119,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810119_C7.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011038,GSM7810120,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810120_C8.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011039,GSM7810121,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810121_C9.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS011040,GSM7810122,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39731185/GSM7810122_C10.txt.gz,txt.gz,,39731185,ALS,Healthy,Yes,Human,Peripheral Blood Mononuclear Cell,,no data available,no data available,no data available,,10x Genomics,single-cell RNA sequencing,,A single-cell RNA-seq library was prepared from PBMC using Chromium Single Cell 3' Library Kit v2 (10x Genomics) following the manufacturers instructions.,,,
ALS012001,F1552,,,,35228715,ALS,Healthy,Yes,Mouse,lumbar spinal cord,,Male,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,C57BL/6J ,,,,
ALS012002,F1554,,,,35228715,ALS,Healthy,Yes,Mouse,lumbar spinal cord,,Male,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,C57BL/6J ,,,,
ALS012003,F1563,,,,35228715,ALS,Healthy,Yes,Mouse,lumbar spinal cord,,Male,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,C57BL/6J ,,,,
ALS012004,F1553,,,,35228715,ALS,Disease,,Mouse,lumbar spinal cord,,Male,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,B6.Cg-Tg(SOD1*G93A)1Gur/J amyotrophic lateral sclerosis-like phenotype,,,,
ALS012005,F1555,,,,35228715,ALS,Disease,,Mouse,lumbar spinal cord,,Male,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,B6.Cg-Tg(SOD1*G93A)1Gur/J amyotrophic lateral sclerosis-like phenotype,,,,
ALS012006,F1561,,,,35228715,ALS,Disease,,Mouse,lumbar spinal cord,,Male,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,B6.Cg-Tg(SOD1*G93A)1Gur/J amyotrophic lateral sclerosis-like phenotype,,,,
ALS012007,F1318,,,,35228715,ALS,Healthy,Yes,Mouse,lumbar spinal cord,,Female,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,C57BL/6J,,,,
ALS012008,F1319,,,,35228715,ALS,Healthy,Yes,Mouse,lumbar spinal cord,,Female,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,C57BL/6J,,,,
ALS012009,F1556,,,,35228715,ALS,Healthy,Yes,Mouse,lumbar spinal cord,,Female,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,C57BL/6J,"All experiments were performed on B6.Cg-Tg(SOD1G93A)1Gur/J (JAX Stock No:004435) and C57BL/6J littermate controls 6,25. In accordance with high-copy number transgenics, mice were checked for copy number alterations and any mice with alterations were not enrolled in the study. All mice were maintained under pathogen-free conditions and all experiments were performed under protocols approved by the New York University Grossman School of Medicine Institute Animal Care Committee (IACUC) in accordance with international and NIH guidelines. All mice were housed in a temperature (1923C) and humidity (3070% relative humidity)-regulated environment with 12-hour light/dark cycle, lights on/off at 6:30, and received standard chow food (Lab Diets, 5053) pellets and water ad libitum. Three male and three female SOD1G93A mice and three male and three female littermate control mice were employed for these studies at age day 90.Mice were anesthetized with Ketamine and Xylazine and then underwent rapid cardiac perfusion with PBS. The spinal column was rapidly removed, and the lumbar spinal cord was retrieved. Tissue was flash-frozen in liquid nitrogen and stored at 80C until sample processing. Single-nucleus pools from frozen lumbar spinal cord were completed as detailed previously with several modifications 24. Briefly, frozen tissue was dounce homogenized with 5 strokes of the loose pestle followed by 10 strokes with the tight pestle at 4C in a low sucrose buffer (0.32 M sucrose, 10 mM HEPES (pH 7.5), 5 mM CaCl2, 0.1 mM EDTA, 3 mM MgAc, 1 mM DTT) with 0.1% Triton X-100 added. The crude nuclei prep was gently mixed with additional low sucrose buffer and was subsequently passed over a pre-wet 30 m strainer. The filtered crude nuclei prep was centrifuged at 2613  g for 10 min at 4C. Supernatant was decanted and the pellet was re-suspended in low sucrose buffer. An additional homogenization step using a TissueRuptor II (Qiagen Inc.) set to the lowest power was completed on each sample for 15 s. High sucrose buffer (1 M sucrose, 10mM HEPES (pH 7.5), 3 mM MgAc, 1 mM DTT) was then layered underneath the crude prep. The crude prep was centrifuged for 25 min at 2613  g at 4C. The supernatant was decanted and re-suspended in resuspension buffer, 1% BSA in PBS with 0.2 U/L of Ambion RNase Inhibitor (Invitrogen, Cat:AM2684), and transferred to a low-bind conical tube. The nuclei were washed of any residual sucrose by centrifugation at 500  g for 5 min at 4C. The pellet was re-suspended in PBS containing 20 g/mL Fc Block CD16/CD32 (Biolegend, Cat: 101301) and incubated for 5 min at 4C. 0.5 g of a nuclear hashing antibody was added to each sample and incubated for 30 min at 4C. Nuclei were washed three times and finally counted using a Countess Automated Cell Counter (ThermoFisher). Three pools of nuclei were generated, each containing 40,000 nuclei from samples representing each of the four experimental groups. Nuclear hashtag antibodies used included: 10g/mL anti-Nuclear Pore Complex Proteins Hashtag Antibodies 14 (BioLegend, Catalog numbers: TotalSeq-A0451, TotalSeq-A0452, TotalSeq-A0453, TotalSeq-A0454).The 10X Chromium controller (10X Genomics) with v3 chemistry was used to capture, barcode and prepare single- nucleus libraries from each of the three pools of nuclei as per manufacturers instructions. The resulting libraries were sequenced on a full lane of an Illumina NovaSeq 6000 S2 flow cell.",,,
ALS012010,F1558,,,,35228715,ALS,Disease,,Mouse,lumbar spinal cord,,Female,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,B6.Cg-Tg(SOD1*G93A)1Gur/J amyotrophic lateral sclerosis-like phenotype,"All experiments were performed on B6.Cg-Tg(SOD1G93A)1Gur/J (JAX Stock No:004435) and C57BL/6J littermate controls 6,25. In accordance with high-copy number transgenics, mice were checked for copy number alterations and any mice with alterations were not enrolled in the study. All mice were maintained under pathogen-free conditions and all experiments were performed under protocols approved by the New York University Grossman School of Medicine Institute Animal Care Committee (IACUC) in accordance with international and NIH guidelines. All mice were housed in a temperature (1923C) and humidity (3070% relative humidity)-regulated environment with 12-hour light/dark cycle, lights on/off at 6:30, and received standard chow food (Lab Diets, 5053) pellets and water ad libitum. Three male and three female SOD1G93A mice and three male and three female littermate control mice were employed for these studies at age day 90.Mice were anesthetized with Ketamine and Xylazine and then underwent rapid cardiac perfusion with PBS. The spinal column was rapidly removed, and the lumbar spinal cord was retrieved. Tissue was flash-frozen in liquid nitrogen and stored at 80C until sample processing. Single-nucleus pools from frozen lumbar spinal cord were completed as detailed previously with several modifications 24. Briefly, frozen tissue was dounce homogenized with 5 strokes of the loose pestle followed by 10 strokes with the tight pestle at 4C in a low sucrose buffer (0.32 M sucrose, 10 mM HEPES (pH 7.5), 5 mM CaCl2, 0.1 mM EDTA, 3 mM MgAc, 1 mM DTT) with 0.1% Triton X-100 added. The crude nuclei prep was gently mixed with additional low sucrose buffer and was subsequently passed over a pre-wet 30 m strainer. The filtered crude nuclei prep was centrifuged at 2613  g for 10 min at 4C. Supernatant was decanted and the pellet was re-suspended in low sucrose buffer. An additional homogenization step using a TissueRuptor II (Qiagen Inc.) set to the lowest power was completed on each sample for 15 s. High sucrose buffer (1 M sucrose, 10mM HEPES (pH 7.5), 3 mM MgAc, 1 mM DTT) was then layered underneath the crude prep. The crude prep was centrifuged for 25 min at 2613  g at 4C. The supernatant was decanted and re-suspended in resuspension buffer, 1% BSA in PBS with 0.2 U/L of Ambion RNase Inhibitor (Invitrogen, Cat:AM2684), and transferred to a low-bind conical tube. The nuclei were washed of any residual sucrose by centrifugation at 500  g for 5 min at 4C. The pellet was re-suspended in PBS containing 20 g/mL Fc Block CD16/CD32 (Biolegend, Cat: 101301) and incubated for 5 min at 4C. 0.5 g of a nuclear hashing antibody was added to each sample and incubated for 30 min at 4C. Nuclei were washed three times and finally counted using a Countess Automated Cell Counter (ThermoFisher). Three pools of nuclei were generated, each containing 40,000 nuclei from samples representing each of the four experimental groups. Nuclear hashtag antibodies used included: 10g/mL anti-Nuclear Pore Complex Proteins Hashtag Antibodies 14 (BioLegend, Catalog numbers: TotalSeq-A0451, TotalSeq-A0452, TotalSeq-A0453, TotalSeq-A0454).The 10X Chromium controller (10X Genomics) with v3 chemistry was used to capture, barcode and prepare single- nucleus libraries from each of the three pools of nuclei as per manufacturers instructions. The resulting libraries were sequenced on a full lane of an Illumina NovaSeq 6000 S2 flow cell.",,,
ALS012011,F1559,,,,35228715,ALS,Disease,,Mouse,lumbar spinal cord,,Female,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,B6.Cg-Tg(SOD1*G93A)1Gur/J amyotrophic lateral sclerosis-like phenotype,"All experiments were performed on B6.Cg-Tg(SOD1G93A)1Gur/J (JAX Stock No:004435) and C57BL/6J littermate controls 6,25. In accordance with high-copy number transgenics, mice were checked for copy number alterations and any mice with alterations were not enrolled in the study. All mice were maintained under pathogen-free conditions and all experiments were performed under protocols approved by the New York University Grossman School of Medicine Institute Animal Care Committee (IACUC) in accordance with international and NIH guidelines. All mice were housed in a temperature (1923C) and humidity (3070% relative humidity)-regulated environment with 12-hour light/dark cycle, lights on/off at 6:30, and received standard chow food (Lab Diets, 5053) pellets and water ad libitum. Three male and three female SOD1G93A mice and three male and three female littermate control mice were employed for these studies at age day 90.Mice were anesthetized with Ketamine and Xylazine and then underwent rapid cardiac perfusion with PBS. The spinal column was rapidly removed, and the lumbar spinal cord was retrieved. Tissue was flash-frozen in liquid nitrogen and stored at 80C until sample processing. Single-nucleus pools from frozen lumbar spinal cord were completed as detailed previously with several modifications 24. Briefly, frozen tissue was dounce homogenized with 5 strokes of the loose pestle followed by 10 strokes with the tight pestle at 4C in a low sucrose buffer (0.32 M sucrose, 10 mM HEPES (pH 7.5), 5 mM CaCl2, 0.1 mM EDTA, 3 mM MgAc, 1 mM DTT) with 0.1% Triton X-100 added. The crude nuclei prep was gently mixed with additional low sucrose buffer and was subsequently passed over a pre-wet 30 m strainer. The filtered crude nuclei prep was centrifuged at 2613  g for 10 min at 4C. Supernatant was decanted and the pellet was re-suspended in low sucrose buffer. An additional homogenization step using a TissueRuptor II (Qiagen Inc.) set to the lowest power was completed on each sample for 15 s. High sucrose buffer (1 M sucrose, 10mM HEPES (pH 7.5), 3 mM MgAc, 1 mM DTT) was then layered underneath the crude prep. The crude prep was centrifuged for 25 min at 2613  g at 4C. The supernatant was decanted and re-suspended in resuspension buffer, 1% BSA in PBS with 0.2 U/L of Ambion RNase Inhibitor (Invitrogen, Cat:AM2684), and transferred to a low-bind conical tube. The nuclei were washed of any residual sucrose by centrifugation at 500  g for 5 min at 4C. The pellet was re-suspended in PBS containing 20 g/mL Fc Block CD16/CD32 (Biolegend, Cat: 101301) and incubated for 5 min at 4C. 0.5 g of a nuclear hashing antibody was added to each sample and incubated for 30 min at 4C. Nuclei were washed three times and finally counted using a Countess Automated Cell Counter (ThermoFisher). Three pools of nuclei were generated, each containing 40,000 nuclei from samples representing each of the four experimental groups. Nuclear hashtag antibodies used included: 10g/mL anti-Nuclear Pore Complex Proteins Hashtag Antibodies 14 (BioLegend, Catalog numbers: TotalSeq-A0451, TotalSeq-A0452, TotalSeq-A0453, TotalSeq-A0454).The 10X Chromium controller (10X Genomics) with v3 chemistry was used to capture, barcode and prepare single- nucleus libraries from each of the three pools of nuclei as per manufacturers instructions. The resulting libraries were sequenced on a full lane of an Illumina NovaSeq 6000 S2 flow cell.",,,
ALS012012,F1560,,,,35228715,ALS,Disease,,Mouse,lumbar spinal cord,,Female,no data available,90 days,,10x Genomics,single-nucleus RNA sequencing,B6.Cg-Tg(SOD1*G93A)1Gur/J amyotrophic lateral sclerosis-like phenotype,,,,
ALS013001,GSM5098907,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33766915/GSM5098907_Sample2_matrix.txt.gz,txt.gz,,33766915,ALS,Healthy,Yes,Mouse,Spinal cord,Vehicle,male,no data available,3.5 months,,DropSeq ,single-cell RNA sequencing,WT,Spinal cords were digested in Accutase; myelin was removed and live cells were isolated using a OptiPrep and Hibernate A gradientSamples were prepared according to the DropSeq protocol,,,
ALS013002,GSM5098908,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33766915/GSM5098908_Sample6_matrix.txt.gz,txt.gz,,33766915,ALS,Healthy,Yes,Mouse,Spinal cord,Vehicle,male,no data available,3.5 months,,DropSeq ,single-cell RNA sequencing,WT,Spinal cords were digested in Accutase; myelin was removed and live cells were isolated using a OptiPrep and Hibernate A gradientSamples were prepared according to the DropSeq protocol,,,
ALS013003,GSM5098909,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33766915/GSM5098909_Sample1_matrix.txt.gz,txt.gz,,33766915,ALS,Disease,No,Mouse,Spinal cord,Vehicle,male,no data available,3.5 months,,DropSeq ,single-cell RNA sequencing,SOD1-G93A,Spinal cords were digested in Accutase; myelin was removed and live cells were isolated using a OptiPrep and Hibernate A gradientSamples were prepared according to the DropSeq protocol,,,
ALS013004,GSM5098910,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33766915/GSM5098910_Sample5_matrix.txt.gz,txt.gz,,33766915,ALS,Disease,No,Mouse,Spinal cord,Vehicle,male,no data available,3.5 months,,DropSeq ,single-cell RNA sequencing,SOD1-G93A,Spinal cords were digested in Accutase; myelin was removed and live cells were isolated using a OptiPrep and Hibernate A gradientSamples were prepared according to the DropSeq protocol,,,
ALS013005,GSM5098911,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33766915/GSM5098911_Sample3_matrix.txt.gz,txt.gz,,33766915,ALS,Disease,No,Mouse,Spinal cord,Necrostatin-1s ,male,no data available,3.5 months,,DropSeq ,single-cell RNA sequencing,SOD1-G93A,Spinal cords were digested in Accutase; myelin was removed and live cells were isolated using a OptiPrep and Hibernate A gradientSamples were prepared according to the DropSeq protocol,,,
ALS013006,GSM5098912,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33766915/GSM5098912_Sample7_matrix.txt.gz,txt.gz,,33766915,ALS,Disease,No,Mouse,Spinal cord,Necrostatin-1s ,male,no data available,3.5 months,,DropSeq ,single-cell RNA sequencing,SOD1-G93A,Spinal cords were digested in Accutase; myelin was removed and live cells were isolated using a OptiPrep and Hibernate A gradientSamples were prepared according to the DropSeq protocol,,,
ALS014001,GSM4862197,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862197_AB7300.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,161 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014002,GSM4862198,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862198_AB7301.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,136 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014003,GSM4862199,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862199_AB7302.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,106 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014004,GSM4862200,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862200_AB7303.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,92 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014005,GSM4862202,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862202_AB7304.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,lymph node,,no data available,no data available,161 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014006,GSM4862204,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862204_AB7305.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,lymph node,,no data available,no data available,136 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014007,GSM4862205,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862205_AB7306.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,lymph node,,no data available,no data available,106 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014008,GSM4862206,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862206_AB7321.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,lymph node,,no data available,no data available,92 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014009,GSM4862207,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862207_AB7322.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,161 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014010,GSM4862208,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862208_AB9832.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,161 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014011,GSM4862209,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862209_AB9833.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,161 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
ALS014012,GSM4862210,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID33277355/GSM4862210_AB9834.txt.gz,txt.gz,,33277355,ALS,Disease,,Mouse,meninges,,no data available,no data available,161 days,,unknown,single-cell RNA sequencing,mSOD1,"mSOD1 mice were at different ages (92 , 106, 136 and 161 days old) were used in the study. Mice were euthanized and spinal cord meninges and cervical LNs were disected. cLN were digested in IMDM (Sigma-Aldrich) media supplemented with Liberase-TL (100g/ml, Roche) and DNase-I (100g/ml, Roche), and spinal cord meninges were digested in RPMI (Sigma-Aldrich) media supplemented with collagenase IV (40U/ml, Roche) and DNase-I (100g/ml, Roche). Both tissues were incubated with frequent agitation at 37oC for 20 min. After the dissociation procedures, cells were washed with sorting buffer, filtered through 100m, 70m and 40m cell strainers, and centrifuged at 380g, 5min, 4oC.Single-cell RNA-seq libraries were prepared as previously described {Jaitin, 2014}. In brief, mRNA from single cells sorted into capture plates were barcoded and converted into cDNA and then pooled using an automated pipeline. The pooled sample was linearly amplified by T7 in vitro transcription, and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration as described previously {Jaitin, 2014}",,,
SMA001001,GSM6355861        ,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36074806/GSM6355861_SMA_,10x_matrix,,36074806,SMA,Disease,No,	Mouse,Spinal cord,,no data available,no data available,postnatal day 4,,10x Genomics,single-cell RNA sequencing,"FVB; mSmn-/-, hSMN22tg/0","Whole spinal cords were obtained from transgenic mice, and the spinal cords were stripped according to established methods and placed in ice-cold phosphate-buffered saline (PBS). The tissue was minced and dissociated with 0.25% trypsin in a centrifuge tube for 30 min at 28 C, followed by 1 mg/mL collagenase II for 20 min, with gentle mixing every 10 min. The enzymatic reaction was terminated through the addition of 10% fetal bovine serum (FBS). The sample was filtered using a 70 m strainer to obtain a single-cell suspension.Using single-cell 3 Library and Gel Bead Kit V3 (10 Genomics, 1000075) and Chromium Single Cell B Chip Kit (10 Genomics, 1000074), the cell suspension (300600 living cells per microliter determined by Count Star) was loaded onto the Chromium single cell controller (10 Genomics) to generate single-cell gel beads in the emulsion according to the manufacturers protocol. In short, single cells were suspended in PBS containing 0.04% bovine serum albumin (BSA). Approximately 6000 cells were added to each channel, and the target cell recovered was estimated to be approximately 3000 cells. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Reverse transcription was performed on an S1000TM Touch Thermal Cycler (Bio Rad) at 53 C for 45 min followed by 85 C for 5 min, and incubated at 4 C. The complementary DNA (cDNA) was generated and then amplified, and the quality was assessed using an Agilent 4200. According to the manufacturers instruction, scRNA-seq libraries were constructed using Single Cell 3 Library and Gel Bead Kit V3. The libraries were finally sequenced using an Illumina Novaseq6000 sequencer with a sequencing depth of at least 100,000 reads per cell with a pair-end 150 bp reading strategy.",,,
SMA001002,GSM6355862,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36074806/GSM6355862_Con_,10x_matrix,,36074806,SMA,Disease,Yes,	Mouse,Spinal cord,,no data available,no data available,postnatal day 4,,10x Genomics,single-cell RNA sequencing,"FVB; mSmn+/-, hSMN22tg/0","Whole spinal cords were obtained from transgenic mice, and the spinal cords were stripped according to established methods and placed in ice-cold phosphate-buffered saline (PBS). The tissue was minced and dissociated with 0.25% trypsin in a centrifuge tube for 30 min at 28 C, followed by 1 mg/mL collagenase II for 20 min, with gentle mixing every 10 min. The enzymatic reaction was terminated through the addition of 10% fetal bovine serum (FBS). The sample was filtered using a 70 m strainer to obtain a single-cell suspension.Using single-cell 3 Library and Gel Bead Kit V3 (10 Genomics, 1000075) and Chromium Single Cell B Chip Kit (10 Genomics, 1000074), the cell suspension (300600 living cells per microliter determined by Count Star) was loaded onto the Chromium single cell controller (10 Genomics) to generate single-cell gel beads in the emulsion according to the manufacturers protocol. In short, single cells were suspended in PBS containing 0.04% bovine serum albumin (BSA). Approximately 6000 cells were added to each channel, and the target cell recovered was estimated to be approximately 3000 cells. Captured cells were lysed, and the released RNAs were barcoded through reverse transcription in individual GEMs. Reverse transcription was performed on an S1000TM Touch Thermal Cycler (Bio Rad) at 53 C for 45 min followed by 85 C for 5 min, and incubated at 4 C. The complementary DNA (cDNA) was generated and then amplified, and the quality was assessed using an Agilent 4200. According to the manufacturers instruction, scRNA-seq libraries were constructed using Single Cell 3 Library and Gel Bead Kit V3. The libraries were finally sequenced using an Illumina Novaseq6000 sequencer with a sequencing depth of at least 100,000 reads per cell with a pair-end 150 bp reading strategy.",,,
SMA002001,GSM7329816,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329816_SMA1_1_baseline.h5,h5,,38750052,SMA,Disease,No,Human,cerebrospinal fluid leukocytes,none,no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002002,GSM7329817,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329817_SMA1_1_6mo.h5,h5,,38750052,SMA,Disease,no ,Human,cerebrospinal fluid leukocytes,nusinersen (6 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002003,GSM7329818,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329818_SMA1_1_10mo.h5,h5,,38750052,SMA,Disease,no ,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002004,GSM7329819,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329819_SMA1_2_baseline.h5,h5,,38750052,SMA,Disease,No,Human,cerebrospinal fluid leukocytes,none,no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002005,GSM7329820,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329820_SMA1_2_6mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (6 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002006,GSM7329822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329822_SMA1_2_10mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002007,GSM7329823,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329823_SMA1_3_baseline.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,none,no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002009,GSM7329825,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329825_SMA1_3_6mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (6 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002012,GSM7329828,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329828_SMA1_4_baseline.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,none,no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002013,GSM7329829,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329829_SMA1_4_6mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (6 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002014,GSM7329830,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329830_SMA1_4_10mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002015,GSM7329831,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329831_SMA1_5_baseline.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,none,no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002016,GSM7329832,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329832_SMA1_5_2mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (2 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002017,GSM7329833,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329833_SMA1_5_10mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002018,GSM7329834,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329834_SMA1_6_baseline.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,none,no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002019,GSM7329835,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329835_SMA1_6_6mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (6 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002020,GSM7329836,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329836_SMA1_6_10mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002021,GSM7329837,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329837_SMA1_7_baseline.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,none,no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002022,GSM7329838,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329838_SMA1_7_2mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (2 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002023,GSM7329839,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329839_SMA1_7_6mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (6 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002024,GSM7329840,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329840_SMA1_7_10mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002025,GSM7329841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329841_SMA1_8_10mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SMA002026,GSM7329842,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38750052/GSM7329842_SMA1_9_10mo.h5,h5,,38750052,SMA,Disease,no,Human,cerebrospinal fluid leukocytes,nusinersen (10 months),no data available,no data available,no data,,10x Genomics,single-cell RNA sequencing,,"Nusinersen was administered to SMA patients by lumbar puncture on days 1, 14, 28, and 63 followed by a repetitive application every 4 months according to the treatment guideline. Treatment was performed between the years 2017 - 2021 in the center in Essen. Before each nusinersen injection, the same amount (5 mL) of CSF was withdrawn to prevent excessive intra_CSF pressure CSF cells were processed within 2 hours post lumbar puncture to ensure optimal sample quality. For processing, CSF was collected into round bottom polypropylene tubes and then centrifuged for 10 min at 300x g. CSF cell pellets were resuspended in 5 ml of X_Vivo15 media (Lonza) and stored on crushed ice. The samples were then transported with same day shipping on crushed ice to the laboratory. Cell suspensions were then centrifuged again for 5 min at 400 x g and resuspended in 50 l of X_Vivo15 media. Out of this volume, 6 l were used for cell counting and the remaining volume was entirely used for scRNA_seq. Single cell suspensions were loaded onto the Chromium Controller (10X Genomics) using the Chromium Single Cell 3 GEM, Library & Gel Bead Kits v3 and v3.1 (10X Genomics). For TCR sequencing, we applied a previously described technique to sequence antigen receptor information from the 3 scRNA_seq libraries. In short, the method involves self_circulating the cDNA library, enriching the VDJ region and re_linearizing to remove the constant region of antigen receptors during enrichment, while maintaining their cell barcode and unique molecular identifier (UMI) information attached to the 3' of the cDNA molecules. Library preparation was performed according to manufacturer's instructions using AMPure beads (Beckman Coulter). Sequencing was carried out on a local Illumina Nextseq 500/2000 and Novaseq6000 with a 28_8_0_91 read setup.",,,
SCA001001,7202,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,female,no data available,5 weeks,"11,690",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001002,72921,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,5 weeks,"8,989",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001003,72922,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,5 weeks,"8,676",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001004,7294,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,No,	Mouse,	Cerebellar cortex,,female,no data available,5 weeks,"6,239",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001005,72931,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,5 weeks,"6,680",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001006,72932,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,5 weeks,"6,810",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001007,22018,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,12 weeks,"7,676",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001008,2061,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,12 weeks,"4,635",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001009,2062,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,12 weeks,"6,599",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001010,22019,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,12 weeks,"5,986",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001011,2063,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,12 weeks,"5,242",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001012,2065,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,12 weeks,"7,879",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001013,6569,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,18 weeks,"20,332",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001014,65701,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,18 weeks,"14,397",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001015,65702,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,18 weeks,"15,911",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001016,6571,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,18 weeks,"18,333",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001017,65731,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,18 weeks,"19,213",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001018,65732,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,18 weeks,"15,911",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001019,1974,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,male,no data available,24 weeks,"12,196",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001020,2020,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,female,no data available,24 weeks,"8,818",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001021,20202,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,female,no data available,24 weeks,"10,013",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001022,1589,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,male,no data available,24 weeks,"6,216",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001023,2021,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,female,no data available,24 weeks,"8,349",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001024,20212,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,female,no data available,24 weeks,"6,886",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001025,5812,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,female,no data available,30 weeks,"8,572",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001026,5822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,female,no data available,30 weeks,"10,670",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001027,58232,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Healthy,Yes,	Mouse,	Cerebellar cortex,none,female,no data available,30 weeks,"12,367",10x Genomics,single-nucleus RNA sequencing,C57; WT,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001028,58231,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,female,no data available,30 weeks,"13,851",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001029,58241,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,	Mouse,	Cerebellar cortex,,female,no data available,30 weeks,"13,353",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001030,58242,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_211027_mouse.h5ad,,,38016472,SCA,Disease,no,Mouse,	Cerebellar cortex,,female,no data available,30 weeks,"10,958",10x Genomics,single-nucleus RNA sequencing,C57; Atxn1 154Q/2Q knock-in,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001031,14,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,65,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001032,409,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,female,no data available,48,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001033,1516,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,30,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001034,729,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,59,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001035,1432,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,female,no data available,83,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001036,1532,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,43,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001037,T99,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,44,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001038,T136,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,female,no data available,64,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001039,T551,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,female,no data available,77,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001040,T1952,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,81,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001041,11,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,42,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001042,12,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Healthy,Yes,Human,Cerebellar cortex,,male,no data available,80,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001043,13,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,No,Human,Cerebellar cortex,,female,no data available,46,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001044,CB,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,no,Human,Cerebellar cortex,,male,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001045,RT,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,no,Human,Cerebellar cortex,,male,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001046,CT,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,no,Human,Cerebellar cortex,,male,no data available,no data available,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001047,UMB1354,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,no,Human,Cerebellar cortex,,female,no data available,37,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001048,CNGA-0064,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,no,Human,Cerebellar cortex,,male,no data available,31,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001049,CNGA-0047,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,no,Human,Cerebellar cortex,,male,no data available,46,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA001050,CNGA-0061,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38016472/GSE246183_230502_human_ctype.h5ad,,whole,38016472,SCA,Disease,no,Human,Cerebellar cortex,,female,no data available,66,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from frozen tissue as previously described.10 For mouse snRNA-seq, hemicerebella of three animals per genotype (WT and SCA1 KI) per timepoint (5, 12, 18, 24, and 30 weeks) were used, for a total of 30 animals. For human post-mortem samples, pieces of cerebellar cortex were harvested from frozen tissue of ten unique individuals per diagnosis (CTRL and SCA1), for a total of 20 human samples. Briefly, frozen mouse or human tissue was gently dounce homogenized in 2mL of ice-cold Nuclei EZ Prep buffer (Sigma; NUC101-1KT) with large clearance pestle A and then a small clearance pestle B for 25 strokes each, then incubated on ice for five minutes with an additional 2mL of cold EZ Prep buffer. Nuclei were centrifuged at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of cold EZ Prep buffer, incubated on ice at five minutes, and centrifuged again at 500xg for five minutes at 4C. Pelleted nuclei were then washed in 4mL of Nuclei Suspension Buffer (NSB) containing 1x phosphate buffered saline (PBS), 0.01% BSA, and 0.1% RNase inhibitor (Clontech/Takara; 2313B) and centrifuged at 500xg for five minutes at 4C. Finally, nuclei were resuspended in 1mL of NSB, filtered through a 40mm cell strainer (Fisher Scientific; 22-363-547), and counted using a Countess II FL Cell Counter (Applied Biosystems; A27978). Single-nucleus suspensions were diluted to approximately 1000 nuclei per ml in NSB. Libraries were prepared from diluted single-nucleus suspensions using the 10x Genomics Chromium Single Cell 3 Reagent Kits v.3 (mouse dataset) or v.3.1 (human dataset) through the Yale Center for Genome Analysis (YCGA). Briefly, 10,000 cells per sample were added to RT Master Mix, loaded on the Single Cell A Chip, and portioned with a pool of about 750,000 barcoded gel beads to form nanoliter-scale Gel Beads-In-Emulsions (GEMs). Each gel bead has primers containing the following: an Illumina R1 sequence (read 1 sequencing primer), a 16-nucleotide barcode, a 12-nucleotide unique molecular identifier (UMI), and a 30-nucleotide poly-dT primer sequence. Upon dissolution of the Gel Beads in a GEM, the primers were released and mixed with the cell lysate and Master Mix. Incubation of the GEMs then produced barcoded, full-length cDNA from poly-adenylated mRNA. Silane magnetic beads were then used to remove leftover biochemical reagents from the post-GEM reaction mixture. Full-length, barcoded cDNA was then amplified by PCR to generate sufficient mass for library construction, and enzymatic fragmentation and size selection were used to optimize the cDNA amplicon size prior to library construction. P5, P7, a sample index, and R2 (read 2 primer sequence) were added during library construction via end repair, A-tailing, adaptor ligation, and PCR. The final libraries contained the P5 and P7 primers used in Illumina bridge amplification. Libraries were sequenced using the NovaSeq6000 at the YCGA. Sample concentrations were normalized to 1.2nM and loaded onto an Illumina NovaSeq S4 flow cell at a concentration that yielded 20k-50k passing filter clusters per cell per sample. Samples were sequenced using paired-end sequencing on an Illumina NovaSeq6000 instrument according to Illumina protocols using 10x sequencing specifications. The 8bp index was read during an additional sequencing read that automatically followed the completion of read 1. Data generated during sequencing runs were simultaneously transferred to the YCGA high-performance computing cluster. A positive control (prepared bacteriophage Phi X library) provided by Illumina was spiked into every lane at a concentration of 0.3% to monitor quality in real time. Signal intensities were converted to individual base calls during a run using the systems Real Time Analysis (RTA) software. Base calls were transferred from the machines dedicated personal computer to the Yale high-performance computing cluster via a 1 Gigabit network mount for downstream analysis. snRNA-seq",,,
SCA002001,GSM6632781,GSM6632781_P7644,,,36457352,SCA,Disease,no,Mouse,Cerebellum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,Pcp2-ATXN1[82Q],"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
SCA002002,GSM6632782,GSM6632782_P7830,,,36457352,SCA,Disease,no,Mouse,Cerebellum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,Pcp2-ATXN1[82Q],"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
SCA002003,GSM6632783,GSM6632783_P7831,,,36457352,SCA,Disease,no,Mouse,Cerebellum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,Pcp2-ATXN1[82Q],"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
SCA002004,GSM6632784,GSM6632784_P7643,,,36457352,SCA,Healthy,yes,Mouse,Cerebellum,none,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,C57Bl6,"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
SCA002005,GSM6632785,GSM6632785_P7832,,,36457352,SCA,Healthy,yes,Mouse,Cerebellum,none,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,C57Bl6,"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
SCA002006,GSM6632786,GSM6632786_P7833,,,36457352,SCA,Healthy,yes,Mouse,Cerebellum,none,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,C57Bl6,"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
SCA003001,GSM8315551        ,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39504355/GSM8315551_SCA7.5wk.seurat.rds,rds,,39504355,SCA,Mixed,mixed,Mouse,Cerebellum,,male and female,no data available,5 weeks,,10x Genomics,single-nucleus RNA sequencing,WT and SCA7-266Q,"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
SCA003002,GSM8315552,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39504355/GSM8315552_SCA7.8wk.seurat.rds,rds,,39504355,SCA,Mixed,mixed,Mouse,Cerebellum,,male and female,no data available,8.5 weeks,,10x Genomics,single-nucleus RNA sequencing,WT and SCA7-266Q,"Frozen or fresh whole cerebellum was placed into 1.5mL tube with 500uL pre-chilled detergent lysis buffer [low sucrose buffer (LSB) (sucrose 0.32M, 10 mM HEPES, 5mM CaCl2, 3mM MgAc, 0.1mM EDTA, 1mM DTT) with 0.1% Triton-X] and the tissue was homogenized using a mechanical homogenizer. A 40um strainer was placed over a pre-chilled 50mL tube and pre-wetted with 1ml LSB. 1mL of LSB was added to the tube containing the crude nuclei in the lysis buffer and mixed gently by pipetting (2-3 times). Crude nuclei prep was then passed over the 40uM strainer into the pre-chilled 50mL tube, washed with 1 ml LSB and centrifuged at 3200g for 10 minutes at 4C. The pellet was resuspended in 3mL of LSB while gently swirling to remove the pellet from the wall, facilitating resuspension, and left on ice for 2 min. The suspension was transferred to an Oak Ridge tube and nuclei were homogenized in LSB for 15-30s, all while keeping the sample on ice. Using a serological pipette, 12.5mL of density sucrose buffer (sucrose 1M, 10 mM HEPES, 3mM MgAc, 1mM DTT) was layered underneath the LSB homogenate, taking care not to create a bubble which would disrupt the density layer. Samples were then centrifuged at 3200g for 20 minutes at 4C and pelleted nuclei were resuspended in the resuspension solution (PBS, 0.4 mg/ml BSA, 0.2 U/l RNAse inhibitor). Nuclei were filtered through a 40um pore-size strainer followed by a 30um and 20um pore-size strainers. A small sample of nuclei was pelleted and added to a slide with VectaShield with DAPI to verify single nuclei isolation under fluorescent microscope.Library construction and sequencing were done by University of Minnesota Genomic Center according to the manufacters instructions (10x Genomics).",,,
Prion001001,mouse25HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Healthy,yes,Mouse,hippocampus,Mock,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001002,mouse48CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Healthy,yes,Mouse,cortex,Mock,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001003,mouse48HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Healthy,yes,Mouse,hippocampus,Mock,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001004,mouse60CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Healthy,yes,Mouse,cortex,Mock,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001005,mouse61CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Healthy,yes,Mouse,cortex,Mock,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001006,mouse73CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Healthy,yes,Mouse,cortex,Mock,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001007,mouse12CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001008,mouse122HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,hippocampus,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001009,mouse132CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001010,mouse132HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,hippocampus,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001011,mouse133CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001012,mouse133HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,hippocampus,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001013,mouse134CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001014,mouse138CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001015,mouse138HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,hippocampus,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001016,mouse140CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001017,mouse140HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,hippocampus,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001018,mouse142CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001019,mouse142HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,hippocampus,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001020,mouse145CX,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,cortex,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion001021,mouse145HP,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36352465/,10x_whole,whole,36352465,Prion,Disease,No,Mouse,hippocampus,,no data available,no data available,,,10x Genomics,single-cell RNA sequencing,RML,"The cortex and hippocampus from both hemispheres of freshly collected brains was dissected on ice and transferred into 6-well culture dishes with dissociation solution (Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I). Tissue was crudely minced with a scalpel and dissociated for 40 min at 37 C by swirling the culture dishes every 34 min. A single cell suspension was made by gently triturating the tissue with a serum-coated p1000 pipette tip 10 times. At this point, cell suspensions were kept on ice and all centrifugation steps were performed at 4 C. Large debris was allowed to settle for 2 min before transferring supernatant to a new 15 mL falcon tube. Debris was further removed using Debris removal solution (Miltenyi Biotech) according to manufacturers instructions. Briefly, the cell pellet was re-suspended in 1550 L of loading buffer, mixed with 450 L of debris removal solution, overlayed with 2 mL of loading buffer, centrifuged at 3000g for 10 min and the top 2 layers were removed. The remaining cells were washed once in 5 mL of loading buffer before removing myelin using Myelin Removal Beads II (Miltenyi Biotech). Briefly, the cell pellet was re-suspended in 270 L of loading buffer, mixed with 30 L Myelin Removal Beads II, incubated for 15 min on ice, washed in 2700 L of loading buffer and bead-labelled cell suspensions were passed through the magnetic field of a MACS separator using LS columns (Miltenyi). The flow through (containing myelin-freed cells) was retained, passed through a 70 m MACS strainer (Miltenyi) and cells were re-suspended in a final volume of 50100 L of loading buffer before counting via trypan blue staining with a hemocytometer.Single cell sequencing libraries were prepared from 10,000 cells using the Chromium Next GEM Single Cell 3 Reagent Kits v3.1 (Dual Index) (10Genomics) according to manufacturers instructions. Briefly, single cell suspension made from the cortex and hippocampus were diluted into cDNA reaction mixtures to sequence 10,000 cells using the provided table from 10genomics. The reaction mixture and gel beads were loaded onto Chromium Next GEM Chip G (10genomics) before partitioning on a Chromium Controller. The resulting GEMs were further processed into sequencing libraries according to the manufacturers protocol without modification, except 15 cycles were used for the final PCR amplification step. Libraries were dual indexed using Dual Index Plate TT Set A and unique indices were used for each library. Quality of the amplified cDNA and final sequencing libraries was assessed using Bioanalyzer High Sensitivity DNA kits (Agilent) on a Bioanalzyer2000 instrument prior to sequencing. Libraries were sequenced to a minimum depth of 30,000 reads per cell on an Illumina NextSeq 2000 instrument using P3 reagents (100 cycles) with the recommended read configuration from 10genomics (Read 128 cycles; i7 Index10 cycles; i5 Index10 cycles; Read 290 cycles).",,,
Prion002001,GSM7943451,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"1,190",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002002,GSM7943452,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"3,627",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002003,GSM7943453,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"3,817",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002004,GSM7943454,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"2,414",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002005,GSM7943455,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"2,413",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002006,GSM7943456,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"2,761",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002007,GSM7943457,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"2,651",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002008,GSM7943458,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"4,592",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002009,GSM7943459,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"8,759",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002010,GSM7943460,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"4,438",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002011,GSM7943461,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"7,905",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002012,GSM7943462,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"5,951",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002013,GSM7943463,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Disease,no,Mouse,cerebrum,, Female,no data available,7 weeks,"6,390",10x Genomics,single-cell RNA sequencing,CD1; RML,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002014,GSM7943464,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"4,209",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002015,GSM7943465,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"4,928",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002016,GSM7943466,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"5,545",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002017,GSM7943467,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"5,377",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002018,GSM7943468,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"5,805",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002019,GSM7943469,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"5,889",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002020,GSM7943470,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"6,265",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
Prion002021,GSM7943471,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw_qi/PMID39580485,csv,whole,39580485,Prion,Healthy,yes,Mouse,cerebrum,Mock, Female,no data available,7 weeks,"6,020",10x Genomics,single-cell RNA sequencing,CD1,"Wildtype CD1 mice were intraperitoneally inoculated with 200 L of 2% brain homogenate from either Rocky Mountain Laboratory Scrapie-infected (RML) or non-infected (Mock) mice.Cerebral brain tissues were dissected in a glass petri dish, minced with a scalpel, and dissociated in 5 mL Hibernate e minus calcium with 20 units/mL papain and 0.005% DNase I for 40 min at 37 C. To promote dissociation, tissues were gently triturated through a wide-bore (~5 mm) serum-coated plastic Pasteur pipette every 10 min. After the 40 min incubation, the tissue was triturated 10 times with a serum-coated standard p1000 pipette tip and single-cell suspension was diluted with 35 mL of loading buffer. Large debris was initially removed by passing the single-cell suspension through a 70 m MACS strainer (Miltenyi), after which cells were pelleted by centrifuging at 300 xg for 5 min at 4 C. Debris was removed from the cell pellet using the debris removal solution from Miltenyi. Neurons were enriched from the debris-liberated cell suspension using the mouse neuron isolation kit (Miltenyi) according to manufacturers instructions.Live single-cell suspensions were processing into sequencing libraries the Chromium Next GEM Single Cell 3 Reagent Kit v3.1 (Dual Index) from 10Genomics according to manufacturer's instructions.",,,
HD002001,GSM7426740        ,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426740_ID_6235_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Female,no data available,63 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002002,GSM7426741,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426741_ID_6236_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Female,no data available,63 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002003,GSM7426742,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426742_ID_6237_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Female,no data available,63 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002004,GSM7426743,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426743_ID_6238_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Female,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002005,GSM7426744,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426744_ID_6239_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Female,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002006,GSM7426745,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426745_ID_6240_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Female,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002007,GSM7426746,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426746_ID_6241_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Female,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002008,GSM7426747,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426747_ID_6249_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Female,no data available,63 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002009,GSM7426748,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426748_ID_6250_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002010,GSM7426749,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426749_ID_6251_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002011,GSM7426750,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426750_ID_6252_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002012,GSM7426751,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426751_ID_6253_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002013,GSM7426752,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426752_ID_6336_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Male,no data available,60 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002014,GSM7426753,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426753_ID_6337_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Male,no data available,60 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002015,GSM7426754,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426754_ID_6338_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Male,no data available,60 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002016,GSM7426755,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426755_ID_6339_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Male,no data available,60 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002017,GSM7426756,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426756_ID_7750_filtered_,10x_matrix,,38237588,HD,Healthy,Yes,Human,Cortex (Brodmann area 4),,Female,no data available,63 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD002018,GSM7426757,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID38237588/GSM7426757_ID_7751_filtered_,10x_matrix,,38237588,HD,Disease,No,Human,Cortex (Brodmann area 4),,Female,no data available,43 years,,10x Genomics,single-nucleus RNA sequencing,,"Nuclei were isolated from fresh-frozen post-mortem human cortex, labeled with cell type-specific probes and separated by FACS as described by Pressl et al 2023.Nuclei were loaded and processed on the 10X platform for snRNAseq. 1000121 Chromium Next GEM Single Cell 3' GEM, Library & Gel Bead Kit v3.1, 16 rxns, 1000215 Dual Index Kit TT Set A 96 rxns, and Chromium Single Cell Controller were used.snRNA/scRNA-seq",,,
HD003001,GSM4601660,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601660_190726_HD_snRNA-H4_,10x_matrix,lack barcode,32681824,HD,Healthy,Yes,Human,Caudate,,Male,no data available,70 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003002,GSM4601661,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601661_190726_HD_snRNA-H5_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Putamen,,Male,no data available,70 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003003,GSM4601662,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601662_190726_HD_snRNA-H6_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Caudate,,Male,no data available,67 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003004,GSM4601663,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601663_190726_HD_snRNA-H7_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Putamen,,Male,no data available,67 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003005,GSM4601664,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601664_190726_HD_snRNA-H8_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,Male,grade 2,61 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003006,GSM4601665,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601665_190726_HD_snRNA-H10_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,Male,grade 2,65 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003007,GSM4601666,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601666_190726_HD_snRNA-H11_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,Male,grade 2,65 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003008,GSM4601667,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601667_190730_HD_snRNA-A1_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,Male,grade 4,58 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003009,GSM4601668,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601668_190730_HD_snRNA-A2_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,Male,grade 4,58 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003010,GSM4601669,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601669_190730_HD_snRNA-A3_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,Female,grade 3,77 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003011,GSM4601670,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601670_190730_HD_snRNA-A4_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,Female,grade 3,77 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003012,GSM4601671,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601671_190730_HD_snRNA-A5_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,Male,grade 2,37 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003013,GSM4601672,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601672_190730_HD_snRNA-B3_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,Male,grade 3,53 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003014,GSM4601673,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601673_190730_HD_snRNA-A7_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,Male,grade 3,53 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003015,GSM4601674,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601674_190730_HD_snRNA-A8_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Caudate,,Male,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003016,GSM4601675,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601675_190730_HD_snRNA-A9_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Putamen,,Male,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003017,GSM4601676,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601676_190730_HD_snRNA-A10_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Caudate,,Female,no data available,32 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003018,GSM4601677,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601677_190730_HD_snRNA-A11_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Putamen,,Female,no data available,32 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003019,GSM4601678,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601678_190730_HD_snRNA-A12_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Caudate,,Female,no data available,77 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003020,GSM4601679,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601679_190730_HD_snRNA-B1_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Putamen,,Female,no data available,77 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003021,GSM4601680,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601680_191108_HD_1_snRNA-G6_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,Male,grade 3,72 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003022,GSM4601681,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601681_191108_HD_2_snRNA-G7_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,Male,grade 3,72 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003023,GSM4601682,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601682_191108_HD_3_snRNA-G8_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,Male,grade 4,56 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003024,GSM4601683,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601683_191108_HD_4_snRNA-G9_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,Male,grade 4,56 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003025,GSM4601684,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601684_191108_HD_5_snRNA-G10_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Caudate,,Female,no data available,82 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003026,GSM4601685,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601685_191108_HD_6_snRNA-G11_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Caudate,,Female,no data available,83 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003027,GSM4601686,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601686_191108_HD_7_snRNA-G12_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Caudate,,Male,no data available,80 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003028,GSM4601687,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601687_191108_HD_8_snRNA-H1_,10x_matrix,,32681824,HD,Healthy,Yes,Human,Putamen,,Male,no data available,80 years,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003029,GSM4601688,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601688_190807_zQ175_snRNA-B4_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175-,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003030,GSM4601689,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601689_190807_zQ175_snRNA-B5_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175-,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003031,GSM4601690,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601690_190807_zQ175_snRNA-B6_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175-,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003032,GSM4601691,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601691_190807_zQ175_snRNA-B7_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175-,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003033,GSM4601692,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601692_190807_zQ175_snRNA-B8_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175+,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003034,GSM4601693,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601693_190807_zQ175_snRNA-B9_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175+,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003035,GSM4601694,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601694_190807_zQ175_snRNA-B10_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175+,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003036,GSM4601695,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601695_190807_zQ175_snRNA-B11_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,6 months,,10x Genomics,single-nucleus RNA sequencing,zQ175+,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003037,GSM4601696,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601696_190912_R62_snRNA-G2_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003038,GSM4601697,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601697_190912_R62_snRNA-G3_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003039,GSM4601698,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601698_190912_R62_snRNA-G4_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003040,GSM4601699,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601699_190912_R62_snRNA-G5_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003041,GSM4601700,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601700_190912_R62_snRNA-G6_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003042,GSM4601701,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601701_190912_R62_snRNA-G7_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003043,GSM4601702,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601702_190912_R62_snRNA-G8_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003044,GSM4601703,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601703_190913_R62_snRNA-G9_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003045,GSM4601704,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601704_190913_R62_snRNA-G10_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003046,GSM4601705,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601705_190913_R62_snRNA-G11_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003047,GSM4601706,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601706_190913_R62_snRNA-G12_,10x_matrix,,32681824,HD,Healthy,Yes,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,CBAxC57 WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003048,GSM4601707,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601707_190913_R62_snRNA-H1_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003049,GSM4601708,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601708_190913_R62_snRNA-H2_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003050,GSM4601709,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601709_190913_R62_snRNA-H3_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003051,GSM4601710,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM4601710_190913_R62_snRNA-H4_,10x_matrix,,32681824,HD,Disease,No,Mouse,Striatum,,Male,no data available,9 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003052,GSM6805775,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM6805775_210407_HDg1_snRNA-A7_,10x_matrix,,32681824,HD,Disease,No,Human,Caudate,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD003053,GSM6805776,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32681824/GSM6805776_210407_HDg1_snRNA-A8_,10x_matrix,,32681824,HD,Disease,No,Human,Putamen,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD004001,GSM5478582,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Cingulate,,Male,no data available,71 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004002,GSM5478583,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Cingulate,,Male,no data available,62 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004003,GSM5478584,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Cingulate,,Female,no data available,48 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004004,GSM5478585,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Cingulate,,Female,no data available,54 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004005,GSM5478586,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Accumbens,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004006,GSM5478587,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Accumbens,,Female,no data available,48 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004007,GSM5478588,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Accumbens,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004008,GSM5478589,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Accumbens,,Male,no data available,71 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004009,GSM5478590,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Caudate,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004010,GSM5478591,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Caudate,,Female,no data available,48 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004011,GSM5478592,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Caudate,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004012,GSM5478593,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Caudate,,Male,no data available,71 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004013,GSM5478594,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Accumbens,,Male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004014,GSM5478595,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Accumbens,,Male,no data available,64 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004015,GSM5478596,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Accumbens,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004016,GSM5478597,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Accumbens,,Female,no data available,55 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004017,GSM5478598,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Accumbens,,Male,no data available,58 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004018,GSM5478599,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Caudate,,Male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004019,GSM5478600,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Caudate,,Male,no data available,36 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004020,GSM5478601,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Caudate,,Male,no data available,64 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004021,GSM5478602,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Caudate,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004022,GSM5478603,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Caudate,,Female,no data available,55 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004023,GSM5478604,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Caudate,,Male,no data available,58 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004024,GSM5478605,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Caudate,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004025,GSM5478606,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Cingulate,,Male,no data available,56 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004026,GSM5478607,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Cingulate,,Male,no data available,64 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004027,GSM5478608,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Cingulate,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004028,GSM5478609,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Cingulate,,Female,no data available,55 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004029,GSM5478610,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Cingulate,,Male,no data available,58 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004030,GSM5478611,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Cingulate,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004031,GSM5478612,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Healthy,Yes,Human,Cingulate,,Male,no data available,75 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD004032,GSM5478613,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36543778/GSE180928_filtered_cell_counts.csv.gz,csv_whole,whole,36543778,HD,Disease,No,Human,Cingulate,,Female,no data available,50 years,,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.",,,
HD005001,GSE245631_Sample5,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample5_counts.csv.gz,csv.gz,whole,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD005002,GSE245631_Sample6,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample6_counts.csv.gz,csv.gz,,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD005003,GSE245631_Sample7,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample7_counts.csv.gz,csv.gz,,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD005004,GSE245631_Sample8,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample8_counts.csv.gz,csv.gz,,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD005005,GSE245631_Sample9,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample9_counts.csv.gz,csv.gz,,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD005006,GSE245631_Sample10,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample10_counts.csv.gz,csv.gz,,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD005007,GSE245631_Sample11,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample11_counts.csv.gz,csv.gz,,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD005008,GSE245631_Sample12,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID37807512/GSE245631_Sample12_counts.csv.gz,csv.gz,,37807512,HD,Disease,No,Mouse,striatum,,Female,no data available,,,Parse Biosciences,single-cell RNA sequencing,zQ175,"Mice were euthanized by pentobarbital overdose and perfused with 0.01 M PBS. Striatum was dissected out of the left hemisphere and flash-frozen. Single nuclei were isolated from flash frozen  hemisphere full striatal in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5min. Samples were passed through a 70 m filter and incubated in additional lysis buffer for 5min and centrifuged at 500  g for 5min at 4 C before two washes in Nuclei Wash and Resuspension buffer (1PBS, 1% BSA, 0.2 U/l RNase inhibitor). Nuclei were fixed using a Parse Biosciences WF100 kit and the manufacturers protocol (Parse Biosciences, Seattle, WA).Single-nucleus suspensions were fixed and frozen for 8 mouse brain tissue samples following the Parse Bioscience Fixation User Manual V1.3.0 (Parse Biosciences). Single-nucleus RNA-seq libraries were generated following the Parse Biosciences Single Cell Whole Transcriptome Kit User Manual V1.3.0 (Parse Biosciences). Quantification of cDNA libraries was performed using Qubit dsDNA HS Assay Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-4626). Quantification of final cDNA libraries was performed using KAPA qPCR (Kapa Biosystems KK4824). Sequencing of single-cell libraries was performed on the Illumina NovaSeq 6000 platform to target an average of ~50,000 reads per cell.",,,
HD006001,GSM8684827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40482637/GSM8684827_1-6_4wk_R62_counts.csv.gz,csv.gz,,40482637,HD,Disease,No,Mouse,brain,,Male,no data available,4 weeks,,10x Genomics,single-nucleus RNA sequencing,R62,"Fresh frozen tissue were OCT embedded, snap frozen over isopentane bath immersed in liquid nitrogen and ~700uM of 30uM sections of tissue were collected. Sections were fixed for 21 hours with 4% PFA and dissociated using Liberase TL (postnatal day 0) or Liberse TH (4-week and 12-week) and processed with the 10x Genomics Chromium Fixed RNA Profiling kit according to manufacter's instructions. Tissue was then dissoaciated with a gentleMACS OctoDissociator and cell quality and number evaluated.Probe hybiridization and library construction were performed with the 10x Genomics Single Cell Gene Expression FLEX according to the manufacter's instructions. 4 samples were multiplexed and 2 samples singleplex. After probe hybridization, nuclei were pooled (if multiplexed), partitioned into GEMs and ligation and extension was in GEMs Samples were sequenced with the Illumina NovaSeq system with a target sequenciong depth of at least 30,000/nuclei.",,,
HD006002,GSM8684828,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40482637/GSM8684828_3-5_4wk_NT_counts.csv.gz,csv.gz,,40482637,HD,Healthy,Yes,Mouse,brain,,Male,no data available,4 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Fresh frozen tissue were OCT embedded, snap frozen over isopentane bath immersed in liquid nitrogen and ~700uM of 30uM sections of tissue were collected. Sections were fixed for 21 hours with 4% PFA and dissociated using Liberase TL (postnatal day 0) or Liberse TH (4-week and 12-week) and processed with the 10x Genomics Chromium Fixed RNA Profiling kit according to manufacter's instructions. Tissue was then dissoaciated with a gentleMACS OctoDissociator and cell quality and number evaluated.Probe hybiridization and library construction were performed with the 10x Genomics Single Cell Gene Expression FLEX according to the manufacter's instructions. 4 samples were multiplexed and 2 samples singleplex. After probe hybridization, nuclei were pooled (if multiplexed), partitioned into GEMs and ligation and extension was in GEMs Samples were sequenced with the Illumina NovaSeq system with a target sequenciong depth of at least 30,000/nuclei.",,,
HD006003,GSM8684829,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40482637/GSM8684829_1-1_4wk_R62_counts.csv.gz,csv.gz,,40482637,HD,Mixed,Mixed,Mouse,brain,,Male,no data available,mix of 4 weeks and 12 weeks,,10x Genomics,single-nucleus RNA sequencing,R62; WT,"Fresh frozen tissue were OCT embedded, snap frozen over isopentane bath immersed in liquid nitrogen and ~700uM of 30uM sections of tissue were collected. Sections were fixed for 21 hours with 4% PFA and dissociated using Liberase TL (postnatal day 0) or Liberse TH (4-week and 12-week) and processed with the 10x Genomics Chromium Fixed RNA Profiling kit according to manufacter's instructions. Tissue was then dissoaciated with a gentleMACS OctoDissociator and cell quality and number evaluated.Probe hybiridization and library construction were performed with the 10x Genomics Single Cell Gene Expression FLEX according to the manufacter's instructions. 4 samples were multiplexed and 2 samples singleplex. After probe hybridization, nuclei were pooled (if multiplexed), partitioned into GEMs and ligation and extension was in GEMs Samples were sequenced with the Illumina NovaSeq system with a target sequenciong depth of at least 30,000/nuclei.",,,
HD006004,GSM8684830,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40482637/GSM8684830_1-p0-1_NT_counts.csv.gz,csv.gz,,40482637,HD,Mixed,Mixed,Mouse,brain,,Male,no data available,postnatal day 0,,10x Genomics,single-nucleus RNA sequencing,R62; WT,"Fresh frozen tissue were OCT embedded, snap frozen over isopentane bath immersed in liquid nitrogen and ~700uM of 30uM sections of tissue were collected. Sections were fixed for 21 hours with 4% PFA and dissociated using Liberase TL (postnatal day 0) or Liberse TH (4-week and 12-week) and processed with the 10x Genomics Chromium Fixed RNA Profiling kit according to manufacter's instructions. Tissue was then dissoaciated with a gentleMACS OctoDissociator and cell quality and number evaluated.Probe hybiridization and library construction were performed with the 10x Genomics Single Cell Gene Expression FLEX according to the manufacter's instructions. 4 samples were multiplexed and 2 samples singleplex. After probe hybridization, nuclei were pooled (if multiplexed), partitioned into GEMs and ligation and extension was in GEMs Samples were sequenced with the Illumina NovaSeq system with a target sequenciong depth of at least 30,000/nuclei.",,,
HD006005,GSM8684831,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40482637/GSM8684831_2-2_12wk_R62_counts.csv.gz,csv.gz,,40482637,HD,Mixed,Mixed,Mouse,brain,,Male,no data available,mix of postnatal day 0 and 12 weeks,,10x Genomics,single-nucleus RNA sequencing,R62; WT,"Fresh frozen tissue were OCT embedded, snap frozen over isopentane bath immersed in liquid nitrogen and ~700uM of 30uM sections of tissue were collected. Sections were fixed for 21 hours with 4% PFA and dissociated using Liberase TL (postnatal day 0) or Liberse TH (4-week and 12-week) and processed with the 10x Genomics Chromium Fixed RNA Profiling kit according to manufacter's instructions. Tissue was then dissoaciated with a gentleMACS OctoDissociator and cell quality and number evaluated.Probe hybiridization and library construction were performed with the 10x Genomics Single Cell Gene Expression FLEX according to the manufacter's instructions. 4 samples were multiplexed and 2 samples singleplex. After probe hybridization, nuclei were pooled (if multiplexed), partitioned into GEMs and ligation and extension was in GEMs Samples were sequenced with the Illumina NovaSeq system with a target sequenciong depth of at least 30,000/nuclei.",,,
HD006006,GSM8684832,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40482637/GSM8684832_1-2_4wk_NT_counts.csv.gz,csv.gz,,40482637,HD,Mixed,Mixed,Mouse,brain,,Male,no data available,mix of 4 weeks and 12 weeks,,10x Genomics,single-nucleus RNA sequencing,R62; WT,"Fresh frozen tissue were OCT embedded, snap frozen over isopentane bath immersed in liquid nitrogen and ~700uM of 30uM sections of tissue were collected. Sections were fixed for 21 hours with 4% PFA and dissociated using Liberase TL (postnatal day 0) or Liberse TH (4-week and 12-week) and processed with the 10x Genomics Chromium Fixed RNA Profiling kit according to manufacter's instructions. Tissue was then dissoaciated with a gentleMACS OctoDissociator and cell quality and number evaluated.Probe hybiridization and library construction were performed with the 10x Genomics Single Cell Gene Expression FLEX according to the manufacter's instructions. 4 samples were multiplexed and 2 samples singleplex. After probe hybridization, nuclei were pooled (if multiplexed), partitioned into GEMs and ligation and extension was in GEMs Samples were sequenced with the Illumina NovaSeq system with a target sequenciong depth of at least 30,000/nuclei.",,,
HD007001,GSM4257550,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_1,10x,,32448329,HD,Healthy,Yes,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,WT/Il6 knock-out,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007002,GSM4257551,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_2,10x,,32448329,HD,Healthy,Yes,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,WT/Il6 knock-out,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007003,GSM4257552,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_3,10x,,32448329,HD,Healthy,Yes,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,WT/Il6 knock-out,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007004,GSM4257553,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_4,10x,,32448329,HD,Healthy,Yes,Mouse,striatum,none,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,WT/WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007005,GSM4257554,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_5,10x,,32448329,HD,Healthy,Yes,Mouse,striatum,none,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,WT/WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007006,GSM4257555,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_6,10x,,32448329,HD,Healthy,Yes,Mouse,striatum,none,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,WT/WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007007,GSM4257556,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_7,10x,,32448329,HD,Disease,No,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,R62/WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007008,GSM4257557,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_8,10x,,32448329,HD,Disease,No,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,R62/WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007009,GSM4257558,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_9,10x,,32448329,HD,Disease,No,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,R62/WT,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007010,GSM4257559,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_10,10x,,32448329,HD,Disease,No,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,R62/Il6 knock-out,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007011,GSM4257560,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_11,10x,,32448329,HD,Disease,No,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,R62/Il6 knock-out,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD007012,GSM4257561,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID32448329/MW-IL6_12,10x,,32448329,HD,Disease,No,Mouse,striatum,,no data available,no data available,,,10x Genomics,single-nucleus RNA sequencing,R62/Il6 knock-out,"Tissue was homogenized in 700 L of homogenization buffer (320 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 0.1% NP-40, 1 mM -mercaptoethanol, and 0.4 U/L RNase inhibitor) with a 2 mL tissue grinder. Tissue was filtered through a 40 m cell strainer and mixed with 450 L solution of 50% OptiPrep density gradient medium, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], and 1 mM -mercaptoethanol. The mixture was then pipetted onto an OptiPrep density gradient containing 750 L of 30% OptiPrep Solution (134 mM sucrose, 5 mM CaCl2, 3 mM Mg(CH3COO)2, 10 mM Tris HCl [pH 7.8], 0.1 mM EDTA [pH 8.0], 1 mM -mercaptoethanol, 0.04% NP-40, and 0.17 U/L RNase Inhibitor) on top of 300 L of 40% OptiPrep Solution inside a microcentrifuge tube. Nuclei were pelleted at the interface of the OptiPrep density gradient by centrifugation. Nuclei were washed three times with 2% BSA and the nuclear pellet was re-suspended in 100 L of 2% BSA.Libraries were constructed according to the 10x Genomics Single Cell Expression v3 User Manual.",,,
HD009001,GSM5573464,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40336225/GSE183903_StrH9_,10x_matrix,,40336225,HD,,,Human,striatum,,no data available,no data available,110 days,,10x Genomics,single-nucleus RNA sequencing,hESC,Total RNA was extracted from the tissue using TRIzol Reagent cording the manufacturers instructions (Invitrogen) and genomic DNA was removed using DNase I (TaKara).All the remaining procedures of single cell including the library construction were performed according to the standard manufacturers protocol (Chromium Single Cell 3 v3).RNA libraries were prepared for sequencing using standard Illumina protocolsRNA-Seq and ScRNA-Seq,,,
HD009002,GSM5573465,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID40336225/GSE183903_Str8_12_,10x_matrix,,40336225,HD,,,Human,striatum,,no data available,no data available,110 days,,10x Genomics,single-nucleus RNA sequencing,hESC,Total RNA was extracted from the tissue using TRIzol Reagent cording the manufacturers instructions (Invitrogen) and genomic DNA was removed using DNase I (TaKara).All the remaining procedures of single cell including the library construction were performed according to the standard manufacturers protocol (Chromium Single Cell 3 v3).RNA libraries were prepared for sequencing using standard Illumina protocolsRNA-Seq and ScRNA-Seq,,,
HD011001,GSM5460313,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460313_Sample_1_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Striatum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011002,GSM5460314,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460314_Sample_2_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Striatum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011003,GSM5460315,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460315_Sample_3_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Striatum,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011004,GSM5460316,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460316_Sample_4_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Striatum,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011005,GSM5460317,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460317_Sample_5_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Striatum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011006,GSM5460318,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460318_Sample_6_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Striatum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011007,GSM5460319,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460319_Sample_7_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Striatum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011008,GSM5460320,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460320_Sample_8_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Striatum,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011009,GSM5460321,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460321_Sample_9_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Striatum,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011010,GSM5460322,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460322_Sample_10_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Striatum,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011011,GSM5460323,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460323_Sample_11_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Striatum,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011012,GSM5460324,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460324_Sample_12_Striatum_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Striatum,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011013,GSM5460325,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460325_Sample_13_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Cortex,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011014,GSM5460326,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460326_Sample_14_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Cortex,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011015,GSM5460327,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460327_Sample_15_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Cortex,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011016,GSM5460328,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460328_Sample_16_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Cortex,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011017,GSM5460329,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460329_Sample_17_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Cortex,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011018,GSM5460330,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460330_Sample_18_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Cortex,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011019,GSM5460331,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460331_Sample_19_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Cortex,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011020,GSM5460332,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460332_Sample_20_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Cortex,,no data available,no data available,12 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011021,GSM5460333,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460333_Sample_21_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Cortex,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011022,GSM5460334,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460334_Sample_22_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Mouse,Cortex,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,WT,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011023,GSM5460335,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460335_Sample_23_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Cortex,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011024,GSM5460336,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM5460336_Sample_24_Cortex_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Mouse,Cortex,,no data available,no data available,8 weeks,,10x Genomics,single-nucleus RNA sequencing,R6/2,"Single nuclei were isolated from  hemisphere striatal or cortex in Nuclei EZ Lysis buffer (Cat#NUC101-1KT, Sigma-Aldrich) and incubated for 5 min. Samples were passed through a 70m filter and incubated in additional lysis buffer for 5 min and centrifuged at 500 g for 5 min at 4C before two washes in Nuclei Wash and Resuspension buffer (1xPBS, 1% BSA, 0.2U/l RNase inhibitor). Nuclei were FACS sorted using DAPI to further isolate single nuclei and remove additional cellular debris. These nuclei were run on the 10x Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011025,GSM6619413,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM6619413_CTR18n6_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Human,astrocyte,,Male,no data available,,,10x Genomics,single-nucleus RNA sequencing,iPSC,"Single-cell suspensions were strained using a 70 m strainer, washed using cold 0.08% BSA (Gibco) in PBS, and counted using TC20 Automated Cell Counter (BioRad) with trypan blue exclusion as described in the 10x Genomics Demonstrated Protocol: Single Cell Suspensions from Cultured Cell Lines for Single Cell RNA Sequencing (Document CG00054). To obtain a single-nuclei suspension, cells were lysed using Nuclei EZ Lysis Buffer (Sigma Aldrich, NUC101-1KT) for 5 min on ice. Lysed cells were centrifuged 500 rcf for 5 min at 4C, then washed by twice resuspending in 1% BSA (Gibco), 0.2 U/L of Human Placenta RNase Inhibitor (NEB), in PBS and centrifuged again. After two washes, the nuclei were strained using a 40m cell strainer, counted using the TC20 Automated Cell counter (Bio-Rad), resuspended at 1000 nuclei/L in 0.08% BSA (Gibco) in PBS, then proceeded immediately with the 10x Genomics Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011026,GSM6619414,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM6619414_CTR33n1_seurat_counts.csv.gz,csv.gz,,36590162,HD,Healthy,Yes,Human,astrocyte,,Female,no data available,,,10x Genomics,single-nucleus RNA sequencing,iPSC,"Single-cell suspensions were strained using a 70 m strainer, washed using cold 0.08% BSA (Gibco) in PBS, and counted using TC20 Automated Cell Counter (BioRad) with trypan blue exclusion as described in the 10x Genomics Demonstrated Protocol: Single Cell Suspensions from Cultured Cell Lines for Single Cell RNA Sequencing (Document CG00054). To obtain a single-nuclei suspension, cells were lysed using Nuclei EZ Lysis Buffer (Sigma Aldrich, NUC101-1KT) for 5 min on ice. Lysed cells were centrifuged 500 rcf for 5 min at 4C, then washed by twice resuspending in 1% BSA (Gibco), 0.2 U/L of Human Placenta RNase Inhibitor (NEB), in PBS and centrifuged again. After two washes, the nuclei were strained using a 40m cell strainer, counted using the TC20 Automated Cell counter (Bio-Rad), resuspended at 1000 nuclei/L in 0.08% BSA (Gibco) in PBS, then proceeded immediately with the 10x Genomics Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011027,GSM6619415,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM6619415_HD46n10_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Human,astrocyte,,Male,no data available,,,10x Genomics,single-nucleus RNA sequencing,iPSC,"Single-cell suspensions were strained using a 70 m strainer, washed using cold 0.08% BSA (Gibco) in PBS, and counted using TC20 Automated Cell Counter (BioRad) with trypan blue exclusion as described in the 10x Genomics Demonstrated Protocol: Single Cell Suspensions from Cultured Cell Lines for Single Cell RNA Sequencing (Document CG00054). To obtain a single-nuclei suspension, cells were lysed using Nuclei EZ Lysis Buffer (Sigma Aldrich, NUC101-1KT) for 5 min on ice. Lysed cells were centrifuged 500 rcf for 5 min at 4C, then washed by twice resuspending in 1% BSA (Gibco), 0.2 U/L of Human Placenta RNase Inhibitor (NEB), in PBS and centrifuged again. After two washes, the nuclei were strained using a 40m cell strainer, counted using the TC20 Automated Cell counter (Bio-Rad), resuspended at 1000 nuclei/L in 0.08% BSA (Gibco) in PBS, then proceeded immediately with the 10x Genomics Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD011028,GSM6619416,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID36590162/GSM6619416_HD53n3_seurat_counts.csv.gz,csv.gz,,36590162,HD,Disease,No,Human,astrocyte,,Male,no data available,,,10x Genomics,single-nucleus RNA sequencing,iPSC,"Single-cell suspensions were strained using a 70 m strainer, washed using cold 0.08% BSA (Gibco) in PBS, and counted using TC20 Automated Cell Counter (BioRad) with trypan blue exclusion as described in the 10x Genomics Demonstrated Protocol: Single Cell Suspensions from Cultured Cell Lines for Single Cell RNA Sequencing (Document CG00054). To obtain a single-nuclei suspension, cells were lysed using Nuclei EZ Lysis Buffer (Sigma Aldrich, NUC101-1KT) for 5 min on ice. Lysed cells were centrifuged 500 rcf for 5 min at 4C, then washed by twice resuspending in 1% BSA (Gibco), 0.2 U/L of Human Placenta RNase Inhibitor (NEB), in PBS and centrifuged again. After two washes, the nuclei were strained using a 40m cell strainer, counted using the TC20 Automated Cell counter (Bio-Rad), resuspended at 1000 nuclei/L in 0.08% BSA (Gibco) in PBS, then proceeded immediately with the 10x Genomics Chromium Single cell 3 gene expression v3 platform.RNA libraries were prepared for sequencing using 10x Genomics single cell v3 and standard Illumina protocols",,,
HD013001,GSM7754778,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754778_GO001_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade 3,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013002,GSM7754779,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754779_GO002_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Male,no data available,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013003,GSM7754780,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754780_GO003_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 3,"[40,49]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013004,GSM7754781,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754781_GO004_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Female,no data available,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013005,GSM7754782,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754782_GO005_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Accumbens,no data available,Male,no data available,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013006,GSM7754783,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754783_GO006_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Female,grade 3,"[40,49]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013007,GSM7754784,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754784_GO007_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Accumbens,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013008,GSM7754785,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754785_GO008_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Male,grade 3,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013009,GSM7754786,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754786_GO009_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Caudate,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013010,GSM7754787,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754787_GO010_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 3,"[40,49]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013011,GSM7754788,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754788_GO011_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Caudate,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013012,GSM7754789,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754789_GO012_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Male,grade 3,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013013,GSM7754790,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754790_GO13_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,	Accumbens,no data available,Male,grade 3,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013014,GSM7754791,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754791_GO14_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,	Accumbens,no data available,Male,grade 3,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013015,GSM7754792,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754792_GO15_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,	Accumbens,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013016,GSM7754793,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754793_GO16_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,	Accumbens,no data available,Female,grade 2," [50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013017,GSM7754794,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754794_GO17_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,	Accumbens,no data available,Male,grade 2,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013018,GSM7754795,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754795_GO18_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Male,grade 3,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013019,GSM7754796,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754796_GO19_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Caudate,no data available,Male,,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013020,GSM7754797,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754797_GO20_mat.csv.gz,csv.gz,,39112488,HD,Disease,Yes,Human,Caudate,no data available,Male,grade 3,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013021,GSM7754798,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754798_GO21_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Caudate,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013022,GSM7754799,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754799_GO22_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 2,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013023,GSM7754800,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754800_GO23_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 2,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013024,GSM7754801,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754801_GO25_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade 3,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013025,GSM7754802,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754802_GO26_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade 3,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013026,GSM7754803,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754803_GO27_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013027,GSM7754804,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754804_GO28_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 2,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013028,GSM7754805,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754805_GO29_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade 2,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013029,GSM7754806,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754806_GO30_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013030,GSM7754807,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754807_GO31_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Male,,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013031,GSM7754808,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754808_GO32_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 2,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013032,GSM7754809,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754809_OF019_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 1,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013033,GSM7754810,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754810_OF020_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Male,," [60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013034,GSM7754811,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754811_OF022_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade 4,"[70,79]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013035,GSM7754812,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754812_OF023_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 1,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013036,GSM7754813,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754813_OF025_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 2,"[80,89]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013037,GSM7754814,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754814_OF026_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,	Accumbens,no data available,Male,,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013038,GSM7754815,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754815_OF027_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade J,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013039,GSM7754816,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754816_OF028_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade J,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013040,GSM7754817,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754817_OF029_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade J,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013041,GSM7754818,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754818_OF030_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 4,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013042,GSM7754819,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754819_OF032_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade J,"[20,29]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013043,GSM7754820,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754820_OF033_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Male,grade J,"[20,29]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013044,GSM7754821,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754821_OF034_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Female,grade J,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013045,GSM7754822,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754822_OF035_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade J,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013046,GSM7754823,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754823_OF036_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Male,grade J,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013047,GSM7754824,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754824_OF037_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Female,grade 4,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013048,GSM7754825,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754825_OF038_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Female,grade J,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013049,GSM7754826,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754826_OF039_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 4,"[20,29]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013050,GSM7754827,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754827_OF040_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade J,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013051,GSM7754828,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754828_OF041_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 4,"[20,29]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013052,GSM7754829,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754829_OF042_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 2,"[30,39]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013053,GSM7754830,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754830_OF043_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Male,grade 4,"[40,49]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013054,GSM7754831,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754831_OF044_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 1,"[80,89]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013055,GSM7754832,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754832_OF045_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Female,grade 1,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013056,GSM7754833,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754833_OF046_mat.csv.gz,csv.gz,,39112488,HD,Disease,Yes,Human,Caudate,no data available,Male,,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013057,GSM7754834,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754834_OF047_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 2,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013058,GSM7754835,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754835_OF048_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 1,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013059,GSM7754836,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754836_OF049_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Caudate,no data available,Female,grade 1,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013060,GSM7754837,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754837_OF050_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 2,"[50,59]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013061,GSM7754838,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754838_OF051_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Female,grade 1,"[80,89]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013062,GSM7754839,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754839_OF052_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Accumbens,no data available,Female,grade 2,"[80,89]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013063,GSM7754840,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754840_OF053_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Male,,"[80,89]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013064,GSM7754841,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754841_OF054_mat.csv.gz,csv.gz,,39112488,HD,Disease,No,Human,Cingulate,no data available,Female,grade 1,"[80,89]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD013065,GSM7754842,/fs/ess/PAS1475/Weidong/ssKIND/scRNA/raw/PMID39112488/GSM7754842_OF055_mat.csv.gz,csv.gz,,39112488,HD,Healthy,Yes,Human,Cingulate,no data available,Female,,"[60,69]",no data available,10x Genomics,single-nucleus RNA sequencing,,"The tissue was homogenized in a Dounce homogenizer with 1215 strokes of the loose pestle and 1215 strokes of the tight pestle on ice in a Triton X-100 based, sucrose containing buffer. The suspension from each sample was filtered through a BD Falcon tubes with a cell strainer caps (Becton Dickinson, cat. no. 352235), washed, re-filtered, washed, followed by a cleanup step using iodixanol gradient centrifugation. The nuclear pellet was then re-suspended in 1% BSA in 545 nuclease-free PBS (containing RNAse inhibitors) and titrated to 600-1200 nuclei/l.Nuclear suspensions were processed by the Chromium Controller (10x Genomics) using single Cell 3 Reagent Kit v2 or v3 (Chromium Single Cell 3 Library & Gel Bead Kit v2/v3, catalog number PN-1000075; Chromium Single Cell A Chip Kit, 48 runs, catalog number: 120236; 10x Genomics). Sequencing and alignment: Sequencing of the snRNAseq libraries was done on Illumina NOVAseq 6000 platformV4 150 bp paired end reads.snRNA (single-nuclei RNA sequencing)",,,
HD014001,GSM8397568,,,matrix,39095390,HD,Healthy,Yes,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC WT,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014002,GSM8397569,,,matrix,39095390,HD,Disease,No,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC CRISPR/Cas9 modification of HD,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014003,GSM8397570,,,matrix,39095390,HD,Healthy,Yes,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014004,GSM8397571,,,matrix,39095390,HD,Healthy,Yes,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014005,GSM8397572,,,matrix,39095390,HD,Disease,No,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC CRISPR/Cas9 modification of HD,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014006,GSM8397573,,,matrix,39095390,HD,Disease,No,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC CRISPR/Cas9 modification of HD,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014007,GSM8397574,,,matrix,39095390,HD,Disease,No,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC CRISPR/Cas9 modification of HD,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014008,GSM8397575,,,matrix,39095390,HD,Healthy,Yes,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC WT,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014009,GSM8397576,,,matrix,39095390,HD,Healthy,Yes,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC WT,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014010,GSM8397577,,,matrix,39095390,HD,Healthy,Yes,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC WT,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014011,GSM8397578,,,matrix,39095390,HD,Healthy,Yes,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC WT,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014012,GSM8397579,,,matrix,39095390,HD,Disease,No,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC CRISPR/Cas9 modification of HD,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014013,GSM8397580,,,matrix,39095390,HD,Disease,No,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC CRISPR/Cas9 modification of HD,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD014014,GSM8397581,,,matrix,39095390,HD,Disease,No,Human,neuronal stem cell,,no data available,no data available,no data available,no data available,10x Genomics,single-cell RNA sequencing,hESC CRISPR/Cas9 modification of HD,"Cells were kept in monolayer on 120-180 g/ml Geltrex coated cell culture dishes and in feeder-free conditions in mTeSR1 medium added with Penicillin (100 489 U/ml) and Streptomycin (100 g/ml) (Euroclone, EC3001D). Once a week, hESC colonies were split with a ratio of 1:10 by ReleSR dissociation. Cells were kept in culture for 3 months and then a new batch was thawed.The Chromium Single Cell 3 Library & Gel Bead Kit v2 (PN- 120237), Chromium Single Cell 3 Chip kit v2 (PN-120236) and Chromium i7 Multiplex Kit (PN-120262) were used according to the manufacturers instructions in the Chromium Single Cell 3 Reagents Kits V2 User Guide",,,
HD015001,HDiPSC,,,,33663567,HD,Disease,,Human,neural progenitor cells,no,no data available,no data available,no data available,,smart-seq,single-cell RNA sequencing,HD iPSC with CAG expansion,"hESCs (Bradley et al., 2011), and hiPSCs were cultured as described (Takahashi et al., 2007). For neuronal induction, hiPSC colonies were induced for neuronal lineage differentiation using dual SMAD inhibition by blocking BMP and TGFb. hiPSC colonies were separated and seeded on Matrigel as single cells and incubated with human induction media [DMEM/F12, Neurobasal, N2, B27] supplemented with 2 SMADi (20 M SB, 100 nM LDN) and 1 M XAV-939 for 10 days. From day 10 to 20 of differentiation, cells were incubated with neural induction media supplemented with 50 nM SAG and 1 M XAV-939, inducing the cells to become neural progenitor cells (NPCs).RNA was extracted from neurons using TCL-buffer (Qiagene, cat. 1031576) with 1% 2-Mercaptoethanol for sc-experiments. For bulk samples, DNA/RNA shield (Zymo Research, cat. R1100-50) was used.library construction was carried out as published (Ding et al., 2019; Picelli et al., 2013)",,,
HD015002,AC2,,,,33663567,ASD,Disease,,Human,neural progenitor cells,no,no data available,no data available,no data available,,smart-seq,single-cell RNA sequencing,CHD8 heterozygous mutant (CRISPR),,,,
HD015003,H66,,,,33663567,HD,Healthy,Control,Human,neural progenitor cells,no,no data available,no data available,no data available,,smart-seq,single-cell RNA sequencing,Wild-type hESC (HUES66),,,,
HD015004,96ex,,,,33663567,HD,Healthy,Control,Human,neural progenitor cells,no,no data available,no data available,no data available,,smart-seq,single-cell RNA sequencing,Isogenic control of 180CAG (CAG-corrected),,,,
HD015005,180CAG,,,,33663567,HD,Disease,,Human,neural progenitor cells,no,no data available,no data available,no data available,,smart-seq,single-cell RNA sequencing,HD iPSC with ~180 CAG repeats,,,,
HD015006,C116,,,,33663567,HD,Healthy,Control,Human,neural progenitor cells,no,no data available,no data available,no data available,,smart-seq,single-cell RNA sequencing,Isogenic control of 72Q line (CAG-corrected),,,,